
<html lang="en"     class="pb-page"  data-request-id="fc6fb8a8-2e47-4279-87a2-470a5f614690"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/jm401911v;website:website:acspubs;issue:issue:10.1021/jmcmar.2014.57.issue-7;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Novel Inhibitors of the MDM2-p53 Interaction Featuring Hydrogen Bond Acceptors as Carboxylic Acid Isosteres" /></meta><meta name="dc.Creator" content="Ana Z.  Gonzalez" /></meta><meta name="dc.Creator" content="Zhihong  Li" /></meta><meta name="dc.Creator" content="Hilary P.  Beck" /></meta><meta name="dc.Creator" content="Jude  Canon" /></meta><meta name="dc.Creator" content="Ada  Chen" /></meta><meta name="dc.Creator" content="David  Chow" /></meta><meta name="dc.Creator" content="Jason  Duquette" /></meta><meta name="dc.Creator" content="John  Eksterowicz" /></meta><meta name="dc.Creator" content="Brian M.  Fox" /></meta><meta name="dc.Creator" content="Jiasheng  Fu" /></meta><meta name="dc.Creator" content="Xin  Huang" /></meta><meta name="dc.Creator" content="Jonathan  Houze" /></meta><meta name="dc.Creator" content="Lixia  Jin" /></meta><meta name="dc.Creator" content="Yihong  Li" /></meta><meta name="dc.Creator" content="Yun  Ling" /></meta><meta name="dc.Creator" content="Mei-Chu  Lo" /></meta><meta name="dc.Creator" content="Alexander M.  Long" /></meta><meta name="dc.Creator" content="Lawrence R.  McGee" /></meta><meta name="dc.Creator" content="Joel  McIntosh" /></meta><meta name="dc.Creator" content="Jonathan D.  Oliner" /></meta><meta name="dc.Creator" content="Tao  Osgood" /></meta><meta name="dc.Creator" content="Yosup  Rew" /></meta><meta name="dc.Creator" content="Anne Y.  Saiki" /></meta><meta name="dc.Creator" content="Paul  Shaffer" /></meta><meta name="dc.Creator" content="Sarah  Wortman" /></meta><meta name="dc.Creator" content="Peter  Yakowec" /></meta><meta name="dc.Creator" content="Xuelei  Yan" /></meta><meta name="dc.Creator" content="Qiuping  Ye" /></meta><meta name="dc.Creator" content="Dongyin  Yu" /></meta><meta name="dc.Creator" content="Xiaoning  Zhao" /></meta><meta name="dc.Creator" content="Jing  Zhou" /></meta><meta name="dc.Creator" content="Steven H.  Olson" /></meta><meta name="dc.Creator" content="Daqing  Sun" /></meta><meta name="dc.Creator" content="Julio C.  Medina" /></meta><meta name="dc.Description" content="We previously reported the discovery of potent and selective morpholinone and piperidinone inhibitors of the MDM2-p53 interaction. These inhibitors have in common a carboxylic acid moiety that enga..." /></meta><meta name="Description" content="We previously reported the discovery of potent and selective morpholinone and piperidinone inhibitors of the MDM2-p53 interaction. These inhibitors have in common a carboxylic acid moiety that enga..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 27, 2014" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm401911v" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2014 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm401911v" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm401911v" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm401911v" /></link>
        
    
    

<title>Novel Inhibitors of the MDM2-p53 Interaction Featuring Hydrogen Bond Acceptors as Carboxylic Acid Isosteres | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm401911v" /></meta><meta property="og:title" content="Novel Inhibitors of the MDM2-p53 Interaction Featuring Hydrogen Bond Acceptors as Carboxylic Acid Isosteres" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/large/jm-2013-01911v_0021.jpeg" /></meta><meta property="og:description" content="We previously reported the discovery of potent and selective morpholinone and piperidinone inhibitors of the MDM2-p53 interaction. These inhibitors have in common a carboxylic acid moiety that engages in an electrostatic interaction with MDM2-His96. Our continued search for potent and diverse inhibitors led to the discovery of novel replacements for these acids uncovering new interactions with the MDM2 protein. In particular, using pyridine or thiazole as isosteres of the carboxylic acid moiety resulted in very potent analogues. From these, AM-6761 (4) emerged as a potent inhibitor with remarkable biochemical (HTRF IC50 = 0.1 nM) and cellular potency (SJSA-1 EdU IC50 = 16 nM), as well as favorable pharmacokinetic properties. Compound 4 also shows excellent antitumor activity in the SJSA-1 osteosarcoma xenograft model with an ED50 of 11 mg/kg. Optimization efforts toward the discovery of these inhibitors as well as the new interactions observed with the MDM2 protein are described herein." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm401911v"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm401911v">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm401911v&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm401911v&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm401911v&amp;href=/doi/10.1021/jm401911v" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2014</span><span class="cit-fg-volume">, 57</span><span class="cit-fg-issue">, 7</span><span class="cit-fg-pageRange">, 2963-2988</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/57/7" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm401924s" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm401955h" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Novel Inhibitors of the MDM2-p53 Interaction Featuring Hydrogen Bond Acceptors as Carboxylic Acid Isosteres</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ana+Z.++Gonzalez">Ana Z. Gonzalez</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zhihong++Li">Zhihong Li</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hilary+P.++Beck">Hilary P. Beck</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jude++Canon">Jude Canon</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ada++Chen">Ada Chen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David++Chow">David Chow</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jason++Duquette">Jason Duquette</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John++Eksterowicz">John Eksterowicz</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Brian+M.++Fox">Brian M. Fox</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jiasheng++Fu">Jiasheng Fu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xin++Huang">Xin Huang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jonathan++Houze">Jonathan Houze</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lixia++Jin">Lixia Jin</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yihong++Li">Yihong Li</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yun++Ling">Yun Ling</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mei-Chu++Lo">Mei-Chu Lo</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alexander+M.++Long">Alexander M. Long</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lawrence+R.++McGee">Lawrence R. McGee</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joel++McIntosh">Joel McIntosh</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jonathan+D.++Oliner">Jonathan D. Oliner</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tao++Osgood">Tao Osgood</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yosup++Rew">Yosup Rew</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anne+Y.++Saiki">Anne Y. Saiki</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul++Shaffer">Paul Shaffer</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sarah++Wortman">Sarah Wortman</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Peter++Yakowec">Peter Yakowec</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xuelei++Yan">Xuelei Yan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Qiuping++Ye">Qiuping Ye</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dongyin++Yu">Dongyin Yu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xiaoning++Zhao">Xiaoning Zhao</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jing++Zhou">Jing Zhou</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Steven+H.++Olson">Steven H. Olson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Daqing++Sun">Daqing Sun</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Julio+C.++Medina">Julio C. Medina</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text"><sup>†</sup>Departments of Therapeutic Discovery, <sup>‡</sup>Pharmaceutics, and <sup>§</sup>Pharmacokinetics and Drug Metabolism, Amgen Inc., 1120 Veterans Boulevard, South San Francisco, California 94080, United States</span></div><div class="aff-info" id="aff2"><span class="aff-text"><sup>∥</sup>Departments of Therapeutic Discovery, and <sup>⊥</sup>Oncology Research, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">#</span> <span class="aff-text">Department of Therapeutic Discovery, Amgen Inc., 360 Binney Street Cambridge, Massachusetts 02142, United States</span></div><div class="corresp-info"><strong>*</strong>Tel 650-244-2654. Fax: 650-837-9369. E-mail: <a href="/cdn-cgi/l/email-protection#03626d62646c6d796243626e64666d2d606c6e"><span class="__cf_email__" data-cfemail="177679767078796d7657767a7072793974787a">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm401911v&amp;href=/doi/10.1021%2Fjm401911v" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2014</span></span><span class="cit-volume">, 57</span><span class="cit-issue">, 7</span><span class="cit-pageRange">, 2963–2988</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">March 6, 2014</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>12 December 2013</li><li><span class="item_label"><b>Published</b> online</span>27 March 2014</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 10 April 2014</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm401911v" title="DOI URL">https://doi.org/10.1021/jm401911v</a></div><div class="article_header-article-copyright"><strong>Copyright © 2014 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D2963%26pageCount%3D26%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DAna%2BZ.%2BGonzalez%252C%2BZhihong%2BLi%252C%2BHilary%2BP.%2BBeck%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D57%26issueNum%3D7%26contentID%3Djm401911v%26title%3DNovel%2BInhibitors%2Bof%2Bthe%2BMDM2-p53%2BInteraction%2BFeaturing%2BHydrogen%2BBond%2BAcceptors%2Bas%2BCarboxylic%2BAcid%2BIsosteres%26numPages%3D26%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D2988%26publicationDate%3DApril%2B2014">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm401911v"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3369</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">32</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm401911v" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Novel Inhibitors of the MDM2-p53 Interaction Featuring Hydrogen Bond Acceptors as Carboxylic Acid Isosteres&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Ana&quot;,&quot;last_name&quot;:&quot;Z. Gonzalez&quot;},{&quot;first_name&quot;:&quot;Zhihong&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Hilary&quot;,&quot;last_name&quot;:&quot;P. Beck&quot;},{&quot;first_name&quot;:&quot;Jude&quot;,&quot;last_name&quot;:&quot;Canon&quot;},{&quot;first_name&quot;:&quot;Ada&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;Chow&quot;},{&quot;first_name&quot;:&quot;Jason&quot;,&quot;last_name&quot;:&quot;Duquette&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;Eksterowicz&quot;},{&quot;first_name&quot;:&quot;Brian&quot;,&quot;last_name&quot;:&quot;M. Fox&quot;},{&quot;first_name&quot;:&quot;Jiasheng&quot;,&quot;last_name&quot;:&quot;Fu&quot;},{&quot;first_name&quot;:&quot;Xin&quot;,&quot;last_name&quot;:&quot;Huang&quot;},{&quot;first_name&quot;:&quot;Jonathan&quot;,&quot;last_name&quot;:&quot;Houze&quot;},{&quot;first_name&quot;:&quot;Lixia&quot;,&quot;last_name&quot;:&quot;Jin&quot;},{&quot;first_name&quot;:&quot;Yihong&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Yun&quot;,&quot;last_name&quot;:&quot;Ling&quot;},{&quot;first_name&quot;:&quot;Mei-Chu&quot;,&quot;last_name&quot;:&quot;Lo&quot;},{&quot;first_name&quot;:&quot;Alexander&quot;,&quot;last_name&quot;:&quot;M. Long&quot;},{&quot;first_name&quot;:&quot;Lawrence&quot;,&quot;last_name&quot;:&quot;R. McGee&quot;},{&quot;first_name&quot;:&quot;Joel&quot;,&quot;last_name&quot;:&quot;McIntosh&quot;},{&quot;first_name&quot;:&quot;Jonathan&quot;,&quot;last_name&quot;:&quot;D. Oliner&quot;},{&quot;first_name&quot;:&quot;Tao&quot;,&quot;last_name&quot;:&quot;Osgood&quot;},{&quot;first_name&quot;:&quot;Yosup&quot;,&quot;last_name&quot;:&quot;Rew&quot;},{&quot;first_name&quot;:&quot;Anne&quot;,&quot;last_name&quot;:&quot;Y. Saiki&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;Shaffer&quot;},{&quot;first_name&quot;:&quot;Sarah&quot;,&quot;last_name&quot;:&quot;Wortman&quot;},{&quot;first_name&quot;:&quot;Peter&quot;,&quot;last_name&quot;:&quot;Yakowec&quot;},{&quot;first_name&quot;:&quot;Xuelei&quot;,&quot;last_name&quot;:&quot;Yan&quot;},{&quot;first_name&quot;:&quot;Qiuping&quot;,&quot;last_name&quot;:&quot;Ye&quot;},{&quot;first_name&quot;:&quot;Dongyin&quot;,&quot;last_name&quot;:&quot;Yu&quot;},{&quot;first_name&quot;:&quot;Xiaoning&quot;,&quot;last_name&quot;:&quot;Zhao&quot;},{&quot;first_name&quot;:&quot;Jing&quot;,&quot;last_name&quot;:&quot;Zhou&quot;},{&quot;first_name&quot;:&quot;Steven&quot;,&quot;last_name&quot;:&quot;H. Olson&quot;},{&quot;first_name&quot;:&quot;Daqing&quot;,&quot;last_name&quot;:&quot;Sun&quot;},{&quot;first_name&quot;:&quot;Julio&quot;,&quot;last_name&quot;:&quot;C. Medina&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2014&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;27&quot;,&quot;issue&quot;:&quot;7&quot;,&quot;volume&quot;:&quot;57&quot;,&quot;pages&quot;:&quot;2963-2988&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm401911v&quot;},&quot;abstract&quot;:&quot;We previously reported the discovery of potent and selective morpholinone and piperidinone inhibitors of the MDM2-p53 interaction. These inhibitors have in common a carboxylic acid moiety that engages in an electrostatic interaction with MDM2-His96. Our continued search for potent and diverse inhibitors led to the discovery of novel replacements for these acids uncovering new interactions with the MDM2 protein. In particular, using pyridine or thiazole as isosteres of the carboxylic acid moiety resulted in very potent analogues. From these, AM-6761 (4) emerged as a potent inhibitor with remarkable biochemical (HTRF IC50 = 0.1 nM) and cellular potency (SJSA-1 EdU IC50 = 16 nM), as well as favorable pharmacokinetic properties. Compound 4 also shows excellent antitumor activity in the SJSA-1 osteosarcoma xenograft model with an ED50 of 11 mg/kg. Optimization efforts toward the discovery of these inhibitors as well as the new interactions observed with the MDM2 protein are described herein.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm401911v&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401911v" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm401911v&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401911v" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm401911v&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401911v" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm401911v&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401911v&amp;href=/doi/10.1021/jm401911v" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm401911v" /></input><a href="/doi/pdf/10.1021/jm401911v" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (5 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm401911v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm401911v%26sid%3Dliteratum%253Aachs%26pmid%3D24601644%26genre%3Darticle%26aulast%3DGonzalez%26date%3D2014%26atitle%3DNovel%2BInhibitors%2Bof%2Bthe%2BMDM2-p53%2BInteraction%2BFeaturing%2BHydrogen%2BBond%2BAcceptors%2Bas%2BCarboxylic%2BAcid%2BIsosteres%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D57%26issue%3D7%26spage%3D2963%26epage%3D2988%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291012" title="Organic acids">Organic acids</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/57/7" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jmcmar.2014.57.issue-7/production/jmcmar.2014.57.issue-7.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/medium/jm-2013-01911v_0021.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/large/jm-2013-01911v_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401911v&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">We previously reported the discovery of potent and selective morpholinone and piperidinone inhibitors of the MDM2-p53 interaction. These inhibitors have in common a carboxylic acid moiety that engages in an electrostatic interaction with MDM2-His96. Our continued search for potent and diverse inhibitors led to the discovery of novel replacements for these acids uncovering new interactions with the MDM2 protein. In particular, using pyridine or thiazole as isosteres of the carboxylic acid moiety resulted in very potent analogues. From these, AM-6761 (<b>4</b>) emerged as a potent inhibitor with remarkable biochemical (HTRF IC<sub>50</sub> = 0.1 nM) and cellular potency (SJSA-1 EdU IC<sub>50</sub> = 16 nM), as well as favorable pharmacokinetic properties. Compound <b>4</b> also shows excellent antitumor activity in the SJSA-1 osteosarcoma xenograft model with an ED<sub>50</sub> of 11 mg/kg. Optimization efforts toward the discovery of these inhibitors as well as the new interactions observed with the MDM2 protein are described herein.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80556" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80556" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Activation of the pro-apoptotic protein p53 is a promising and highly sought out approach toward cancer treatment.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Upon cellular stress, p53 activation leads to the transcription of multiple downstream genes that regulate cell cycle control, apoptosis, DNA repair, and senescence.<a onclick="showRef(event, 'ref2 ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref4">(2-4)</a> About half of all human cancers progress either by mutation or deletion of p53.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> However, for the remaining half that retains wild-type p53 activity, survival is achieved by other mechanisms such as upregulation of its natural antagonists. Amplified in many tumor tissues, MDM2 (murine double minute 2) has been identified as p53’s main negative regulator.<a onclick="showRef(event, 'ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref6 ref7 ref8">(6-8)</a> Many research programs, including our own, aim to design small molecules that bind to MDM2 at its p53 active site, impeding MDM2’s interaction with p53. This results in increased levels of unbound p53 and reactivation of its pathways. From these efforts, several inhibitors have recently emerged and are now being tested in the clinic, most of which were registered within the past two years.<a onclick="showRef(event, 'ref9 ref10 ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11 ref12 ref13">(9-13)</a> Consequently, this is arguably one of the most exciting times in over 30 years of research on the p53 pathway.<a onclick="showRef(event, 'ref13 ref14 ref15 ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref15 ref16 ref17">(13-17)</a></div><div class="NLM_p">Recently, we reported on a series of piperidinone-derivatives as potent and selective inhibitors of the MDM2-p53 interaction. Our optimization efforts within this series led to the discovery of AMG 232 (<b>1</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>), which is currently being tested in the clinic.<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17, 18)</a> Inhibitor <b>1</b> is highly potent (<i>K</i><sub>d</sub> = 0.045 nM; SJSA-1 EdU IC<sub>50</sub> = 9.1 nM)<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> with remarkable pharmacokinetic properties (<i>h</i>Hep CL<sub>int</sub> = 6.3 μL/min/10<sup>6</sup> cells) and in vivo efficacy in the SJSA-1 osteosarcoma xenograft model (ED<sub>50</sub> = 9.1 mg/kg).<a onclick="showRef(event, 'ref17 ref20'); return false;" href="javascript:void(0);" class="ref ref17 ref20">(17, 20)</a> Because <b>1</b> is among the most potent inhibitors of the MDM2/p53 interaction reported to date and has good pharmacokinetic properties in preclinical models, with this work, we aim to identify compounds with distinct metabolic profiles to <b>1</b> should a compound with a different metabolite profile or clearance route is needed.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/medium/jm-2013-01911v_0025.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/large/jm-2013-01911v_0025.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Co-crystal structures of potent piperidinone inhibitors bound to human MDM2 (6–110) highlighting their interaction to MDM2-His96. Coordinates for compounds <b>2</b> (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4OAB">4OAB</a>), <b>3</b> (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4OGN">4OGN</a>), and <b>4</b> (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4ODE">4ODE</a>) bound to MDM2 have been deposited in the PDB.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/large/jm-2013-01911v_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401911v&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Crystallographic analysis of analogous inhibitors such as <b>2</b> bound to MDM2 shows that the carboxylate interacts with the imidazole of the His96 side chain of MDM2.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> This unique interaction resulted in a nearly 100-fold improvement in binding affinity.<a onclick="showRef(event, 'cit18e'); return false;" href="javascript:void(0);" class="ref cit18e">(18e)</a> The amide of the oxindole-derived MDM2 inhibitors was reported to engage in similar interactions with His96.<a onclick="showRef(event, 'ref16 cit18e'); return false;" href="javascript:void(0);" class="ref ref16 cit18e">(16, 18e)</a> Thus, we set out to explore this and other acid replacements within our series. In this article, we described our efforts to identify acid replacements, which led to the discovery of <b>4</b>, an exquisitely potent thiazolyl-containing inhibitor of the MDM2-p53 interaction. Inhibitor <b>4</b> also exhibits excellent pharmacokinetic properties (<i>h</i>Hep CL<sub>int</sub> = 5.5 μL/min/10<sup>6</sup> cells) and in vivo efficacy in the SJSA-1 osteosarcoma xenograft model (ED<sub>50</sub> = 11 mg/kg).</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85213" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85213" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The route to the isosteres of acid <b>5</b>, compounds <b>6</b>–<b>8</b>, and <b>12</b> is depicted in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. Many acid-containing heterocycles were synthesized from common nitrile intermediate <b>53</b> (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). From <b>53</b>, addition of ethanol under acidic conditions resulted in imidate <b>54</b> that was taken directly to iminium <b>55</b> by the addition of ammonia. Intermediate <b>55</b> can be transformed to either imidazole inhibitor <b>45</b> or pyrimidine <b>27</b> through the sequential reaction of <b>55</b> with ethyl-3-oxo-propionate or 4-chloroacetic acid methyl ester, respectively, followed by saponification.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/medium/jm-2013-01911v_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/large/jm-2013-01911v_0005.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/large/jm-2013-01911v_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401911v&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) trifluoromethanesulfonamide, DIEA, HATU, DMF, rt, 5 h, 41%; (b) <i>N</i>-methylmorpholine, 28% NH<sub>3</sub>/H<sub>2</sub>O, isobutyl chloroformate, THF, 0 °C, 3 h, 75%; (c) trifluoroacetic anhydride, TEA, 0 °C, 1 h, 92%; (d) NaN<sub>3</sub>, DMF, 90 °C, 5 days, 65%; (e) NaHCO<sub>3</sub>, NH<sub>4</sub>OH, MeOH, 70 °C, 12 h, quant.; (f) CDI, DBU, dioxane, 100 °C, 2 days, 15% (last two steps).</p></p></figure><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/medium/jm-2013-01911v_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/large/jm-2013-01911v_0006.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/large/jm-2013-01911v_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401911v&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 1-(cyanomethyl)tetrahydro-1-<i>H</i>-thiophene-1-ium bromide, DIEA, HATU, DCM, rt, 4 h, quant.; then, oxone, DMF/H<sub>2</sub>O, rt, 3 h, 64%; (b) NH<sub>3</sub>, DIEA, HATU, 55 °C, 1 h, 88%; (c) trifluoroacetic anhydride, TEA, 0 °C, 1 h, 90%; (d) HCl, ethanol, 1 h, rt, quant.; (e) ethyl 3-hydrazinyl-3-oxopropanoate, EtOH, 12 h, 63%; (f) LiOH, MeOH/THF/H<sub>2</sub>O, 50 °C, 1 h; (g) NH<sub>3</sub>, ethanol, 12 h, rt, 100%; (h) ethyl trans-4-oxo-2-butenoate, 130 °C, 1 h, 8%; (i) ethyl-2-formyl-3-oxo-propionate, DMA, 100 °C, 2 h, 66%; (j) P<sub>2</sub>S<sub>5</sub>, ethanol, 70 °C, 12 h, 66%; (k) 4-chloroacetic acid methyl ester, EtOH, 90 °C, 3 h, 57% (both steps); (l) ethyl-2-chloro-3-oxopropanoate, toluene, 100 °C, 5 h, 66%; (m) ethyl bromo pyruvate, dioxane, 3 h, rt; then, pyridine and TFA, 12 h, rt, 22%; (n) oxalyl chloride, DMF, 1 h; then, tris(trimethylsilyloxy)ethylene, 90 °C, 12 h, 10%.</p></p></figure><div class="NLM_p">Alternatively, nitrile intermediate <b>53</b> could be converted to thioamide <b>56</b> with phosphorus pentasulfide. From <b>56</b>, a variety of thiazole isomers could be synthesized by the addition of the corresponding ester reagent followed by saponification of the resulting ester to give inhibitors <b>32</b>, <b>33</b>, and <b>37</b>.</div><div class="NLM_p">Synthesis of pyrazole inhibitor <b>31</b> (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>) commenced by C3-alkylation of piperidinone intermediate <b>57</b> with (2-chloromethyl)ethyltrimethylsilane giving ether <b>58</b>. Intermediate <b>58</b> was then transformed to primary alcohol <b>59</b> with boron trifluoride and then to mesylate <b>60</b> by reaction with methanesulfonic anhydride. The mesylate moiety of <b>60</b> could then be displaced with hydrazine to give <b>61</b> that was converted to pyrazole <b>62</b> by the addition of ethyl-2-formyl-3-oxo-propionate. Finally, inhibitor <b>31</b> was obtained through oxidation of the <i>tert</i>-butyl thioether to its corresponding sulfone followed by saponification of the ethyl ester to the acid.</div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/medium/jm-2013-01911v_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/large/jm-2013-01911v_0007.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/large/jm-2013-01911v_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401911v&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (2-chloromethoxy)ethyltrimethylsilane, LDA, THF, −78 °C, 1 h, 52%; (b) BF<sub>3</sub>–OEt<sub>2</sub>, DCM, 0 °C, 3 h, 33%; (c) methanesulfonic anhydride, NEt<sub>3</sub>, DCM, 30 min, rt, quant.; (d) hydrazine, EtOH, 90 °C, 12 h, 40% conversion; (e) ethyl-2-formyl-3-oxo-propionate, 100 °C, DMA, 2 h, 38%; (f) mCPBA, DCM, 0 °C, 30 min, 30%; (g) LiOH, MeOH/THF/H<sub>2</sub>O, 50 °C, 1 h, 30% (last two steps).</p></p></figure><div class="NLM_p">Addition of triphenylphosphine and carbon tetrabromide to alcohol <b>59</b> yields alkylbromide <b>63</b> (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>). This intermediate undergoes displacement by 2-mercaptopyrimidine to form thioether <b>64</b>. Oxidation of <b>64</b> to bis-sulfone <b>65</b> proceeded smoothly with mCPBA. Finally, inhibitor <b>14</b> was formed by reaction of <b>65</b> with hydroxylamine-<i>O</i>-sulfonic acid.</div><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/medium/jm-2013-01911v_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/large/jm-2013-01911v_0008.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/large/jm-2013-01911v_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401911v&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) triphenylphosphine, CBr<sub>4</sub>, MeCN, 55 °C, 5 h, 86%; (b) 2-mercaptopyrimidine, K<sub>2</sub>CO<sub>3</sub>, DMF, rt, 12 h; (c) oxone, THF/H<sub>2</sub>O, rt, 12 h, 48% (last two steps); (d) hydroxylamine-<i>O</i>-sulfonic acid, K<sub>2</sub>CO<sub>3</sub>, MeOH, 12 h, rt, 46%.</p></p></figure><div class="NLM_p">Highlighted in Schemes <a class="ref internalNav" href="#sch5" aria-label="5">5</a> and <a class="ref internalNav" href="#sch6" aria-label="6">6</a> are the synthetic routes used to access some of our most potent thiazole inhibitors. Coupling between acid <b>9</b> and ethyl 4-(bis(trimethylsilyl)amino)but-2-ynoate in the presence of TBAF produced propargylamide <b>67</b> that could then undergo one pot cyclization to thiazole <b>68</b> by refluxing in toluene in the presence of Lawesson’s reagent (Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>). From <b>68</b>, alkylation α to the ester moiety with either methyl iodide or 1,2-dibromoethane resulted in inhibitors <b>39</b> and <b>40</b> after saponification of the ethyl ester.</div><figure id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/medium/jm-2013-01911v_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/large/jm-2013-01911v_0009.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/large/jm-2013-01911v_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401911v&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) oxalyl chloride, THF, DMF, rt, 1 h, quant.; (b) ethyl 4-(bis(trimethylsilyl)amino)but-2-ynoate, TBAF, THF, rt, 12 h; then, HCl/water, 72%; (c) Lawesson’s reagent, toluene, 60 °C, 3 h, 63%; (d) LiOH, MeOH/THF/H<sub>2</sub>O, 50 °C, 1 h; (f) MeI, NaO<i><sup>t</sup></i>Bu, DMF, 0 °C, 30 min, 62%; (e) 1,2-dibromoethane, NaO<sup>t</sup>Bu, DMF, 0 °C, 30 min, 80%.</p></p></figure><figure id="sch6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/medium/jm-2013-01911v_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/large/jm-2013-01911v_0010.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 6. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/large/jm-2013-01911v_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401911v&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) glycine methyl ester hydrochloride, EDC, HOAt, NaHCO<sub>3</sub>, DMF, 40 °C, 3 h, quant.; (b) LiOH, MeOH/THF/H<sub>2</sub>O, 50 °C, 1 h; (c) MgCl<sub>2</sub>, CDI, methyl potassium malonate, 50 °C, 12 h, 63%; (d) Lawesson’s reagent, toluene, 100 °C, 3 h, 71%; (e) Burgess’ reagent, DCE, 120 °C, 7 h, 62%; (f) <i>N</i>-fluorobenzenesulfonimide, NaO<sup>t</sup>Bu, DMF, 0 °C, 1 h; then step b, <b>41</b>, 11%; <b>42</b>, 4%.</p></p></figure><div class="NLM_p">Alternatively, coupling of acid <b>69</b> with glycine methyl ester followed by saponification provided intermediate <b>70</b> (Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a>). Addition of methyl potassium malonate to <b>70</b> followed by decarboxylation resulted in the formation of β-keto ester <b>71</b> that, similar to <b>67</b>, can undergo cyclization to thiazole <b>72</b> in the presence of Lawesson’s reagent. Reaction of <b>72</b> with <i>N</i>-fluorobenzenesulfonimide resulted in fluorination at the α carbon to the ester, but the reaction was sluggish and not chemoselective providing a mixture of <b>41</b> and <b>42</b> that could be separated via preparative HPLC. Oxazole <b>43</b> was formed from cyclization of <b>71</b> in the presence of Burgess’ reagent.</div><div class="NLM_p">Morpholinone inhibitors <b>46</b> and <b>47</b> were synthesized starting from C2-Me morpholinone <b>73</b> (Scheme <a class="ref internalNav" href="#sch7" aria-label="7">7</a>). Alkylation with methyl (6-bromomethyl)nicotinate yields C2-disubstituted <b>74</b> as a nearly 1:1 mixture of epimers at C2. Deprotection of silylether, Mitsunobu reaction, and oxidation of the resulting thioether to the corresponding sulfone produced <b>76</b> that can be easily transformed to a mixture of <b>46</b> and <b>47</b> by saponification. The isomers were separated by preparative HPLC.</div><figure id="sch7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/medium/jm-2013-01911v_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/large/jm-2013-01911v_0011.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 7. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/large/jm-2013-01911v_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401911v&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) methyl (6-bromomethyl)nicotinate, LDA, THF, −78 °C, 2 h, 78%,  1:1 d.r.; (b) TBAF, THF, rt, 12 h, 60%; (c) <sup>t</sup>BuSH, cyanomethyltri-<i>N</i>-butylphosphorane, 110 °C, 12 h, 61%; (d) mCPBA, DCM, 30 min, 0 °C, quant.; (e) LiOH, MeOH/THF/H<sub>2</sub>O, 50 °C, 1 h.</p></p></figure><div class="NLM_p">Finally, many of the nicotinic acid analogues were synthesized through simple alkylation of <b>57</b> with the corresponding alkylbromide (Scheme <a class="ref internalNav" href="#sch8" aria-label="8">8</a>). Alkylation with 5-bromo-2-(bromomethyl)pyridine results in <b>78</b> that can be functionalized to inhibitors such as <b>23</b> through standard Pd-mediated coupling conditions.</div><figure id="sch8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/medium/jm-2013-01911v_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/large/jm-2013-01911v_0012.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 8. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/large/jm-2013-01911v_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401911v&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <i>tert</i>-butyl-2-(bromomethyl)isonicotinate, LDA, THF, −78 °C, 4 h, 71%, 3:1 d.r.; (b) mCPBA, DCM, 30 min, 0 °C, quant.; (c) LiOH, MeOH/THF/H<sub>2</sub>O, 50 °C, 1 h; (d) 5-bromo-2-(bromomethyl)pyridine, LDA, THF, −78 °C, 2 h, 18% (single isomer); (e) Pd(dba)<sub>2</sub>, Q-phos, (2-(<i>tert</i>-butoxy)-2-oxoethyl)zinc(II) chloride, THF, 60 °C, 4 h, 37%; (f) formic acid, 6 h, 75%.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31018" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31018" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Piperidinone Inhibitors</h3><div class="NLM_p">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> briefly summarizes our initial efforts to replace the carboxylic acid moiety with a variety of functional groups.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> At first, we examined known acid isosteres or functionalities that could form an electrostatic interaction with MDM2-His96. Analogues featuring tetrazole (<b>6</b>) and 1,2,4-oxadiazolone (<b>7</b>) as acid isosteres demonstrated potency similar to that of the parent carboxylic acid (<b>5</b>) in the MDM2-p53 biochemical assay (HTRF-based neutralization assay measuring inhibition of the interaction between MDM2 and p53) and cell proliferation assays (EdU using SJSA-1 tumor cells). However, unlike <b>5</b>, compounds <b>6</b> and <b>7</b> are moderate inhibitors of CYP3A4. Acylsulfonamide analogues such as <b>8</b> showed a substantial reduction in potency in the biochemical and cell based assays and also displayed moderate CYP3A4 inhibition. Substitution of the carboxylic acid with an α-keto acid (<b>10</b>) provided an inhibitor with a profile similar to that of the corresponding acid (<b>9</b>) in the in vitro assays (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) but also displayed poor pharmacokinetic properties in vivo in preclinical models (data not shown). The carboxylic acid <b>5</b> and the α-hydroxyl ketone <b>11</b> afford similar activity in the HTRF assay suggesting that an ionized group is not essential for potent binding to MDM2. Encouraged by this result, we explored amides as replacements for the carboxylic acid (<b>12</b> and <b>13</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). It was reassuring to observe that <b>13</b> had potency similar to that of the analogous carboxylic acid <b>9</b> in the HTRF assay, although <b>12</b> and <b>13</b> are approximately 10-fold less potent in the cell proliferation assay compared to their parent acids <b>5</b> and <b>9</b>, respectively, and give rise to the aforementioned CYP3A4 inhibition liability. A great variety of amides and amides isosteres, such as sulfonamide <b>14</b>, provided less potent compounds and also carried the CYP3A4 inhibition. Our efforts to improve potency by engaging additional residues on the MDM2 protein such as Lys94 led us to synthesize pyrrolidines <b>15</b> and <b>16</b> containing an appended carboxylic acid. These inhibitors have potency similar to that of the carboxylic acid analogue (<b>9</b>) in the MDM2-p53 HTRF assay and no activity in the CYP3A4 inhibition assay. We hypothesized that the pyrrolidineamide moiety of <b>15</b> and <b>16</b> bind to MDM2 through a hydrogen bond interaction with MDM2-His96. Since <b>15</b> and <b>16</b> are epimers at the stereocenter bearing the carboxylic acid moiety and have similar potency in the biochemical assay, it was postulated that this group was not making a specific interaction with the protein; however, the appending acid facilitated the decrease in CYP3A4 inhibition. Therefore, it was hypothesized that heterocyclic derivatives could similarly interact with MDM2-His96 serving as viable replacements of the carboxylic acid moiety. Indeed, pyridine <b>17</b> has potency similar to that of the carboxylic acid <b>9</b> in the biochemical assay (HTRF IC<sub>50</sub> in the serum free assay for <b>17</b> and <b>9</b> is 0.30 ± 0.01 and 0.10 ± 0.01 nM, respectively; Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Notably, the phenyl-analogue <b>18</b> was 30-fold less potent than <b>17</b>, presumably due to the loss of the hydrogen bond interaction between the pyridine nitrogen and the imidazole moiety on MDM2-His96. Although encouraged by the intrinsic affinity of <b>17</b> toward MDM2 in the HTRF assay, it was necessary to address its potent inhibition of CYP3A4. Thus, we introduced a carboxylic acid with the intention to achieve a similar decrease in CYP3A4 inhibition as previously observed with pyrrolidine amides <b>15</b> and <b>16</b>. This led to the discovery of isonicotinic acid <b>19</b>, which shows significant improvement in the biochemical and cell based assays while displaying no activity in the CYP3A4 inhibition assay. Exploration of other heterocycles led to the discovery of thiazole <b>20</b>, a highly potent inhibitor of the MDM2-p53 interaction in the HTRF and cell proliferation assays with negligible CYP3A4 inhibition. As a result, we decided to explore other heterocycles including nicotinic acid isomers of <b>19</b> as well as thiazole inhibitors such as <b>20</b>.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Carboxylic Acid Replacements</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/medium/jm-2013-01911v_0013.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/medium/jm-2013-01911v_0014.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">IC<sub>50</sub> in the biochemical assay using serum free buffer.</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">IC<sub>50</sub> in the biochemical assay using buffer containing 15% human serum.</p></div><div class="footnote" id="t1fn3"><sup>Table c</sup><p class="last">Cellular potency in SJSA-1 osteosarcoma tumor cells in the presence of 10% human serum.</p></div><div class="footnote" id="t1fn4"><sup>Table d</sup><p class="last">Estimated CYP3A4 inhibition IC<sub>50</sub>, Midazolam, at 3 μM.</p></div><div class="footnote" id="t1fn5"><sup>Table e</sup><p class="last">Mean and standard deviation of at least two runs.</p></div></div><div></div></div><div class="NLM_p">First, we probed the position of the carboxylic acid on the pyridine ring. To this end, inhibitors <b>19</b>, <b>21</b>, and <b>3</b> were synthesized (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Notably, the meta (<b>19</b>)- and para-substituted (<b>3</b>) analogues offer similar potency in the MDM2-p53 biochemical assay. However, <b>3</b> is significantly more potent than <b>19</b> in the cell based assays, including the mechanism based p21 assay with SJSA-1 cells (p21 IC<sub>50</sub> for <b>3</b> and <b>19</b> of 5 nM and 47 nM, respectively). Unfortunately, <b>3</b> also features an increased potential for drug–drug interactions by time-dependent inhibition of CYP3A4 (TDI, 61% inhibition at a concentration of 10 μM; Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>).<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Co-crystal structure of <b>3</b> bound to human MDM2 (17–111) shows a hydrogen bond interaction between the pyridine moiety and MDM2-His96 confirming our hypothesis for the binding of these inhibitors (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). Our measurements show the hydrogen bond between the pyridine and the imidazole moieties to be classical in nature (C–C–N-H ∠ 170°) with little to no π-hydrogen bond contribution.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Introduction of the <i>meta</i>-fluoro substituent at the C6-arene (<b>22</b>) resulted in a 10-fold increase in potency in the serum-free HTRF assay when compared to that of parent <b>3</b>. However, this increase in potency did not materialize when <b>22</b> was tested in the same assay run in the presence of 15% human serum or the cell based assay. Homologation of the carboxylic acid to acetic acid gave inhibitor <b>23</b>, which was 2-fold less potent in the HTRF-serum free assay and 3-fold less potent in the cell proliferation assay relative to <b>3</b> but had improved stability in the hepatocytes assay as well as decreased CYP3A4 TDI (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). We sought to further improve metabolic stability by hindering the carboxylic acid on <b>23</b>. Thus, <b>24</b> was synthesized and evaluated in vitro for metabolic stability. Rewardingly, <b>24</b> was noticeably more stable (<i>h</i>Hep CL<sub>int</sub> = <0.1 μL/min/10<sup>6</sup> cells) compared to the α-unsubstituted acid <b>23</b> (<i>h</i>Hep CL<sub>int</sub> = 3.4 μL/min/10<sup>6</sup> cells) in our in vitro human hepatocyte assay. Attempts to introduce methyl substituents on the nicotinic acid core caused a decrease in potency (<b>25</b> and <b>26</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Replacing the pyridine by either a pyrimidine (<b>27</b> and <b>28</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) or a pyrazine (<b>29</b>) yielded inhibitors with similar potency in the biochemical and cellular assays. Notably, the p<i>K</i><sub>a</sub> of the nitrogen in these heterocycles (pyridine p<i>K</i><sub>a</sub>, ∼5.2; pyrimidine p<i>K</i><sub>a</sub>, ∼1.3; and pyrazine p<i>K</i><sub>a</sub>, ∼0.6) has little to no effect on the CYP3A4 TDI of the inhibitors. Finally, benzoic acid <b>30</b> was 150-fold less potent than <b>3</b> in the serum-free biochemical assay (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>), confirming the importance of the hydrogen bond interaction observed in the cocrystal structure of <b>3</b> between the pyridine nitrogen and MDM2-His96 (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). A similar observation was previously made when we compared the pyridine derivative <b>17</b> (HTRF serum free IC<sub>50</sub> = 0.30 ± 0.01 nM) to its phenyl analogue <b>18</b> (HTRF serum free IC<sub>50</sub> = 137 nM) (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).</div><div class="NLM_p">We investigated other nitrogen-containing heterocycles, many of which exhibited good potency (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). For example, the pyrazole <b>31</b> afforded potency similar to that of the carboxylic acid analogue <b>9</b> in the biochemical and cell-based assays, but again presented a considerable CYP3A4 TDI liability. Both thiazole-4-carboxylic acid <b>32</b> and thiazole-5-carboxylic acid <b>33</b> were synthesized, <b>33</b> being 4- and 40-fold more potent than <b>32</b> in the biochemical (HTRF, serum free) and cell based assays, respectively, showing that the position of the carboxylic acid substituent plays an important role in potency (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). As previously observed, hydroxy ketone <b>34</b> had similar potency compared to that of the parent acid (<b>33</b>) suggesting that the ionizable carboxylic acid group was not essential for affinity to MDM2 or potent cellular activity. However, <b>34</b> has poor metabolic stability in human hepatocytes and high CYP3A4 inhibition (IC<sub>50</sub><b>=</b> 0.8 μM). The reduced activity of the unsubstituted thiazole, <b>36</b>, in the CYP3A4 TDI assay compared to that of the analogous thiazole-5-carboxylic acid derivative, <b>35</b>, suggested that the acid was in part responsible for the observed time-dependent inhibition of CYP3A4 and that changes around the carboxylic acid could help address this potential liability.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Optimization of the Pyridine Series and Other Six-Membered Heterocyclic Analogues</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/medium/jm-2013-01911v_0015.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/medium/jm-2013-01911v_0016.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">IC<sub>50</sub> in the biochemical assay using serum free buffer.</p></div><div class="footnote" id="t2fn2"><sup>Table b</sup><p class="last">IC<sub>50</sub> in the biochemical assay using buffer containing 15% human serum.</p></div><div class="footnote" id="t2fn3"><sup>Table c</sup><p class="last">Cellular potency in SJSA-1 osteosarcoma tumor cells in the presence of 10% human serum.</p></div><div class="footnote" id="t2fn4"><sup>Table d</sup><p class="last">Time-dependent inhibition, % CYP3A4 activity of Rifampin, 30 min, at 10 μM.</p></div><div class="footnote" id="t2fn5"><sup>Table e</sup><p class="last">Human hepatocyte stability.</p></div><div class="footnote" id="t2fn6"><sup>Table f</sup><p class="last">Mean and standard deviation of at least two runs.</p></div></div><div></div></div><div class="NLM_p">Thus, as observed within the nicotinic acid series (<b>3</b> and <b>23</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>), homologation of the acid gave inhibitor <b>37</b>, which is 2-fold more potent than the corresponding thiazole-4-carboxylic acid (<b>32</b>) in the p53-MDM2 HTRF assay and is devoid of CYP3A4 TDI activity. Likewise, <b>38</b> and <b>4</b> show significantly less CYP3A4 TDI (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Optimization of the Thioazole Series and Other Five-Membered Heterocyclic Derivatives</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/medium/jm-2013-01911v_0017.gif" alt="" id="fx5" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/medium/jm-2013-01911v_0018.gif" alt="" id="fx6" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>Table a</sup><p class="last">IC<sub>50</sub> in the biochemical assay using serum free buffer.</p></div><div class="footnote" id="t3fn2"><sup>Table b</sup><p class="last">IC<sub>50</sub> in the biochemical assay using buffer containing 15% human serum.</p></div><div class="footnote" id="t3fn3"><sup>Table c</sup><p class="last">Cellular potency in SJSA-1 osteosarcoma tumor cells in the presence of 10% human serum.</p></div><div class="footnote" id="t3fn4"><sup>Table d</sup><p class="last">Time-dependent inhibition, % CYP3A4 activity of Rifampin, 30 min, at 10 μM.</p></div><div class="footnote" id="t3fn5"><sup>Table e</sup><p class="last">Human hepatocyte stability.</p></div><div class="footnote" id="t3fn6"><sup>Table f</sup><p class="last">Mean and standard deviation of at least two runs.</p></div></div><div></div></div><div class="NLM_p">A cocrystal structure of <b>4</b> bound to human MDM2 (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) demonstrates that this inhibitor binds to MDM2 filling the critical pockets naturally occupied by the three key residues of p53: Leu26, Trp23, and Phe19.9 The 3-chlorophenyl occupies the Leu26 pocket, engaging in a π–π stacking interaction with the imidazole of the His96. The 3-fluoro-4-chlorophenyl is buried in the Trp23 pocket. The small lipophilic cyclopropyl group projects toward the Phe19 pocket, while the <i>tert</i>-butyl sulfone is within van der Waals distance from the “glycine shelf”, named after Gly58 on MDM2, maximizing hydrophobic contact with the protein. Finally, the thiazole-nitrogen forms a hydrogen bond (2.9 Å) with the imidazole-NH of His96.</div><figure id="fig2" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/medium/jm-2013-01911v_0026.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/large/jm-2013-01911v_0026.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Co-crystal structure of <b>4</b> bound to human MDM2 (6–110). White labels indicate positions normally occupied by key p53 residues. MDM2 residues His96 and Gly58 are labeled in yellow. Coordinates for compound <b>4</b> (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4ODE">4ODE</a>) bound to MDM2 have been deposited in the PDB.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/large/jm-2013-01911v_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401911v&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Introducing substituents α to the carboxylic acid of <b>4</b> or <b>38</b> did not critically alter the overall profile of the inhibitors (<b>39</b>–<b>42</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Finally, other heterocycles such as oxazole (<b>43</b>), triazole (<b>44</b>), and imidazole (<b>45</b>) were also synthesized and evaluated. While many of these substitutions were tolerated, they did not lead to increased potency (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>).</div><div class="NLM_p">Compounds <b>3</b>, <b>4</b>, <b>33</b>, <b>35</b>, and <b>38</b> were selected for their potency and evaluated in rodent pharmacokinetic experiments (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). The majority of these inhibitors exhibit low clearance in rodent species. The addition of a <i>meta</i>-fluoro substituent at the C5-arene on <b>4</b> and <b>35</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>) improved their metabolic stability in rat and mouse and increased oral bioavailability compared to that of the <i>des</i>-fluoro derivatives. These results, together with good cellular potency, favorable in vitro stability in human hepatocytes, and reduced liability to cause potential drug–drug interactions through inhibition of CYP3A4, lead to the selection of <b>4</b> for further evaluation in our tumor xenograft model.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Rodent PK Profiles of Selected Compounds</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/medium/jm-2013-01911v_0019.gif" alt="" id="fx7" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>Table a</sup><p class="last">Rat/mouse iv vehicle: 10.0% DMAC, 10.0% EtOH, 30.0% propylene glycol, and 50.0% saline (0.45% NaCl/49.55% water).</p></div><div class="footnote" id="t4fn2"><sup>Table b</sup><p class="last">Mouse iv vehicle: 0.5% methyl cellulose, 1% Tween 80, and 98.5% water.</p></div></div><div></div></div><div class="NLM_p">First, we confirmed that the cytotoxicity observed with <b>4</b> is attributable to activation of the p53 pathway. Thus, we evaluated the ability of <b>4</b> to inhibit the proliferation of HCT116 p53<sup>wt</sup> and p53<sup>–/–</sup> tumor cells in vitro (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>).<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Compound <b>4</b> displayed robust dose-dependent cell growth inhibitions of HCT116 wild-type p53 cells (IC<sub>50</sub> = 11 nM) and no inhibition of p53 deficient cells at doses <10 μM. Similarly, <b>4</b> also exhibited a dose-dependent increase of p21 mRNA, a direct transcriptional readout of p53 activity, in HCT116 p53<sup>wt</sup> cells (IC<sub>50</sub> = 58 nM). No induction was observed when HTC116 p53<sup>–/–</sup> tumor cells were treated with <b>4</b> at concentrations up to 10 μM.</div><figure id="fig3" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/medium/jm-2013-01911v_0027.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/large/jm-2013-01911v_0027.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Cell activity of <b>4</b> is p53-dependent. (a) In HCT116 p53<sup>wt</sup> and p53<sup>–/–</sup> cells, the percentage of BrdU positive cells was measured 16 h postcompound treatment by flow cytometry. The DMSO control was designated as 0% inhibition. (b) In HCT116 p53<sup>wt</sup> and p53<sup>–/–</sup> cells, total RNA was extracted 7 h postcompound treatment, and p21 mRNA was measured by quantitative RT-PCR.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/large/jm-2013-01911v_0027.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401911v&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In a pharmacodynamic in vivo xenograft assay with SJSA-1 osteosarcoma tumor cells, <b>4</b> demonstrated significant time-dependent p21 induction over the vehicle (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). A maximum 15-fold induction of p21 mRNA was observed 4 h after dosing QD for 4 days at 25 mg/kg. These data indicated that <b>4</b> achieved an on-mechanism inhibition of MDM2 and induction of p53 signaling, and provided dose-selection guidance for the xenograft study.</div><figure id="fig4" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/medium/jm-2013-01911v_0028.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/large/jm-2013-01911v_0028.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. PD study results of <b>4</b> in the SJSA-1 tumor xenograft: Female athymic nude mice (<i>n</i> = 4/group) were implanted subcutaneously with 5 × 10<sup>6</sup> SJSA-1 cells. When tumors reached ∼175 mm<sup>3</sup>, 25 mg/kg of <b>4</b> or the vehicle was administered orally once daily (QD) for 4 days. Mice were sacrificed on day 4 at 1, 2, 4, 8, and 24 h postdose. Tumors were immediately removed and snap-frozen. p21 mRNA levels were measured by quantitative RT-PCR. Tumors treated with vehicle served as a negative control and indicated the baseline p21 mRNA level. Data are represented as the mean p21 fold induction over vehicle, and error bars represent standard error of the mean (SEM) of data from five mice. Concentrations in plasma (red dots) were analyzed by LC/MS/MS. *<i>p</i> < 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/large/jm-2013-01911v_0028.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401911v&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We tested the ability of <b>4</b> to inhibit tumor growth in a mouse xenograft model bearing the same SJSA-1 osteosarcoma tumor used in the pharmacodynamic assay (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>).<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> In this study, <b>4</b> caused robust dose-dependent tumor growth inhibition with the highest dose of 50 mg/kg causing 6% tumor regression. The calculated ED<sub>50</sub> was 11 mg/kg. Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a> compares the cellular potency of inhibitor <b>4</b> to other known inhibitors that are currently in the clinic for the treatment of cancer.</div><figure id="fig5" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/medium/jm-2013-01911v_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/large/jm-2013-01911v_0001.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. SJSA-1 cells (5 × 10<sup>6</sup>) were implanted subcutaneously into female athymic nude mice. Treatment with vehicle or <b>4</b> at 5, 12.5, 25, or 50 mg/kg QD by oral gavage began on day 9 when tumors had reached ∼200 mm<sup>3</sup> (<i>n</i> = 10/group). Tumor sizes and body weights were measured twice per week. Data are represented as the mean tumor volumes, and the error bars represented the SEM of data from 10 mice. * <i>p</i> < 0.005.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/large/jm-2013-01911v_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401911v&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig6" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/medium/jm-2013-01911v_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/large/jm-2013-01911v_0002.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Chemical structures and potencies of some known MDM2 inhibitors currently being tested in the clinic: RG7112, RG7388, SAR299155, and <b>4</b>. <sup>a</sup> IC<sub>50</sub> in the EdU cell proliferation assay (SJSA-1 and 10% human serum).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/large/jm-2013-01911v_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401911v&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To better understand its metabolism, inhibitor <b>4</b> was incubated in hepatocytes (10<sup>6</sup> cells/mL) from five different species and its degradation products were evaluated by LC-MS/MS (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>). The reported chromatograms show that oxidative metabolites <b>M1</b>, <b>M2</b>, and <b>M3</b> are generated across species, including human hepatocytes.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> The acyl glucuronide metabolite of <b>4</b> was not observed in this experiment. Interestingly, this contrasts from <b>1</b> for which metabolite profiles were qualitatively similar across species with only it is acyl glucuronide observed in these incubates.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Therefore, glucuronidation of <b>1</b> is predicted to be the primary metabolic pathway in humans.</div><figure id="fig7" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/medium/jm-2013-01911v_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/large/jm-2013-01911v_0003.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Metabolite profiles of <b>4</b> from hepatocyte incubation at 10 μM after 2 h.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/large/jm-2013-01911v_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401911v&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Morpholinone Inhibitors</h3><div class="NLM_p">Recently, we disclosed our efforts toward the optimization of potent morpholinone inhibitors. From these studies, we concluded that whereas morpholinone inhibitors are about 3- to 5-fold less potent than piperidinones, this core substitution had a profound effect on the in vitro and in vivo metabolic stability of these analogues, giving them divergent metabolism.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></div><div class="NLM_p">Thus, we decided to explore some of the most potent acid replacements encountered thus far on the morpholinone core. To this end, nicotinic acid inhibitor <b>46</b> was synthesized. A direct comparison between inhibitors <b>3</b> and <b>46</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>) shows morpholinone <b>46</b> to be, as expected, 3- to 5-fold less potent than piperidinone <b>3</b> in the EdU cell assay. Surprisingly, its C2-epimer <b>47</b> turned out to be 2-fold more potent than <b>46</b> (EdU assay, Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). The cocrystal structures of <b>46</b> and <b>47</b> bound to MDM2 (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>) allowed us to confirm the relative configuration of these inhibitors. The structure of <b>46</b> bound to MDM2 (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>a) depicts the pyridine nitrogen engaging in a hydrogen bond interaction with the imidazole-NH of His96 similar to that observed with inhibitors <b>3</b> and <b>4</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). In contrast, the binding of <b>47</b> to MDM2 shows interactions that have yet to been seen in the nicotinic acid series (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>b). In this case, there is no hydrogen bond observed between the inhibitor and His96. However, there are direct hydrogen bonds observed between the acid in <b>47</b> and the backbone NH and side chain hydroxyl of Ser17. Furthermore, there is a water mediated hydrogen bond between this acid and the side chain of Gln18. The enhanced potency of <b>47</b> can be rationalized by these new interactions offsetting the loss of the hydrogen bond to His96.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Comparison between Nicotinic Acid Inhibitors Derived from the Piperidinone and Morpholinone Scaffolds</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/medium/jm-2013-01911v_0020.gif" alt="" id="fx8" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>Table a</sup><p class="last">Assays conducted in the presence of 10% human serum.</p></div><div class="footnote" id="t5fn2"><sup>Table b</sup><p class="last">Mean and standard deviation of at least two runs.</p></div></div><div></div></div><figure id="fig8" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/medium/jm-2013-01911v_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/large/jm-2013-01911v_0004.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Co-crystal structures of (a) <b>46</b>, (b) <b>47</b>, (c) <b>48</b>, and (d) <b>49</b> bound to human MDM2 (<b>46</b>, <b>47</b> MDM2, 6–110; <b>48</b>, <b>49</b> MDM2, 17–111). <sup>a</sup> IC<sub>50</sub> in the biochemical assay using buffer containing 15% human serum. <sup>b</sup> Cellular potency in SJSA-1 osteosarcoma tumor cells in the presence of 10% human serum. Coordinates for compounds <b>46</b> (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4OGT">4OGT</a>), <b>47</b> (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4ODF">4ODF</a>), <b>48</b> (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4OCC">4OCC</a>), and <b>49</b> (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4OGV">4OGV</a>) bound to MDM2 have been deposited in the PDB.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/large/jm-2013-01911v_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401911v&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Our previous studies on the morpholinone series showed that, in general, the C2-<i>R</i> isomer is more potent than its C2-<i>S</i> epimer. This can be best exemplified by comparing epimeric morpholinone inhibitors <b>48</b> (SJSA-1 EdU IC<sub>50</sub> = 38 nM) and <b>49</b> (SJSA-1 EdU IC<sub>50</sub> = 247 nM) (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>c-d). Notably, in this case, the carboxylate moiety of both <b>48</b> and <b>49</b> interacts with the imidazole moiety of His96.</div><div class="NLM_p last">We also synthesized <b>50</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>), a piperidinone inhibitor with S-stereochemistry at C3 (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). Crystallographic data of <b>50</b> bound to MDM2 (1.85 Ă resolution) was obtained, but we were unable to identify a defined density for the nicotinic acid moiety. Evidently, in this case, the piperidinone core precludes the nicotinic acid from picking up the hydrogen bonds with either His96 or Ser17. This finding is in agreement with the observed loss in potency of <b>50</b> (SJSA-1 EdU IC<sub>50</sub> = 238 nM) compared to <b>3</b> (SJSA-1 EdU IC<sub>50</sub> = 5 nM).</div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71311" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71311" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Evaluation of the carboxylic acid moiety of <b>1</b> identified known acid isosteres such as tetrazole (<b>6</b>), oxadiazolone (<b>7</b>), and α-keto acid (<b>10</b>) as viable replacements, maintaining potency similar to that of <b>1</b> in the biochemical and cell based assays. However, these analogues are moderate inhibitors of CYP3A4. Insights into the binding of these inhibitors to MDM2 (<b>2</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) led us to hypothesize that the electrostatic interaction between MDM2 and the carboxylic acid moiety could be replaced by a dipole–dipole interaction with a hydrogen bond donor or acceptor. Further studies led to the discovery that replacement of the acid with hydrogen bond acceptor moieties, such as amides (<b>13</b>, <b>15</b>, and <b>16</b>) and heterocycles like pyridine (<b>3</b>), pyrimidine (<b>28</b>), pyrazine (<b>29</b>), thiazole (<b>4</b>), pyrazole (<b>31</b>), oxazole (<b>43</b>), triazole (<b>44</b>), and imidazole (<b>45</b>), provide potent inhibitors of the MDM2-p53 interaction. Notably, phenyl analogues <b>18</b> and <b>30</b>, which cannot engage in a hydrogen bond binding interaction with MDM2-His96, have significantly less affinity for the protein than their corresponding pyridine analogues (<b>17</b> and <b>3</b> respectively), corroborating the importance of this interaction for potent binding. The aforementioned interaction of these novel heterocyclic inhibitors with MDM2-His96 was confirmed with the MDM2 cocrystal structures of pyridine <b>3</b> and thiazole <b>4</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). Although heterocycles are not often thought of as carboxylic acids isosteres, there is precedence for the successful use of pyridines as replacements of carboxylic acids.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a></div><div class="NLM_p last">Among these new analogues, compound <b>4</b> shows excellent biochemical potency (HTRF IC<sub>50</sub> = 0.1 nM, Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>), cellular potency (SJSA-1 EdU IC<sub>50</sub> = 16 nM), and MDM2 selectivity over MDMX (MDMX HTRF IC<sub>50</sub> > 100 μM), as well as good pharmacokinetic properties.<a onclick="showRef(event, 'ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref30 ref31">(30, 31)</a> Compound <b>4</b> also shows robust antitumor activity in the SJSA-1 osteosarcoma xenograft study with a calculated ED<sub>50</sub> of 11 mg/kg. Compounds <b>4</b> and <b>1</b> exhibit comparable potency and efficacy. However, while glucuronidation is the main route of metabolism of <b>1</b>, inhibitor <b>4</b> is cleared primarily by oxidative pathways. Thus, <b>4</b> could provide for a viable alternative to <b>1</b> should a compound with a different metabolic profile or clearance mechanism be desired.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28426" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28426" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> General Chemistry</h3><div class="NLM_p">Reactions were conducted under an inert gas atmosphere (nitrogen or argon) at the temperature indicated. Commercial reagents and anhydrous solvents were used without further purification. Analytical thin layer chromatography (TLC) was performed on Analtech silica gel with organic binder 250 μm TLC plates. Removal of solvents was conducted by using a rotary evaporator, and residual solvent was removed from nonvolatile compounds using a vacuum manifold maintained at approximately 1 Torr. All yields reported are isolated yields. Preparative reversed-phase high pressure liquid chromatography (RP-HPLC) was performed using an Agilent 1100 Series HPLC and Phenomenex Gemini C18 column (5 μm, 100 mm ×30 mm i.d.), eluting with a binary solvent system A and B using a gradient elusion [A, H<sub>2</sub>O with 0.1% trifluoroacetic acid (TFA); B, CH<sub>3</sub>CN with 0.1% TFA] with UV detection at 220 nm. All final compounds were purified to ≥95% purity as determined by an Agilent 1100 Series HPLC with UV detection at 220 nm using the following method: Zorbax SB-C8 column (3.5 μm, 150 mm × 4.6 mm i.d.); mobile phase, A = H<sub>2</sub>O with 0.1% TFA and B = CH<sub>3</sub>CN with 0.1% TFA; gradient: 5–95% B (0.0–15.0 min); and flow rate, 1.5 mL/min. Low-resolution mass spectral (MS) data were determined on an Agilent 1100 Series LCMS with UV detection at 254 nm and a low resolution electrospray mode (ESI). High-resolution mass spectra (HRMS) were obtained on an Agilent 6510 Q-TOF MS with a Agilent 1200 LC on the front end. <sup>1</sup>H NMR spectra were obtained on a Bruker Avance III 500 (500 MHz) or Bruker Avance II 400 (400 MHz) spectrometer. Chemical shifts (δ) are reported in parts per million (ppm) relative to residual undeuterated solvent as an internal reference. The following abbreviations were used to explain the multiplicities: s = single; d = doublet, t = triplet, q = quartet, dd = doublet of doublets, dt = doublet of triplets, m = multiplet, and br = broad.</div><div id="sec5_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14"> 2-((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-1-(<i>tert</i>-Butylsulfonyl)butan-2-yl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)acetamide (<b>12</b>)</h4><div class="NLM_p last">To a solution of <b>5</b> (213 mg, 0.375 mmol) and <i>N</i>-methylmorpholine (57.7 μL, 0.524 mmol) in THF (1.87 mL) was added isobutyl chloroformate (58.8 μL, 0.450 mmol) at 0 °C. The cloudy colorless solution was stirred at 0 °C for 1 h. Then, 28% ammonia in water (50.6 μL, 0.749 mmol) was added to the mixture at 0 °C, and the resulting mixture was stirred at 0 °C for 3 h. The reaction mixture was extracted with ethyl acetate and water. The combined organic layer was dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated under reduced pressure to provide a crude product as a pale yellow solid. Purification by RP-HPLC (40% to 55% CH<sub>3</sub>CN/H<sub>2</sub>O in 25 min, flow rate = 45 mL/min) provided 2-((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-1-(<i>tert</i>-butylsulfonyl)butan-2-yl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)acetamide (160 mg, 0.282 mmol, 75% yield) (<b>12</b>) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.21–7.26 (m, 2H), 7.05–7.21 (m, 3H), 6.96–7.02 (m, 1H), 6.87 (dt, <i>J</i> = 6.4, 2.0 Hz, 1H), 6.79 (br. s., 1H), 6.27 (br. s., 1H), 4.99 (d, <i>J</i> = 10.8 Hz, 1H), 4.08 (dd, <i>J</i> = 13.2, 11.1 Hz, 1H), 3.21–3.37 (m, 2H), 2.74–2.84 (m, 2H), 2.56–2.70 (m, 1H), 2.35 (t, <i>J</i> = 13.7 Hz, 1H), 2.14 (ddd, <i>J</i> = 14.2, 9.8, 7.2 Hz, 1H), 2.02 (dd, <i>J</i> = 13.7, 2.9 Hz, 1H), 1.49 (td, <i>J</i> = 7.0, 2.9 Hz, 1H), 1.44 (s, 9H), 1.43 (s, 3H), 0.41 (t, <i>J</i> = 7.5 Hz, 3H). Mass spectrum (ESI) <i>m</i>/<i>z</i> = 567.2 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> found 567.1841 [M + H]<sup>+</sup>, calcd for C<sub>28</sub>H<sub>36</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>4</sub>S 567.1851.</div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> 2-((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-1-(<i>tert</i>-Butylsulfonyl)butan-2-yl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)-<i>N</i>-((trifluoromethyl)sulfonyl)acetamide (<b>8</b>)</h4><div class="NLM_p last">A solution of <b>5</b> (50 mg, 0.088 mmol) and trifluoromethanesulfonamide (52.4 mg, 0.32 mmol) in DMF (0.281 mL) was treated with HATU (134 mg, 0.352 mmol) and diisopropylethylamine (0.092 mL, 0.528 mmol) successively. Then, the reaction was stirred at room temperature for 5 h. After this period, the crude mixture was diluted in 5 mL of 1 N HCl, then 30 mL of water, and extracted with diethyl ether (3 × 30 mL). The combined organic layers were dried over MgSO<sub>4</sub> and filtered, and the filtrate was concentrated under vacuum. Purification by RP-HPLC (25–75% AcCN/H<sub>2</sub>O in 30 min) provided 2-((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-1-(<i>tert</i>-butylsulfonyl)butan-2-yl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)-<i>N</i>-((trifluoromethyl)sulfonyl)acetamide (<b>8</b>) (25 mg, 0.036 mmol, 41% yield) as a white foam. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.27 (s, 4H), 7.05–7.18 (m, 2H), 6.94 (s, 1H), 6.78–6.86 (m, 1H), 4.92–5.11 (m, 1H), 3.95–4.13 (m, 1H), 3.30–3.44 (m, 1H), 3.19–3.29 (m, 1H), 2.92–3.08 (m, 1H), 2.77–2.86 (m, 1H), 2.60–2.71 (m, 1H), 2.45–2.58 (m, 1H), 2.11–2.27 (m, 1H), 1.78–1.89 (m, 1H), 1.51 (s, 3H), 1.45 (s, 9H), 0.42 (t, <i>J</i> = 7.53 Hz, 3H). Mass spectrum (ESI) <i>m</i>/<i>z</i> = 699.0 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> found 699.1346 [M + H]<sup>+</sup>, calcd for C<sub>29</sub>H<sub>35</sub>Cl<sub>2</sub>F<sub>3</sub>N<sub>2</sub>O<sub>6</sub>S<sub>2</sub> 699.1344.</div></div><div id="sec5_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> 2-((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-1-(<i>tert</i>-Butylsulfonyl)butan-2-yl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)acetonitrile (<b>51</b>)</h4><div class="NLM_p last">A solution of 2-((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-1-(<i>tert</i>-butylsulfonyl)butan-2-yl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)acetamide (<b>12</b>) (180 mg, 0.317 mmol) and triethylamine (221 μL, 1.586 mmol) in THF (2.64 mL) was treated with 2,2,2-trifluoroacetic anhydride (113 μL, 0.793 mmol) at 0 °C. After being stirred at 0 °C for 90 min, the reaction was quenched (sat. aq. NH<sub>4</sub>Cl), extracted (2 × EtOAc), and washed (brine). The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. Purification of the residue by combi-flash (24 g SiO<sub>2</sub>, 30% EtOAc/Hex) provided 2-((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-1-(<i>tert</i>-butylsulfonyl)butan-2-yl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)acetonitrile (<b>51</b>) (160 mg, 0.291 mmol, 92% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.21–7.26 (m, 2H), 7.06–7.21 (m, 4H), 6.99 (s, 1H), 6.85–6.90 (m, 1H), 4.99 (d, <i>J</i> = 10.8 Hz, 1H), 4.07 (dd, <i>J</i> = 13.3, 11.0 Hz, 1H), 3.20–3.36 (m, 2H), 2.95 (d, <i>J</i> = 16.8 Hz, 1H), 2.77 (dd, <i>J</i> = 13.2, 2.2 Hz, 1H), 2.72 (d, <i>J</i> = 16.8 Hz, 1H), 2.42 (t, <i>J</i> = 14.0 Hz, 1H), 2.13 (ddd, <i>J</i> = 14.3, 9.9, 7.3 Hz, 1H), 2.05 (dd, <i>J</i> = 14.1, 2.9 Hz, 1H), 1.47–1.54 (m, 1H), 1.46 (s, 3H), 1.43 (s, 9H), 0.41 (t, <i>J</i> = 7.5 Hz, 3H). Mass spectrum (ESI) <i>m</i>/<i>z</i> = 549.2 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> (3<i>R</i>,5<i>R</i>,6<i>S</i>)-3-((1<i>H</i>-Tetrazol-5-yl)methyl)-1-((<i>S</i>)-1-(<i>tert</i>-butylsulfonyl)butan-2-yl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methylpiperidin-2-one (<b>6</b>)</h4><div class="NLM_p last">To a solution of 2-((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-1-(<i>tert</i>-butylsulfonyl)butan-2-yl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)acetonitrile (<b>51</b>) (57 mg, 0.104 mmol) in DMF (259 μL) was added sodium azide (67.4 mg, 1.037 mmol) and ammonium chloride (55.5 mg, 1.037 mmol). The resulting mixture was stirred at 90 °C for 5 days. Then, the reaction was acidified (aq. 10% citric acid), extracted (2 × EtOAc), and washed (brine). The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. Purification by RP-HPLC (40% to 55% CH<sub>3</sub>CN/H<sub>2</sub>O, 0.1% TFA each, in 25 min, flow rate = 45 mL/min) provided (3<i>R</i>,5<i>R</i>,6<i>S</i>)-3-((1H-tetrazol-5-yl)methyl)-1-((<i>S</i>)-1-(<i>tert</i>-butylsulfonyl)butan-2-yl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methylpiperidin-2-one (<b>6</b>) (40 mg, 0.068 mmol, 65% yield) as a white foam. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.20–7.27 (m, 2H), 7.10–7.17 (m, 2H), 7.00 (d, <i>J</i> = 1.8 Hz, 3H), 6.88 (d, <i>J</i> = 6.7 Hz, 1H), 5.03 (d, <i>J</i> = 10.6 Hz, 1H), 4.10 (t, <i>J</i> = 12.0 Hz, 1H), 3.55–3.62 (m, 1H), 3.42 (d, <i>J</i> = 16.0 Hz, 1H), 3.3–3.39 (m, 1H), 3.14 (t, <i>J</i> = 11.3 Hz, 1H), 2.84 (d, <i>J</i> = 13.3 Hz, 1H), 2.57 (t, <i>J</i> = 13.8 Hz, 1H), 2.10–2.24 (m, 1H), 1.95–2.02 (m, 1H), 1.46 (s, 9H), 1.36–1.43 (m, 1H), 1.32 (s, 3H), 0.42 (t, <i>J</i> = 7.5 Hz, 3H). Mass spectrum (ESI) <i>m</i>/<i>z</i> = 592.2 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> found 592.1913 [M + H]<sup>+</sup>, calcd for C<sub>28</sub>H<sub>35</sub>Cl<sub>2</sub>N<sub>5</sub>O<sub>3</sub>S 592.1916.</div></div><div id="sec5_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> 2-((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-1-(<i>tert</i>-Butylsulfonyl)butan-2-yl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)-<i>N</i>′-hydroxyacetimidamide (<b>52</b>)</h4><div class="NLM_p last">A round-bottomed flask equipped with a reflux condensor was charged with a suspension of 2-((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-1-(<i>tert</i>-butylsulfonyl)butan-2-yl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)acetonitrile (<b>51</b>) (0.100 g, 0.182 mmol) and hydroxyammonium chloride (0.011 mL, 0.273 mmol) in MeOH (4 mL). Then, sodium hydrogencarbonate (0.023 g, 0.273 mmol) was added. The reaction was refluxed overnight. The reaction was cooled to room temperature and quenched (sat. aq. NH<sub>4</sub>Cl), extracted (2 × EtOAc), and washed (brine). The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The compound was used on the next step without further purification. Mass spectrum (ESI) <i>m</i>/<i>z</i> = 582.2 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> 3-(((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-1-(<i>tert</i>-Butylsulfonyl)butan-2-yl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)methyl)-1,2,4-oxadiazol-5(4<i>H</i>)-one (<b>7</b>)</h4><div class="NLM_p last">To a solution of 2-((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-1-(<i>tert</i>-butylsulfonyl)butan-2-yl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)-<i>N</i>′-hydroxyacetimidamide (<b>52</b>) (0.090 g, 0.154 mmol) in dioxane (2 mL) was added DBU (0.069 mL, 0.463 mmol) via syringe followed by 1,1′-carbonyldiimidazole (0.075 g, 0.463 mmol). The reaction was refluxed for 2 days. After this period, the reaction mixture was allowed to cool to room temperature. The crude was quenched with water (25 mL). Extracted with EtOAc (100 mL) and the organic layer washed with brine (10 mL). The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The crude product was purified by reversed phase preparatory HPLC (GeminiTM Prep C18 5 mm column; Phenomenex, Torrance, CA) (eluent, 40–65% CH<sub>3</sub>CN/H<sub>2</sub>O, 0.1% TFA each, 30 min) to provide 3-(((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-1-(<i>tert</i>-butylsulfonyl)butan-2-yl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)methyl)-1,2,4-oxadiazol-5(4<i>H</i>)-one (<b>7</b>) (0.014 g, 0.023 mmol, 15% yield over last two steps). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 10.30 (s, 1H), 7.27 (m, 4H), 7.09–7.20 (m, 2H), 6.96 (s, 1H), 6.85 (d, <i>J</i> = 7.09 Hz, 1H), 5.00 (d, <i>J</i> = 10.76 Hz, 1H), 4.02 (t, <i>J</i> = 12.10 Hz, 1H), 3.34 (m, 1H), 3.22 (d, <i>J</i> = 15.65 Hz, 1H), 3.06 (ddd, <i>J</i> = 13.69, 10.88, 2.57 Hz, 1H), 2.74–2.84 (m, 2H), 2.58 (t, <i>J</i> = 13.82 Hz, 1H), 2.14 (ddd, <i>J</i> = 14.12, 9.84, 7.58 Hz, 1H), 1.87 (dd, <i>J</i> = 13.82, 2.57 Hz, 2H), 1.30–1.54 (m, 12H), 0.42 (t, <i>J</i> = 7.46 Hz, 3H). Mass spectrum (ESI) <i>m</i>/<i>z</i> = 608.2 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> found 608.1758 [M + H]<sup>+</sup>, calcd for C<sub>29</sub>H<sub>35</sub>Cl<sub>2</sub>N<sub>3</sub>O<sub>5</sub>S 608.1753.</div></div><div id="sec5_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> 3-((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-Butylsulfonyl)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)-2-oxopropanoic Acid (<b>10</b>)<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a></h4><div class="NLM_p">Part A: A solution of 2-((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylsulfonyl)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)acetic acid (<b>9</b>) (300 mg, 0.517 mmol) and 1-(cyanomethyl)tetrahydro-1<i>H</i>-thiophen-1-ium bromide (161 mg, 0.775 mmol) in DCM (5167 μL) was treated with HATU (236 mg, 0.620 mmol) and DIEA (269 μL, 1.550 mmol) at room temperature. The reaction was stirred at this temperature for 4 h. After this period, the reaction was quenched (sat. aq. NH<sub>4</sub>Cl), extracted (2 × EtOAc), and washed (brine). The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. Purification by combi-flash (12 g SiO<sub>2</sub>, 0% to 70% acetone/ethyl acetate) provided the intermediate cyanosulfur ylide (356 mg, 0.516 mmol, 100% yield). Mass spectrum (ESI) <i>m</i>/<i>z</i> = 689.2 [M + H]<sup>+</sup>.</div><div class="NLM_p last">Part B: To a solution of the sulfur ylide formed in part A (356 mg, 0.516 mmol) in DMF (3.44 mL) and water (1.72 mL) was added oxone (635 mg, 1.032 mmol) at room temperature. The reaction was stirred for 2.5 h. After this period, the reaction was quenched (2.5 mL, 1 N aq. HCl), extracted (2 × EtOAc), and washed (brine). The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. Purification of the crude product by RP-HPLC (45 to 65% CH<sub>3</sub>CN/H<sub>2</sub>O, both containing 0.1% TFA, in 30 min, flow rate = 45 mL/min) provided 3-((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylsulfonyl)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)-2-oxopropanoic acid (<b>10</b>) (200 mg, 0.329 mmol, 64% yield) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.88–8.09 (m, 1H), 7.51 (m, <i>J</i> = 12.5 Hz, 1H), 6.69–7.16 (m, 6H), 4.91 (d, <i>J</i> = 10.6 Hz, 1H), 4.13–4.21 (m, 1H), 4.03 (d, <i>J</i> = 11.0 Hz, 1H), 3.29–3.41 (m, 1H), 2.85 (d, <i>J</i> = 12.5 Hz, 1H), 2.66–2.79 (m, 1H), 2.50 (t, <i>J</i> = 13.1 Hz, 1H), 2.23 (d, <i>J</i> = 11.2 Hz, 1H), 1.67–1.85 (m, 2H), 1.43 (br. s., 3H), 1.41 (s, 9H), 0.25–0.46 (m, 2H), −0.45– –0.24 (m, 1H), −1.19– –1.01 (m, 1H). Mass spectrum (ESI) <i>m</i>/<i>z</i> = 608.2 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> found 608.1630 [M + H]<sup>+</sup>, calcd for C<sub>30</sub>H<sub>35</sub>Cl<sub>2</sub>NO<sub>6</sub>S 608.1640.</div></div><div id="sec5_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> 2-((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-Butylsulfonyl)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)acetamide (<b>13</b>)</h4><div class="NLM_p last">To a solution of 2-((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylsulfonyl)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)acetic acid (<b>9</b>) (300 mg, 0.517 mmol), HATU (393 mg, 1.033 mmol) and <i>N</i>,<i>N</i>-diisopropylethylamine (0.270 mL, 1.550 mmol) in DMF (1.00 mL) was added a 7 N ammonia solution in methanol (0.369 mL, 2.58 mmol). The reaction was stirred at 40 °C for 1 h. The crude material was concentrated and absorbed onto a plug of silica gel and purified by chromatography through a Redi-Sep prepacked silica gel column (40 g), eluting with a gradient of 0% to 40% acetone/MeOH (9:1) in DCM, to provide 2-((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylsulfonyl)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)acetamide (<b>13</b>) (264 mg, 0.456 mmol, 88% yield). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.27 (s, 2H), 7.04–7.18 (m, 2H), 6.96–7.04 (m, 1H) 6.92–6.96 (m, 1H), 6.71–6.92 (m, 1H), 6.43–6.63 (m, 1H), 5.44–5.63 (m, 1H), 4.96 (d, <i>J</i> = 10.8 Hz, 1H), 4.13 (q, <i>J</i> = 7.2 Hz, 1H), 3.32 (s, 1H), 2.96 (s, 1H), 2.89 (s, 1H), 2.81 (s, 1H), 2.57–2.80 (m, 3H), 2.38 (s, 1H), 2.05 (s, 2H), 1.97–2.08 (m, 1H), 1.36–1.51 (m, 12H), 1.27 (t, <i>J</i> = 7.2 Hz, 2H). Mass spectrum (ESI) <i>m</i>/<i>z</i> = 579.0 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> found 579.1851 [M + H]<sup>+</sup>, calcd for C<sub>29</sub>H<sub>36</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>4</sub>S 579.1851.</div></div><div id="sec5_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> 2-((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-Butylsulfonyl)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)acetonitrile (<b>53</b>)</h4><div class="NLM_p last">A solution of 2-((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylsulfonyl)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)acetamide (<b>13</b>) (125 mg, 0.216 mmol) and triethylamine (0.150 mL, 1.078 mmol) in tetrahydrofuran (3 mL) was treated with trifluoroacetic anhydride (0.075 mL, 0.539 mmol) at 0 °C. After being stirred at 0 °C overnight, the reaction was quenched with water (10 mL), extracted (3 × 10 mL EtOAc), and washed with brine (10 mL). The combined organic layer was dried (MgSO<sub>4</sub>) and concentrated under reduced pressure. The crude product was purified by flash chromatography (acetone/hexanes: 0–50%) to give 2-((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylsulfonyl)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)acetonitrile (<b>53</b>) (92 mg, 0.164 mmol, 90% yield). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.27 (s, 2H), 7.11–7.20 (m, 3H), 7.11 (s, 1H), 6.94–7.05 (m, 1H), 6.86–6.94 (m, 1H), 4.95 (d, <i>J</i> = 10.5 Hz, 1H), 4.13 (d, <i>J</i> = 7.1 Hz, 1H), 3.20 (s, 1H), 2.98 (s, 1H), 3.01 (s, 1H), 2.80 (s, 1H), 2.84 (m, 2H), 2.48 (s, 1H), 2.05 (s, 1H), 2.03 (dd, <i>J</i> = 13.9, 3.2 Hz, 2H), 1.48 (s, 3H), 1.44 (s, 9H), 1.27 (t, <i>J</i> = 7.2 Hz, 2H). Mass spectrum (ESI) <i>m</i>/<i>z</i> = 561.2 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> Ethyl 2-((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-Butylsulfonyl)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)acetimidate (<b>54</b>)</h4><div class="NLM_p last">A solution of 2-((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylsulfonyl)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)acetonitrile (<b>53</b>) (90 mg, 0.160 mmol) in ethanol (1.603 mL) was bubbled with HCl for 15 min. The reaction was stirred overnight reaching complete conversion. The crude was concentrated and used in the next step without further purification. Mass spectrum (ESI) <i>m</i>/<i>z</i> = 607.2 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> 1-Amino-2-((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylsulfonyl)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)ethaniminium (<b>55</b>)</h4><div class="NLM_p last">A solution of <b>54</b> (0.097 g, 0.160 mmol) in ethanol (1.6 mL) was bubbled with ammonia for 30 min. The reaction was allowed to stir for 3 h at room temperature when complete conversion to the desired product was observed. The crude was concentrated and used in the next step without further purification. Mass spectrum (ESI) <i>m</i>/<i>z</i> = 578.3 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 2-((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-Butylsulfonyl)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)ethanethioamide (<b>56</b>)</h4><div class="NLM_p last">To a solution of 2-((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylsulfonyl)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)acetonitrile (<b>53</b>) (100 mg, 0.178 mmol) in ethanol (1.781 mL) was added diphosphorus pentasulfide (0.076 mL, 0.712 mmol), and the reaction was allowed to stir at 90 °C overnight. After this period, the crude material was concentrated and adsorbed onto a plug of silica gel and purified by chromatography through a Redi-Sep prepacked silica gel column (40 g), eluting with a gradient of 0% to 100% acetone in DCM, to provide 2-((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylsulfonyl)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)ethanethioamide (<b>56</b>) (70 mg, 0.118 mmol, 66% yield). Mass spectrum (ESI) <i>m</i>/<i>z</i> = 595.0 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 2-(((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-Butylsulfonyl)-1-cyclopropylethyl)-6-(4-chloro-3-fluorophenyl)-5-(3-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)methyl)pyrimidine-5-carboxylic Acid (<b>28</b>)</h4><div class="NLM_p">Part A: A solution of 1-amino-2-((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylsulfonyl)-1-cyclopropylethyl)-6-(4-chloro-3-fluorophenyl)-5-(3-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)ethaniminium (45 mg, 0.075 mmol) and ethyl-2-formyl-3-oxopropionate (0.109 mL, 0.753 mmol) in dimethylacetamide (1 mL) was heated in the microwave at 100 °C for 2 h. After this period, the reaction was concentrated, and the crude material was absorbed onto a plug of silica gel and purified by chromatography through a Redi-Sep prepacked silica gel column (12 g), eluting with a gradient of 0% to 50% 9:1 acetone/MeOH in DCM to provide ethyl 2-(((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylsulfonyl)-1-cyclopropylethyl)-6-(4-chloro-3-fluorophenyl)-5-(3-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)methyl)pyrimidine-5-carboxylate (35 mg, 0.050 mmol, 66% yield) as a yellow oil. Mass spectrum (ESI) <i>m</i>/<i>z</i> = 704.2 [M + H]<sup>+</sup>.</div><div class="NLM_p last">Part B: To a solution of ethyl 2-(((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylsulfonyl)-1-cyclopropylethyl)-6-(4-chloro-3-fluorophenyl)-5-(3-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)methyl)pyrimidine-5-carboxylate (35 mg, 0.050 mmol) in THF (2 mL) and MeOH (1 mL) was added lithium hydroxide (1.0 mL, 2 M). The solution was stirred at 50 °C for 30 min. After this period, the reaction was neutralized (2 mL/1 M HCl), concentrated, and diluted with MeOH (2 mL). Purification by prep HPLC (25–75% acetonitrile/water both solvents containing 0.1% TFA, in 30 min, flow rate =45 mL/min) provided 2-(((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylsulfonyl)-1-cyclopropylethyl)-6-(4-chloro-3-fluorophenyl)-5-(3-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)methyl)pyrimidine-5-carboxylic acid (<b>28</b>) (25 mg, 0.037 mmol, 74% yield) as a white amorphous solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.24 (s, 2H), 6.95–7.26 (m, 6H), 5.03 (d, <i>J</i> = 10.56 Hz, 1H), 4.37 (t, <i>J</i> = 11.84 Hz, 1H), 3.71 (d, <i>J</i> = 12.13 Hz, 1H), 3.44–3.56 (m, 1H), 3.38 (s, 1H), 2.91 (d, <i>J</i> = 11.74 Hz, 1H), 2.57–2.72 (m, 1H), 2.42 (t, <i>J</i> = 13.69 Hz, 1H), 1.81–1.94 (m, 2H), 1.75 (dd, <i>J</i> = 3.23, 13.60 Hz, 1H), 1.44 (s, 3H), 1.42 (s, 9H), 0.25–0.50 (m, 2H), −0.27 (br. s., 1H), −0.95 (br. s., 1H). Mass spectrum (ESI) <i>m</i>/<i>z</i> = 676.0 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> found 676.1809 [M+H]<sup>+</sup>, calcd for C<sub>33</sub>H<sub>36</sub>Cl<sub>2</sub>FN<sub>3</sub>O<sub>5</sub>S 676.1815.</div></div><div id="sec5_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 2-(((3<i>R</i>,5<i>R</i>,6<i>S</i>)-5-(3-Chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)methyl)pyrimidine-5-carboxylic Acid (<b>27</b>)</h4><div class="NLM_p last">Compound <b>27</b> was prepared according to a similar procedure described for the synthesis of <b>28</b>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 9.17 (s, 2H), 7.04–7.27 (m, 3H), 6.88–7.04 (m, 2H), 6.69–6.88 (m, 2H), 6.56–6.69 (m, 1H), 4.56 (d, <i>J</i> = 10.8 Hz, 1H), 4.52 (s, 1H), 3.57 (d, <i>J</i> = 12.7 Hz, 1H), 3.45 (d, <i>J</i> = 12.7 Hz, 1H), 3.17 (br. s., 1H), 3.03–3.14 (m, 1H), 2.88 (d, <i>J</i> = 13.7 Hz, 1H), 2.50 (d, <i>J</i> = 13.4 Hz, 1H), 2.24–2.41 (m, 1H), 1.95–2.18 (m, 3H), 1.26–1.53 (m, 9H), 1.14–1.34 (m, 2H), 0.86–1.05 (m, 1H), 0.63–0.86 (m, 1H). Mass spectrum (ESI) <i>m</i>/<i>z</i> = 658.2 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> found 658.1913 [M + H]<sup>+</sup>, calcd for C<sub>33</sub>H<sub>37</sub>Cl<sub>2</sub>N<sub>3</sub>O<sub>5</sub>S 658.1909.</div></div><div id="sec5_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 2-(2-(((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-Butylsulfonyl)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)methyl)-1<i>H</i>-imidazol-4-yl)acetic Acid (<b>45</b>)</h4><div class="NLM_p last">To a solution of 2-((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylsulfonyl)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)acetimidamide (<b>55</b>) (80 mg, 0.138 mmol) in acetonitrile (1 mL) was added ethyl trans-4-oxo-2-butenoate (21.26 μL, 0.166 mmol), and the mixture was heated to 130 °C for 1 h in the microwave. The reaction was concentrated and diluted in THF (1 mL) and MeOH (1 mL), and LiOH (1 mL, 2 M) was added, and the reaction was stirred at 50 °C for 1 h. After this period, the reaction was cooled and concentrated, diluted in MeOH, and filtered. Purification by RP-HPLC (25–75% CH<sub>3</sub>CN/H<sub>2</sub>O both solvents containing 0.1% TFA, 30 min, flow rate = 45 mL/min) provided <b>45</b> (8 mg, 8% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.10–7.56 (m, 1H), 6.87 (d, <i>J</i> = 12.13 Hz, 7H), 4.58–4.83 (m, 1H), 3.92–4.21 (m, 2H), 3.40–3.73 (m, 3H), 3.05–3.32 (m, 2H), 2.49–2.80 (m, 2H), 2.11–2.39 (m, 1H), 1.42–1.68 (m, 2H), 1.07–1.36 (m, 12H), −0.16–0.28 (m, 2H), −0.74– –0.43 (m, 1H), −1.55– –1.16 (m, 1H). Mass spectrum (ESI) <i>m</i>/<i>z</i> = 660.2 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 2-(5-(((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-Butylsulfonyl)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)methyl)-4<i>H</i>-1,2,4-triazol-3-yl)acetic Acid (<b>44</b>)</h4><div class="NLM_p">Part A: A solution of ethyl 2-((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylsulfonyl)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)acetimidate (<b>55</b>) (95 mg, 0.156 mmol) and ethyl 3-hydrazinyl-3-oxopropanoate (27.4 mg, 0.188 mmol) in EtOH was heated to 75 °C and stirred overnight. The crude material was concentrated and absorbed onto a plug of silica gel and purified by chromatography through a Redi-Sep prepacked silica gel column (12 g), eluting with a gradient of 0% to 40% acetone/MeOH (9:1) in DCM, to provide ethyl 2-(5-(((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylsulfonyl)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)methyl)-4<i>H</i>-1,2,4-triazol-3-yl)acetate (68 mg, 0.099 mmol, 63% yield) as a light-yellow solid. Mass spectrum (ESI) <i>m</i>/<i>z</i> = 689.0 [M + H]<sup>+</sup>.</div><div class="NLM_p last">Part B: To a solution of ethyl 2-(5-(((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylsulfonyl)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)methyl)-4<i>H</i>-1,2,4-triazol-3-yl)acetate (68 mg, 0.099 mmol) in THF (0.5 mL)/methanol (0.5 mL)/water (0.5 mL) was added lithium hydroxide (1 mL, 2 M). The reaction was stirred for 30 min at 50 °C. After this time, the reaction was quenched with 10% citric acid solution (5 mL), diluted in water (10 mL), and washed with ether (3 × 15 mL). The combined organic layer was dried over MgSO<sub>4</sub>, filtered, and concentrated. Purification by RP-HPLC (25–75% CH<sub>3</sub>CN/H2O both solvents containing 0.1% TFA, 30 min, flow rate = 45 mL/min) provided 2-(5-(((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylsulfonyl)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)methyl)-4<i>H</i>-1,2,4-triazol-3-yl)acetic acid (<b>44</b>) (47 mg, 0.071 mmol, 72% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.31–7.75 (bs, 2H), 6.89–7.25 (m, 6H), 4.96 (d, <i>J</i> = 10.56 Hz, 1H), 4.27 (t, <i>J</i> = 12.03 Hz, 1H), 4.06 (br. s., 3H), 3.34–3.68 (m, 2H), 2.91 (d, <i>J</i> = 12.72 Hz, 1H), 2.64–2.83 (m, 1H), 2.44 (t, <i>J</i> = 14.28 Hz, 1H), 1.75–1.90 (m, 2H), 1.58–1.73 (m, 1H), 1.44 (s, 9H), 1.40 (br. s., 3H), 1.31–1.37 (m, 1H), 0.31–0.49 (m, 1H), 0.05–0.29 (m, 1H), −0.50– –0.18 (m, 1H), −1.48– –0.99 (m, 1H). Mass spectrum (ESI) <i>m</i>/<i>z</i> = 661.0 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 2-(((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-Butylsulfonyl)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)methyl)thiazole-4-carboxylic Acid (<b>32</b>)</h4><div class="NLM_p last">To a mixture of 2-((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylsulfonyl)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)ethanethioamide (<b>56</b>) (90 mg, 0.151 mmol) and potassium bicarbonate (121 mg, 1.209 mmol) was added dry dioxane (1 mL) and ethyl bromopyruvate (0.0568 mL, 0.453 mmol). The reaction was allowed to stir under argon for 3 h. After this period, the mixture was cooled to 0 °C, and a solution of trifluoroacetic acid anhydride (0.084 mL, 0.604 mmol) and pyridine (0.111 mL, 1.360 mmol) in dioxane (1 mL) was added. The reaction was allowed to warm to room temperature overnight. The crude was washed with brine (30 mL) and diethyl ether (3 × 30 mL). The combined organic layers were dried over magnesium sulfate, filtered, and concentrated. The crude material was absorbed onto a plug of silica gel and purified by chromatography through a Redi-Sep prepacked silica gel column (12 g), eluting with a gradient of 0% to 50% acetone in DCM, to provide the intermediate ester (Mass spectrum (ESI) <i>m</i>/<i>z</i> = 691.2 [M + H]<sup>+</sup>). This material was diluted with THF (2 mL), MeOH (1 mL), and LiOH (1 mL, 2 M). The mixture was stirred at 50 °C for 1 h, then cooled, neutralized with 1 M HCl (2 mL), and concentrated. Purification of the crude product by RP-HPLC (45 to 65% AcCN/H2O, both containing 0.1% TFA, in 30 min, flow rate = 45 mL/min) provided 2-(((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylsulfonyl)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)methyl)thiazole-4-carboxylic acid (<b>32</b>) (22 mg, 0.033 mmol, 22% yield over the last two steps). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.16 (s, 1H), 7.08–7.17 (m, 1H), 6.99–7.06 (m, 3H), 6.94 (s, 2H), 6.68–6.86 (m, 2H), 4.92 (d, <i>J</i> = 10.56 Hz, 1H), 4.21–4.39 (m, <i>J</i> = 12.52 Hz, 1H), 3.61 (d, <i>J</i> = 14.28 Hz, 1H), 3.41 (d, <i>J</i> = 14.28 Hz, 1H), 3.04–3.19 (m, <i>J</i> = 16.43 Hz, 1H), 2.85 (d, <i>J</i> = 13.89 Hz, 1H), 2.26 (t, <i>J</i> = 13.89 Hz, 2H), 1.65–1.91 (m, 2H), 1.36 (s, 9H), 1.33 (s, 3H), 0.25–0.43 (m, 1H), 0.05–0.23 (m, 1H), −0.54– –0.24 (m, 1H), −1.31– –0.98 (m, 1H). Mass spectrum (ESI) <i>m</i>/<i>z</i> = 663.0 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> found 663.1518 [M + H]<sup>+</sup>, calcd for C<sub>32</sub>H<sub>36</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>5</sub>S<sub>2</sub> 663.1521.</div></div><div id="sec5_1_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 2-(((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-Butylsulfonyl)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)methyl)thiazole-5-carboxylic Acid (<b>33</b>)</h4><div class="NLM_p">Part A: A solution of 2-((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylsulfonyl)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)ethanethioamide (<b>56</b>) (100 mg, 0.168 mmol) and ethyl 2-chloro-3-oxopropanoate (50.6 mg, 0.336 mmol) in toluene (1 mL) was stirred at 100 °C in the microwave for 5 h. After this period, the crude was concentrated and absorbed onto a plug of silica gel and purified by chromatography through a Redi-Sep prepacked silica gel column (40 g), eluting with a gradient of 0% to 40% acetone in DCM, to provide ethyl 2-(((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylsulfonyl)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)methyl)thiazole-5-carboxylate (77 mg, 0.111 mmol, 66% yield) as a light yellow solid. Mass spectrum (ESI) <i>m</i>/<i>z</i> = 691.0 [M + H]<sup>+</sup>.</div><div class="NLM_p last">Part B: To a solution of methyl 2-(((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylsulfonyl)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)methyl)thiazole-5-carboxylate (77 mg, 0.114 mmol) in THF (2 mL) and MeOH (1 mL) was added lithium hydroxide (2 mL, 2 M). After this period, the reaction was neutralized (4 mL, 1 M HCl) and concentrated. Purification of the crude product by RP-HPLC (45% to 65% AcCN/H<sub>2</sub>O, both containing 0.1% TFA, in 30 min, flow rate = 45 mL/min) provided 2-(((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylsulfonyl)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)methyl)thiazole-5-carboxylic acid (<b>33</b>) (64 mg, 0.096 mmol, 85% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.46 (s, 1H), 7.28 (br. s., 4H), 7.11 (d, <i>J</i> = 4.50 Hz, 2H), 7.01 (s, 1H), 6.90 (br. s., 1H), 5.00 (d, <i>J</i> = 10.76 Hz, 1H), 4.29–4.51 (m, <i>J</i> = 13.50 Hz, 1H), 3.72 (d, <i>J</i> = 14.08 Hz, 1H), 3.56 (d, <i>J</i> = 13.89 Hz, 1H), 3.24 (t, <i>J</i> = 12.91 Hz, 1H), 2.95 (d, <i>J</i> = 13.50 Hz, 1H), 2.64–2.79 (m, 1H), 2.35 (t, <i>J</i> = 13.79 Hz, 1H), 1.75–2.06 (m, 2H), 1.40–1.50 (m, 12H), 0.24–0.48 (m, 2H), −0.28 (br. s., 1H), −1.00 (br. s., 1H). Mass spectrum (ESI) <i>m</i>/<i>z</i> = 663.0 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> found 663.1522 [M + H]<sup>+</sup>, calcd for C<sub>32</sub>H<sub>36</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>5</sub>S<sub>2</sub> 663.1521.</div></div><div id="sec5_1_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 2-(2-(((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-Butylsulfonyl)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)methyl)thiazol-4-yl)acetic Acid (<b>37</b>)</h4><div class="NLM_p">Part A: To a solution of 2-((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylsulfonyl)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)ethanethioamide (<b>56</b>) (70 mg, 0.118 mmol) in ethanol (1.2 mL) was added 4-chloroacetoacetic acid methyl ester (70.8 μL, 0.470 mmol), and the mixture was stirred at 90 °C for 3 h. The crude was concentrated and taken onto the next step without further purification. Mass spectrum (ESI) <i>m</i>/<i>z</i> = 691.0 [M + H]<sup>+</sup>.</div><div class="NLM_p last">Part B: To a solution of methyl 2-(2-(((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylsulfonyl)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)methyl)thiazol-4-yl)acetate (from Part A) in MeOH (1 mL) and THF (1 mL) was added lithium hydroxide (1 mL, 2 M) and stirred at 50 °C for 1 h. After this period, 2 mL of 1 N HCL was added, and the crude was concentrated. The crude material was absorbed onto a plug of silica gel and purified by chromatography through a Redi-Sep prepacked silica gel column (12 g), eluting with a gradient of 0% to 40% MeOH/acetone (1:9 with 1% acetic acid) and DCM, to provide 2-(2-(((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylsulfonyl)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)methyl)thiazol-4-yl)acetic acid (<b>37</b>) (45 mg, 0.066 mmol, 57% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 6.81–7.25 (m, 8H), 4.97 (d, <i>J</i> = 10.76 Hz, 1H), 4.24–4.55 (m, 1H), 3.86 (d, <i>J</i> = 1.37 Hz, 2H), 3.68 (d, <i>J</i> = 14.09 Hz, 1H), 3.41 (d, <i>J</i> = 14.09 Hz, 1H), 3.13–3.26 (m, 1H), 2.87–2.96 (m, 1H), 2.62–2.73 (m, 1H), 2.20–2.29 (m, 1H), 2.15–2.19 (m, 1H), 1.76–1.85 (m, 1H), 1.43 (s, 9H), 1.38 (s, 3H), 0.10–0.45 (m, 2H), −0.56– –0.21 (m, 1H), −1.22– –0.95 (m, 1H). Mass spectrum (ESI) <i>m</i>/<i>z</i> = 677.0 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> found 677.1682 [M + H]<sup>+</sup>, calcd for C<sub>33</sub>H<sub>38</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>5</sub>S<sub>2</sub> 667.1677.</div></div><div id="sec5_1_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 2-(((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-Butylsulfonyl)-1-cyclopropylethyl)-6-(4-chloro-3-fluorophenyl)-5-(3-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)methyl)thiazole-5-carboxylic Acid (<b>35</b>)</h4><div class="NLM_p last">Compound <b>35</b> was prepared in a manner similar to a procedure described for the synthesis of <b>33</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.36 (s, 1H), 7.09–7.18 (m, 1H), 7.02 (dd, <i>J</i> = 1.37, 3.72 Hz, 2H), 6.90–6.96 (m, 1H), 6.76–6.86 (m, 1H), 6.34–6.73 (m, 3H), 4.91 (d, <i>J</i> = 10.56 Hz, 1H), 4.32 (t, <i>J</i> = 12.03 Hz, 1H), 3.63 (d, <i>J</i> = 13.89 Hz, 1H), 3.43 (d, <i>J</i> = 13.89 Hz, 1H), 3.06 (t, <i>J</i> = 11.64 Hz, 1H), 2.86 (d, <i>J</i> = 12.32 Hz, 1H), 2.60 (t, <i>J</i> = 9.19 Hz, 1H), 2.23 (t, <i>J</i> = 13.89 Hz, 1H), 1.87 (br. s., 1H), 1.36 (s, 9H), 1.35 (br. s., 3H), 0.30 (br. s., 2H), −0.34 (br. s., 1H), −1.05 (br. s., 1H). Mass spectrum (ESI) <i>m</i>/<i>z</i> = 681.0 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> found 681.1429 [M + H]<sup>+</sup>, calcd for C<sub>32</sub>H<sub>35</sub>Cl<sub>2</sub>FN<sub>2</sub>O<sub>5</sub>S<sub>2</sub> 681.1427.</div></div><div id="sec5_1_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> (3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-Butylsulfonyl)-1-cyclopropylethyl)-6-(4-chloro-3-fluorophenyl)-5-(3-chlorophenyl)-3-methyl-3-(thiazol-2-ylmethyl)piperidin-2-one (<b>36</b>)</h4><div class="NLM_p last">Compound <b>36</b> was obtained as a side product during the synthesis of <b>41</b> and <b>42</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.81–7.97 (m, 1H), 7.31–7.53 (m, 3H), 7.10 (br. s., 5H), 4.96 (d, <i>J</i> = 10.37 Hz, 1H), 4.26–4.42 (m, <i>J</i> = 9.00 Hz, 1H), 3.77 (d, <i>J</i> = 10.76 Hz, 1H), 3.48–3.66 (m, 1H), 3.02–3.25 (m, 1H), 2.92 (d, <i>J</i> = 16.24 Hz, 1H), 2.60–2.76 (m, 1H), 2.18–2.36 (m, 1H), 1.88–2.05 (m, 1H), 1.44 (s, 12H), 0.36 (br. s., 2H), −0.28 (br. s., 1H), −0.97 (br. s., 1H). Mass spectrum (ESI) <i>m</i>/<i>z</i> = 637.0 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> found 637.1531 [M + H]<sup>+</sup>, calcd for C<sub>31</sub>H<sub>35</sub>Cl<sub>2</sub>FN<sub>2</sub>O<sub>3</sub>S<sub>2</sub> 637.1528.</div></div><div id="sec5_1_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> (5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-Butylthio)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-3-((2-(trimethylsilyl)ethoxy)methyl)piperidin-2-one (<b>58</b>)</h4><div class="NLM_p last">In a 25 mL round-bottomed flask evacuated and filled with argon was added THF (2 mL) and then diisopropylamine (0.703 mL, 5.02 mmol). This solution was cooled to −78 °C. At this temperature, butyllithium (2.0 mL, 4.89 mmol, 1 M) was added, and the mixture was allowed to stir for 30 min. In a separate flask, also evacuated and filled with argon, (5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylthio)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methylpiperidin-2-one (<b>57</b>) (600 mg, 1.223 mmol) was placed and diluted with THF (2 mL), and this solution was also cooled to −78 °C. To this, the solution of freshly produced LDA was added maintaining the temperature at −78 °C. The solution was allowed to slowly reach room temperature overnight. After this period, the mixture was quenched with sat. aq. ammonium chloride (50 mL) and was washed with diethyl ether (3 × 50 mL). The combined organic layer was dried over magnesium sulfate, filtered, and concentrated. The crude material was absorbed onto a plug of silica gel and purified by chromatography through a Redi-Sep prepacked silica gel column (80 g), eluting with a gradient of 0% to 50% acetone in hexanes, to provide (5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylthio)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-3-((2-(trimethylsilyl)ethoxy)methyl)piperidin-2-one (<b>58</b>) (393 mg, 0.633 mmol, 52% yield) as white oil and a 2:1 mixture of isomers. Mass spectrum (ESI) <i>m</i>/<i>z</i> = 620.2 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> (3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-Butylthio)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-(hydroxymethyl)-3-methylpiperidin-2-one (<b>59</b>)</h4><div class="NLM_p last">To a mixture of (5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylthio)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-3-((2-(trimethylsilyl)ethoxy)methyl)piperidin-2-one (<b>58</b>) (2:1 mixture of isomers) (0.393 g, 0.633 mmol) in DCM (6.33 mL), under argon, at 0 °C, was added BF<sub>3</sub>·OEt<sub>2</sub> (0.241 mL, 1.899 mmol). After 3 h, the crude was diluted with sat. aq. NaHCO<sub>3</sub> (20 mL). The aqueous layer was extracted with DCM (3 × 20 mL). The combined organic layers were washed with brine (20 mL), dried over magnesium sulfate, and concentrated. Purification by flash chromatography, (80 g) eluting with 10% to 20% acetone/hexanes, provided first (3<i>S</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylthio)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-(hydroxymethyl)-3-methylpiperidin-2-one (56 mg, 0.108 mmol, 17% yield) (fastest eluting isomer) and then (3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylthio)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-(hydroxymethyl)-3-methylpiperidin-2-one (<b>59</b>) (110 mg, 0.211 mmol, 33% yield) (slowest eluting isomer). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.04–7.41 (m, 7H), 6.90 (d, <i>J</i> = 7.24 Hz, 1H), 4.78 (d, <i>J</i> = 9.59 Hz, 1H), 3.82–4.08 (m, 1H), 3.81–4.15 (m, 1H), 3.38–3.63 (m, 2H), 2.44–3.01 (m, 2H), 2.21–2.37 (m, 1H), 2.05–2.16 (m, 1H), 1.52–1.99 (m, 2H), 1.37–1.45 (m, 9H), 1.33–1.37 (m, 3H), 0.44–0.61 (m, 1H), 0.29–0.43 (m, 1H), 0.01 (dd, <i>J</i> = 4.30, 8.80 Hz, 1H), −0.69 (br. s., 1H). Mass spectrum (ESI) <i>m</i>/<i>z</i> = 520.2 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> ((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-Butylthio)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)methyl Methanesulfonate (<b>60</b>)</h4><div class="NLM_p last">(3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-Butylthio)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-(hydroxymethyl)-3-methylpiperidin-2-one (<b>59</b>) (100 mg, 0.192 mmol) was dissolved in DCM (0.768 mL). Then, methanesulfonic anhydride (41.8 mg, 0.240 mmol) and triethylamine (0.0335 mL, 0.240 mmol) were added at room temperature. After stirring for 30 min, the crude was diluted with sat. aq. NaHCO<sub>3</sub> (10 mL) and extracted with DCM (2 × 20 mL). The combined organic layer was washed with brine, dried over magnesium sulfate, and concentrated. The product was used in the next step without further purification (quantitative yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.03–7.24 (m, 7H), 6.79–6.85 (m, 1H), 4.54–4.76 (m, 2H), 4.25 (d, <i>J</i> = 9.78 Hz, 1H), 3.77–3.98 (m, 1H), 3.26–3.44 (m, 1H), 3.06–3.17 (m, 3H), 2.50–2.62 (m, 1H), 2.37 (br. s., 1H), 2.09–2.27 (m, 1H), 1.20–1.41 (m, 12H), 0.36–0.57 (m, 1H), 0.15–0.34 (m, 1H), −0.20– –0.05 (m, 1H), −0.95– –0.67 (m, 1H). Mass spectrum (ESI) <i>m</i>/<i>z</i> = 598.2 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 1-(((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-Butylsulfonyl)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)methyl)-1<i>H</i>-pyrazole-4-carboxylic Acid (<b>31</b>)</h4><div class="NLM_p">Part A: To a solution of ((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylthio)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)methyl methanesulfonate (<b>60</b>) (115 mg, 0.192 mmol) in EtOH (2 mL) was added hydrazine (0.181 mL, 5.76 mmol), and the mixture was stirred in the microwave at 90 °C for 36 h. The conversion was about 40% toward the desired product (<b>61</b>). The reaction mixture was concentrated from toluene (10 mL). The concentrate was taken to the next step without further purification assuming 40% yield. Mass spectrum (ESI) <i>m</i>/<i>z</i> = 534.2 [M + H]<sup>+</sup>.</div><div class="NLM_p">Part B: A solution of (3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylsulfonyl)-1-cyclopropylethyl)-6-(4-chloro-3-fluorophenyl)-5-(3-chlorophenyl)-3-(hydrazinylmethyl)-3-methylpiperidin-2-one (<b>61</b>) (45 mg, 0.077 mmol) (containing starting material from the last step) and ethyl-2-formyl-3-oxopropionate (0.111 mL, 0.770 mmol) in dimethylacetamide (1 mL) was heated in the microwave at 100 °C for 2 h. After this period, the reaction was concentrated, and the crude material was absorbed onto a plug of silica gel and purified by chromatography through a Redi-Sep prepacked silica gel column (12 g), eluting with a gradient of 0% to 50% 9:1 acetone/MeOH in DCM to provide ethyl 1-(((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylthio)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)methyl)-1<i>H</i>-pyrazole-4-carboxylate (<b>62</b>) (19 mg, 0.030 mmol, 38% yield) as a yellow oil. Mass spectrum (ESI) <i>m</i>/<i>z</i> = 642.1 [M + H]<sup>+</sup>.</div><div class="NLM_p">Part C: To a solution of <b>62</b> (19 mg, 0.031 mmol) in DCM (1 mL) was added 3-chloroperoxybenzoic acid, (77%) (13.86 mg, 0.062 mmol) at 0 °C. After stirring for 30 min at this temperature, the reaction was quenched with sat. aq. sodium bicarbonate (2 mL), extracted with dichloromethane (3 × 10 mL), and brine (10 mL), and the combined organic layer was dried over magnesium sulfate. The crude mixture was concentrated.</div><div class="NLM_p last">The crude was then diluted in THF (2 mL) and MeOH (1 mL), and then lithium hydroxide (2 mL, 2 M) was added. After this period, the reaction was neutralized (4 mL, 1 M HCl) and concentrated. Purification of the crude product by RP-HPLC (45% to 65% AcCN/H2O, both containing 0.1% TFA, in 30 min, flow rate = 45 mL/min) provided 1-(((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylsulfonyl)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)methyl)-1H-pyrazole-4-carboxylic acid (<b>31</b>) (6 mg, 9.28 μmol, 30% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.10 (d, <i>J</i> = 9.39 Hz, 2H), 6.83–7.22 (m, 7H), 6.71–6.80 (m, 1H), 4.93 (d, <i>J</i> = 10.56 Hz, 1H), 4.81 (d, <i>J</i> = 13.89 Hz, 1H), 4.29–4.39 (m, 1H), 4.24 (d, <i>J</i> = 13.89 Hz, 1H), 2.92 (d, <i>J</i> = 11.35 Hz, 1H), 2.71 (t, <i>J</i> = 10.27 Hz, 1H), 2.34–2.47 (m, 1H), 2.24 (t, <i>J</i> = 13.79 Hz, 1H), 1.94–2.10 (m, 2H), 1.44 (s, 9H), 1.36–1.40 (m, 3H), 0.37 (d, <i>J</i> = 7.63 Hz, 2H), −0.33 (br. s., 1H), −0.94 (br. s., 1H). Mass spectrum (ESI) <i>m</i>/<i>z</i> = 646.2 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> found 646.1906 [M + H]<sup>+</sup>, calcd for C<sub>32</sub>H<sub>37</sub>Cl<sub>2</sub>N<sub>3</sub>O<sub>5</sub>S 646.1909.</div></div><div id="sec5_1_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> (3<i>S</i>,5<i>R</i>,6<i>S</i>)-3-(Bromomethyl)-1-((<i>S</i>)-2-(<i>tert</i>-butylthio)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methylpiperidin-2-one (<b>63</b>)</h4><div class="NLM_p last">(3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-Butylthio)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-(hydroxymethyl)-3-methylpiperidin-2-one (<b>59</b>) (326 mg, 0.626 mmol), carbon tetrabromide (312 mg, 0.939 mmol), and triphenylphosphine (246 mg, 0.939 mmol) were stirred in CH<sub>3</sub>CN (1.25 mL). After stirring overnight, the mixture was heated at 55 °C for 5 h. The resulting thick oil was diluted in DCM and concentrated onto silica gel. This was purified by flash chromatography (SiO<sub>2</sub>, 24 g), eluted with 0% to 15% ethyl acetate/hexanes, to provide (3<i>S</i>,5<i>R</i>,6<i>S</i>)-3-(bromomethyl)-1-((<i>S</i>)-2-(<i>tert</i>-butylthio)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methylpiperidin-2-one (<b>63</b>) (313 mg, 0.536 mmol, 86% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.05–7.25 (m, 5H), 6.90–7.03 (m, 2H), 6.83 (td, <i>J</i> = 1.49, 7.38 Hz, 1H), 4.68 (d, <i>J</i> = 10.37 Hz, 1H), 4.00 (d, <i>J</i> = 10.37 Hz, 1H), 3.78 (d, <i>J</i> = 10.37 Hz, 1H), 3.59 (t, <i>J</i> = 11.35 Hz, 1H), 3.05 (dt, <i>J</i> = 5.97, 10.51 Hz, 1H), 2.61 (dd, <i>J</i> = 4.50, 12.13 Hz, 1H), 2.12–2.23 (m, 2H), 1.39–1.43 (m, 3H), 1.33–1.37 (m, 9H), 1.30 (s, 2H), 0.35–0.51 (m, 1H), 0.16–0.30 (m, 1H), −0.15 (qd, J = 4.92, 9.88 Hz, 1H), −0.96– –0.82 (m, 1H). Mass spectrum (ESI) <i>m</i>/<i>z</i> = 584.0 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> (3<i>S</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-Butylthio)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-3-((pyrimidin-2-ylthio)methyl)piperidin-2-one (<b>64</b>)</h4><div class="NLM_p last">(3<i>S</i>,5<i>R</i>,6<i>S</i>)-3-(Bromomethyl)-1-((<i>S</i>)-2-(<i>tert</i>-butylthio)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methylpiperidin-2-one (<b>63</b>) (104 mg, 0.178 mmol), 2-mercapto-pyrimidine (19.99 mg, 0.178 mmol), and potassium carbonate (29.6 mg, 0.214 mmol) were stirred in DMF (0.5 mL). After stirring overnight, additional 12 mg of 2-mercaptopyrimidine and 30 mg of potassium carbonate were added. After 2 h, this was diluted with water and extracted with ethyl acetate. The organic layer was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated to provide (3<i>S</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylthio)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-3-((pyrimidin-2-ylthio)methyl)piperidin-2-one (<b>64</b>) (quantitative yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.59 (d, <i>J</i> = 4.89 Hz, 1H), 8.50 (d, <i>J</i> = 4.89 Hz, 2H), 7.01–7.25 (m, 6H), 6.80 (t, <i>J</i> = 1.86 Hz, 1H), 6.63–6.68 (m, 1H), 4.64 (d, <i>J</i> = 10.37 Hz, 1H), 4.19 (d, <i>J</i> = 14.09 Hz, 1H), 4.13 (q, <i>J</i> = 7.04 Hz, 1H), 3.52–3.87 (m, 1H), 3.30–3.45 (m, 1H), 2.60 (dd, <i>J</i> = 4.70, 12.13 Hz, 1H), 2.09–2.22 (m, 2H), 1.43 (s, 3H), 1.35 (s, 9H), 1.29 (s, 2H), 0.36–0.47 (m, 1H), 0.17–0.29 (m, 1H), −0.15 (dd, <i>J</i> = 4.70, 9.59 Hz, 1H), −0.91 (d, <i>J</i> = 4.89 Hz, 1H). Mass spectrum (ESI) <i>m</i>/<i>z</i> = 614.2 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> (3<i>S</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-Butylsulfonyl)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-3-((pyrimidin-2-ylsulfonyl)methyl)piperidin-2-one (<b>65</b>)</h4><div class="NLM_p last">(3<i>S</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-Butylthio)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-3-((pyrimidin-2-ylthio)methyl)piperidin-2-one (<b>64</b>) (119 mg, 0.194 mmol) was dissolved in THF (2 mL), and water (1 mL) and oxone (714 mg, 1.162 mmol) were added. After stirring overnight, the reaction mixture was diluted with water and extracted with ethyl acetate. The organic layer was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated. The crude was purified by preparatory TLC eluting with 30% acetone in hexanes to provide (3<i>S</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylsulfonyl)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-3-((pyrimidin-2-ylsulfonyl)methyl)piperidin-2-one (<b>65</b>) (62 mg, 0.091 mmol, 48% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.98 (d, <i>J</i> = 4.89 Hz, 2H), 7.55 (t, <i>J</i> = 4.89 Hz, 1H), 7.14–7.25 (m, 4H), 7.06–7.12 (m, 2H), 6.89–7.01 (m, 2H), 4.97 (d, <i>J</i> = 10.76 Hz, 1H), 4.25 (t, <i>J</i> = 12.42 Hz, 1H), 4.00–4.18 (m, 1H), 3.59 (dt, <i>J</i> = 4.11, 11.74 Hz, 1H), 2.88 (d, <i>J</i> = 14.48 Hz, 1H), 2.73 (br. s., 1H), 2.31–2.49 (m, 2H), 1.61 (s, 3H), 1.56 (br. s., 2H), 1.43 (s, 9H), 0.14–0.39 (m, 2H), −0.34 (br. s., 1H), −1.07 (br. s., 1H). Mass spectrum (ESI) <i>m</i>/<i>z</i> = 678.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> ((3<i>S</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-Butylsulfonyl)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)methanesulfonamide (<b>14</b>)</h4><div class="NLM_p last">(3<i>S</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-Butylsulfonyl)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-3-((pyrimidin-2-ylsulfonyl)methyl)piperidin-2-one (<b>65</b>) (24 mg, 0.035 mmol) and potassium carbonate (25 mg, 0.181 mmol) were stirred in MeOH (0.5 mL). After stirring overnight, complete conversion to the sulfinic acid was observed. Then, hydroxylamine-<i>o</i>-sulfonic acid (31 mg, 0.053 mmol) was added. After stirring overnight, the reaction mixture was diluted with water and extracted with ethyl acetate. The organic layer was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The crude was purified by preparative TLC eluted with 30% acetone/hexanes to provide ((3<i>S</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylsulfonyl)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)methanesulfonamide (<b>14</b>) (10 mg, 0.016 mmol, 46% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.05–7.24 (m, 6H), 7.00 (s, 1H), 6.89 (br. s., 1H), 5.38 (br. s., 2H), 4.96 (d, <i>J</i> = 10.56 Hz, 1H), 4.34 (t, <i>J</i> = 11.44 Hz, 1H), 3.45–3.74 (m, 2H), 3.31 (t, <i>J</i> = 11.15 Hz, 1H), 2.91 (d, <i>J</i> = 13.69 Hz, 1H), 2.73 (br. s., 1H), 2.46 (t, <i>J</i> = 13.60 Hz, 1H), 1.95 (dd, <i>J</i> = 2.93, 13.89 Hz, 1H), 1.90 (br. s., 1H), 1.60 (s, 3H), 1.44 (s, 9H), 0.19–0.47 (m, 2H), −0.32 (br. s., 1H), −1.08 (br. s., 1H). Mass spectrum (ESI) <i>m</i>/<i>z</i> = 615.1 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> found 615.1523 [M + H]<sup>+</sup>, calcd for C<sub>28</sub>H<sub>36</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>5</sub>S<sub>2</sub> 615.1521.</div></div><div id="sec5_1_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 2-(2-(((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-Butylsulfonyl)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)methyl)thiazol-5-yl)acetic Acid (<b>38</b>)</h4><div class="NLM_p">Part A: To a solution of 2-((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylsulfonyl)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)acetyl chloride (196 mg, 0.327 mmol) in THF (1.15 mL) was added ethyl 4-(bis(trimethylsilyl)amino)but-2-ynoate (89 mg, 0.327 mmol) and then tetra-<i>N</i>-butylammonium fluoride, 1 M solution in THF (0.052 mL, 0.052 mmol). The solution was stirred at room temperature overnight. After this period, the reaction was acidified with 1 M HCl (5 mL), then extracted with diethyl ether (3 × 30 mL) and brine (30 mL). The combined organic layers were dried over magnesium sulfate, filtered, and concentrated. The crude material was absorbed onto a plug of silica gel and purified by chromatography through a Redi-Sep prepacked silica gel column (40 g), eluting with a gradient of 0% to 40% acetone in DCM, to provide ethyl 4-(2-((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylsulfonyl)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)acetamido)but-2-ynoate (<b>67</b>) (162 mg, 0.235 mmol, 72% yield) as a white solid. Mass spectrum (ESI) <i>m</i>/<i>z</i> = 688.3 [M]<sup>+</sup>.</div><div class="NLM_p">Part B: A solution of ethyl 4-(2-((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylsulfonyl)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)acetamido)but-2-ynoate (<b>67</b>) (162 mg, 0.235 mmol) and Lawesson’s reagent (47.5 mg, 0.117 mmol) in toluene (0.435 mL) was stirred at 60 °C for 3 h. The reaction was then cooled and concentrated. The crude material was absorbed onto a plug of silica gel and purified by chromatography through a Redi-Sep prepacked silica gel column (40 g), eluting with isocratic 15% acetone in DCM to provide ethyl 2-(2-(((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylsulfonyl)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)methyl)thiazol-5-yl)acetate (<b>68</b>) (105 mg, 0.149 mmol, 63% yield) as a white solid. Mass spectrum (ESI) <i>m</i>/<i>z</i> = 704.2 [M]<sup>+</sup>.</div><div class="NLM_p last">Part C: To a solution of ethyl 2-(2-(((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylsulfonyl)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)methyl)thiazol-5-yl)acetate (<b>68</b>) (33 mg, 0.047 mmol) in THF (2 mL) and MeOH (1 mL) was added lithium hydroxide (1 mL, 2 M). The reaction was stirred at 50 °C for 1 h. Purification of the crude product by RP-HPLC (25 to 75% CH<sub>3</sub>CN/H<sub>2</sub>O, both containing 0.1% TFA, in 30 min, flow rate = 45 mL/min) provided 2-(2-(((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylsulfonyl)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)methyl)thiazol-5-yl)acetic acid (<b>38</b>) (18 mg, 0.027 mmol, 57% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.72 (s, 1H), 6.96–7.26 (m, 6H), 6.79–6.92 (m, 2H), 4.94 (d, <i>J</i> = 10.76 Hz, 1H), 4.24–4.45 (m, 1H), 3.92 (s, 2H), 3.64–3.77 (m, 1H), 3.55 (br. s., 1H), 3.24 (t, <i>J</i> = 11.93 Hz, 1H), 2.91 (d, <i>J</i> = 12.72 Hz, 1H), 2.71 (br. s., 1H), 2.31 (t, <i>J</i> = 13.69 Hz, 1H), 1.74–1.95 (m, 2H), 1.43 (s, 9H), 1.42 (br. s., 3H), 0.34 (br. s., 1H), 0.22 (br. s., 1H), −0.35 (br. s., 1H), −1.06 (br. s., 1H). Mass spectrum (ESI) <i>m</i>/<i>z</i> = 677.2 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> found 677.1673 [M + H]<sup>+</sup>, calcd for C<sub>33</sub>H<sub>38</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>5</sub>S<sub>2</sub> 677.1677.</div></div><div id="sec5_1_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 2-(2-(((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-Butylsulfonyl)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)methyl)thiazol-5-yl)-2-methylpropanoic Acid (<b>39</b>)</h4><div class="NLM_p">Part A: To a solution of ethyl 2-(2-(((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylsulfonyl)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)methyl)thiazol-5-yl)acetate (<b>68</b>) (50 mg, 0.071 mmol) in DMF (0.269 mL) was added sodium <i>tert</i>-butoxide (18 mg, 0.203 mmol) at 0 °C. After stirring for 15 min, methyl iodide (0.00836 mL, 0.135 mmol) was added. The reaction was quenched with sat. aq. ammonium chloride (5 mL) and extracted with diethyl ether (3 × 10 mL). The combined organic layers were dried over magnesium sulfate, filtered, and concentrated. The crude material was absorbed onto a plug of silica gel and purified by chromatography through a Redi-Sep prepacked silica gel column (40 g), eluting with a gradient of 0% to 40% acetone in DCM, to provide ethyl 2-(2-(((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylsulfonyl)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)methyl)thiazol-5-yl)-2-methylpropanoate (32 mg, 0.044 mmol, 62% yield). Mass spectrum (ESI) <i>m</i>/<i>z</i> = 733.2 [M + H]<sup>+</sup>.</div><div class="NLM_p last">Part B: To a solution of ethyl 2-(2-(((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylsulfonyl)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)methyl)thiazol-5-yl)-2-methylpropanoate (32 mg, 0.044 mmol) in THF (2 mL) and MeOH (1 mL) was added lithium hydroxide (1 mL, 2 M). The solution was stirred at 50 °C for 30 min. After this period, the reaction was neutralized (2 mL, 1 M HCl) and concentrated. Purification of the crude product by RP-HPLC (25 to 75% CH<sub>3</sub>CN/H2O, both containing 0.1% TFA, in 30 min, flow rate =45 mL/min) provided 2-(2-(((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylsulfonyl)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)methyl)thiazol-5-yl)-2-methylpropanoic acid (<b>39</b>) (23 mg, 0.033 mmol, 75% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.71 (s, 1H), 7.02–7.26 (m, 6H), 6.96 (s, 1H), 6.81–6.90 (m, 1H), 4.94 (d, <i>J</i> = 10.76 Hz, 1H), 4.37 (t, <i>J</i> = 11.84 Hz, 1H), 3.73 (d, <i>J</i> = 14.28 Hz, 1H), 3.45 (d, <i>J</i> = 14.28 Hz, 1H), 3.07–3.22 (m, 1H), 2.61–2.77 (m, 2H), 2.27 (t, <i>J</i> = 13.79 Hz, 1H), 1.89–1.99 (m, 1H), 1.84 (d, <i>J</i> = 11.93 Hz, 1H), 1.72 (d, <i>J</i> = 0.98 Hz, 6H), 1.44 (s, 9H), 1.43 (s, 3H), 0.13–0.45 (m, 2H), −0.34 (br. s., 1H), −1.03 (br. s., 1H). Mass spectrum (ESI) <i>m</i>/<i>z</i> = 705.0 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> found 705.2002 [M + H]<sup>+</sup>, calcd for C<sub>35</sub>H<sub>42</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>5</sub>S<sub>2</sub> 705.1990.</div></div><div id="sec5_1_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 1-(2-(((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-Butylsulfonyl)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)methyl)thiazol-5-yl)cyclopropanecarboxylic Acid (<b>40</b>)</h4><div class="NLM_p last">Compound <b>40</b> was synthesized through a procedure similar to that described for the synthesis of <b>39</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.34–7.43 (m, 1H), 6.84 (s, 6H), 6.74 (s, 1H), 6.63 (d, <i>J</i> = 6.26 Hz, 1H), 4.71 (d, <i>J</i> = 10.76 Hz, 1H), 4.01–4.20 (m, <i>J</i> = 8.02 Hz, 1H), 3.49 (d, <i>J</i> = 13.11 Hz, 2H), 3.27 (d, <i>J</i> = 13.89 Hz, 2H), 2.82–3.03 (m, 1H), 2.48 (br. s., 1H), 2.06 (t, <i>J</i> = 13.79 Hz, 1H), 1.68 (br. s., 4H), 1.25–1.30 (m, 1H), 1.21 (s, 12H), −0.08–0.22 (m, 2H), −0.57 (br. s., 1H), −1.26 (br. s., 1H). Mass spectrum (ESI) <i>m</i>/<i>z</i> = 703.0 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 2-(2-((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-Butylsulfonyl)-1-cyclopropylethyl)-6-(4-chloro-3-fluorophenyl)-5-(3-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)acetamido)acetic Acid (<b>70</b>)</h4><div class="NLM_p">Part A: A solution of 2-((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylsulfonyl)-1-cyclopropylethyl)-6-(4-chloro-3-fluorophenyl)-5-(3-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)acetic acid (<b>69</b>)<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> (22.00 g, 36.8 mmol) and glycine methyl ester hydrochloride (11.54 g, 92 mmol) in DMF (100.0 mL) was treated with EDC (17.62 g, 92 mmol), HOAT (12.51 g, 92 mmol), and sodium hydrogencarbonate (15.44 g, 184 mmol) successively at room temperature. The reaction was stirred at 40 °C overnight. After this period, the reaction was diluted (1 N aq. HCl), extracted (2 × EtOAc), and washed (1 × sat. aq. NaHCO<sub>3</sub>, and 2 × brine). The combined organic layer was dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated under reduced pressure. The product of this step was used in the next process without further purification. Mass spectrum (ESI) <i>m</i>/<i>z</i> = 669.2 [M + H]<sup>+</sup>.</div><div class="NLM_p">Part B: To a solution of methyl 2-(2-((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylsulfonyl)-1-cyclopropylethyl)-6-(4-chloro-3-fluorophenyl)-5-(3-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)acetamido)acetate (see part A) (24.60 g, 36.7 mmol) in THF (40 mL), MeOH (40 mL), and H<sub>2</sub>O (80 mL) was added lithium hydroxide (4.40 g, 184 mmol). The reaction was stirred at room temperature.</div><div class="NLM_p last">The reaction was quenched with ice-cold 1 N aq. HCl, extracted with EtOAc, and washed with brine. The combined organic layer were dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated under reduced pressure. The crude product crystallized with 60 mL of EtOAc/50 mL hexanes, and the mother liquor was purified by flash column chromatography: 220g SiO<sub>2</sub>, with a gradient of 35% to 50% acetone in hexanes, over 15 min to give 2-(2-((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylsulfonyl)-1-cyclopropylethyl)-6-(4-chloro-3-fluorophenyl)-5-(3-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)acetamido)acetic acid (<b>70</b>) (21.6 g, 32.9 mmol, 90% yield over the last two steps). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.45 (br. s., 1H), 7.14–7.37 (m, 2H), 7.09–7.15 (m, 2H), 7.03 (s, 1H), 6.90–6.97 (m, 1H), 4.98 (d, <i>J</i> = 10.51 Hz, 1H), 4.29 (t, <i>J</i> = 11.49 Hz, 1H), 4.07–4.18 (m, 2H), 3.25–3.39 (m, 1H), 3.06 (d, <i>J</i> = 13.45 Hz, 1H), 2.87–2.94 (m, 1H), 2.83 (d, <i>J</i> = 13.45 Hz, 1H), 2.68 (br. s., 1H), 2.21–2.48 (m, 2H), 1.84 (br. s., 1H), 1.44 (s, 9H), 1.37 (s, 3H), 0.19–0.45 (m, 2H), −0.27 (br. s., 1H), −1.08 (br. s., 1H). Mass spectrum (ESI) <i>m</i>/<i>z</i> = 655.2 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> Methyl 2-(2-(((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylsulfonyl)-1-cyclopropylethyl)-6-(4-chloro-3-fluorophenyl)-5-(3-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)methyl)thiazol-5-yl)acetate (<b>71</b>)</h4><div class="NLM_p">Part A: To a 200-mL round-bottomed flask was added methyl potassium malonate (4.76 g, 30.5 mmol) and magnesium chloride (2.178 g, 22.88 mmol) in 30 mL of THF. This mixture was allowed to stir at 50 °C for 4 h.</div><div class="NLM_p">2-(2-((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylsulfonyl)-1-cyclopropylethyl)-6-(4-chloro-3-fluorophenyl)-5-(3-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)acetamido)acetic acid (<b>70</b>) (5.00 g, 7.63 mmol) was dissolved in THF (40 mL). Then, 1,1′-carbonyldiimidazole (4.33 g, 26.7 mmol) was added portionwise to the solution. The mixture was stirred for 2 h at 50 °C. After this period, the above mixture was added to the methyl magnesium malonate suspension at 50 °C, and the reaction was allowed to stir at 50 °C overnight. The reaction mixture was diluted with EtOAc and washed with 1 M sodium bisulfate. The aqueous layer was extracted twice with EtOAc and washed with sat. aq. NaHCO<sub>3</sub> and brine. The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The crude material was purified by flash column chromatography (120 g SiO<sub>2</sub>, 25% to 40% acetone/hexanes gradient over 15 min) to give methyl 4-(2-((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylsulfonyl)-1-cyclopropylethyl)-6-(4-chloro-3-fluorophenyl)-5-(3-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)acetamido)-3-oxobutanoate (<b>71</b>) (3.40 g, 4.78 mmol, 63% yield). Mass spectrum (ESI) <i>m</i>/<i>z</i> = 711.2 [M + H]<sup>+</sup>.</div><div class="NLM_p last">Part B: To a 500-mL round-bottomed flask was added methyl 4-(2-((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylsulfonyl)-1-cyclopropylethyl)-6-(4-chloro-3-fluorophenyl)-5-(3-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)acetamido)-3-oxobutanoate (<b>71</b>) (4.00 g, 5.62 mmol) and Lawesson’s reagent (2.273 g, 5.62 mmol) in toluene (50 mL). The mixture was heated at reflux for 3 h. After this time, the reaction was cooled and concentrated under reduced pressure. The crude product was purified by flash column chromatography (330 g SiO<sub>2</sub>, 35% to 50% EtOAc/hexanes gradient over 20 min) to give methyl 2-(2-(((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylsulfonyl)-1-cyclopropylethyl)-6-(4-chloro-3-fluorophenyl)-5-(3-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)methyl)thiazol-5-yl)acetate (<b>72</b>) (2.8 g, 71% yield). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.62 (s, 1H), 7.03–7.14 (m, 3H), 6.96 (s, 4H), 4.95 (d, <i>J</i> = 10.76 Hz, 1H), 4.38 (t, <i>J</i> = 11.98 Hz, 1H), 3.89 (s, 2H), 3.69 (d, <i>J</i> = 14.18 Hz, 1H), 3.32 (d, <i>J</i> = 14.18 Hz, 1H), 3.01 (br. s., 1H), 2.93 (d, <i>J</i> = 12.72 Hz, 1H), 2.60–2.76 (m, 1H), 2.23 (t, <i>J</i> = 13.82 Hz, 1H), 2.18 (s, 3H), 2.00 (br. s., 1H), 1.90 (dd, <i>J</i> = 2.32, 13.57 Hz, 1H), 1.44 (s, 9H), 1.40 (s, 3H), 0.26–0.46 (m, 2H), −0.29 (d, <i>J</i> = 3.18 Hz, 1H), −1.00 (br. s., 1H). Mass spectrum (ESI) <i>m</i>/<i>z</i> = 709.2 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 2-(2-(((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-Butylsulfonyl)-1-cyclopropylethyl)-6-(4-chloro-3-fluorophenyl)-5-(3-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)methyl)thiazol-5-yl)acetic Acid (<b>4</b>)</h4><div class="NLM_p last">To a solution of methyl 2-(2-(((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylsulfonyl)-1-cyclopropylethyl)-6-(4-chloro-3-fluorophenyl)-5-(3-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)methyl)thiazol-5-yl)acetate (<b>72</b>) (5.70 g, 8.03 mmol) in THF (60 mL), MeOH (40 mL), and H<sub>2</sub>O (80 mL) was added lithium hydroxide (0.962 g, 40.2 mmol). The reaction was stirred at room temperature for 1.5 h. The reaction was quenched with ice-cold 1 N aq. HCl, extracted with EtOAc, and washed with brine. The combined organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The crude product was purified by flash column chromatography (220 g SiO<sub>2</sub>, 40% to 50% acetone/hexanes gradient over 10 min) to provide 2-(2-(((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylsulfonyl)-1-cyclopropylethyl)-6-(4-chloro-3-fluorophenyl)-5-(3-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)methyl)thiazol-5-yl)acetic acid (<b>4</b>) (5.10 g, 91% yield). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.78 (br. s., 1H), 6.96–7.17 (m, 5H), 6.89 (d, <i>J</i> = 6.60 Hz, 1H), 4.96 (d, <i>J</i> = 10.51 Hz, 1H), 4.34 (t, <i>J</i> = 11.86 Hz, 2H), 3.96 (s, 2H), 3.67–3.82 (m, 2H), 3.61 (br. s., 1H), 2.91 (d, <i>J</i> = 12.96 Hz, 1H), 2.69 (br. s., 1H), 2.32 (t, <i>J</i> = 13.94 Hz, 1H), 1.80–1.97 (m, 2H), 1.44 (s, 9H), 1.26 (s, 3H), 0.37 (d, <i>J</i> = 4.16 Hz, 2H), −0.29 (br. s., 1H), −0.98 (br. s., 1H). <sup>13</sup>C NMR (150 MHz, (CD<sub>3</sub>)<sub>2</sub>SO) δ 175.4, 171.9, 165.8, 158.9, 158.6, 144.2, 141.9, 141.6, 133.3, 131.9, 130.9, 127.7, 127.4, 126.6, 119.6, 119.5, 118.7, 116.7, 114.8, 69.9, 59.9, 58.7, 58.6, 44.4, 43.9, 43.6, 41.2, 38.2, 33.4, 26.5, 14.6, 7.3, 4.6. Mass spectrum (ESI) <i>m</i>/<i>z</i> = 695.2 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> found 695.1584 [M + H]<sup>+</sup>, calcd for C<sub>33</sub>H<sub>37</sub>Cl<sub>2</sub>FN<sub>2</sub>O<sub>5</sub>S<sub>2</sub> 695.1583.</div></div><div id="sec5_1_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 2-(2-(((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-Butylsulfonyl)-1-cyclopropylethyl)-6-(4-chloro-3-fluorophenyl)-5-(3-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)methyl)thiazol-5-yl)-2-fluoroacetic Acid (<b>41</b>) and 2-(2-(((3<i>R</i>,5<i>R</i>,<i>6S)</i>-1-((<i>S</i>)-2-(<i>tert</i>-Butylsulfonyl)-1-cyclopropylethyl)-6-(4-chloro-3-fluorophenyl)-5-(3-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)methyl)thiazol-5-yl)-2,2-difluoroacetic Acid (<b>42</b>)</h4><div class="NLM_p">Part A: To a solution of ethyl 2-(2-(((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylsulfonyl)-1-cyclopropylethyl)-6-(4-chloro-3-fluorophenyl)-5-(3-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)methyl)thiazol-5-yl)acetate (<b>72</b>) (21 mg, 0.029 mmol) in DMF (0.269 mL) was added sodium <i>tert</i>-butoxide (5.86 mg, 0.061 mmol) at 0 °C. After stirring for 15 min, <i>N</i>-fluorobenzenesulphonimide (19.21 mg, 0.061 mmol) was added. After 30 min, LCMS showed a mixture of compounds containing unreacted starting material, mono-, difluorination, and deacetylation products. The crude mixture was quenched (0.5 mL water), concentrated, and taken into the next step without further purification.</div><div class="NLM_p">Part B: The mixture from the previous step was diluted in THF (2 mL), MeOH (1 mL), and 1 mL of 2 M LiOH and heated and 50 °C for 30 min. After this period, the reaction was cooled, quenched with 1 N HCl (2 mL), and concentrated. Purification by preparative HPLC (25–75% CH<sub>3</sub>CN/H<sub>2</sub>O both solvents containing 0.1% TFA) provided, in order of elution, first 2-(2-(((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylsulfonyl)-1-cyclopropylethyl)-6-(4-chloro-3-fluorophenyl)-5-(3-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)methyl)thiazol-5-yl)-2-fluoroacetic acid (<b>41</b>) (2.4 mg, 3.36 μmol, 12% yield) as a 1:1 mixture of isomers; then, 2-(2-(((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylsulfonyl)-1-cyclopropylethyl)-6-(4-chloro-3-fluorophenyl)-5-(3-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)methyl)thiazol-5-yl)-2,2-difluoroacetic acid (<b>42</b>) (0.8 mg, 4% yield, Mass spectrum (ESI) <i>m</i>/<i>z</i> = 731.0 [M + H]<sup>+</sup>); and then, (3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylsulfonyl)-1-cyclopropylethyl)-6-(4-chloro-3-fluorophenyl)-5-(3-chlorophenyl)-3-methyl-3-(thiazol-2-ylmethyl)piperidin-2-one (<b>36</b>) (3 mg, 16% yield), as white amorphous solids.</div><div id="sec5_1_36_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i50" class="anchor-spacer"></div><h5 class="article-section__title" id="_i50"> Characterization of <b>41</b></h5><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.89–8.03 (m, 1H), 7.10 (d, <i>J</i> = 1.96 Hz, 7H), 5.95–6.30 (m, 1H), 4.86–5.11 (m, 1H), 4.24–4.44 (m, 1H), 3.64–3.79 (m, 1H), 3.34–3.54 (m, 1H), 3.06–3.21 (m, 1H), 2.88–3.02 (m, 1H), 2.18–2.39 (m, 1H), 1.78–2.08 (m, 2H), 1.44 (s, 12H), 0.38 (br. s., 2H), −0.26– –0.24 (m, 1H), −0.38– –0.19 (m, 1H), −0.99 (br. s., 1H). Mass spectrum (ESI) <i>m</i>/<i>z</i> = 713.0 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> found 713.1489 [M+H]<sup>+</sup>, calcd for C<sub>33</sub>H<sub>36</sub>Cl<sub>2</sub>F<sub>2</sub>N<sub>2</sub>O<sub>5</sub>S<sub>2</sub> 713.1486.</div></div></div><div id="sec5_1_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> 2-(2-(((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-Butylsulfonyl)-1-cyclopropylethyl)-6-(4-chloro-3-fluorophenyl)-5-(3-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)methyl)oxazol-5-yl)acetic Acid (<b>43</b>)</h4><div class="NLM_p">Part A: To a solution of methyl 4-(2-((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylsulfonyl)-1-cyclopropylethyl)-6-(4-chloro-3-fluorophenyl)-5-(3-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)acetamido)-3-oxobutanoate (<b>71</b>) (19 mg, 0.027 mmol) in DCE (1.3 mL) was added (methoxycarbonylsulfamoyl)triethyl-ammonium hydroxide (25.4 mg, 0.107 mmol). The solution was stirred for 5 h in the microwave. The reaction did not reach completion; thus, additional (methoxycarbonylsulfamoyl)triethyl-ammonium hydroxide (25.4 mg, 0.107 mmol) was added, and the reaction was set again in the microwave for 2 more hours, after which period only the desired product was observed. The crude mixture was concentrated and absorbed onto a plug of silica gel and purified by chromatography through a Redi-Sep prepacked silica gel column (40 g), eluting with a gradient of 5% to 60% acetone in hexanes, to provide methyl 2-(2-(((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylsulfonyl)-1-cyclopropylethyl)-6-(4-chloro-3-fluorophenyl)-5-(3-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)methyl)oxazol-5-yl)acetate (12 mg, 0.017 mmol, 65% yield) as a white solid. Mass spectrum (ESI) <i>m</i>/<i>z</i> = 693.0 [M + H]<sup>+</sup>.</div><div class="NLM_p last">Part B: To a solution of ethyl 2-(2-(((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylsulfonyl)-1-cyclopropylethyl)-6-(4-chloro-3-fluorophenyl)-5-(3-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)methyl)oxazol-5-yl)acetate (12 mg, 0.017 mmol) in THF (2 mL) and MeOH (1 mL) was added lithium hydroxide (1 mL, 2 M). The solution was stirred at 50 °C for 30 min. After this period, the reaction was neutralized (2 mL, 1 M HCl) and concentrated. Purification by preparative HPLC (25–75% acetonitrile/water both solvents containing 0.1% TFA) provided 2-(2-(((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylsulfonyl)-1-cyclopropylethyl)-6-(4-chloro-3-fluorophenyl)-5-(3-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)methyl)oxazol-5-yl)acetic acid (<b>43</b>) (8 mg, 0.012 mmol, 69% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.29 (s, 2H), 7.14 (d, <i>J</i> = 5.28 Hz, 2H), 7.02 (s, 2H), 6.91–6.98 (m, 1H), 5.00 (d, <i>J</i> = 10.37 Hz, 1H), 4.39 (t, <i>J</i> = 12.03 Hz, 1H), 3.78 (s, 2H), 3.25–3.48 (m, 2H), 3.07–3.23 (m, 1H), 2.94 (d, <i>J</i> = 13.89 Hz, 1H), 2.68 (t, <i>J</i> = 10.76 Hz, 1H), 2.29 (br. s., 2H), 1.87–2.01 (m, 1H), 1.73 (d, <i>J</i> = 14.09 Hz, 1H), 1.46 (s, 9H), 1.42 (s, 3H), 0.38 (br. s., 2H), −0.26 (br. s., 1H), −0.98 (br. s., 1H). Mass spectrum (ESI) <i>m</i>/<i>z</i> = 679.0 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> found 679.1812 [M + H]<sup>+</sup>, calcd for C<sub>33</sub>H<sub>37</sub>Cl<sub>2</sub>FN<sub>2</sub>O<sub>6</sub>S 679.1812.</div></div><div id="sec5_1_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> Methyl 6-(((2<i>S</i>,5<i>R</i>,6<i>R</i>)-4-((<i>S</i>)-2-((<i>tert</i>-butyldimethylsilyl)oxy)-1-cyclopropylethyl)-6-(3-chlorophenyl)-5-(4-chlorophenyl)-2-methyl-3-oxomorpholin-2-yl)methyl)nicotinate and methyl 6-(((2<i>R</i>,5<i>R</i>,6<i>R</i>)-4-((<i>S</i>)-2-((<i>tert</i>-butyldimethylsilyl)oxy)-1-cyclopropylethyl)-6-(3-chlorophenyl)-5-(4-chlorophenyl)-2-methyl-3-oxomorpholin-2-yl)methyl)nicotinate (<b>74</b>)</h4><div class="NLM_p">Part A: Lithium bis(trimethylsilyl)amide (1.0 M solution in tetrahydrofuran, 17.3 mL, 17.3 mmol) was added to an oven-dried, 3-neck round-bottom flask containing (5<i>R</i>,6<i>R</i>)-4-((<i>S</i>)-2-((<i>tert</i>-butyldimethylsilyl)oxy)-1-cyclopropylethyl)-6-(3-chlorophenyl)-5-(4-chlorophenyl)morpholin-3-one<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> in tetrahydrofuran at −78 °C under argon. Methyl iodide (1.08 mL, 17.3 mmol) in tetrahydrofuran was added subsequently. After stirring at −78 °C for 1 h, the reaction was quenched with sat. aq. ammonium chloride (20 mL), extracted with ethyl acetate (2 × 30 mL), and washed with brine (30 mL). The combined organic layer was dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated under reduced pressure. Purification of the residue by flash column chromatography (silica gel, gradient elution of 0% to 80% ethyl acetate in hexanes) afforded (2<i>S</i>,5<i>R</i>,6<i>R</i>)-4-((<i>S</i>)-2-((<i>tert</i>-butyldimethylsilyl)oxy)-1-cyclopropylethyl)-6-(3-chloro-phenyl)-5-(4-chlorophenyl)-2-methylmorpholin-3-one and (2<i>R</i>,5<i>R</i>,6<i>R</i>)-4-((<i>S</i>)-2-((<i>tert</i>-butyldimethylsilyl)oxy)-1-cyclopropylethyl)-6-(3-chloro-phenyl)-5-(4-chlorophenyl)-2-methylmorpholin-3-one (<b>73</b>) as a 2:1 mixture of diastereomers. Mass spectrum (ESI) <i>m</i>/<i>z</i> = 533.2 [M + H]<sup>+</sup>.</div><div id="sec600" class="NLM_sec NLM_sec_level_4"><div id="ac_i53" class="anchor-spacer"></div><h5 class="article-section__title" id="_i53"> Methyl 6-(bromomethyl)nicotinate</h5><div class="NLM_p"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/medium/jm-2013-01911v_0023.gif" alt="" id="fx9" /></img></div><div class="NLM_p">In a round-bottomed flask equipped with a reflux condenser, a mixture of methyl 6-methyl nicotinate (10.0 g, 66.2 mmol), <i>N</i>-bromosuccinimide (7.1 g, 39.7 mmol), and benzoyl peroxide (1.6 g, 6.62 mmol) in carbon tetrachloride was stirred under nitrogen at 75 °C for 2 days. The cooled reaction mixture was filtered, the filter cake was washed with dichloromethane, and the filtrate was concentrated under reduced pressure. Purification of the residue by flash column chromatography (silica gel column, gradient elution of 5% to 25% ethyl acetate in hexanes) afforded methyl 6-(bromomethyl)nicotinate as a yellow solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.17 (d, <i>J</i> = 1.56 Hz, 1H), 8.31 (dd, <i>J</i> = 2.15, 8.02 Hz, 1H), 7.54 (d, <i>J</i> = 8.22 Hz, 1H), 4.59 (s, 2H), 3.97 (s, 3H). MS (ESI) <i>m</i>/<i>z</i>: 230.0 [M + H]<sup>+</sup>.</div><div class="NLM_p">Part B: A three-necked, oven-dried, round-bottomed flask was cooled under argon and charged with diisopropylamine (2.48 mL, 17.7 mmol) and tetrahydrofuran (20 mL) and cooled to 0 °C. <i>n</i>-Butyllithium (2.5 M in hexanes, 7.08 mL, 17.70 mmol) was added dropwise, and the reaction was stirred for 10 min at 0 °C. The reaction mixture was cooled to −78 °C, and a solution of (2<i>S</i>,5<i>R</i>,6<i>R</i>)-4-((<i>S</i>)-2-((<i>tert</i>-butyldimethylsilyl)oxy)-1-cyclopropylethyl)-6-(3-chloro-phenyl)-5-(4-chlorophenyl)-2-methylmorpholin-3-one and (2<i>R</i>,5<i>R</i>,6<i>R</i>)-4-((<i>S</i>)-2-((<i>tert</i>-butyldimethylsilyl)oxy)-1-cyclopropylethyl)-6-(3-chloro-phenyl)-5-(4-chlorophenyl)-2-methylmorpholin-3-one (<b>73</b>) in tetrahydrofuran (30 mL), also at −78 °C, was added. After stirring at −78 °C for 15 min, a solution of methyl 6-(bromomethyl)nicotinate (4.07 g, 17.70 mmol) in tetrahydrofuran (20 mL) at −78 °C was added. The reaction was stirred at this temperature for 1 h.</div><div class="NLM_p last">The resulting mixture was quenched with saturated ammonium chloride (50 mL), extracted with ethyl acetate (3 × 50 mL), and washed with water (50 mL) and brine (50 mL). The combined organic layer was dried over magnesium sulfate, filtered, and concentrated. Purification of the residue by flash column chromatography (silica gel column, gradient elution of 0% to 25% acetone in hexanes) afforded <b>74</b>.</div></div><div id="sec601" class="NLM_sec NLM_sec_level_4"><div id="ac_i54" class="anchor-spacer"></div><h5 class="article-section__title" id="_i54"> Methyl 6-(((2<i>R</i>,5<i>R</i>,6<i>R</i>)-4-((<i>S</i>)-2-((<i>tert</i>-butyldimethylsilyl)oxy)-1-cyclopropylethyl)-6-(3-chlorophenyl)-5-(4-chlorophenyl)-2-methyl-3-oxomorpholin-2-yl)methyl)nicotinate (<b>74a</b>, Faster Eluting Isomer)</h5><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.00 (d, <i>J</i> = 2.15 Hz, 1H), 8.10 (d, <i>J</i> = 7.63 Hz, 1H), 7.23 (d, <i>J</i> = 8.22 Hz, 1H), 7.11 (d, <i>J</i> = 8.22 Hz, 2H), 7.00–7.08 (m, 2H), 6.92 (t, <i>J</i> = 7.83 Hz, 1H), 6.71–6.86 (m, 2H), 6.53 (d, <i>J</i> = 7.63 Hz, 1H), 4.85 (d, <i>J</i> = 9.78 Hz, 1H), 4.69 (d, <i>J</i> = 9.98 Hz, 1H), 4.20 (t, <i>J</i> = 9.98 Hz, 1H), 3.84 (s, 3H), 3.77 (d, <i>J</i> = 13.50 Hz, 1H), 3.38–3.43 (m, <i>J</i> = 4.50 Hz, 1H), 3.33 (d, <i>J</i> = 14.28 Hz, 1H), 2.04–2.18 (m, 1H), 1.52 (s, 3H), 0.87 (s, 9H), 0.81 (d, <i>J</i> = 0.78 Hz, 1H), 0.25–0.32 (m, 2H), 0.00 (s, 3H), −0.04 (s, 3H), −0.34– –0.26 (m, <i>J</i> = 8.80 Hz, 1H), −0.63 (dd, <i>J</i> = 4.21, 9.29 Hz, 1H). Mass spectrum (ESI) <i>m</i>/<i>z</i> = 683.2 [M + H]<sup>+</sup>.</div></div><div id="sec602" class="NLM_sec NLM_sec_level_4"><div id="ac_i55" class="anchor-spacer"></div><h5 class="article-section__title" id="_i55"> Characterization Data for the Slowest Eluting Isomer, Methyl 6-(((2<i>S</i>,5<i>R</i>,6<i>R</i>)-4-((<i>S</i>)-2-((<i>tert</i>-butyldimethylsilyl)oxy)-1-cyclopropylethyl)-6-(3-chlorophenyl)-5-(4-chlorophenyl)-2-methyl-3-oxomorpholin-2-yl)methyl)nicotinate (<b>74b</b>, Slower Eluting Isomer)</h5><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.20–9.25 (m, 1H), 8.21–8.28 (m, 1H), 7.43 (d, <i>J</i> = 8.02 Hz, 1H), 7.24 (br s, 2H), 7.11–7.19 (m, 3H), 7.02 (t, <i>J</i> = 7.83 Hz, 1H), 6.92–6.98 (m, 1H), 6.86–6.91 (m, 1H), 6.52 (d, <i>J</i> = 7.83 Hz, 1H), 4.78 (d, <i>J</i> = 9.78 Hz, 1H), 4.62 (d, <i>J</i> = 9.78 Hz, 1H), 3.98–4.06 (m, 1H), 3.96 (s, 3H), 3.89–3.95 (m, 1H), 3.73 (d, <i>J</i> = 13.50 Hz, 1H), 3.46–3.52 (m, <i>J</i> = 5.67, 10.17 Hz, 1H), 1.76 (s, 3H), 1.31–1.43 (m, 1H), 0.91 (s, 9H), 0.28–0.48 (m, 2H), 0.05 (s, 3H), 0.02 (s, 3H), −0.15– –0.02 (m, 1H), −0.56– –0.38 (m, 1H). Mass spectrum (ESI) <i>m</i>/<i>z</i> = 683.1 [M + H]<sup>+</sup>.</div></div></div><div id="sec5_1_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> Methyl 6-(((2<i>R</i>,5<i>R</i>,6<i>R</i>)-6-(3-chlorophenyl)-5-(4-chlorophenyl)-4-((<i>S</i>)-1-cyclopropyl-2-hydroxyethyl)-2-methyl-3-oxomorpholin-2-yl)methyl)nicotinate (<b>75a</b>)</h4><div class="NLM_p last">Tetrabutylammonium fluoride (1.0 M solution in tetrahydrofuran, 0.70 mL, 0.70 mmol) was added to a solution of <b>74a</b> (300 mg, 0.44 mmol) in tetrahydrofuran (5 mL) and stirred at ambient temperature overnight. The resulting mixture was quenched with saturated ammonium chloride (10 mL) and washed with ethyl acetate (3 × 15 mL). The combined organic layer was dried over magnesium sulfate, filtered, and concentrated. Purification of the residue by flash column chromatography (silica gel column, gradient elution of 0% to 25% ethyl acetate in hexanes) afforded <b>75a</b> (60%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.10 (dd, <i>J</i> = 0.78, 2.15 Hz, 1H), 8.16–8.24 (m, <i>J</i> = 5.87 Hz, 1H), 7.29 (d, <i>J</i> = 8.22 Hz, 1H), 7.17–7.25 (m, 3H), 7.11 (t, <i>J</i> = 1.66 Hz, 1H), 7.07 (t, <i>J</i> = 7.92 Hz, 1H), 6.91–7.02 (m, 2H), 6.61 (d, <i>J</i> = 7.63 Hz, 1H), 4.85–4.92 (m, 1H), 4.73–4.82 (m, 1H), 3.95 (s, 3H), 3.82 (s, 1H), 3.56–3.66 (m, 1H), 3.34–3.48 (m, 2H), 3.12–3.25 (m, 2H), 1.60 (s, 3H), 0.68–0.78 (m, 1H), 0.48–0.68 (m, 2H), 0.21–0.31 (m, 1H), 0.04–0.19 (m, 1H). Mass spectrum (ESI) <i>m</i>/<i>z</i> = 569.0 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> Methyl 6-(((2<i>R</i>,5<i>R</i>,6<i>R</i>)-4-((<i>S</i>)-2-(<i>tert</i>-butylthio)-1-cyclopropylethyl)-6-(3-chlorophenyl)-5-(4-chlorophenyl)-2-methyl-3-oxomorpholin-2-yl)methyl)nicotinate (<b>76a</b>)</h4><div class="NLM_p last">Cyanomethylenetributylphosphorane (0.356 g, 1.48 mmol) and <i>tert</i>-butanethiol (0.133 g, 1.48 mmol) were added to a solution of <b>75a</b> (210 mg, 0.37 mmol) in toluene (2 mL), and the mixture was stirred at 70 °C overnight. The resulting mixture was cooled and concentrated. Purification of the residue by flash column chromatography (silica gel column, gradient elution of 0% to 35% ethyl acetate in hexanes) afforded <b>76a</b> (61%). Mass spectrum (ESI) <i>m</i>/<i>z</i> = 641.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> 6-(((2<i>R</i>,5<i>R</i>,6<i>R</i>)-4-((<i>S</i>)-2-(<i>tert</i>-Butylsulfonyl)-1-cyclopropylethyl)-6-(3-chlorophenyl)-5-(4-chlorophenyl)-2-methyl-3-oxomorpholin-2-yl)methyl)nicotinic Acid (<b>46</b>)</h4><div class="NLM_p">Part A: 3-Chloroperbenzoic acid (77 wt.%, 0.031 g, 0.14 mmol) was added to a solution of <b>76a</b> (60 mg, 0.07 mmol) in dichloromethane (3 mL) at 0 °C. The reaction was quenched after 30 min with 1 N sodium thiosulfate (5 mL) and washed with ethyl acetate (3 × 10 mL). The combined organic layer was dried over magnesium sulfate, filtered, and concentrated. Purification of the residue by flash column chromatography (silica gel column, gradient elution of 0% to 40% acetone in hexanes) afforded <b>77a</b>. Mass spectrum (ESI) <i>m</i>/<i>z</i> = 673.0 [M + H]<sup>+</sup>.</div><div class="NLM_p last">Part B: Lithium hydroxide (1 mL, 2 M solution) was added to a solution of <b>77a</b> (30 mg, 0.045 mmol) in methanol (1 mL) and tetrahydrofuran (1 mL) at room temperature. The resulting mixture was heated at 50 °C for 1 h. The reaction mixture was cooled, quenched with a 10% citric acid solution (5 mL), and extracted with ethyl acetate (3 × 10 mL). The combined organic layers were dried over magnesium sulfate, filtered, and concentrated. Purification of the residue by flash column chromatography (silica gel column, gradient elution of 0% to 100% ethyl acetate in hexanes) afforded <b>46</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.33 (s, 1H), 8.56 (d, <i>J</i> = 8.61 Hz, 1H), 7.63 (d, <i>J</i> = 8.22 Hz, 1H), 7.19–7.26 (m, 2H), 7.11–7.18 (m, 3H), 7.04 (t, <i>J</i> = 8.12 Hz, 2H), 6.82 (d, <i>J</i> = 7.63 Hz, 1H), 5.17 (d, <i>J</i> = 9.78 Hz, 1H), 5.06 (d, <i>J</i> = 9.78 Hz, 1H), 4.15–4.27 (m, <i>J</i> = 12.72 Hz, 1H), 3.89 (d, <i>J</i> = 13.11 Hz, 2H), 3.72 (d, <i>J</i> = 13.30 Hz, 1H), 2.92 (d, <i>J</i> = 13.50 Hz, 1H), 2.71 (t, <i>J</i> = 9.68 Hz, 1H), 1.81–1.97 (m, 1H), 1.68 (s, 3H), 1.40 (s, 9H), 0.31–0.54 (m, 2H), −0.33– –0.20 (m, 1H), −0.79– –0.59 (m, 1H). Mass spectrum (ESI) <i>m</i>/<i>z</i> = 659.0 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> found 659.1748 [M+H]<sup>+</sup>, calcd for C<sub>33</sub>H<sub>36</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>6</sub>S 679.1749.</div></div><div id="sec5_1_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> 6-(((2<i>S</i>,5<i>R</i>,6<i>R</i>)-4-((<i>S</i>)-2-(<i>tert</i>-Butylsulfonyl)-1-cyclopropylethyl)-6-(3-chlorophenyl)-5-(4-chlorophenyl)-2-methyl-3-oxomorpholin-2-yl)methyl)nicotinic Acid (<b>47</b>)</h4><div class="NLM_p last">Compound <b>47</b> was synthesized in a manner similar to that for <b>46</b> starting from <b>74b</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.33 (s, 1H), 8.56 (d, <i>J</i> = 8.61 Hz, 1H), 7.63 (d, <i>J</i> = 8.22 Hz, 1H), 7.27 (br s, 4H), 7.11–7.17 (m, 2H), 7.04 (t, <i>J</i> = 8.12 Hz, 1H), 6.82 (d, <i>J</i> = 7.63 Hz, 1H), 5.17 (d, <i>J</i> = 9.78 Hz, 1H), 5.06 (d, <i>J</i> = 9.78 Hz, 1H), 4.13–4.28 (m, <i>J</i> = 11.74 Hz, 1H), 3.89 (d, <i>J</i> = 13.11 Hz, 2H), 3.72 (d, <i>J</i> = 13.30 Hz, 1H), 2.91 (d, <i>J</i> = 13.89 Hz, 1H), 2.62–2.79 (m, 1H), 1.80–1.98 (m, 1H), 1.68 (s, 3H), 1.40 (s, 9H), 0.27–0.54 (m, 2H), −0.36– –0.19 (m, 1H), −0.75– –0.59 (m, 1H). Spectrum (ESI) <i>m</i>/<i>z</i> = 659.0 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> found 659.1755 [M + H]<sup>+</sup>, calcd for C<sub>33</sub>H<sub>36</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>6</sub>S 679.1749.</div></div><div id="sec5_1_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> 2-(((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-Butylsulfonyl)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)methyl)isonicotinic Acid (<b>19</b>)</h4><div class="NLM_p">Part A: An oven-dried, cooled under Argon, round-bottomed flask was charged with diisopropylamine (0.065 mL, 0.459 mmol) and THF (1 mL), and then butyllithium (0.287 mL, 0.459 mmol) was added at 0 °C. The reaction was stirred at this temperature for 10 min. The reaction solution was then cooled to −78 °C. To this, a solution of (5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylthio)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methylpiperidin-2-one (<b>57</b>) (150 mg, 0.306 mmol) was added in THF (1 mL) at −78 °C. The reaction was stirred at −78 °C for 15 min, then warmed up to −20 °C and stirred at this temperature for an additional 15 min. The reaction was then cooled again to −78 °C, and a solution of <i>tert</i>-butyl 2-(bromomethyl)isonicotinate (125 mg, 0.459 mmol) in THF (1 mL) was added. The reaction was stirred for 4 h at −78 °C. After this time, the reaction mixture was diluted with EtOAc and washed with sat. NH<sub>4</sub>Cl, water, brine. The crude was purified by column (silica gel, eluting with ethyl acetate and hexanes) to give a 3:1 mixture of isomers of <i>tert</i>-butyl 2-(((5R,6S)-1-((S)-2-(<i>tert</i>-butylthio)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)methyl)isonicotinate (147 mg, 0.216 mmol, 71% yield). Mass spectrum (ESI) <i>m</i>/<i>z</i> = 681.2 [M + H]<sup>+</sup>.</div><div class="NLM_p">Part B: To a solution of <i>tert</i>-butyl 2-(((5R,6S)-1-((S)-2-(<i>tert</i>-butylthio)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)methyl)isonicotinate in <i>N</i>,<i>N</i>-dimethylformamide (1.5 mL) was added 3-chloroperoxybenzoic acid, 75% max. (145 mg, 0.647 mmol) at 0 °C. The reaction was allowed to stir for 40 min after which it was quenched (1.5 mL of 1 M aq. Na<sub>2</sub>S<sub>2</sub>O<sub>3</sub>), extracted (EtOAc), and washed (1 × sat. aq. NaHCO<sub>3</sub>, 1 × water, and 1 × brine). The combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated under reduced pressure to give a crude of <i>tert</i>-butyl 2-(((5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylsulfonyl)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)methyl)isonicotinate (167 mg, 0.234 mmol, quantitative yield). The crude was used on the next reaction without further purification. Mass spectrum (ESI) <i>m</i>/<i>z</i> = 713.2 [M + H]<sup>+</sup>.</div><div class="NLM_p last">Part C: To a solution of <i>tert</i>-butyl 2-(((5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylsulfonyl)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)methyl)isonicotinate (154 mg, 0.216 mmol) in DCM (3 mL) was added TFA (3 mL), and the reaction was stirred at room temperature for 3 h. Concentration gave a residue, which was purified by preparative HPLC to give 2-(((3<i>S</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylsulfonyl)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)methyl)isonicotinic acid (22 mg, 0.033 mmol, 16% yield), and then 2-(((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylsulfonyl)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)methyl)isonicotinic acid <b>19</b> (96 mg, 0.146 mmol, 68% yield). Characterization for <b>19</b>: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.98 (br. s., 1H), 8.02–8.19 (m, 2H), 7.05–7.26 (m, 5H), 7.03 (s, 1H), 6.90 (d, <i>J</i> = 5.28 Hz, 1H), 5.00 (d, <i>J</i> = 10.76 Hz, 2H), 4.33 (t, <i>J</i> = 11.84 Hz, 1H), 3.80 (d, <i>J</i> = 13.50 Hz, 1H), 3.29–3.53 (m, 2H), 2.89 (d, <i>J</i> = 13.50 Hz, 1H), 2.77 (br. s., 1H), 2.45 (t, <i>J</i> = 13.79 Hz, 1H), 1.90 (d, <i>J</i> = 12.72 Hz, 1H), 1.82 (br. s., 1H), 1.42 (s, 9H), 1.38 (s, 3H), 0.33 (d, <i>J</i> = 6.65 Hz, 2H), −0.34 (br. s., 1H), −0.95 (br. s., 1H). Mass spectrum (ESI) <i>m</i>/<i>z</i> = 657.2 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> found 657.1951 [M + H]<sup>+</sup>, calcd for C<sub>34</sub>H<sub>38</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>6</sub>S 657.1957.</div></div><div id="sec5_1_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> (3<i>R</i>,5<i>R</i>,6<i>S</i>)-3-((5-Bromopyridin-2-yl)methyl)-1-((<i>S</i>)-2-(<i>tert</i>-butylthio)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methylpiperidin-2-one (<b>78</b>)</h4><div class="NLM_p last">An oven-dried 10 mL flask equipped with a stir bar and rubber inlet was fitted with a needle and argon balloon. The flask was filled with THF (1.2 mL) and submerged in an ice–water bath. Diisopropylamine (82 μL, 0.587 mmol) was added, followed by butyllithium (235 μL, 0.587 mmol). After 2 h, at −78 °C, a solution of (5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylthio)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methylpiperidin-2-one (<b>58</b>) (192 mg, 0.391 mmol) in THF (1.2 mL) was added dropwise via a plastic syringe under an argon atmosphere over 5 min. After 1 h, the reaction was warmed to −40 °C and a solution of 5-bromo-2-(bromomethyl)pyridine (147 mg, 0.587 mmol) in THF (1.2 mL) was added to the reaction mixture. After stirring for 3 h at this temperature, the reaction mixture was quenched with sat. aq. NH<sub>4</sub>Cl and partitioned with EtOAc. The combined organic layers were dried over sodium sulfate, filtered, and concentrated. The residue was dissolved in DCM and loaded onto a dry silica gel cartridge and eluted on a 25 g gold-capped ISCO Redisep silica gel column with 0–40% EtOAc/hexanes to give <b>79 (</b>45 mg, 18% yield). <sup>1</sup>H NMR (500 MHz, CD<sub>2</sub>Cl<sub>2</sub>) δ 8.58 (d, <i>J</i> = 2.4 Hz, 1H), 7.78 (dd, <i>J</i> = 2.4, 8.3 Hz, 1H), 7.20 (d, <i>J</i> = 8.3 Hz, 3H), 7.16–7.10 (m, 2H), 7.08 (s, 1H), 6.95 (br. s., 2H), 6.88–6.85 (m, 1H), 4.73 (d, <i>J</i> = 10.5 Hz, 1H), 3.47 (t, <i>J</i> = 11.0 Hz, 1H), 3.42 (d, <i>J</i> = 12.7 Hz, 1H), 3.37–3.30 (m, 1H), 3.11 (d, <i>J</i> = 13.0 Hz, 1H), 2.54 (dd, <i>J</i> = 5.1, 12.0 Hz, 1H), 2.41–2.22 (m, 1H), 2.06 (t, <i>J</i> = 13.4 Hz, 1H), 1.85 (dd, <i>J</i> = 3.2, 13.7 Hz, 1H), 1.65–1.59 (m, 1H), 1.31 (s, 9H), 1.25 (s, 3H), 0.47–0.37 (m, 1H), 0.32–0.22 (m, 1H), −0.06– –0.17 (m, 1H), −0.74– –0.89 (m, 1H). Mass spectrum (ESI) <i>m</i>/<i>z</i> = 661.0 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> 2-(6-(((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-Butylsulfonyl)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)methyl)pyridin-3-yl)acetic Acid (<b>23</b>)</h4><div class="NLM_p">Part A: To a vial containing (3<i>R</i>,5<i>R</i>,6<i>S</i>)-3-((5-bromopyridin-2-yl)methyl)-1-((<i>S</i>)-2-(<i>tert</i>-butylthio)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methylpiperidin-2-one (<b>78</b>) (13.0 mg, 0.020 mmol) was added Q-Phos (0.839 mg, 1.181 μmol) and tris(dibenzylideneacetone)dipalladium(0) (2.163 mg, 2.362 μmol). The solids were diluted in THF (98 μL), and (2-(<i>tert</i>-butoxy)-2-oxoethyl)zinc(II) chloride (47.2 μL, 0.024 mmol) was added. The vial was placed on a hot plate at 60 °C. After 4 h, the reaction mixture was diluted with DCM and loaded onto a 4 g gold-capped ISCO silica gel column that had been preflushed with hexanes. The column was eluted with a gradient of 0–100% EtOAc/hexanes to give <i>tert</i>-butyl 2-(6-(((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylthio)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)methyl)pyridin-3-yl)acetate (5.0 mg, 37%). Mass spectrum (ESI) <i>m</i>/<i>z</i> = 695.2 [M + H]<sup>+</sup>.</div><div class="NLM_p last">Part B: To a vial containing <i>tert</i>-butyl 2-(6-(((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylsulfonyl)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)methyl)pyridin-3-yl)acetate (obtained with a procedure similar to that depicted for the synthesis of <b>19</b>, part B) (4.0 mg, 5.50 μmol) was added formic acid (0.211 μL, 5.50 μmol). The vial was heated on a hot plate at 40 °C for 6 h. The reaction mixture was concentrated. The compound was loaded onto a Uniplate Silica Gel HLF (catalog number 47521; 250 μm) plate and eluted with 50% acetone/hexanes. The most polar band was cut and eluted with 6 mL of EtOAc. The eluent was concentrated to give 2-(6-(((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylsulfonyl)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)methyl)pyridin-3-yl)acetic acid (<b>23</b>) (2.77 mg, 4.12 μmol, 75%) as a white pellet. <sup>1</sup>H NMR (500 MHz, CD<sub>2</sub>Cl<sub>2</sub>) δ 8.48 (d, <i>J</i> = 2.0 Hz, 1H), 7.62 (dd, <i>J</i> = 2.3, 7.9 Hz, 1H), 7.27 (d, <i>J</i> = 8.1 Hz, 2H), 7.23–7.03 (m, 5H), 7.03–6.94 (m, 1H), 6.94–6.81 (m, 1H), 4.92 (d, <i>J</i> = 10.8 Hz, 1H), 4.36 (br. s., 1H), 3.67 (s, 2H), 3.48 (d, <i>J</i> = 12.7 Hz, 1H), 3.21 (ddd, <i>J</i> = 2.9, 10.8, 13.7 Hz, 1H), 3.10 (d, <i>J</i> = 12.7 Hz, 1H), 2.94 (d, <i>J</i> = 12.5 Hz, 1H), 2.61 (br. s., 1H), 2.20–2.09 (m, 1H), 1.93 (br. s., 1H), 1.81 (dd, <i>J</i> = 2.9, 13.4 Hz, 1H), 1.40 (s, 9H), 1.27 (s, 3H), 0.33 (br. s., 1H), 0.24 (br. s., 1H), −0.32 (br. s., 1H), −1.05 (br. s., 1H). Mass spectrum (ESI) <i>m</i>/<i>z</i> = 671.2 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> (3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-Butylsulfonyl)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-3-(pyridin-2-ylmethyl)piperidin-2-one (<b>17</b>)</h4><div class="NLM_p last">Compound <b>17</b> was synthesized in a manner similar to that described for the preparation of <b>19</b>. <sup>1</sup>H NMR (500 MHz, CD<sub>2</sub>Cl<sub>2</sub>) δ 8.55 (dd, <i>J</i> = 0.9, 4.8 Hz, 1H), 7.65 (dt, <i>J</i> = 1.8, 7.6 Hz, 1H), 7.27 (d, <i>J</i> = 7.8 Hz, 1H), 7.25–7.16 (m, 4H), 7.16–7.06 (m, 3H), 7.03–7.00 (m, 1H), 6.91 (td, <i>J</i> = 1.7, 6.8 Hz, 1H), 4.94 (d, <i>J</i> = 10.8 Hz, 1H), 4.45–4.26 (m, 1H), 3.50 (d, <i>J</i> = 12.7 Hz, 1H), 3.32 (ddd, <i>J</i> = 3.2, 10.8, 13.6 Hz, 1H), 3.10 (d, <i>J</i> = 12.7 Hz, 1H), 2.94 (d, <i>J</i> = 13.2 Hz, 1H), 2.10 (t, <i>J</i> = 13.6 Hz, 1H), 1.93 (br. s., 1H), 1.77 (dd, <i>J</i> = 2.8, 13.3 Hz, 1H), 1.40 (s, 9H), 1.26 (s, 3H), 0.34 (br. s., 1H), 0.23 (br. s., 1H), −0.31 (br. s., 1H), −1.07 (br. s., 1H). Mass spectrum (ESI) <i>m</i>/<i>z</i> = 613.2 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> found 613.2058 [M + H]<sup>+</sup>, calcd for C<sub>33</sub>H<sub>38</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>3</sub>S 613.2058.</div></div><div id="sec5_1_47" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> 4-(((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylsulfonyl)-1-Cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)methyl)benzoic Acid (<b>30</b>)</h4><div class="NLM_p last">Compound <b>30</b> was synthesized in a manner similar to that described for the preparation of <b>19</b>. <sup>1</sup>H NMR (500 MHz, CD<sub>2</sub>Cl<sub>2</sub>) δ 8.06 (d, <i>J</i> = 8.3 Hz, 2 H), 7.42 (d, <i>J</i> = 8.3 Hz, 2 H), 7.26–7.05 (m, 4 H), 6.95–6.78 (m, 3 H), 6.78–6.74 (m, 1 H), 4.89 (d, <i>J</i> = 10.8 Hz, 1 H), 4.37 (br. s., 1 H), 3.42–3.33 (m, 1 H), 3.00 (d, <i>J</i> = 13.2 Hz, 1 H), 2.98–2.90 (m, 2 H), 2.60 (br. s., 1 H), 2.24 (t, <i>J</i> = 13.8 Hz, 1 H), 1.80 (dd, <i>J</i> = 3.1, 13.8 Hz, 1 H), 1.43–1.36 (m, 10 H), 1.27 (s, 3 H), 0.36 (br. s., 1 H), 0.29 (br. s., 1 H), −0.32 (br. s., 1 H), −1.02 (br. s., 1 H). Mass spectrum (ESI) <i>m</i>/<i>z</i> = 656.2 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> found 656.2014 [M + H]<sup>+</sup>, calcd for C<sub>35</sub>H<sub>39</sub>Cl<sub>2</sub>NO<sub>5</sub>S 656.2004.</div></div><div id="sec5_1_48" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> (3<i>R</i>,5<i>R</i>,6<i>S</i>)-3-Benzyl-1-((<i>S</i>)-2-(<i>tert</i>-butylsulfonyl)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methylpiperidin-2-one (<b>18</b>)</h4><div class="NLM_p last">Compound <b>18</b> was synthesized in a manner similar to that described for the preparation of <b>19</b>. <sup>1</sup>H NMR (500 MHz, CD<sub>2</sub>Cl<sub>2</sub>) δ 7.40–7.29 (m, 6 H), 7.08–7.05 (m, 2 H), 6.86–6.72 (m, 5 H), 4.84 (d, <i>J</i> = 10.8 Hz, 1 H), 4.37 (br. s., 1 H), 3.38 (d, <i>J</i> = 13.2 Hz, 1 H), 2.98–2.84 (m, 2 H), 2.81 (d, <i>J</i> = 13.2 Hz, 1 H), 2.59 (br. s., 1 H), 2.22–2.12 (m, 1 H), 1.83 (dd, <i>J</i> = 2.7, 13.7 Hz, 1 H), 1.40 (s, 10 H), 1.28 (s, 3 H), 0.34 (br. s., 1 H), 0.27 (br. s., 1 H), −0.34 (br. s., 1 H), −1.04 (br. s., 1 H). Mass spectrum (ESI) <i>m</i>/<i>z</i> = 612.2 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_49" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> 6-(((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-Butylsulfonyl)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)methyl)picolinic Acid (<b>21</b>)</h4><div class="NLM_p last">Compound <b>21</b> was synthesized in a manner similar to that described for the preparation of <b>19</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.22 (d, <i>J</i> = 7.63 Hz, 1H), 8.02 (t, <i>J</i> = 7.63 Hz, 1H), 7.57–7.67 (m, 1H), 7.61 (d, <i>J</i> = 7.63 Hz, 1H), 7.07–7.25 (m, 6H), 6.97 (s, 1H), 6.76–6.86 (m, 1H), 4.98 (d, <i>J</i> = 10.56 Hz, 1H), 4.38 (t, <i>J</i> = 11.84 Hz, 1H), 3.35–3.55 (m, 2H), 3.12–3.28 (m, 1H), 2.93 (d, <i>J</i> = 13.11 Hz, 1H), 2.70 (br. s., 1H), 2.44 (t, <i>J</i> = 13.79 Hz, 1H), 1.84 (dd, <i>J</i> = 2.35, 13.89 Hz, 2H), 1.44 (s, 9H), 1.32 (s, 3H), 0.23–0.52 (m, 2H), −0.31 (br. s., 1H), −1.05 (br. s., 1H). Mass spectrum (ESI) <i>m</i>/<i>z</i> = 657.2 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> found 657.1962 [M + H]<sup>+</sup>, calcd for C<sub>34</sub>H<sub>38</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>5</sub>S 657.1957.</div></div><div id="sec5_1_50" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> 6-(((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-Butylsulfonyl)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)methyl)nicotinic Acid (<b>3</b>)</h4><div class="NLM_p last">Compound <b>3</b> was synthesized in a manner similar to that described for the preparation of <b>19</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.37 (s, 1H), 8.67 (d, <i>J</i> = 7.63 Hz, 1H), 7.74 (d, <i>J</i> = 8.22 Hz, 1H), 6.98–7.25 (m, 6H), 6.84–6.93 (m, 1H), 5.00 (d, <i>J</i> = 10.76 Hz, 1H), 4.26 (t, <i>J</i> = 12.13 Hz, 1H), 3.92 (d, <i>J</i> = 13.30 Hz, 1H), 3.39–3.55 (m, 1H), 3.28 (d, <i>J</i> = 13.30 Hz, 1H), 2.86 (d, <i>J</i> = 12.91 Hz, 1H), 2.76 (t, <i>J</i> = 9.59 Hz, 1H), 2.52 (t, <i>J</i> = 13.79 Hz, 1H), 1.87 (d, <i>J</i> = 12.52 Hz, 1H), 1.80 (br. s., 1H), 1.41 (s, 13H), 0.35 (d, <i>J</i> = 6.85 Hz, 2H), −0.34 (br. s., 1H), −0.92 (br. s., 1H). Mass spectrum (ESI) <i>m</i>/<i>z</i> = 657.2 [M + H]<sup>+</sup>. <sup>13</sup>C NMR (150 MHz, (CD<sub>3</sub>)<sub>2</sub>SO) δ 175.4, 166.7, 163.5, 162.7, 159.9, 158.6, 158.5, 158.3, 149.9, 144.7, 139.5, 137.7, 132.7, 132.1, 130.9, 128.8, 127.8, 127.2, 126.6, 125.5, 125.3, 118.8, 114.9, 69.1, 59.6, 58.8, 45.5, 44.6, 44.2, 43.7, 38.7, 25.8, 14.6, 2.0. HRMS (ESI) <i>m</i>/<i>z</i> found 657.1954 [M + H]<sup>+</sup>, calcd for C<sub>34</sub>H<sub>38</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>5</sub>S 657.1957.</div></div><div id="sec5_1_51" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> 6-(((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-Butylsulfonyl)-1-cyclopropylethyl)-6-(4-chloro-3-fluorophenyl)-5-(3-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)methyl)nicotinic Acid (<b>22</b>)</h4><div class="NLM_p last">To a mixture of (3<i>R</i>,5<i>R</i>,6<i>S</i>)-3-((5-bromopyridin-2-yl)methyl)-1-((<i>S</i>)-2-(<i>tert</i>-butylsulfonyl)-1-cyclopropylethyl)-6-(4-chloro-3-fluorophenyl)-5-(3-chlorophenyl)-3-methylpiperidin-2-one (27 mg, 0.038 mmol), tripotassium phosphate (9.28 mg, 0.044 mmol), palladium(II) acetate (1.450 mg, 6.46 μmol), and 1,3-bis(dicyclohexylphosphino)propane bis(tetrafluoroborate) (4.65 mg, 7.60 μmol) was added DMSO (0.463 mL), followed by DBU (0.00916 mL, 0.061 mmol) and water (0.021 mL, 1.140 mmol). The reaction vial was evacuated and backfilled with carbon monoxide 4 times. Then, the reaction was heated at 80 °C overnight. The crude reaction mixture was filtered using a 25 mm GD/X disposable siringe filter (Whatman catalog number 6878-2504), washed with DCM, and concentrated. The concentrated crude was then diluted with MeOH. Purification by RP-HPLC (25 to 75% CH<sub>3</sub>CN/H<sub>2</sub>O in 30 min, both solvents containing 0.1% TFA, flow rate = 45 mL/min) provided 6-(((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylsulfonyl)-1-cyclopropylethyl)-6-(4-chloro-3-fluorophenyl)-5-(3-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)methyl)nicotinic acid (<b>22</b>) (13 mg, 0.019 mmol, 51% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.33 (s, 1H), 8.58 (d, <i>J</i> = 6.85 Hz, 1H), 7.65 (d, <i>J</i> = 6.65 Hz, 1H), 6.98–7.25 (m, 6H), 6.93 (d, <i>J</i> = 2.93 Hz, 1H), 5.01 (d, <i>J</i> = 10.37 Hz, 1H), 4.16–4.41 (m, 1H), 3.76 (br. s., 1H), 3.28–3.57 (m, 2H), 2.88 (d, <i>J</i> = 13.50 Hz, 2H), 2.71 (d, <i>J</i> = 4.11 Hz, 1H), 2.44 (t, <i>J</i> = 13.60 Hz, 1H), 1.85 (d, <i>J</i> = 12.72 Hz, 2H), 1.41 (s, 9H), 1.40 (br. s., 3H), 0.40 (d, <i>J</i> = 6.26 Hz, 2H), −0.28 (br. s., 1H), −0.89 (br. s., 1H). Mass spectrum (ESI) <i>m</i>/<i>z</i> = 675.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_52" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> 2-(6-(((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-Butylsulfonyl)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)methyl)pyridin-3-yl)-2-methylpropanoic Acid (<b>24</b>)</h4><div class="NLM_p last">Compound <b>24</b> was synthesized in a manner similar to that described for the preparation of <b>19</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.82–8.95 (m, 1H), 8.12 (d, <i>J</i> = 8.80 Hz, 1H), 7.57 (d, <i>J</i> = 8.41 Hz, 1H), 7.07 (s, 6H), 6.80–6.94 (m, 1H), 4.94 (d, <i>J</i> = 10.76 Hz, 1H), 4.30 (t, <i>J</i> = 10.86 Hz, 1H), 3.63 (d, <i>J</i> = 12.91 Hz, 1H), 3.43 (d, <i>J</i> = 13.30 Hz, 1H), 3.33 (t, <i>J</i> = 11.15 Hz, 1H), 2.82–2.96 (m, 1H), 2.66–2.77 (m, 1H), 2.32–2.43 (m, 2H), 1.74–1.94 (m, <i>J</i> = 19.95 Hz, 2H), 1.69 (s, 6H), 1.42 (s, 9H), 1.37 (s, 3H), 0.29 (br. s., 2H), −0.34 (br. s., 1H), −0.95 (br. s., 1H). Mass spectrum (ESI) <i>m</i>/<i>z</i> = 699.2 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> found 699.2410 [M + H]<sup>+</sup>, calcd for C<sub>37</sub>H<sub>44</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>5</sub>S 699.2426.</div></div><div id="sec5_1_53" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> 6-(((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-Butylsulfonyl)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)methyl)-2-methylnicotinic Acid (<b>25</b>)</h4><div class="NLM_p last">Compound <b>25</b> was synthesized in a manner similar to that described for the preparation of <b>19</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.58 (d, <i>J</i> = 7.83 Hz, 1H), 7.48–7.69 (m, 2H), 6.96–7.23 (m, 6H), 6.91 (br. s., 1H), 5.00 (d, <i>J</i> = 10.56 Hz, 1H), 4.17–4.32 (m, 1H), 3.92 (br. s., 1H), 3.47 (t, <i>J</i> = 11.64 Hz, 1H), 3.27 (d, <i>J</i> = 14.09 Hz, 1H), 2.99 (s, 3H), 2.88 (d, <i>J</i> = 12.91 Hz, 1H), 2.78 (br. s., 1H), 2.49 (t, <i>J</i> = 14.28 Hz, 1H), 1.83 (d, <i>J</i> = 13.89 Hz, 2H), 1.41 (s, 9H), 1.38 (br. s., 3H), 0.35 (br. s., 2H), −0.32 (br. s., 1H), −0.88 (br. s., 1H). Mass spectrum (ESI) <i>m</i>/<i>z</i> = 671.2 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> found 671.2119 [M + H]<sup>+</sup>, calcd for C<sub>34</sub>H<sub>38</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>5</sub>S 671.2113.</div></div><div id="sec5_1_54" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> 6-(((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-Butylsulfonyl)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)methyl)-4-methylnicotinic Acid (<b>26</b>)</h4><div class="NLM_p last">Compound <b>26</b> was synthesized in a manner similar to that described for the preparation of <b>19</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.39 (s, 1H), 7.47–7.63 (m, 2H), 6.91–7.24 (m, 6H), 6.88 (d, <i>J</i> = 5.67 Hz, 1H), 4.97 (d, <i>J</i> = 10.56 Hz, 1H), 4.24 (t, <i>J</i> = 12.03 Hz, 1H), 3.87 (d, <i>J</i> = 13.11 Hz, 1H), 3.43 (t, <i>J</i> = 11.54 Hz, 1H), 3.21 (d, <i>J</i> = 12.72 Hz, 1H), 2.86 (s, 3H), 2.74 (d, <i>J</i> = 10.96 Hz, 3H), 1.86 (d, <i>J</i> = 13.89 Hz, 1H), 1.80 (br. s., 1H), 1.43 (s, 3H), 1.40 (s, 9H), 0.35 (d, <i>J</i> = 6.85 Hz, 2H), −0.35 (br. s., 1H), −0.91 (br. s., 1H). Mass spectrum (ESI) <i>m</i>/<i>z</i> = 671.2 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_55" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> 5-(((3<i>R,</i>5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-Butylsulfonyl)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)methyl)pyrazine-2-carboxylic Acid (<b>29</b>)</h4><div class="NLM_p last">Compound <b>29</b> was synthesized in a manner similar to that described for the preparation of <b>19</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.34 (s, 1H), 8.59 (s, 1H), 7.16 (br. s., 5H), 7.11–7.15 (m, 2H), 7.05 (s, 1H), 6.93–7.01 (m, 1H), 5.02 (d, <i>J</i> = 10.76 Hz, 1H), 4.36 (t, <i>J</i> = 12.03 Hz, 1H), 3.34–3.65 (m, 3H), 2.91 (d, <i>J</i> = 11.54 Hz, 1H), 2.68 (br. s., 1H), 2.38 (t, <i>J</i> = 13.69 Hz, 1H), 1.81 (br. s., 1H), 1.76 (dd, <i>J</i> = 3.03, 13.60 Hz, 1H), 1.43 (s, 9H), 1.31 (s, 3H), 0.22–0.45 (m, 2H), −0.30 (d, <i>J</i> = 3.52 Hz, 1H), −0.99 (br. s., 1H). Mass spectrum (ESI) <i>m</i>/<i>z</i> = 658.2 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> found 658.1902 [M + H]<sup>+</sup>, calcd for C<sub>33</sub>H<sub>37</sub>Cl<sub>2</sub>N<sub>3</sub>O<sub>5</sub>S 658.1909.</div></div><div id="sec5_1_56" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> (3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-Butylsulfonyl)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-((5-(2-hydroxyacetyl)thiazol-2-yl)methyl)-3-methylpiperidin-2-one (<b>34</b>)</h4><div class="NLM_p">Part A: To 2-(((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylsulfonyl)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)methyl)thiazole-5-carboxylic acid (<b>33</b>) (0.061 g, 0.091 mmol) in THF (0.913 mL) was added oxalyl chloride (0.01215 mL, 0.137 mmol) and one drop of DMF. After 1 h, the crude was concentrated under vacuum and taken into the next step without further purification.</div><div class="NLM_p last">Part B: To 2-(((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylsulfonyl)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)methyl)thiazole-5-carbonyl chloride (62 mg, 0.091 mmol) was added tris(trimethylsilyloxy)ethylene (90 μL, 0.272 mmol). The reaction was stirred at 90 °C. After stirring overnight, the reaction was cooled and charged with 1.8 M aqueous HCl (1 mL) and THF (1 mL). The mixture was diluted with water (10 mL) extracted with ethyl acetate (2 × 20 mL). The combined organics were washed with brine, dried over MgSO<sub>4</sub>, and concentrated under reduced pressure. Silica gel chromatography (gradient elution 30 to 100% EtOAc in hexanes) afforded (3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylsulfonyl)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-((5-(2-hydroxyacetyl)thiazol-2-yl)methyl)-3-methylpiperidin-2-one (<b>34</b>) (6 mg, 8.85 μmol, 10% yield over the last two steps). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.23 (s, 1H), 7.03 (d, <i>J</i> = 5.28 Hz, 8H), 4.90 (d, <i>J</i> = 10.76 Hz, 1H), 4.70 (d, <i>J</i> = 1.76 Hz, 2H), 4.30 (t, <i>J</i> = 11.93 Hz, 1H), 3.61 (d, <i>J</i> = 13.89 Hz, 1H), 3.39–3.51 (m, 1H), 3.11–3.25 (m, <i>J</i> = 2.93 Hz, 1H), 2.84 (d, <i>J</i> = 15.06 Hz, 1H), 2.52–2.68 (m, 1H), 2.24 (t, <i>J</i> = 13.50 Hz, 1H), 1.61–1.70 (m, 2H), 1.36 (s, 9H), 1.32 (s, 3H), 0.25–0.36 (m, 1H), 0.08–0.23 (m, 1H), −0.39 (br. s., 1H), −1.09 (br. s., 1H). Mass spectrum (ESI) <i>m</i>/<i>z</i> = 677.0 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_57" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> 3-((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-Butylsulfonyl)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)-2-oxopropanoic Acid (<b>11</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.24 (br. s., 2H), 7.03–7.20 (m, 4H), 6.97 (s, 1H), 6.86 (dt, <i>J</i> = 6.5, 1.9 Hz, 1H), 4.97 (d, <i>J</i> = 10.8 Hz, 1H), 4.22–4.39 (m, 2H), 4.07 (dd, <i>J</i> = 13.2, 10.9 Hz, 1H), 3.14–3.34 (m, 3H), 2.71–2.93 (m, 3H), 2.32 (t, <i>J</i> = 13.8 Hz, 1H), 2.08–2.20 (m, 1H), 2.00 (dd, <i>J</i> = 13.9, 2.9 Hz, 1H), 1.48–1.55 (m, 1H), 1.43 (s, 9H), 1.41 (s, 3H), 0.41 (t, <i>J</i> = 7.5 Hz, 3H). Mass spectrum (ESI) <i>m</i>/<i>z</i> = 582.2 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> found 582.1855 [M + H]<sup>+</sup>, calcd for C<sub>29</sub>H<sub>37</sub>Cl<sub>2</sub>NO<sub>5</sub>S 582.1848.</div></div><div id="sec5_1_58" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> (<i>R</i>)-1-(2-((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-Butylsulfonyl)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)acetyl)pyrrolidine-3-carboxylic Acid (<b>15</b>)</h4><div class="NLM_p">Part A: To a solution of methyl β-<i>dl</i>-prolinate-HCl (133 mg, 1.033 mmol) in DMF (1 mL) was added 2-((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylsulfonyl)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)acetic acid (<b>9</b>) (200 mg, 0.344 mmol), HATU (262 mg, 0.689 mmol), and DIEA (0.481 mL, 2.76 mmol). After stirring overnight, this was diluted with ethyl acetate and washed twice with water. The mixture of isomers were separated via SFC, 20% isopropanol (NH<sub>4</sub>OH)/CO<sub>2</sub> (100 bar), IC (2 × 15 cm), and 3 mL/min to provide in order of elution (stereochemistry arbitrarily assigned); (<i>R</i>)-methyl 1-(2-((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylsulfonyl)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)acetyl)pyrrolidine-3-carboxylate (38 mg, 0.055 mmol, 16%, Mass spectrum (ESI) <i>m</i>/<i>z</i> = 691.3 [M + H]<sup>+</sup>) and then (<i>S</i>)-methyl 1-(2-((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylsulfonyl)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)acetyl)pyrrolidine-3-carboxylate (42 mg, 0.061 mmol, 18% yield). Mass spectrum (ESI) <i>m</i>/<i>z</i> = 691.3 [M + H]<sup>+</sup>.</div><div class="NLM_p last">Part B: To a mixture of (<i>R</i>)-methyl 1-(2-((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylsulfonyl)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)acetyl)pyrrolidine-3-carboxylate (fastest eluting isomer) (38 mg, 0.055 mmol) in MeOH (0.500 mL) and THF (1 mL) was added 1.0 M aq. LiOH (0.330 mL, 0.330 mmol) solution. After 90 min, the reaction mixture was acidified with 5% aq. HCl, diluted with water and extracted with ethyl acetate. The organic layer was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated to provide (<i>R</i>)-1-(2-((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-butylsulfonyl)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)acetyl)pyrrolidine-3-carboxylic acid (<b>15</b>) (36 mg, 0.053 mmol, 97% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.23 (br. s., 4H), 7.08 (d, <i>J</i> = 5.09 Hz, 2H), 7.00 (s, 1H), 6.93 (br. s., 1H), 4.94 (dd, <i>J</i> = 3.03, 10.86 Hz, 1H), 4.35 (br. s., 1H), 3.91 (d, <i>J</i> = 7.04 Hz, 1H), 3.83 (t, <i>J</i> = 7.53 Hz, 1H), 3.62–3.75 (m, 1H), 3.31–3.62 (m, 2H), 3.07–3.29 (m, 1H), 2.77–3.02 (m, 3H), 2.71 (br. s., 1H), 2.16–2.45 (m, 4H), 1.90 (br. s., 1H), 1.44 (s, 9H), 1.41 (d, <i>J</i> = 3.33 Hz, 3H), 0.13–0.48 (m, 2H), −0.31 (br. s., 1H), −1.04 (br. s., 1H). Mass spectrum (ESI) <i>m</i>/<i>z</i> = 677.2 [M+H]<sup>+</sup>). HRMS (ESI) <i>m</i>/<i>z</i> found 677.2223 [M + H]<sup>+</sup>, calcd for C<sub>34</sub>H<sub>42</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>6</sub>S 677.2219.</div></div><div id="sec5_1_59" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> (<i>S</i>)-1-(2-((3<i>R</i>,5<i>R</i>,6<i>S</i>)-1-((<i>S</i>)-2-(<i>tert</i>-Butylsulfonyl)-1-cyclopropylethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)acetyl)pyrrolidine-3-carboxylic Acid (<b>16</b>)</h4><div class="NLM_p last">Compound <b>16</b> was synthesized in a manner similar to that described for the preparation of <b>15</b> from the slowest eluting isomer in part A. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.22 (br. s., 4H), 7.08 (d, <i>J</i> = 4.89 Hz, 2H), 6.99 (br. s., 1H), 6.93 (t, <i>J</i> = 4.11 Hz, 1H), 4.94 (d, <i>J</i> = 10.56 Hz, 1H), 4.34 (br. s., 1H), 3.60–4.04 (m, 3H), 3.35–3.60 (m, 2H), 3.07–3.27 (m, 1H), 2.75–3.00 (m, 3H), 2.71 (br. s., 1H), 2.15–2.40 (m, 4H), 1.90 (br. s., 1H), 1.44 (s, 9H), 1.41 (d, <i>J</i> = 3.13 Hz, 3H), 0.15–0.44 (m, 2H), −0.31 (br. s., 1H), −1.06 (br. s., 1H). Mass spectrum (ESI) <i>m</i>/<i>z</i> = 677.2 [M + H]<sup>+</sup>). HRMS (ESI) <i>m</i>/<i>z</i> found 677.2210 [M + H]<sup>+</sup>, calcd for C<sub>34</sub>H<sub>42</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>6</sub>S 677.2219.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i77"><a href="/doi/suppl/10.1021/jm401911v">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21884" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21884" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">In vitro biological assays, in vivo protocols, determination of cocrystal structures of <b>3</b>, <b>4</b>, and <b>46</b>–<b>49</b> bound to MDM2. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm401911v/suppl_file/jm401911v_si_001.pdf">jm401911v_si_001.pdf (98.39 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Coordinates for compounds <b>3</b> (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4OGN">4OGN</a>), <b>4</b> (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4ODE">4ODE</a>), <b>46</b> (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4OGT">4OGT</a>), <b>47</b> (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4ODF">4ODF</a>), <b>48</b> (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4OCC">4OCC</a>), and <b>49</b> (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4OGV">4OGV</a>) bound to MDM2 have been deposited in the Protein Data Bank.</p><div class="testing" data-doi="10.1021/jm401911v" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66147" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66147" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ana Z. Gonzalez</span> - <span class="hlFld-Affiliation affiliation">†Departments of Therapeutic
Discovery, ‡Pharmaceutics, and §Pharmacokinetics and Drug Metabolism, Amgen
Inc., 1120 Veterans Boulevard, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">∥Departments of Therapeutic Discovery, and ⊥Oncology Research, Amgen Inc., One Amgen
Center Drive, Thousand Oaks, California 91320, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Therapeutic Discovery, Amgen Inc., 360 Binney Street Cambridge, Massachusetts 02142, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#e4858a85838b8a9e85a4858983818aca878b89"><span class="__cf_email__" data-cfemail="8aebe4ebede5e4f0ebcaebe7edefe4a4e9e5e7">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhihong Li</span> - <span class="hlFld-Affiliation affiliation">†Departments of Therapeutic
Discovery, ‡Pharmaceutics, and §Pharmacokinetics and Drug Metabolism, Amgen
Inc., 1120 Veterans Boulevard, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">∥Departments of Therapeutic Discovery, and ⊥Oncology Research, Amgen Inc., One Amgen
Center Drive, Thousand Oaks, California 91320, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Therapeutic Discovery, Amgen Inc., 360 Binney Street Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hilary P. Beck</span> - <span class="hlFld-Affiliation affiliation">†Departments of Therapeutic
Discovery, ‡Pharmaceutics, and §Pharmacokinetics and Drug Metabolism, Amgen
Inc., 1120 Veterans Boulevard, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">∥Departments of Therapeutic Discovery, and ⊥Oncology Research, Amgen Inc., One Amgen
Center Drive, Thousand Oaks, California 91320, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Therapeutic Discovery, Amgen Inc., 360 Binney Street Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jude Canon</span> - <span class="hlFld-Affiliation affiliation">†Departments of Therapeutic
Discovery, ‡Pharmaceutics, and §Pharmacokinetics and Drug Metabolism, Amgen
Inc., 1120 Veterans Boulevard, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">∥Departments of Therapeutic Discovery, and ⊥Oncology Research, Amgen Inc., One Amgen
Center Drive, Thousand Oaks, California 91320, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Therapeutic Discovery, Amgen Inc., 360 Binney Street Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ada Chen</span> - <span class="hlFld-Affiliation affiliation">†Departments of Therapeutic
Discovery, ‡Pharmaceutics, and §Pharmacokinetics and Drug Metabolism, Amgen
Inc., 1120 Veterans Boulevard, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">∥Departments of Therapeutic Discovery, and ⊥Oncology Research, Amgen Inc., One Amgen
Center Drive, Thousand Oaks, California 91320, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Therapeutic Discovery, Amgen Inc., 360 Binney Street Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David Chow</span> - <span class="hlFld-Affiliation affiliation">†Departments of Therapeutic
Discovery, ‡Pharmaceutics, and §Pharmacokinetics and Drug Metabolism, Amgen
Inc., 1120 Veterans Boulevard, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">∥Departments of Therapeutic Discovery, and ⊥Oncology Research, Amgen Inc., One Amgen
Center Drive, Thousand Oaks, California 91320, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Therapeutic Discovery, Amgen Inc., 360 Binney Street Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jason Duquette</span> - <span class="hlFld-Affiliation affiliation">†Departments of Therapeutic
Discovery, ‡Pharmaceutics, and §Pharmacokinetics and Drug Metabolism, Amgen
Inc., 1120 Veterans Boulevard, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">∥Departments of Therapeutic Discovery, and ⊥Oncology Research, Amgen Inc., One Amgen
Center Drive, Thousand Oaks, California 91320, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Therapeutic Discovery, Amgen Inc., 360 Binney Street Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John Eksterowicz</span> - <span class="hlFld-Affiliation affiliation">†Departments of Therapeutic
Discovery, ‡Pharmaceutics, and §Pharmacokinetics and Drug Metabolism, Amgen
Inc., 1120 Veterans Boulevard, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">∥Departments of Therapeutic Discovery, and ⊥Oncology Research, Amgen Inc., One Amgen
Center Drive, Thousand Oaks, California 91320, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Therapeutic Discovery, Amgen Inc., 360 Binney Street Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brian M. Fox</span> - <span class="hlFld-Affiliation affiliation">†Departments of Therapeutic
Discovery, ‡Pharmaceutics, and §Pharmacokinetics and Drug Metabolism, Amgen
Inc., 1120 Veterans Boulevard, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">∥Departments of Therapeutic Discovery, and ⊥Oncology Research, Amgen Inc., One Amgen
Center Drive, Thousand Oaks, California 91320, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Therapeutic Discovery, Amgen Inc., 360 Binney Street Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jiasheng Fu</span> - <span class="hlFld-Affiliation affiliation">†Departments of Therapeutic
Discovery, ‡Pharmaceutics, and §Pharmacokinetics and Drug Metabolism, Amgen
Inc., 1120 Veterans Boulevard, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">∥Departments of Therapeutic Discovery, and ⊥Oncology Research, Amgen Inc., One Amgen
Center Drive, Thousand Oaks, California 91320, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Therapeutic Discovery, Amgen Inc., 360 Binney Street Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xin Huang</span> - <span class="hlFld-Affiliation affiliation">Department
of Therapeutic Discovery, Amgen Inc., 360 Binney Street Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jonathan Houze</span> - <span class="hlFld-Affiliation affiliation">†Departments of Therapeutic
Discovery, ‡Pharmaceutics, and §Pharmacokinetics and Drug Metabolism, Amgen
Inc., 1120 Veterans Boulevard, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">∥Departments of Therapeutic Discovery, and ⊥Oncology Research, Amgen Inc., One Amgen
Center Drive, Thousand Oaks, California 91320, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Therapeutic Discovery, Amgen Inc., 360 Binney Street Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lixia Jin</span> - <span class="hlFld-Affiliation affiliation">†Departments of Therapeutic
Discovery, ‡Pharmaceutics, and §Pharmacokinetics and Drug Metabolism, Amgen
Inc., 1120 Veterans Boulevard, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">∥Departments of Therapeutic Discovery, and ⊥Oncology Research, Amgen Inc., One Amgen
Center Drive, Thousand Oaks, California 91320, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Therapeutic Discovery, Amgen Inc., 360 Binney Street Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yihong Li</span> - <span class="hlFld-Affiliation affiliation">†Departments of Therapeutic
Discovery, ‡Pharmaceutics, and §Pharmacokinetics and Drug Metabolism, Amgen
Inc., 1120 Veterans Boulevard, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">∥Departments of Therapeutic Discovery, and ⊥Oncology Research, Amgen Inc., One Amgen
Center Drive, Thousand Oaks, California 91320, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Therapeutic Discovery, Amgen Inc., 360 Binney Street Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yun Ling</span> - <span class="hlFld-Affiliation affiliation">†Departments of Therapeutic
Discovery, ‡Pharmaceutics, and §Pharmacokinetics and Drug Metabolism, Amgen
Inc., 1120 Veterans Boulevard, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">∥Departments of Therapeutic Discovery, and ⊥Oncology Research, Amgen Inc., One Amgen
Center Drive, Thousand Oaks, California 91320, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Therapeutic Discovery, Amgen Inc., 360 Binney Street Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mei-Chu Lo</span> - <span class="hlFld-Affiliation affiliation">†Departments of Therapeutic
Discovery, ‡Pharmaceutics, and §Pharmacokinetics and Drug Metabolism, Amgen
Inc., 1120 Veterans Boulevard, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">∥Departments of Therapeutic Discovery, and ⊥Oncology Research, Amgen Inc., One Amgen
Center Drive, Thousand Oaks, California 91320, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Therapeutic Discovery, Amgen Inc., 360 Binney Street Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alexander M. Long</span> - <span class="hlFld-Affiliation affiliation">Department
of Therapeutic Discovery, Amgen Inc., 360 Binney Street Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lawrence R. McGee</span> - <span class="hlFld-Affiliation affiliation">†Departments of Therapeutic
Discovery, ‡Pharmaceutics, and §Pharmacokinetics and Drug Metabolism, Amgen
Inc., 1120 Veterans Boulevard, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">∥Departments of Therapeutic Discovery, and ⊥Oncology Research, Amgen Inc., One Amgen
Center Drive, Thousand Oaks, California 91320, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Therapeutic Discovery, Amgen Inc., 360 Binney Street Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joel McIntosh</span> - <span class="hlFld-Affiliation affiliation">†Departments of Therapeutic
Discovery, ‡Pharmaceutics, and §Pharmacokinetics and Drug Metabolism, Amgen
Inc., 1120 Veterans Boulevard, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">∥Departments of Therapeutic Discovery, and ⊥Oncology Research, Amgen Inc., One Amgen
Center Drive, Thousand Oaks, California 91320, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Therapeutic Discovery, Amgen Inc., 360 Binney Street Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jonathan D. Oliner</span> - <span class="hlFld-Affiliation affiliation">†Departments of Therapeutic
Discovery, ‡Pharmaceutics, and §Pharmacokinetics and Drug Metabolism, Amgen
Inc., 1120 Veterans Boulevard, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">∥Departments of Therapeutic Discovery, and ⊥Oncology Research, Amgen Inc., One Amgen
Center Drive, Thousand Oaks, California 91320, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Therapeutic Discovery, Amgen Inc., 360 Binney Street Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tao Osgood</span> - <span class="hlFld-Affiliation affiliation">†Departments of Therapeutic
Discovery, ‡Pharmaceutics, and §Pharmacokinetics and Drug Metabolism, Amgen
Inc., 1120 Veterans Boulevard, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">∥Departments of Therapeutic Discovery, and ⊥Oncology Research, Amgen Inc., One Amgen
Center Drive, Thousand Oaks, California 91320, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Therapeutic Discovery, Amgen Inc., 360 Binney Street Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yosup Rew</span> - <span class="hlFld-Affiliation affiliation">†Departments of Therapeutic
Discovery, ‡Pharmaceutics, and §Pharmacokinetics and Drug Metabolism, Amgen
Inc., 1120 Veterans Boulevard, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">∥Departments of Therapeutic Discovery, and ⊥Oncology Research, Amgen Inc., One Amgen
Center Drive, Thousand Oaks, California 91320, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Therapeutic Discovery, Amgen Inc., 360 Binney Street Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anne Y. Saiki</span> - <span class="hlFld-Affiliation affiliation">†Departments of Therapeutic
Discovery, ‡Pharmaceutics, and §Pharmacokinetics and Drug Metabolism, Amgen
Inc., 1120 Veterans Boulevard, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">∥Departments of Therapeutic Discovery, and ⊥Oncology Research, Amgen Inc., One Amgen
Center Drive, Thousand Oaks, California 91320, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Therapeutic Discovery, Amgen Inc., 360 Binney Street Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul Shaffer</span> - <span class="hlFld-Affiliation affiliation">Department
of Therapeutic Discovery, Amgen Inc., 360 Binney Street Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sarah Wortman</span> - <span class="hlFld-Affiliation affiliation">†Departments of Therapeutic
Discovery, ‡Pharmaceutics, and §Pharmacokinetics and Drug Metabolism, Amgen
Inc., 1120 Veterans Boulevard, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">∥Departments of Therapeutic Discovery, and ⊥Oncology Research, Amgen Inc., One Amgen
Center Drive, Thousand Oaks, California 91320, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Therapeutic Discovery, Amgen Inc., 360 Binney Street Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peter Yakowec</span> - <span class="hlFld-Affiliation affiliation">Department
of Therapeutic Discovery, Amgen Inc., 360 Binney Street Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xuelei Yan</span> - <span class="hlFld-Affiliation affiliation">†Departments of Therapeutic
Discovery, ‡Pharmaceutics, and §Pharmacokinetics and Drug Metabolism, Amgen
Inc., 1120 Veterans Boulevard, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">∥Departments of Therapeutic Discovery, and ⊥Oncology Research, Amgen Inc., One Amgen
Center Drive, Thousand Oaks, California 91320, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Therapeutic Discovery, Amgen Inc., 360 Binney Street Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Qiuping Ye</span> - <span class="hlFld-Affiliation affiliation">†Departments of Therapeutic
Discovery, ‡Pharmaceutics, and §Pharmacokinetics and Drug Metabolism, Amgen
Inc., 1120 Veterans Boulevard, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">∥Departments of Therapeutic Discovery, and ⊥Oncology Research, Amgen Inc., One Amgen
Center Drive, Thousand Oaks, California 91320, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Therapeutic Discovery, Amgen Inc., 360 Binney Street Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dongyin Yu</span> - <span class="hlFld-Affiliation affiliation">†Departments of Therapeutic
Discovery, ‡Pharmaceutics, and §Pharmacokinetics and Drug Metabolism, Amgen
Inc., 1120 Veterans Boulevard, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">∥Departments of Therapeutic Discovery, and ⊥Oncology Research, Amgen Inc., One Amgen
Center Drive, Thousand Oaks, California 91320, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Therapeutic Discovery, Amgen Inc., 360 Binney Street Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiaoning Zhao</span> - <span class="hlFld-Affiliation affiliation">†Departments of Therapeutic
Discovery, ‡Pharmaceutics, and §Pharmacokinetics and Drug Metabolism, Amgen
Inc., 1120 Veterans Boulevard, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">∥Departments of Therapeutic Discovery, and ⊥Oncology Research, Amgen Inc., One Amgen
Center Drive, Thousand Oaks, California 91320, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Therapeutic Discovery, Amgen Inc., 360 Binney Street Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jing Zhou</span> - <span class="hlFld-Affiliation affiliation">†Departments of Therapeutic
Discovery, ‡Pharmaceutics, and §Pharmacokinetics and Drug Metabolism, Amgen
Inc., 1120 Veterans Boulevard, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">∥Departments of Therapeutic Discovery, and ⊥Oncology Research, Amgen Inc., One Amgen
Center Drive, Thousand Oaks, California 91320, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Therapeutic Discovery, Amgen Inc., 360 Binney Street Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Steven H. Olson</span> - <span class="hlFld-Affiliation affiliation">†Departments of Therapeutic
Discovery, ‡Pharmaceutics, and §Pharmacokinetics and Drug Metabolism, Amgen
Inc., 1120 Veterans Boulevard, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">∥Departments of Therapeutic Discovery, and ⊥Oncology Research, Amgen Inc., One Amgen
Center Drive, Thousand Oaks, California 91320, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Therapeutic Discovery, Amgen Inc., 360 Binney Street Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daqing Sun</span> - <span class="hlFld-Affiliation affiliation">†Departments of Therapeutic
Discovery, ‡Pharmaceutics, and §Pharmacokinetics and Drug Metabolism, Amgen
Inc., 1120 Veterans Boulevard, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">∥Departments of Therapeutic Discovery, and ⊥Oncology Research, Amgen Inc., One Amgen
Center Drive, Thousand Oaks, California 91320, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Therapeutic Discovery, Amgen Inc., 360 Binney Street Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Julio C. Medina</span> - <span class="hlFld-Affiliation affiliation">†Departments of Therapeutic
Discovery, ‡Pharmaceutics, and §Pharmacokinetics and Drug Metabolism, Amgen
Inc., 1120 Veterans Boulevard, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">∥Departments of Therapeutic Discovery, and ⊥Oncology Research, Amgen Inc., One Amgen
Center Drive, Thousand Oaks, California 91320, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Therapeutic Discovery, Amgen Inc., 360 Binney Street Cambridge, Massachusetts 02142, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d2072e9580-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i79">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80002" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80002" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Simon Wong for the time-dependent inhibition (TDI) determinations and Manuel Ventura and Dhanashri Bagal for the acquisition of high resolution mass spectra.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i80" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i80"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i81" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i81"> Abbreviations Used </h2><tr><td class="NLM_term">Boc</td><td class="NLM_def"><p class="first last"><i>tert</i>-butoxycarbonyl</p></td></tr><tr><td class="NLM_term">BrdU</td><td class="NLM_def"><p class="first last">5-bromo-2-deoxyuridine</p></td></tr><tr><td class="NLM_term">CL</td><td class="NLM_def"><p class="first last">clearance</p></td></tr><tr><td class="NLM_term">CYP3A4</td><td class="NLM_def"><p class="first last">cytochrome P450 3A4</p></td></tr><tr><td class="NLM_term">DCM</td><td class="NLM_def"><p class="first last">dichloromethane</p></td></tr><tr><td class="NLM_term">DMBCl</td><td class="NLM_def"><p class="first last">2,4-dimethoxybenzyl chloride</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last"><i>N,N</i>-diemethylformamide</p></td></tr><tr><td class="NLM_term">DMP</td><td class="NLM_def"><p class="first last">Dess-Martin periodinane</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">dimethylsulfoxide</p></td></tr><tr><td class="NLM_term">dr</td><td class="NLM_def"><p class="first last">diastereoselectivity ratio</p></td></tr><tr><td class="NLM_term">EdU</td><td class="NLM_def"><p class="first last">5-ethynyl-2′-deoxyuridine</p></td></tr><tr><td class="NLM_term">EtOAc</td><td class="NLM_def"><p class="first last">ethyl acetate</p></td></tr><tr><td class="NLM_term">FACS</td><td class="NLM_def"><p class="first last">fluorescence-activated cell sorting</p></td></tr><tr><td class="NLM_term">hPXR</td><td class="NLM_def"><p class="first last">human pregnane X receptor</p></td></tr><tr><td class="NLM_term">HTRF</td><td class="NLM_def"><p class="first last">homogeneous time-resolved fluorescence</p></td></tr><tr><td class="NLM_term">LiHMDS</td><td class="NLM_def"><p class="first last">lithium bis(trimethylsilyl)amide</p></td></tr><tr><td class="NLM_term">MDM2</td><td class="NLM_def"><p class="first last">murine double minute 2</p></td></tr><tr><td class="NLM_term">MsCl</td><td class="NLM_def"><p class="first last">methanesulfonyl chloride</p></td></tr><tr><td class="NLM_term">NaHMDS</td><td class="NLM_def"><p class="first last">sodium bis(trimethylsilyl)amide</p></td></tr><tr><td class="NLM_term">NMO</td><td class="NLM_def"><p class="first last"><i>N</i>-methylmorpholinine <i>N</i>-oxide</p></td></tr><tr><td class="NLM_term">QD</td><td class="NLM_def"><p class="first last">once a day dosing</p></td></tr><tr><td class="NLM_term">qRT-PCR</td><td class="NLM_def"><p class="first last">quantitative reverse transcription polymerase chain reaction</p></td></tr><tr><td class="NLM_term">SEM</td><td class="NLM_def"><p class="first last">standard error of mean</p></td></tr><tr><td class="NLM_term">SPR</td><td class="NLM_def"><p class="first last">surface plasmon resonance</p></td></tr><tr><td class="NLM_term">TBAF</td><td class="NLM_def"><p class="first last">tetrabutylammonium fluoride</p></td></tr><tr><td class="NLM_term">TDI</td><td class="NLM_def"><p class="first last">time dependent inhibition</p></td></tr><tr><td class="NLM_term">TEA</td><td class="NLM_def"><p class="first last">triethylamine</p></td></tr><tr><td class="NLM_term">TES</td><td class="NLM_def"><p class="first last">triethylsilyl</p></td></tr><tr><td class="NLM_term">TESCl</td><td class="NLM_def"><p class="first last">triethylsilyl chloride</p></td></tr><tr><td class="NLM_term">TFA</td><td class="NLM_def"><p class="first last">trifluoroacetic acid</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i82">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21560" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21560" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 32 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Wells, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McClendon, C. L.</span><span> </span><span class="NLM_article-title">Reaching for high-hanging fruit in drug discovery at protein–protein interfacese</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">450</span><span class="NLM_x">, </span> <span class="NLM_fpage">1001</span><span class="NLM_x">–</span> <span class="NLM_lpage">1009</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=450&publication_year=2007&pages=1001-1009&author=J.+A.+Wellsauthor=C.+L.+McClendon&title=Reaching+for+high-hanging+fruit+in+drug+discovery+at+protein%E2%80%93protein+interfacese"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWells%26aufirst%3DJ.%2BA.%26aulast%3DMcClendon%26aufirst%3DC.%2BL.%26atitle%3DReaching%2520for%2520high-hanging%2520fruit%2520in%2520drug%2520discovery%2520at%2520protein%25E2%2580%2593protein%2520interfacese%26jtitle%3DNature%26date%3D2007%26volume%3D450%26spage%3D1001%26epage%3D1009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Levine, A. J.</span><span> </span><span class="NLM_article-title">p53, the cellular gatekeeper for growth and division</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">323</span><span class="NLM_x">–</span> <span class="NLM_lpage">331</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm401911v&amp;key=10.1016%2FS0092-8674%2800%2981871-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm401911v&amp;key=9039259" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm401911v&amp;key=1%3ACAS%3A528%3ADyaK2sXhtFahtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=1997&pages=323-331&author=A.+J.+Levine&title=p53%2C+the+cellular+gatekeeper+for+growth+and+division"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">p53, The cellular gatekeeper for growth and division</span></div><div class="casAuthors">Levine, Arnold J.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">323-331</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review, with 55 refs., of p53 transcription factor protein structure, function, and roles in cell cycle regulation, apoptosis, and cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGou4CgTSWvZVbVg90H21EOLACvtfcHk0lg_7HNd8doEMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXhtFahtLg%253D&md5=bfbec429d10b9718fe9e9ea5dce9109b</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2981871-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252981871-1%26sid%3Dliteratum%253Aachs%26aulast%3DLevine%26aufirst%3DA.%2BJ.%26atitle%3Dp53%252C%2520the%2520cellular%2520gatekeeper%2520for%2520growth%2520and%2520division%26jtitle%3DCell%26date%3D1997%26volume%3D88%26spage%3D323%26epage%3D331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Lane, D. P.</span><span> </span><span class="NLM_article-title">p53, guardian of the genome</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">358</span><span class="NLM_x">, </span> <span class="NLM_fpage">15</span><span class="NLM_x">–</span> <span class="NLM_lpage">16</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=358&publication_year=1992&pages=15-16&author=D.+P.+Lane&title=p53%2C+guardian+of+the+genome"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLane%26aufirst%3DD.%2BP.%26atitle%3Dp53%252C%2520guardian%2520of%2520the%2520genome%26jtitle%3DNature%26date%3D1992%26volume%3D358%26spage%3D15%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Toledo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahl, G. M.</span><span> </span><span class="NLM_article-title">Regulating the p53 pathway: <i>in vitro</i> hypotheses, <i>in vivo</i> veritas</span> <span class="citation_source-journal">Nat. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_fpage">909</span><span class="NLM_x">–</span> <span class="NLM_lpage">923</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm401911v&amp;key=10.1038%2Fnrc2012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm401911v&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1Clsr3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=909-923&author=F.+Toledoauthor=G.+M.+Wahl&title=Regulating+the+p53+pathway%3A+in+vitro+hypotheses%2C+in+vivo+veritas"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Regulating the p53 pathway: in vitro hypotheses, in vivo veritas</span></div><div class="casAuthors">Toledo, Franck; Wahl, Geoffrey M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">909-923</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Mutations in TP53, the gene that encodes the tumor suppressor p53, are found in 50% of human cancers, and increased levels of its neg. regulators MDM2 and MDM4 (also known as MDMX) down-regulate p53 function in many of the rest.  Understanding p53 regulation remains a crucial goal to design broadly applicable anticancer strategies based on this pathway.  This review of in vitro studies, human tumor data and recent mouse models shows that p53 post-translational modifications have modulatory roles, and MDM2 and MDM4 have more profound roles for regulating p53.  Importantly, MDM4 emerges as an independent target for drug development, as its inactivation is crucial for full p53 activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqN3wMkB-VB7Vg90H21EOLACvtfcHk0liZ-3aAtzIBZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1Clsr3E&md5=0f87a2342dd6dcd4ab3de2a0245eabd6</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrc2012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2012%26sid%3Dliteratum%253Aachs%26aulast%3DToledo%26aufirst%3DF.%26aulast%3DWahl%26aufirst%3DG.%2BM.%26atitle%3DRegulating%2520the%2520p53%2520pathway%253A%2520in%2520vitro%2520hypotheses%252C%2520in%2520vivo%2520veritas%26jtitle%3DNat.%2520Rev.%26date%3D2006%26spage%3D909%26epage%3D923" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Hainaut, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollstein, M.</span><span> </span><span class="NLM_article-title">p53 and human cancers: the first ten thousand mutations</span> <span class="citation_source-journal">Adv. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">81</span><span class="NLM_x">–</span> <span class="NLM_lpage">137</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2000&pages=81-137&author=P.+Hainautauthor=M.+Hollstein&title=p53+and+human+cancers%3A+the+first+ten+thousand+mutations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHainaut%26aufirst%3DP.%26aulast%3DHollstein%26aufirst%3DM.%26atitle%3Dp53%2520and%2520human%2520cancers%253A%2520the%2520first%2520ten%2520thousand%2520mutations%26jtitle%3DAdv.%2520Cancer%2520Res.%26date%3D2000%26volume%3D77%26spage%3D81%26epage%3D137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Oliner, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinzler, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meltzer, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogelstein, B.</span><span> </span><span class="NLM_article-title">Amplification of a gene encoding a p53-associated protein in human sarcomas</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">358</span><span class="NLM_x">, </span> <span class="NLM_fpage">80</span><span class="NLM_x">–</span> <span class="NLM_lpage">83</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=358&publication_year=1992&pages=80-83&author=J.+D.+Olinerauthor=K.+W.+Kinzlerauthor=P.+S.+Meltzerauthor=D.+Georgeauthor=B.+Vogelstein&title=Amplification+of+a+gene+encoding+a+p53-associated+protein+in+human+sarcomas"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOliner%26aufirst%3DJ.%2BD.%26aulast%3DKinzler%26aufirst%3DK.%2BW.%26aulast%3DMeltzer%26aufirst%3DP.%2BS.%26aulast%3DGeorge%26aufirst%3DD.%26aulast%3DVogelstein%26aufirst%3DB.%26atitle%3DAmplification%2520of%2520a%2520gene%2520encoding%2520a%2520p53-associated%2520protein%2520in%2520human%2520sarcomas%26jtitle%3DNature%26date%3D1992%26volume%3D358%26spage%3D80%26epage%3D83" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Chene, P.</span><span> </span><span class="NLM_article-title">Inhibiting the p53-MDM2 interaction: An important target for cancer therapy</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">102</span><span class="NLM_x">–</span> <span class="NLM_lpage">109</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm401911v&amp;key=10.1038%2Fnrc991" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm401911v&amp;key=12563309" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm401911v&amp;key=1%3ACAS%3A528%3ADC%252BD3sXisVCru7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=102-109&author=P.+Chene&title=Inhibiting+the+p53-MDM2+interaction%3A+An+important+target+for+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibiting the p53-MDM2 interaction: An important target for cancer therapy</span></div><div class="casAuthors">Chene, Patrick</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">102-109</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  P53 is an attractive therapeutic target in oncol. because its tumor-suppressor activity can be stimulated to eradicate tumor cells.  Inhibiting the p53-MDM2 interaction is a promising approach for activating p53, because this assocn. is well characterized at the structural and biol. levels.  MDM2 inhibits p53 transcriptional activity, favors its nuclear export and stimulates its degrdn., so inhibiting the p53-MDM2 interaction with synthetic mols. should lead to p53-mediated cell-cycle arrest or apoptosis in p53-pos. stressed cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpC1Ihu0XrL47Vg90H21EOLACvtfcHk0liZ-3aAtzIBZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXisVCru7k%253D&md5=a66dab38cd424a4ca6f8b349aa72fd0e</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnrc991&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc991%26sid%3Dliteratum%253Aachs%26aulast%3DChene%26aufirst%3DP.%26atitle%3DInhibiting%2520the%2520p53-MDM2%2520interaction%253A%2520An%2520important%2520target%2520for%2520cancer%2520therapy%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2003%26volume%3D3%26spage%3D102%26epage%3D109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Vogelstein, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levine, A. J.</span><span> </span><span class="NLM_article-title">Surfing the p53 network</span> <span class="citation_source-journal">Nature (London)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">408</span><span class="NLM_x">, </span> <span class="NLM_fpage">307</span><span class="NLM_x">–</span> <span class="NLM_lpage">310</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm401911v&amp;key=10.1038%2F35042675" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm401911v&amp;key=11099028" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm401911v&amp;key=1%3ACAS%3A528%3ADC%252BD3cXosVemtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=408&publication_year=2000&pages=307-310&author=B.+Vogelsteinauthor=D.+Laneauthor=A.+J.+Levine&title=Surfing+the+p53+network"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Surfing the p53 network</span></div><div class="casAuthors">Vogelstein, Bert; Lane, David; Levine, Arnold J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">408</span>
        (<span class="NLM_cas:issue">6810</span>),
    <span class="NLM_cas:pages">307-310</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUz4RWc7xOzrVg90H21EOLACvtfcHk0lhPbCYe557OSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXosVemtrY%253D&md5=136728653fb9e30f8ac0c48bf7701a08</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2F35042675&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35042675%26sid%3Dliteratum%253Aachs%26aulast%3DVogelstein%26aufirst%3DB.%26aulast%3DLane%26aufirst%3DD.%26aulast%3DLevine%26aufirst%3DA.%2BJ.%26atitle%3DSurfing%2520the%2520p53%2520network%26jtitle%3DNature%2520%2528London%2529%26date%3D2000%26volume%3D408%26spage%3D307%26epage%3D310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Kussie, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorina, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcchal, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elenbaas, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreau, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levine, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavletich, N. P.</span><span> </span><span class="NLM_article-title">Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">274</span><span class="NLM_x">, </span> <span class="NLM_fpage">948</span><span class="NLM_x">–</span> <span class="NLM_lpage">953</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm401911v&amp;key=10.1126%2Fscience.274.5289.948" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm401911v&amp;key=8875929" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm401911v&amp;key=1%3ACAS%3A528%3ADyaK28XmslKnt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1996&pages=948-953&author=P.+H.+Kussieauthor=S.+Gorinaauthor=V.+Marcchalauthor=B.+Elenbaasauthor=J.+Moreauauthor=A.+J.+Levineauthor=N.+P.+Pavletich&title=Structure+of+the+MDM2+oncoprotein+bound+to+the+p53+tumor+suppressor+transactivation+domain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain</span></div><div class="casAuthors">Kussie, Paul H.; Gorina, Svetlana; Marechal, Vincent; Elenbaas, Brian; Moreau, Jacque; Levine, Arnold J.; Pavletich, Nikola P.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">274</span>
        (<span class="NLM_cas:issue">5289</span>),
    <span class="NLM_cas:pages">948-953</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The MDM2 oncoprotein is a cellular inhibitor of the p53 tumor suppressor in that it can bind the transactivation domain of p53 and downregulate its ability to activate transcription.  In certain cancers, MDM2 amplification is a common event and contributes to the inactivation of p53.  The crystal structure of the 109-residue amino-terminal domain of MDM2 bound to a 15-residue transactivation domain peptide of p53 revealed that MDM2 has a deep hydrophobic cleft on which the p53 peptide binds as an amphipathic α helix.  The interface relies on the steric complementarity between the MDM2 cleft and the hydrophobic face of the p53 α helix and, in particular, on a triad of p53 amino acids - Phe19, Trp23, and Leu26 - which insert deep into the MDM2 cleft.  These same p53 residues are also involved in transactivation, supporting the hypothesis that MDM2 inactivates p53 by concealing its transactivation domain.  The structure also suggests that the amphipathic α helix may be a common structural motif in the binding of a diverse family of transactivation factors to the TATA-binding protein-assocd. factors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotkRIRDnQnX7Vg90H21EOLACvtfcHk0lhPbCYe557OSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XmslKnt7k%253D&md5=3702422b0a761617cff1498f47f30eeb</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1126%2Fscience.274.5289.948&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.274.5289.948%26sid%3Dliteratum%253Aachs%26aulast%3DKussie%26aufirst%3DP.%2BH.%26aulast%3DGorina%26aufirst%3DS.%26aulast%3DMarcchal%26aufirst%3DV.%26aulast%3DElenbaas%26aufirst%3DB.%26aulast%3DMoreau%26aufirst%3DJ.%26aulast%3DLevine%26aufirst%3DA.%2BJ.%26aulast%3DPavletich%26aufirst%3DN.%2BP.%26atitle%3DStructure%2520of%2520the%2520MDM2%2520oncoprotein%2520bound%2520to%2520the%2520p53%2520tumor%2520suppressor%2520transactivation%2520domain%26jtitle%3DScience%26date%3D1996%26volume%3D274%26spage%3D948%26epage%3D953" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Garcia-Echevarria, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chene, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blommers, M. J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furet, P.</span><span> </span><span class="NLM_article-title">Discovery of potent antagonists of the interaction between human double minute 2 and tumor suppressor p53</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">3205</span><span class="NLM_x">–</span> <span class="NLM_lpage">3208</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=3205-3208&author=C.+Garcia-Echevarriaauthor=P.+Cheneauthor=M.+J.+J.+Blommersauthor=P.+Furet&title=Discovery+of+potent+antagonists+of+the+interaction+between+human+double+minute+2+and+tumor+suppressor+p53"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGarcia-Echevarria%26aufirst%3DC.%26aulast%3DChene%26aufirst%3DP.%26aulast%3DBlommers%26aufirst%3DM.%2BJ.%2BJ.%26aulast%3DFuret%26aufirst%3DP.%26atitle%3DDiscovery%2520of%2520potent%2520antagonists%2520of%2520the%2520interaction%2520between%2520human%2520double%2520minute%25202%2520and%2520tumor%2520suppressor%2520p53%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D3205%26epage%3D3208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Arkin, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, J. A.</span><span> </span><span class="NLM_article-title">Small-molecule inhibitors of protein–protein interactions: progressing towards the dream</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">301</span><span class="NLM_x">–</span> <span class="NLM_lpage">317</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=301-317&author=M.+R.+Arkinauthor=J.+A.+Wells&title=Small-molecule+inhibitors+of+protein%E2%80%93protein+interactions%3A+progressing+towards+the+dream"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArkin%26aufirst%3DM.%2BR.%26aulast%3DWells%26aufirst%3DJ.%2BA.%26atitle%3DSmall-molecule%2520inhibitors%2520of%2520protein%25E2%2580%2593protein%2520interactions%253A%2520progressing%2520towards%2520the%2520dream%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D3%26spage%3D301%26epage%3D317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="note"><p class="first last">For other small molecule MDM2-inhibitor scaffolds see imidazolines;</p></div><div class="NLM_citation" id="cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Vassilev, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vu, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graves, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carvajal, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podlaski, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filipovic, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kammlott, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukacs, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fotouhi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, E. A.</span><span> </span><span class="NLM_article-title">In vivo activation of the p53 pathway by small molecule antagonists of MDM2</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">303</span><span class="NLM_x">, </span> <span class="NLM_fpage">844</span><span class="NLM_x">–</span> <span class="NLM_lpage">848</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=303&publication_year=2004&pages=844-848&author=L.+T.+Vassilevauthor=B.+T.+Vuauthor=B.+Gravesauthor=D.+Carvajalauthor=F.+Podlaskiauthor=Z.+Filipovicauthor=N.+Kongauthor=U.+Kammlottauthor=C.+Lukacsauthor=C.+Kleinauthor=N.+Fotouhiauthor=E.+A.+Liu&title=In+vivo+activation+of+the+p53+pathway+by+small+molecule+antagonists+of+MDM2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVassilev%26aufirst%3DL.%2BT.%26aulast%3DVu%26aufirst%3DB.%2BT.%26aulast%3DGraves%26aufirst%3DB.%26aulast%3DCarvajal%26aufirst%3DD.%26aulast%3DPodlaski%26aufirst%3DF.%26aulast%3DFilipovic%26aufirst%3DZ.%26aulast%3DKong%26aufirst%3DN.%26aulast%3DKammlott%26aufirst%3DU.%26aulast%3DLukacs%26aufirst%3DC.%26aulast%3DKlein%26aufirst%3DC.%26aulast%3DFotouhi%26aufirst%3DN.%26aulast%3DLiu%26aufirst%3DE.%2BA.%26atitle%3DIn%2520vivo%2520activation%2520of%2520the%2520p53%2520pathway%2520by%2520small%2520molecule%2520antagonists%2520of%2520MDM2%26jtitle%3DScience%26date%3D2004%26volume%3D303%26spage%3D844%26epage%3D848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Vu, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassilev, L.</span><span> </span><span class="NLM_article-title">Small-molecule inhibitors of the p53-MDM2 interaction</span> <span class="citation_source-journal">Curr. Top. Microbiol. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">348</span><span class="NLM_x">, </span> <span class="NLM_fpage">151</span><span class="NLM_x">–</span> <span class="NLM_lpage">172</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=348&publication_year=2011&pages=151-172&author=B.+T.+Vuauthor=L.+Vassilev&title=Small-molecule+inhibitors+of+the+p53-MDM2+interaction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVu%26aufirst%3DB.%2BT.%26aulast%3DVassilev%26aufirst%3DL.%26atitle%3DSmall-molecule%2520inhibitors%2520of%2520the%2520p53-MDM2%2520interaction%26jtitle%3DCurr.%2520Top.%2520Microbiol.%2520Immunol.%26date%3D2011%26volume%3D348%26spage%3D151%26epage%3D172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last">Benzodiazepinediones:</p></div><div class="NLM_citation" id="cit12c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Parks, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaFrance, L. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calvo, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milkiewicz, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lattance, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramachandren, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carver, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrella, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maguire, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grasberger, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, T.</span><span> </span><span class="NLM_article-title">1,4-Benzodiazepine-2,5-diones as small molecule antagonists of the HDM2-p53 interaction: discovery and SAR</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">765</span><span class="NLM_x">–</span> <span class="NLM_lpage">770</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=765-770&author=D.+J.+Parksauthor=L.+V.+LaFranceauthor=R.+R.+Calvoauthor=K.+L.+Milkiewiczauthor=V.+Guptaauthor=J.+Lattanceauthor=K.+Ramachandrenauthor=T.+E.+Carverauthor=E.+C.+Petrellaauthor=M.+D.+Cummingsauthor=D.+Maguireauthor=B.+L.+Grasbergerauthor=T.+Lu&title=1%2C4-Benzodiazepine-2%2C5-diones+as+small+molecule+antagonists+of+the+HDM2-p53+interaction%3A+discovery+and+SAR"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DParks%26aufirst%3DD.%2BJ.%26aulast%3DLaFrance%26aufirst%3DL.%2BV.%26aulast%3DCalvo%26aufirst%3DR.%2BR.%26aulast%3DMilkiewicz%26aufirst%3DK.%2BL.%26aulast%3DGupta%26aufirst%3DV.%26aulast%3DLattance%26aufirst%3DJ.%26aulast%3DRamachandren%26aufirst%3DK.%26aulast%3DCarver%26aufirst%3DT.%2BE.%26aulast%3DPetrella%26aufirst%3DE.%2BC.%26aulast%3DCummings%26aufirst%3DM.%2BD.%26aulast%3DMaguire%26aufirst%3DD.%26aulast%3DGrasberger%26aufirst%3DB.%2BL.%26aulast%3DLu%26aufirst%3DT.%26atitle%3D1%252C4-Benzodiazepine-2%252C5-diones%2520as%2520small%2520molecule%2520antagonists%2520of%2520the%2520HDM2-p53%2520interaction%253A%2520discovery%2520and%2520SAR%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D765%26epage%3D770" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Parks, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaFrance, L. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calvo, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milkiewicz, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marugan, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raboisson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schubert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koblish, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franks, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lattanze, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carver, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maguire, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grasberger, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maroney, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, T.</span><span> </span><span class="NLM_article-title">Enhanced pharmacokinetic properties of 1,4-benzodiazepine-2,5-dione antagonists of the HDM2-p53 protein–protein interaction through structure-based drug design</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">3310</span><span class="NLM_x">–</span> <span class="NLM_lpage">3314</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=3310-3314&author=D.+J.+Parksauthor=L.+V.+LaFranceauthor=R.+R.+Calvoauthor=K.+L.+Milkiewiczauthor=J.+L.+Maruganauthor=P.+Raboissonauthor=C.+Schubertauthor=H.+K.+Koblishauthor=S.+Zhaoauthor=C.+F.+Franksauthor=J.+Lattanzeauthor=T.+E.+Carverauthor=M.+D.+Cummingsauthor=D.+Maguireauthor=B.+L.+Grasbergerauthor=A.+C.+Maroneyauthor=T.+Lu&title=Enhanced+pharmacokinetic+properties+of+1%2C4-benzodiazepine-2%2C5-dione+antagonists+of+the+HDM2-p53+protein%E2%80%93protein+interaction+through+structure-based+drug+design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DParks%26aufirst%3DD.%2BJ.%26aulast%3DLaFrance%26aufirst%3DL.%2BV.%26aulast%3DCalvo%26aufirst%3DR.%2BR.%26aulast%3DMilkiewicz%26aufirst%3DK.%2BL.%26aulast%3DMarugan%26aufirst%3DJ.%2BL.%26aulast%3DRaboisson%26aufirst%3DP.%26aulast%3DSchubert%26aufirst%3DC.%26aulast%3DKoblish%26aufirst%3DH.%2BK.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DFranks%26aufirst%3DC.%2BF.%26aulast%3DLattanze%26aufirst%3DJ.%26aulast%3DCarver%26aufirst%3DT.%2BE.%26aulast%3DCummings%26aufirst%3DM.%2BD.%26aulast%3DMaguire%26aufirst%3DD.%26aulast%3DGrasberger%26aufirst%3DB.%2BL.%26aulast%3DMaroney%26aufirst%3DA.%2BC.%26aulast%3DLu%26aufirst%3DT.%26atitle%3DEnhanced%2520pharmacokinetic%2520properties%2520of%25201%252C4-benzodiazepine-2%252C5-dione%2520antagonists%2520of%2520the%2520HDM2-p53%2520protein%25E2%2580%2593protein%2520interaction%2520through%2520structure-based%2520drug%2520design%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D3310%26epage%3D3314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Grasberger, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schubert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parks, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carver, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koblish, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaFrance, L. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milkiewicz, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calvo, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maguire, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lattanze, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franks, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramachandren, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bylebyl, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manthey, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrella, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pantoliano, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deckman, I. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spurlino, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maroney, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomczuk, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molloy, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bone, R. F.</span><span> </span><span class="NLM_article-title">Discovery and co-crystal structure of benzodiazepinedione HDM2 antagonists that activate p53 in cells</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">909</span><span class="NLM_x">–</span> <span class="NLM_lpage">912</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049137g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=909-912&author=B.+L.+Grasbergerauthor=T.+Luauthor=C.+Schubertauthor=D.+J.+Parksauthor=T.+E.+Carverauthor=H.+K.+Koblishauthor=M.+D.+Cummingsauthor=L.+V.+LaFranceauthor=K.+L.+Milkiewiczauthor=R.+R.+Calvoauthor=D.+Maguireauthor=J.+Lattanzeauthor=C.+F.+Franksauthor=S.+Zhaoauthor=K.+Ramachandrenauthor=G.+R.+Bylebylauthor=M.+Zhangauthor=C.+L.+Mantheyauthor=E.+C.+Petrellaauthor=M.+W.+Pantolianoauthor=I.+C.+Deckmanauthor=J.+C.+Spurlinoauthor=A.+C.+Maroneyauthor=B.+E.+Tomczukauthor=C.+J.+Molloyauthor=R.+F.+Bone&title=Discovery+and+co-crystal+structure+of+benzodiazepinedione+HDM2+antagonists+that+activate+p53+in+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12e&amp;dbid=16384&amp;doi=10.1021%2Fjm049137g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049137g%26sid%3Dliteratum%253Aachs%26aulast%3DGrasberger%26aufirst%3DB.%2BL.%26aulast%3DLu%26aufirst%3DT.%26aulast%3DSchubert%26aufirst%3DC.%26aulast%3DParks%26aufirst%3DD.%2BJ.%26aulast%3DCarver%26aufirst%3DT.%2BE.%26aulast%3DKoblish%26aufirst%3DH.%2BK.%26aulast%3DCummings%26aufirst%3DM.%2BD.%26aulast%3DLaFrance%26aufirst%3DL.%2BV.%26aulast%3DMilkiewicz%26aufirst%3DK.%2BL.%26aulast%3DCalvo%26aufirst%3DR.%2BR.%26aulast%3DMaguire%26aufirst%3DD.%26aulast%3DLattanze%26aufirst%3DJ.%26aulast%3DFranks%26aufirst%3DC.%2BF.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DRamachandren%26aufirst%3DK.%26aulast%3DBylebyl%26aufirst%3DG.%2BR.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DManthey%26aufirst%3DC.%2BL.%26aulast%3DPetrella%26aufirst%3DE.%2BC.%26aulast%3DPantoliano%26aufirst%3DM.%2BW.%26aulast%3DDeckman%26aufirst%3DI.%2BC.%26aulast%3DSpurlino%26aufirst%3DJ.%2BC.%26aulast%3DMaroney%26aufirst%3DA.%2BC.%26aulast%3DTomczuk%26aufirst%3DB.%2BE.%26aulast%3DMolloy%26aufirst%3DC.%2BJ.%26aulast%3DBone%26aufirst%3DR.%2BF.%26atitle%3DDiscovery%2520and%2520co-crystal%2520structure%2520of%2520benzodiazepinedione%2520HDM2%2520antagonists%2520that%2520activate%2520p53%2520in%2520cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D909%26epage%3D912" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolf, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bista, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meireles, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camacho, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holak, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Domling, A.</span><span> </span><span class="NLM_article-title">1,4-Thienodiazepine-2,5-diones via MCR (I): Synthesis, virtual space and p53-Mdm2 activity</span> <span class="citation_source-journal">Chem. Biol. Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">76</span><span class="NLM_x">, </span> <span class="NLM_fpage">116</span><span class="NLM_x">–</span> <span class="NLM_lpage">129</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12f&amp;dbid=16&amp;doi=10.1021%2Fjm401911v&amp;key=10.1111%2Fj.1747-0285.2010.00989.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12f&amp;dbid=8&amp;doi=10.1021%2Fjm401911v&amp;key=20492448" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12f&amp;dbid=32&amp;doi=10.1021%2Fjm401911v&amp;key=1%3ACAS%3A528%3ADC%252BC3cXptleqs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2010&pages=116-129&author=Y.+Huangauthor=S.+Wolfauthor=M.+Bistaauthor=L.+Meirelesauthor=C.+Camachoauthor=T.+A.+Holakauthor=A.+Domling&title=1%2C4-Thienodiazepine-2%2C5-diones+via+MCR+%28I%29%3A+Synthesis%2C+virtual+space+and+p53-Mdm2+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12fR"><div class="casContent"><span class="casTitleNuber">12f</span><div class="casTitle"><span class="NLM_cas:atitle">1,4-Thienodiazepine-2,5-diones via MCR (I): Synthesis, virtual space and p53-Mdm2 activity</span></div><div class="casAuthors">Huang, Yijun; Wolf, Siglinde; Bista, Michal; Meireles, Lidio; Camacho, Carlos; Holak, Tad A.; Domling, Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">116-129</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">1,4-Thienodiazepine-2,5-diones have been synthesized via the Ugi-Deprotection-Cyclization (UDC) approach starting from Gewald 2-aminothiophenes, e.g. I, in a convergent and versatile manner.  The resulting scaffold is unprecedented, cyclic, and peptidomimetic with four points of diversity introduced from readily available starting materials.  In addn. to eighteen synthesized and characterized compds., a virtual compd. library was generated and evaluated for chem. space distribution and drug-like properties.  A small focused compd. library of 1,4-thienodiazepine-2,5-diones, e.g. II, has been screened for the activity against p53-Mdm2 interaction.  Biol. evaluations demonstrated that some compds. exhibited promising antagonistic activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpK0Ctp2sc40rVg90H21EOLACvtfcHk0lgVIDcJoahDxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXptleqs7s%253D&md5=030992e421fc773c9de45306758dcef0</span></div><a href="/servlet/linkout?suffix=cit12f&amp;dbid=16384&amp;doi=10.1111%2Fj.1747-0285.2010.00989.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1747-0285.2010.00989.x%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DWolf%26aufirst%3DS.%26aulast%3DBista%26aufirst%3DM.%26aulast%3DMeireles%26aufirst%3DL.%26aulast%3DCamacho%26aufirst%3DC.%26aulast%3DHolak%26aufirst%3DT.%2BA.%26aulast%3DDomling%26aufirst%3DA.%26atitle%3D1%252C4-Thienodiazepine-2%252C5-diones%2520via%2520MCR%2520%2528I%2529%253A%2520Synthesis%252C%2520virtual%2520space%2520and%2520p53-Mdm2%2520activity%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2010%26volume%3D76%26spage%3D116%26epage%3D129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last">Spiro-oxoindoles;</p></div><div class="NLM_citation" id="cit12g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Ding, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikolovska-Coleska, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shangary, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stuckey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krajewski, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roller, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span> </span><span class="NLM_article-title">Structure-based design of spiro-oxindoles as potent, specific small-molecule inhibitors of the MDM2-p53 interaction</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">3432</span><span class="NLM_x">–</span> <span class="NLM_lpage">3435</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm051122a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12g&amp;dbid=32&amp;doi=10.1021%2Fjm401911v&amp;key=1%3ACAS%3A528%3ADC%252BD28XksFKksrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=3432-3435&author=K.+Dingauthor=Y.+Luauthor=Z.+Nikolovska-Coleskaauthor=G.+Wangauthor=S.+Qiuauthor=S.+Shangaryauthor=W.+Gaoauthor=D.+Qinauthor=J.+Stuckeyauthor=K.+Krajewskiauthor=P.+P.+Rollerauthor=S.+Wang&title=Structure-based+design+of+spiro-oxindoles+as+potent%2C+specific+small-molecule+inhibitors+of+the+MDM2-p53+interaction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12gR"><div class="casContent"><span class="casTitleNuber">12g</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design of Spiro-oxindoles as Potent, Specific Small-Molecule Inhibitors of the MDM2-p53 Interaction</span></div><div class="casAuthors">Ding, Ke; Lu, Yipin; Nikolovska-Coleska, Zaneta; Wang, Guoping; Qiu, Su; Shangary, Sanjeev; Gao, Wei; Qin, Dongguang; Stuckey, Jeanne; Krajewski, Krzysztof; Roller, Peter P.; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3432-3435</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Potent, specific, non-peptide small-mol. inhibitors of the MDM2-p53 interaction were successfully designed.  The most potent inhibitor (MI-63) has a Ki value of 3 nM binding to MDM2 and greater than 10,000-fold selectivity over Bcl-2/Bcl-xL proteins.  MI-63 is highly effective in activation of p53 function and in inhibition of cell growth in cancer cells with wild-type p53 status.  MI-63 has excellent specificity over cancer cells with deleted p53 and shows a minimal toxicity to normal cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptppiErNrFXrVg90H21EOLACvtfcHk0lgVIDcJoahDxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XksFKksrc%253D&md5=186a2ba028ad9b8f71107aa1c2555421</span></div><a href="/servlet/linkout?suffix=cit12g&amp;dbid=16384&amp;doi=10.1021%2Fjm051122a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm051122a%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DK.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DNikolovska-Coleska%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DQiu%26aufirst%3DS.%26aulast%3DShangary%26aufirst%3DS.%26aulast%3DGao%26aufirst%3DW.%26aulast%3DQin%26aufirst%3DD.%26aulast%3DStuckey%26aufirst%3DJ.%26aulast%3DKrajewski%26aufirst%3DK.%26aulast%3DRoller%26aufirst%3DP.%2BP.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DStructure-based%2520design%2520of%2520spiro-oxindoles%2520as%2520potent%252C%2520specific%2520small-molecule%2520inhibitors%2520of%2520the%2520MDM2-p53%2520interaction%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D3432%26epage%3D3435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Yu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shangary, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McEachern, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikolovska-Coleska, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span> </span><span class="NLM_article-title">Potent and orally active small molecule inhibitors of the MDM2-p53 interaction</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">7970</span><span class="NLM_x">–</span> <span class="NLM_lpage">7973</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901400z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7970-7973&author=S.+Yuauthor=D.+Qinauthor=S.+Shangaryauthor=J.+Chenauthor=G.+Wangauthor=K.+Dingauthor=D.+McEachernauthor=S.+Qiuauthor=Z.+Nikolovska-Coleskaauthor=R.+Millerauthor=S.+Kangauthor=D.+Yangauthor=S.+Wang&title=Potent+and+orally+active+small+molecule+inhibitors+of+the+MDM2-p53+interaction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12h&amp;dbid=16384&amp;doi=10.1021%2Fjm901400z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901400z%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DS.%26aulast%3DQin%26aufirst%3DD.%26aulast%3DShangary%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DDing%26aufirst%3DK.%26aulast%3DMcEachern%26aufirst%3DD.%26aulast%3DQiu%26aufirst%3DS.%26aulast%3DNikolovska-Coleska%26aufirst%3DZ.%26aulast%3DMiller%26aufirst%3DR.%26aulast%3DKang%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DPotent%2520and%2520orally%2520active%2520small%2520molecule%2520inhibitors%2520of%2520the%2520MDM2-p53%2520interaction%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D7970%26epage%3D7973" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12i"><span><span class="NLM_label">(i) </span><span class="NLM_contrib-group">Wang, S.; Yu, S.; Sun, W.; Shangary, S. K.; Sun, D.; Zou, P.; McEachern, D.; Zhao, Y.</span><span> </span><span class="NLM_article-title">Preparation of Spiro-oxindole Derivatives as MDM2 Antagonists</span>. US2011/0112052A1,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=S.+Wang&author=S.+Yu&author=W.+Sun&author=S.+K.+Shangary&author=D.+Sun&author=P.+Zou&author=D.+McEachern&author=Y.+Zhao&title=Preparation+of+Spiro-oxindole+Derivatives+as+MDM2+Antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12i&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DS.%26atitle%3DPreparation%2520of%2520Spiro-oxindole%2520Derivatives%2520as%2520MDM2%2520Antagonists%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last">3-Imidazolyndole:</p></div><div class="NLM_citation" id="cit12j"><span><span class="NLM_label">(j) </span><span class="NLM_contrib-group">Furet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chéne, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Pover, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stachyra Valat, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hergovich Lisztwan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kallen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masuya, K.</span><span> </span><span class="NLM_article-title">The central valine concept provides an entry in a class of non-peptide inhibitors of the p53-MDM2 interaction</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">3498</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=3498&author=P.+Furetauthor=P.+Ch%C3%A9neauthor=A.+De+Poverauthor=T.+Stachyra+Valatauthor=J.+Hergovich+Lisztwanauthor=J.+Kallenauthor=K.+Masuya&title=The+central+valine+concept+provides+an+entry+in+a+class+of+non-peptide+inhibitors+of+the+p53-MDM2+interaction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12j&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFuret%26aufirst%3DP.%26aulast%3DCh%25C3%25A9ne%26aufirst%3DP.%26aulast%3DDe%2BPover%26aufirst%3DA.%26aulast%3DStachyra%2BValat%26aufirst%3DT.%26aulast%3DHergovich%2BLisztwan%26aufirst%3DJ.%26aulast%3DKallen%26aufirst%3DJ.%26aulast%3DMasuya%26aufirst%3DK.%26atitle%3DThe%2520central%2520valine%2520concept%2520provides%2520an%2520entry%2520in%2520a%2520class%2520of%2520non-peptide%2520inhibitors%2520of%2520the%2520p53-MDM2%2520interaction%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D3498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12k"><span><span class="NLM_label">(k) </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, X.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartkovitz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karnachi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">So, S.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tovar, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filipovic, Z. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glenn, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Packman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassilev, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graves, B.</span><span> </span><span class="NLM_article-title">Discovery of potent and orally active p53-MDM2 inhibitors RO5353 and RO2468 for potential clinical development</span> <span class="citation_source-journal">Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">124</span><span class="NLM_x">–</span> <span class="NLM_lpage">7</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml400359z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12k&amp;dbid=32&amp;doi=10.1021%2Fjm401911v&amp;key=1%3ACAS%3A528%3ADC%252BC2cXksVal" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=124-7&author=Z.+Zhangauthor=X.-J.+Chuauthor=J.-J.+Liuauthor=Q.+Dingauthor=J.+Zhangauthor=D.+Bartkovitzauthor=N.+Jiangauthor=P.+Karnachiauthor=S.-S.+Soauthor=C.+Tovarauthor=Z.+M.+Filipovicauthor=B.+Higginsauthor=K.+Glennauthor=K.+Packmanauthor=Z.+Vassilevauthor=B.+Graves&title=Discovery+of+potent+and+orally+active+p53-MDM2+inhibitors+RO5353+and+RO2468+for+potential+clinical+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12kR"><div class="casContent"><span class="casTitleNuber">12k</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent and Orally Active p53-MDM2 Inhibitors RO5353 and RO2468 for Potential Clinical Development</span></div><div class="casAuthors">Zhang, Zhuming; Chu, Xin-Jie; Liu, Jin-Jun; Ding, Qingjie; Zhang, Jing; Bartkovitz, David; Jiang, Nan; Karnachi, Prabha; So, Sung-Sau; Tovar, Christian; Filipovic, Zoran M.; Higgins, Brian; Glenn, Kelli; Packman, Kathryn; Vassilev, Lyubomir; Graves, Bradford</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">124-127</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The development of small-mol. MDM2 inhibitors to restore dysfunctional p53 activities represents a novel approach for cancer treatment.  In a previous communication, the efforts leading to the identification of a non-imidazoline MDM2 inhibitor, RG7388, were disclosed and revealed the desirable in vitro and in vivo pharmacol. properties that this class of pyrrolidine-based inhibitors possesses.  Given this richness and the crit. need for a wide variety of chem. structures to ensure success in the clinic, research was expanded to evaluate addnl. derivs.  Here we report two new potent, selective, and orally active p53-MDM2 antagonists, RO5353 and RO2468 (I and II, resp.), as follow-ups with promising potential for clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhz706p6MGerVg90H21EOLACvtfcHk0lhF3tx0h9Gjvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXksVal&md5=30b9dff342ff18ce8dafe7f564d4a771</span></div><a href="/servlet/linkout?suffix=cit12k&amp;dbid=16384&amp;doi=10.1021%2Fml400359z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400359z%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DChu%26aufirst%3DX.-J.%26aulast%3DLiu%26aufirst%3DJ.-J.%26aulast%3DDing%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DBartkovitz%26aufirst%3DD.%26aulast%3DJiang%26aufirst%3DN.%26aulast%3DKarnachi%26aufirst%3DP.%26aulast%3DSo%26aufirst%3DS.-S.%26aulast%3DTovar%26aufirst%3DC.%26aulast%3DFilipovic%26aufirst%3DZ.%2BM.%26aulast%3DHiggins%26aufirst%3DB.%26aulast%3DGlenn%26aufirst%3DK.%26aulast%3DPackman%26aufirst%3DK.%26aulast%3DVassilev%26aufirst%3DZ.%26aulast%3DGraves%26aufirst%3DB.%26atitle%3DDiscovery%2520of%2520potent%2520and%2520orally%2520active%2520p53-MDM2%2520inhibitors%2520RO5353%2520and%2520RO2468%2520for%2520potential%2520clinical%2520development%26jtitle%3DMed.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D124%26epage%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12l"><span><span class="NLM_label">(l) </span><span class="NLM_contrib-group">Ding, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikolovska-Coleska, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qju, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stuckey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krajewski, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roller, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomita, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parrish, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deschamps, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span> </span><span class="NLM_article-title">Structure-based desing of potent non-peptide MDM2 inhibitors</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">127</span><span class="NLM_x">, </span> <span class="NLM_fpage">10130</span><span class="NLM_x">–</span> <span class="NLM_lpage">10131</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja051147z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2005&pages=10130-10131&author=K.+Dingauthor=Y.+Luauthor=Z.+Nikolovska-Coleskaauthor=S.+Qjuauthor=Y.+Dingauthor=W.+Gaoauthor=J.+Stuckeyauthor=K.+Krajewskiauthor=P.+P.+Rollerauthor=Y.+Tomitaauthor=D.+A.+Parrishauthor=J.+R.+Deschampsauthor=S.+Wang&title=Structure-based+desing+of+potent+non-peptide+MDM2+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12l&amp;dbid=16384&amp;doi=10.1021%2Fja051147z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja051147z%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DK.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DNikolovska-Coleska%26aufirst%3DZ.%26aulast%3DQju%26aufirst%3DS.%26aulast%3DDing%26aufirst%3DY.%26aulast%3DGao%26aufirst%3DW.%26aulast%3DStuckey%26aufirst%3DJ.%26aulast%3DKrajewski%26aufirst%3DK.%26aulast%3DRoller%26aufirst%3DP.%2BP.%26aulast%3DTomita%26aufirst%3DY.%26aulast%3DParrish%26aufirst%3DD.%2BA.%26aulast%3DDeschamps%26aufirst%3DJ.%2BR.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DStructure-based%2520desing%2520of%2520potent%2520non-peptide%2520MDM2%2520inhibitors%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2005%26volume%3D127%26spage%3D10130%26epage%3D10131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12m"><span><span class="NLM_label">(m) </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McEachern, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ochsenbein, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferey, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carry, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deschamps, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span> </span><span class="NLM_article-title">Diastereomeric spirooxindoles as highly potent and efficacious MDM2 inhibitors</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">135</span><span class="NLM_x">, </span> <span class="NLM_fpage">7223</span><span class="NLM_x">–</span> <span class="NLM_lpage">7234</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja3125417" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12m&amp;dbid=32&amp;doi=10.1021%2Fjm401911v&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntVWrtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2013&pages=7223-7234&author=Y.+Zhaoauthor=L.+Liuauthor=W.+Sunauthor=J.+Luauthor=D.+McEachernauthor=X.+Liauthor=S.+Yuauthor=D.+Bernardauthor=P.+Ochsenbeinauthor=V.+Fereyauthor=J.-C.+Carryauthor=J.+R.+Deschampsauthor=D.+Sunauthor=S.+Wang&title=Diastereomeric+spirooxindoles+as+highly+potent+and+efficacious+MDM2+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12mR"><div class="casContent"><span class="casTitleNuber">12m</span><div class="casTitle"><span class="NLM_cas:atitle">Diastereomeric Spirooxindoles as Highly Potent and Efficacious MDM2 Inhibitors</span></div><div class="casAuthors">Zhao, Yujun; Liu, Liu; Sun, Wei; Lu, Jianfeng; McEachern, Donna; Li, Xiaoqin; Yu, Shanghai; Bernard, Denzil; Ochsenbein, Philippe; Ferey, Vincent; Carry, Jean-Christophe; Deschamps, Jeffrey R.; Sun, Duxin; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">135</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">7223-7234</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Small-mol. inhibitors that block the MDM2-p53 protein-protein interaction (MDM2 inhibitors) are being intensely pursued as a new therapeutic strategy for cancer treatment.  We previously published a series of spirooxindole-contg. compds. as a new class of MDM2 small-mol. inhibitors.  We report herein a reversible ring-opening-cyclization reaction for some of these spirooxindoles, which affords four diastereomers from a single compd.  Our biochem. binding data showed that the stereochem. in this class of compds. has a major effect on their binding affinities to MDM2, with >100-fold difference between the most potent and the least potent stereoisomers.  Our study has led to the identification of a set of highly potent MDM2 inhibitors with a stereochem. that is different from that of our previously reported compds.  The most potent compd. (MI-888) binds to MDM2 with a Ki value of 0.44 nM and achieves complete and long-lasting tumor regression in an animal model of human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOEWm0CbFl2rVg90H21EOLACvtfcHk0lhF3tx0h9Gjvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntVWrtr0%253D&md5=5c05b0adc0d14506602d0884b64411b0</span></div><a href="/servlet/linkout?suffix=cit12m&amp;dbid=16384&amp;doi=10.1021%2Fja3125417&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja3125417%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DSun%26aufirst%3DW.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DMcEachern%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DYu%26aufirst%3DS.%26aulast%3DBernard%26aufirst%3DD.%26aulast%3DOchsenbein%26aufirst%3DP.%26aulast%3DFerey%26aufirst%3DV.%26aulast%3DCarry%26aufirst%3DJ.-C.%26aulast%3DDeschamps%26aufirst%3DJ.%2BR.%26aulast%3DSun%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DDiastereomeric%2520spirooxindoles%2520as%2520highly%2520potent%2520and%2520efficacious%2520MDM2%2520inhibitors%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2013%26volume%3D135%26spage%3D7223%26epage%3D7234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12n"><span><span class="NLM_label">(n) </span><span class="NLM_contrib-group">Hardcastle, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valeur, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmed, S. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackburn, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennaceur, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clegg, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drummond, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endicott, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golding, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gruber, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haggerty, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrington, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutton, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kemp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonnell, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newell, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noble, M. E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payne, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Revill, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riedinger, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lunec, J.</span><span> </span><span class="NLM_article-title">Isoindolinone inhibitors of the Murine Double Minute 2 (MDM2)-p53 protein–protein interaction: structure–activity studies leading to improved potency</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">1233</span><span class="NLM_x">–</span> <span class="NLM_lpage">1243</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1011929" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=1233-1243&author=J.+R.+Hardcastleauthor=J.+Liuauthor=E.+Valeurauthor=A.+Watsonauthor=S.+U.+Ahmedauthor=T.+J.+Blackburnauthor=K.+Bennaceurauthor=W.+Cleggauthor=C.+Drummondauthor=J.+A.+Endicottauthor=B.+T.+Goldingauthor=R.+J.+Griffinauthor=J.+Gruberauthor=K.+Haggertyauthor=R.+W.+Harringtonauthor=C.+Huttonauthor=S.+Kempauthor=X.+Luauthor=J.+M.+McDonnellauthor=D.+R.+Newellauthor=M.+E.+M.+Nobleauthor=S.+L.+Payneauthor=C.+H.+Revillauthor=C.+Riedingerauthor=Q.+Xuauthor=J.+Lunec&title=Isoindolinone+inhibitors+of+the+Murine+Double+Minute+2+%28MDM2%29-p53+protein%E2%80%93protein+interaction%3A+structure%E2%80%93activity+studies+leading+to+improved+potency"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12n&amp;dbid=16384&amp;doi=10.1021%2Fjm1011929&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1011929%26sid%3Dliteratum%253Aachs%26aulast%3DHardcastle%26aufirst%3DJ.%2BR.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DValeur%26aufirst%3DE.%26aulast%3DWatson%26aufirst%3DA.%26aulast%3DAhmed%26aufirst%3DS.%2BU.%26aulast%3DBlackburn%26aufirst%3DT.%2BJ.%26aulast%3DBennaceur%26aufirst%3DK.%26aulast%3DClegg%26aufirst%3DW.%26aulast%3DDrummond%26aufirst%3DC.%26aulast%3DEndicott%26aufirst%3DJ.%2BA.%26aulast%3DGolding%26aufirst%3DB.%2BT.%26aulast%3DGriffin%26aufirst%3DR.%2BJ.%26aulast%3DGruber%26aufirst%3DJ.%26aulast%3DHaggerty%26aufirst%3DK.%26aulast%3DHarrington%26aufirst%3DR.%2BW.%26aulast%3DHutton%26aufirst%3DC.%26aulast%3DKemp%26aufirst%3DS.%26aulast%3DLu%26aufirst%3DX.%26aulast%3DMcDonnell%26aufirst%3DJ.%2BM.%26aulast%3DNewell%26aufirst%3DD.%2BR.%26aulast%3DNoble%26aufirst%3DM.%2BE.%2BM.%26aulast%3DPayne%26aufirst%3DS.%2BL.%26aulast%3DRevill%26aufirst%3DC.%2BH.%26aulast%3DRiedinger%26aufirst%3DC.%26aulast%3DXu%26aufirst%3DQ.%26aulast%3DLunec%26aufirst%3DJ.%26atitle%3DIsoindolinone%2520inhibitors%2520of%2520the%2520Murine%2520Double%2520Minute%25202%2520%2528MDM2%2529-p53%2520protein%25E2%2580%2593protein%2520interaction%253A%2520structure%25E2%2580%2593activity%2520studies%2520leading%2520to%2520improved%2520potency%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D1233%26epage%3D1243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12o"><span><span class="NLM_label">(o) </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McEachern, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shargary, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernard, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span> </span><span class="NLM_article-title">A potent small-molecule inhibitor of the MDM2-p53 interaction (MI-888) achieve complete and durable tumor regression in mice</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">5553</span><span class="NLM_x">–</span> <span class="NLM_lpage">5561</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm4005708" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=5553-5561&author=Y.+Zhaoauthor=S.+Yuauthor=W.+Sunauthor=L.+Liuauthor=J.+Luauthor=D.+McEachernauthor=S.+Shargaryauthor=P.+Bernardauthor=X.+Liauthor=T.+Zhaoauthor=P.+Zouauthor=D.+Sunauthor=S.+Wang&title=A+potent+small-molecule+inhibitor+of+the+MDM2-p53+interaction+%28MI-888%29+achieve+complete+and+durable+tumor+regression+in+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12o&amp;dbid=16384&amp;doi=10.1021%2Fjm4005708&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4005708%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DS.%26aulast%3DSun%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DMcEachern%26aufirst%3DD.%26aulast%3DShargary%26aufirst%3DS.%26aulast%3DBernard%26aufirst%3DP.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DZhao%26aufirst%3DT.%26aulast%3DZou%26aufirst%3DP.%26aulast%3DSun%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DA%2520potent%2520small-molecule%2520inhibitor%2520of%2520the%2520MDM2-p53%2520interaction%2520%2528MI-888%2529%2520achieve%2520complete%2520and%2520durable%2520tumor%2520regression%2520in%2520mice%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D5553%26epage%3D5561" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12p"><span><span class="NLM_label">(p) </span><span class="NLM_contrib-group">Zhuang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheng, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span> </span><span class="NLM_article-title">Discovery, synthesis, and biological evaluation of orally active pyrrolidone derivatives as novel inhibitors of p53-MDM2 protein-protein interaction</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9630</span><span class="NLM_x">–</span> <span class="NLM_lpage">9642</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300969t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9630-9642&author=C.+Zhuangauthor=Z.+Miaoauthor=L.+Zhuauthor=G.+Dongauthor=Z.+Guoauthor=S.+Wangauthor=Y.+Zhangauthor=Y.+Wuauthor=J.+Yaoauthor=C.+Shengauthor=W.+Zhang&title=Discovery%2C+synthesis%2C+and+biological+evaluation+of+orally+active+pyrrolidone+derivatives+as+novel+inhibitors+of+p53-MDM2+protein-protein+interaction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12p&amp;dbid=16384&amp;doi=10.1021%2Fjm300969t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300969t%26sid%3Dliteratum%253Aachs%26aulast%3DZhuang%26aufirst%3DC.%26aulast%3DMiao%26aufirst%3DZ.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DDong%26aufirst%3DG.%26aulast%3DGuo%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DYao%26aufirst%3DJ.%26aulast%3DSheng%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DW.%26atitle%3DDiscovery%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520orally%2520active%2520pyrrolidone%2520derivatives%2520as%2520novel%2520inhibitors%2520of%2520p53-MDM2%2520protein-protein%2520interaction%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9630%26epage%3D9642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13h"><span>Information from <a href="http://www.clinicaltrials.gov" class="extLink">www.clinicaltrials.gov</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Information+from+www.clinicaltrials.gov."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13h&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13a"><span><span class="NLM_label">(a) </span> RG7112 (Hoffmann-La Roche) (see ref  <span class="NLM_xref">15b</span>.);</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+RG7112+%28Hoffmann-La+Roche%29+%28see+ref+15b.%29%3B"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13b"><span><span class="NLM_label">(b) </span> RG7388 (Hoffmann-La Roche) (see ref  <span class="NLM_xref">16</span>.);</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+RG7388+%28Hoffmann-La+Roche%29+%28see+ref+16.%29%3B"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13c"><span><span class="NLM_label">(c) </span> SAR299155 (Sanofi): <span class="NLM_contrib-group">Carry, J.-C.; Garcia-Echeverria, C.</span><span> </span><span class="NLM_article-title">Inhibitors of the p53/hdm2 protein-protein interaction- path to the clinic</span>.  <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">2480</span><span class="NLM_x">–</span> <span class="NLM_lpage">2485</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=2480-2485&author=J.-C.+Carry&author=C.+Garcia-Echeverria&title=Inhibitors+of+the+p53%2Fhdm2+protein-protein+interaction-+path+to+the+clinic"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCarry%26aufirst%3DJ.-C.%26atitle%3DInhibitors%2520of%2520the%2520p53%252Fhdm2%2520protein-protein%2520interaction-%2520path%2520to%2520the%2520clinic%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D2480%26epage%3D2485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13d"><span><span class="NLM_label">(d) </span> MK-8242 (Merck).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+MK-8242+%28Merck%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13e"><span><span class="NLM_label">(e) </span> AMG 232 (Amgen) (see ref  <span class="NLM_xref">17</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+AMG+232+%28Amgen%29+%28see+ref+17%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13f"><span><span class="NLM_label">(f) </span> CGM-097 (Novartis).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+CGM-097+%28Novartis%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13g"><span><span class="NLM_label">(g) </span> DS-3032b (Daiichi Sankyo).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+DS-3032b+%28Daiichi+Sankyo%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13g&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Kamal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azhar Mohammed, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaik, T. B.</span><span> </span><span class="NLM_article-title">p-53-MDM2 inhibitors: patent review (2009–2010)</span> <span class="citation_source-journal">Expert Opin. Ther. Patents</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">95</span><span class="NLM_x">–</span> <span class="NLM_lpage">105</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm401911v&amp;key=10.1517%2F13543776.2012.656593" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm401911v&amp;key=1%3ACAS%3A528%3ADC%252BC38Xit1yntLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=95-105&author=A.+Kamalauthor=A.+Azhar+Mohammedauthor=T.+B.+Shaik&title=p-53-MDM2+inhibitors%3A+patent+review+%282009%E2%80%932010%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">p53-Mdm2 inhibitors: patent review (2009 - 2010)</span></div><div class="casAuthors">Kamal, Ahmed; Mohammed, Ameruddin Azhar; Shaik, Thokhir B.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">95-105</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: p53 plays a central role in protecting the integrity of the genome.  Its activity is ubiquitously lost in cancers, either by inactivation of its protein (p53 pathway) or by mutation in the p53 gene, thereby indicating its importance in understanding cancer and as a therapeutic target.  Activated p53 is known to induce cell cycle arrest thereby leading to apoptosis and has been the subject of intensive research in the area of medicinal chem.  Efforts are in progress to synthesize a variety of scaffolds that could inhibit the p53-Mdm2 interaction by binding to Mdm2 in the region where p53 is likely to bind.  These mols. have the potential to be developed as anticancer drug candidates and have been largely explored by both academia and industry.  Interestingly, some of these mols. are in the early stage of clin. trials.Areas covered: Areas covered in this review include patents relating to p53-Mdm2 inhibitors during the time period 2009 - 2010.  The focus of the review was on small-mol. inhibitors.Expert opinion: Inducing apoptosis in cancerous cells by the activation of p53 is an area that is being actively explored.  There are strong indications that it could become a therapeutic method for the treatment of cancer.  As a result, extensive research is being performed by both academia and industry.  It is obsd. that small mols. that are present in early clin. trials are expected to be developed as potential drugs for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIGmUfa-aEL7Vg90H21EOLACvtfcHk0lj6kBx986On2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xit1yntLw%253D&md5=26fe3be7f8d25e3a5e4913b306003b09</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1517%2F13543776.2012.656593&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2012.656593%26sid%3Dliteratum%253Aachs%26aulast%3DKamal%26aufirst%3DA.%26aulast%3DAzhar%2BMohammed%26aufirst%3DA.%26aulast%3DShaik%26aufirst%3DT.%2BB.%26atitle%3Dp-53-MDM2%2520inhibitors%253A%2520patent%2520review%2520%25282009%25E2%2580%25932010%2529%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Patents%26date%3D2012%26volume%3D22%26spage%3D95%26epage%3D105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Tovar, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graves, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Packman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filipovic, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tardell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrido, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolinsky, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">To, K.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podlaski, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wovkulich, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassilev, L. T.</span><span> </span><span class="NLM_article-title">MDM2 Small-molecule antagonist RG7112 activates p53 signaling and regresses human tumors in preclinical cancer models</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">2587</span><span class="NLM_x">–</span> <span class="NLM_lpage">2597</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2013&pages=2587-2597&author=C.+Tovarauthor=B.+Gravesauthor=K.+Packmanauthor=Z.+Filipovicauthor=B.+Higginsauthor=M.+Xiaauthor=C.+Tardellauthor=R.+Garridoauthor=E.+Leeauthor=K.+Kolinskyauthor=K.-H.+Toauthor=M.+Linnauthor=F.+Podlaskiauthor=P.+Wovkulichauthor=B.+Vuauthor=L.+T.+Vassilev&title=MDM2+Small-molecule+antagonist+RG7112+activates+p53+signaling+and+regresses+human+tumors+in+preclinical+cancer+models"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTovar%26aufirst%3DC.%26aulast%3DGraves%26aufirst%3DB.%26aulast%3DPackman%26aufirst%3DK.%26aulast%3DFilipovic%26aufirst%3DZ.%26aulast%3DHiggins%26aufirst%3DB.%26aulast%3DXia%26aufirst%3DM.%26aulast%3DTardell%26aufirst%3DC.%26aulast%3DGarrido%26aufirst%3DR.%26aulast%3DLee%26aufirst%3DE.%26aulast%3DKolinsky%26aufirst%3DK.%26aulast%3DTo%26aufirst%3DK.-H.%26aulast%3DLinn%26aufirst%3DM.%26aulast%3DPodlaski%26aufirst%3DF.%26aulast%3DWovkulich%26aufirst%3DP.%26aulast%3DVu%26aufirst%3DB.%26aulast%3DVassilev%26aufirst%3DL.%2BT.%26atitle%3DMDM2%2520Small-molecule%2520antagonist%2520RG7112%2520activates%2520p53%2520signaling%2520and%2520regresses%2520human%2520tumors%2520in%2520preclinical%2520cancer%2520models%26jtitle%3DCancer%2520Res.%26date%3D2013%26volume%3D73%26spage%3D2587%26epage%3D2597" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit15b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Vu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolkulich, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pizzolato, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glenn, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tovar, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Packman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassilev, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graves, B.</span><span> </span><span class="NLM_article-title">Discovery of RG7112: A small-molecule MDM2 inhibitor in clinical development</span> <span class="citation_source-journal">Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">466</span><span class="NLM_x">–</span> <span class="NLM_lpage">469</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml4000657" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=32&amp;doi=10.1021%2Fjm401911v&amp;key=1%3ACAS%3A528%3ADC%252BC3sXltV2nur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=466-469&author=B.+Vuauthor=P.+Wolkulichauthor=G.+Pizzolatoauthor=A.+Loveyauthor=Q.+Dingauthor=N.+Jiangauthor=J.-J.+Liuauthor=C.+Zhaoauthor=K.+Glennauthor=Y.+Wenauthor=C.+Tovarauthor=K.+Packmanauthor=L.+T.+Vassilevauthor=B.+Graves&title=Discovery+of+RG7112%3A+A+small-molecule+MDM2+inhibitor+in+clinical+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15bR"><div class="casContent"><span class="casTitleNuber">15b</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of RG7112: A Small-Molecule MDM2 Inhibitor in Clinical Development</span></div><div class="casAuthors">Vu, Binh; Wovkulich, Peter; Pizzolato, Giacomo; Lovey, Allen; Ding, Qingjie; Jiang, Nan; Liu, Jin-Jun; Zhao, Chunlin; Glenn, Kelli; Wen, Yang; Tovar, Christian; Packman, Kathryn; Vassilev, Lyubomir; Graves, Bradford</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">466-469</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The p53 tumor suppressor is a potent transcription factor that plays a key role in the regulation of cellular responses to stress.  It is controlled by its neg. regulator MDM2, which binds directly to p53 and inhibits its transcriptional activity.  MDM2 also targets p53 for degrdn. by the proteasome.  Many tumors produce high levels of MDM2, thereby impairing p53 function.  Restoration of p53 activity by inhibiting the p53-MDM2 interaction may represent a novel approach to cancer treatment.  RG7112 (2g) is the first clin. small-mol. MDM2 inhibitor designed to occupy the p53-binding pocket of MDM2.  In cancer cells expressing wild-type p53, RG7112 stabilizes p53 and activates the p53 pathway, leading to cell cycle arrest, apoptosis, and inhibition or regression of human tumor xenografts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZDyQMojUKIrVg90H21EOLACvtfcHk0lj6kBx986On2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXltV2nur0%253D&md5=3965eb84198ff25eb9bc5f4c3823e850</span></div><a href="/servlet/linkout?suffix=cit15b&amp;dbid=16384&amp;doi=10.1021%2Fml4000657&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml4000657%26sid%3Dliteratum%253Aachs%26aulast%3DVu%26aufirst%3DB.%26aulast%3DWolkulich%26aufirst%3DP.%26aulast%3DPizzolato%26aufirst%3DG.%26aulast%3DLovey%26aufirst%3DA.%26aulast%3DDing%26aufirst%3DQ.%26aulast%3DJiang%26aufirst%3DN.%26aulast%3DLiu%26aufirst%3DJ.-J.%26aulast%3DZhao%26aufirst%3DC.%26aulast%3DGlenn%26aufirst%3DK.%26aulast%3DWen%26aufirst%3DY.%26aulast%3DTovar%26aufirst%3DC.%26aulast%3DPackman%26aufirst%3DK.%26aulast%3DVassilev%26aufirst%3DL.%2BT.%26aulast%3DGraves%26aufirst%3DB.%26atitle%3DDiscovery%2520of%2520RG7112%253A%2520A%2520small-molecule%2520MDM2%2520inhibitor%2520in%2520clinical%2520development%26jtitle%3DMed.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D466%26epage%3D469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Ding, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, X.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartkovitz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podlaski, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tovar, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filipovic, Z. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glenn, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Packman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassilev, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graves, B.</span><span> </span><span class="NLM_article-title">Discovery of RG7388, a potent and selective p53-MDM2 inhibitor in clinical development</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">5979</span><span class="NLM_x">–</span> <span class="NLM_lpage">5983</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm400487c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=5979-5983&author=Q.+Dingauthor=Z.+Zhangauthor=J.-J.+Liuauthor=N.+Jiangauthor=J.+Zhangauthor=T.+M.+Rossauthor=X.-J.+Chuauthor=D.+Bartkovitzauthor=F.+Podlaskiauthor=C.+Jansonauthor=C.+Tovarauthor=Z.+M.+Filipovicauthor=B.+Higginsauthor=K.+Glennauthor=K.+Packmanauthor=L.+T.+Vassilevauthor=B.+Graves&title=Discovery+of+RG7388%2C+a+potent+and+selective+p53-MDM2+inhibitor+in+clinical+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm400487c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400487c%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DJ.-J.%26aulast%3DJiang%26aufirst%3DN.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DRoss%26aufirst%3DT.%2BM.%26aulast%3DChu%26aufirst%3DX.-J.%26aulast%3DBartkovitz%26aufirst%3DD.%26aulast%3DPodlaski%26aufirst%3DF.%26aulast%3DJanson%26aufirst%3DC.%26aulast%3DTovar%26aufirst%3DC.%26aulast%3DFilipovic%26aufirst%3DZ.%2BM.%26aulast%3DHiggins%26aufirst%3DB.%26aulast%3DGlenn%26aufirst%3DK.%26aulast%3DPackman%26aufirst%3DK.%26aulast%3DVassilev%26aufirst%3DL.%2BT.%26aulast%3DGraves%26aufirst%3DB.%26atitle%3DDiscovery%2520of%2520RG7388%252C%2520a%2520potent%2520and%2520selective%2520p53-MDM2%2520inhibitor%2520in%2520clinical%2520development%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D5979%26epage%3D5983" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Sun, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rew, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartberger, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beck, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chow, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deignan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duquette, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eksterowicz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, A. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez-Lopez De Turiso, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gribble, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houze, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kayser, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, M.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGee, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntosh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mihalic, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliner, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osgood, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roveto, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saiki, A. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaffer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toteva, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wortman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yakowec, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medina, J. C.</span><span> </span><span class="NLM_article-title">Discovery of AMG 232, a potent, selective, and orally bioavailable inhibitor of the MDM2-p53 interaction</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">1454</span><span class="NLM_x">–</span> <span class="NLM_lpage">1472</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm401753e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=1454-1472&author=D.+Sunauthor=Z.+Liauthor=Y.+Rewauthor=M.+D.+Bartbergerauthor=H.+P.+Beckauthor=J.+Canonauthor=A.+Chenauthor=X.+Chenauthor=D.+Chowauthor=J.+Deignanauthor=J.+Duquetteauthor=J.+Eksterowiczauthor=B.+Fisherauthor=B.+M.+Foxauthor=J.+Fuauthor=A.+Z.+Gonzalezauthor=F.+Gonzalez-Lopez+De+Turisoauthor=M.+Gribbleauthor=J.+Houzeauthor=X.+Huangauthor=M.+Jiangauthor=L.+Jinauthor=F.+Kayserauthor=J.+Liuauthor=M.-C.+Loauthor=A.+M.+Longauthor=B.+Lucasauthor=L.+R.+McGeeauthor=J.+McIntoshauthor=J.+Mihalicauthor=J.+D.+Olinerauthor=T.+Osgoodauthor=M.+L.+Petersonauthor=P.+Rovetoauthor=A.+Y.+Saikiauthor=P.+Shafferauthor=M.+Totevaauthor=Y.+Wangauthor=Y.+C.+Wangauthor=S.+Wortmanauthor=P.+Yakowecauthor=X.+Yanauthor=Q.+Yeauthor=D.+Yuauthor=M.+Yuauthor=X.+Zhaoauthor=X.+Zhouauthor=J.+Zhuauthor=S.+H.+Olsonauthor=J.+C.+Medina&title=Discovery+of+AMG+232%2C+a+potent%2C+selective%2C+and+orally+bioavailable+inhibitor+of+the+MDM2-p53+interaction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm401753e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401753e%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DRew%26aufirst%3DY.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DBeck%26aufirst%3DH.%2BP.%26aulast%3DCanon%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DChow%26aufirst%3DD.%26aulast%3DDeignan%26aufirst%3DJ.%26aulast%3DDuquette%26aufirst%3DJ.%26aulast%3DEksterowicz%26aufirst%3DJ.%26aulast%3DFisher%26aufirst%3DB.%26aulast%3DFox%26aufirst%3DB.%2BM.%26aulast%3DFu%26aufirst%3DJ.%26aulast%3DGonzalez%26aufirst%3DA.%2BZ.%26aulast%3DGonzalez-Lopez%2BDe%2BTuriso%26aufirst%3DF.%26aulast%3DGribble%26aufirst%3DM.%26aulast%3DHouze%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DJiang%26aufirst%3DM.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DKayser%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DLo%26aufirst%3DM.-C.%26aulast%3DLong%26aufirst%3DA.%2BM.%26aulast%3DLucas%26aufirst%3DB.%26aulast%3DMcGee%26aufirst%3DL.%2BR.%26aulast%3DMcIntosh%26aufirst%3DJ.%26aulast%3DMihalic%26aufirst%3DJ.%26aulast%3DOliner%26aufirst%3DJ.%2BD.%26aulast%3DOsgood%26aufirst%3DT.%26aulast%3DPeterson%26aufirst%3DM.%2BL.%26aulast%3DRoveto%26aufirst%3DP.%26aulast%3DSaiki%26aufirst%3DA.%2BY.%26aulast%3DShaffer%26aufirst%3DP.%26aulast%3DToteva%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DY.%2BC.%26aulast%3DWortman%26aufirst%3DS.%26aulast%3DYakowec%26aufirst%3DP.%26aulast%3DYan%26aufirst%3DX.%26aulast%3DYe%26aufirst%3DQ.%26aulast%3DYu%26aufirst%3DD.%26aulast%3DYu%26aufirst%3DM.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DOlson%26aufirst%3DS.%2BH.%26aulast%3DMedina%26aufirst%3DJ.%2BC.%26atitle%3DDiscovery%2520of%2520AMG%2520232%252C%2520a%2520potent%252C%2520selective%252C%2520and%2520orally%2520bioavailable%2520inhibitor%2520of%2520the%2520MDM2-p53%2520interaction%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D1454%26epage%3D1472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="note"><p class="first last">For reports on our team’s efforts see:</p></div><div class="NLM_citation" id="cit18a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Allen, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourbeau, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wohlhieter, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartberger, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michelsen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hungate, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gadwood, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaston, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mann, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matison, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reichelt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yakowec, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, E. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliner, J. D.</span><span> </span><span class="NLM_article-title">Discovery and optimization of chromenotriazolopyrimidines as potent inhibitors of the mouse double minute 2-tumor protein 53 protein–protein interaction</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">7044</span><span class="NLM_x">–</span> <span class="NLM_lpage">7053</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900681h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7044-7053&author=J.+G.+Allenauthor=M.+P.+Bourbeauauthor=G.+E.+Wohlhieterauthor=M.+D.+Bartbergerauthor=K.+Michelsenauthor=R.+Hungateauthor=R.+C.+Gadwoodauthor=R.+D.+Gastonauthor=B.+Evansauthor=L.+W.+Mannauthor=M.+E.+Matisonauthor=S.+Schneiderauthor=X.+Huangauthor=D.+Yuauthor=P.+S.+Andrewsauthor=A.+Reicheltauthor=A.+M.+Longauthor=P.+Yakowecauthor=E.+Y.+Yangauthor=T.+A.+Leeauthor=J.+D.+Oliner&title=Discovery+and+optimization+of+chromenotriazolopyrimidines+as+potent+inhibitors+of+the+mouse+double+minute+2-tumor+protein+53+protein%E2%80%93protein+interaction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18a&amp;dbid=16384&amp;doi=10.1021%2Fjm900681h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900681h%26sid%3Dliteratum%253Aachs%26aulast%3DAllen%26aufirst%3DJ.%2BG.%26aulast%3DBourbeau%26aufirst%3DM.%2BP.%26aulast%3DWohlhieter%26aufirst%3DG.%2BE.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DMichelsen%26aufirst%3DK.%26aulast%3DHungate%26aufirst%3DR.%26aulast%3DGadwood%26aufirst%3DR.%2BC.%26aulast%3DGaston%26aufirst%3DR.%2BD.%26aulast%3DEvans%26aufirst%3DB.%26aulast%3DMann%26aufirst%3DL.%2BW.%26aulast%3DMatison%26aufirst%3DM.%2BE.%26aulast%3DSchneider%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DYu%26aufirst%3DD.%26aulast%3DAndrews%26aufirst%3DP.%2BS.%26aulast%3DReichelt%26aufirst%3DA.%26aulast%3DLong%26aufirst%3DA.%2BM.%26aulast%3DYakowec%26aufirst%3DP.%26aulast%3DYang%26aufirst%3DE.%2BY.%26aulast%3DLee%26aufirst%3DT.%2BA.%26aulast%3DOliner%26aufirst%3DJ.%2BD.%26atitle%3DDiscovery%2520and%2520optimization%2520of%2520chromenotriazolopyrimidines%2520as%2520potent%2520inhibitors%2520of%2520the%2520mouse%2520double%2520minute%25202-tumor%2520protein%252053%2520protein%25E2%2580%2593protein%2520interaction%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D7044%26epage%3D7053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit18b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Beck, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeGraffenreid, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rew, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saiki, A. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliner, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salyers, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, S.</span><span> </span><span class="NLM_article-title">Improvement of the synthesis and pharmacokinetic properties of chromenotriazolopyrimidine MDM2-p53 protein–protein inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">2752</span><span class="NLM_x">–</span> <span class="NLM_lpage">2755</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=2752-2755&author=H.+P.+Beckauthor=M.+DeGraffenreidauthor=B.+Foxauthor=J.+G.+Allenauthor=Y.+Rewauthor=S.+Schneiderauthor=A.+Y.+Saikiauthor=D.+Yuauthor=J.+D.+Olinerauthor=K.+Salyersauthor=Q.+Yeauthor=S.+Olson&title=Improvement+of+the+synthesis+and+pharmacokinetic+properties+of+chromenotriazolopyrimidine+MDM2-p53+protein%E2%80%93protein+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBeck%26aufirst%3DH.%2BP.%26aulast%3DDeGraffenreid%26aufirst%3DM.%26aulast%3DFox%26aufirst%3DB.%26aulast%3DAllen%26aufirst%3DJ.%2BG.%26aulast%3DRew%26aufirst%3DY.%26aulast%3DSchneider%26aufirst%3DS.%26aulast%3DSaiki%26aufirst%3DA.%2BY.%26aulast%3DYu%26aufirst%3DD.%26aulast%3DOliner%26aufirst%3DJ.%2BD.%26aulast%3DSalyers%26aufirst%3DK.%26aulast%3DYe%26aufirst%3DQ.%26aulast%3DOlson%26aufirst%3DS.%26atitle%3DImprovement%2520of%2520the%2520synthesis%2520and%2520pharmacokinetic%2520properties%2520of%2520chromenotriazolopyrimidine%2520MDM2-p53%2520protein%25E2%2580%2593protein%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D2752%26epage%3D2755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit18c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Rew, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez Lopez De Turiso, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartberger, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beck, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chow, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deignan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kayser, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopecky, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michelsen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliner, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osgood, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ragains, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saiki, A. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toteva, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yakowec, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medina, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, S. H.</span><span> </span><span class="NLM_article-title">Structure-based design of novel inhibitors of the MDM2-p53 interaction</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">4936</span><span class="NLM_x">–</span> <span class="NLM_lpage">4954</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300354j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18c&amp;dbid=32&amp;doi=10.1021%2Fjm401911v&amp;key=1%3ACAS%3A528%3ADC%252BC38XlvV2ktbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4936-4954&author=Y.+Rewauthor=D.+Sunauthor=F.+Gonzalez+Lopez+De+Turisoauthor=M.+D.+Bartbergerauthor=H.+P.+Beckauthor=J.+Canonauthor=A.+Chenauthor=D.+Chowauthor=J.+Deignanauthor=B.+M.+Foxauthor=D.+Gustinauthor=X.+Huangauthor=M.+Jiangauthor=X.+Jiaoauthor=L.+Jinauthor=F.+Kayserauthor=D.+J.+Kopeckyauthor=Y.+Liauthor=M.+Loauthor=A.+M.+Longauthor=K.+Michelsenauthor=J.+D.+Olinerauthor=T.+Osgoodauthor=M.+Ragainsauthor=A.+Y.+Saikiauthor=S.+Schneiderauthor=M.+Totevaauthor=P.+Yakowecauthor=X.+Yanauthor=Q.+Yeauthor=D.+Yuauthor=X.+Zhaoauthor=J.+Zhouauthor=J.+C.+Medinaauthor=S.+H.+Olson&title=Structure-based+design+of+novel+inhibitors+of+the+MDM2-p53+interaction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18cR"><div class="casContent"><span class="casTitleNuber">18c</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design of Novel Inhibitors of the MDM2-p53 Interaction</span></div><div class="casAuthors">Rew, Yosup; Sun, Daqing; Gonzalez-Lopez De Turiso, Felix; Bartberger, Michael D.; Beck, Hilary P.; Canon, Jude; Chen, Ada; Chow, David; Deignan, Jeffrey; Fox, Brian M.; Gustin, Darin; Huang, Xin; Jiang, Min; Jiao, Xianyun; Jin, Lixia; Kayser, Frank; Kopecky, David J.; Li, Yihong; Lo, Mei-Chu; Long, Alexander M.; Michelsen, Klaus; Oliner, Jonathan D.; Osgood, Tao; Ragains, Mark; Saiki, Anne Y.; Schneider, Steve; Toteva, Maria; Yakowec, Peter; Yan, Xuelei; Ye, Qiuping; Yu, Dongyin; Zhao, Xiaoning; Zhou, Jing; Medina, Julio C.; Olson, Steven H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4936-4954</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Structure-based rational design led to the discovery of novel inhibitors of the MDM2-p53 protein-protein interaction.  The affinity of these compds. for MDM2 was improved through conformational control of both the piperidinone ring and the appended N-alkyl substituent.  Optimization afforded bis(chlorophenyl)piperidinylacetic acid deriv. I (AM-8553), a potent and selective MDM2 inhibitor with excellent pharmacokinetic properties and in vivo efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPKe8WW2Cuh7Vg90H21EOLACvtfcHk0lgJJZjObYreyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlvV2ktbs%253D&md5=88ba0795dfab1b5e2dc1cd5977b9f335</span></div><a href="/servlet/linkout?suffix=cit18c&amp;dbid=16384&amp;doi=10.1021%2Fjm300354j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300354j%26sid%3Dliteratum%253Aachs%26aulast%3DRew%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DD.%26aulast%3DGonzalez%2BLopez%2BDe%2BTuriso%26aufirst%3DF.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DBeck%26aufirst%3DH.%2BP.%26aulast%3DCanon%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DA.%26aulast%3DChow%26aufirst%3DD.%26aulast%3DDeignan%26aufirst%3DJ.%26aulast%3DFox%26aufirst%3DB.%2BM.%26aulast%3DGustin%26aufirst%3DD.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DJiang%26aufirst%3DM.%26aulast%3DJiao%26aufirst%3DX.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DKayser%26aufirst%3DF.%26aulast%3DKopecky%26aufirst%3DD.%2BJ.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLo%26aufirst%3DM.%26aulast%3DLong%26aufirst%3DA.%2BM.%26aulast%3DMichelsen%26aufirst%3DK.%26aulast%3DOliner%26aufirst%3DJ.%2BD.%26aulast%3DOsgood%26aufirst%3DT.%26aulast%3DRagains%26aufirst%3DM.%26aulast%3DSaiki%26aufirst%3DA.%2BY.%26aulast%3DSchneider%26aufirst%3DS.%26aulast%3DToteva%26aufirst%3DM.%26aulast%3DYakowec%26aufirst%3DP.%26aulast%3DYan%26aufirst%3DX.%26aulast%3DYe%26aufirst%3DQ.%26aulast%3DYu%26aufirst%3DD.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DMedina%26aufirst%3DJ.%2BC.%26aulast%3DOlson%26aufirst%3DS.%2BH.%26atitle%3DStructure-based%2520design%2520of%2520novel%2520inhibitors%2520of%2520the%2520MDM2-p53%2520interaction%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D4936%26epage%3D4954" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit18d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Lucas, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGee, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medina, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, E.</span><span> </span><span class="NLM_article-title">An expeditious synthesis of the MDM2-p53 inhibitor AM-8553</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">134</span><span class="NLM_x">, </span> <span class="NLM_fpage">12855</span><span class="NLM_x">–</span> <span class="NLM_lpage">12860</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja305123v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18d&amp;dbid=32&amp;doi=10.1021%2Fjm401911v&amp;key=1%3ACAS%3A528%3ADC%252BC38Xpt1Cit7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2012&pages=12855-12860&author=B.+S.+Lucasauthor=B.+Fisherauthor=L.+R.+McGeeauthor=S.+H.+Olsonauthor=J.+C.+Medinaauthor=E.+Cheung&title=An+expeditious+synthesis+of+the+MDM2-p53+inhibitor+AM-8553"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18dR"><div class="casContent"><span class="casTitleNuber">18d</span><div class="casTitle"><span class="NLM_cas:atitle">An Expeditious Synthesis of the MDM2-p53 Inhibitor AM-8553</span></div><div class="casAuthors">Lucas, Brian S.; Fisher, Benjamin; McGee, Lawrence R.; Olson, Steven H.; Medina, Julio C.; Cheung, Eugene</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">12855-12860</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The development of the structurally complex MDM2/p53 inhibitor AM-8553 was impeded by the low yield of the initial synthesis.  A second generation synthesis is described that features a Noyori dynamic kinetic resoln. (DKR), a highly diastereoselective allylation, and a novel oxazoline-assisted piperidinone forming reaction to provide AM-8553 (I) in 35.6% yield and 11 steps.  Safety: significant exotherm obsd. in ketone α-arylation reaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQFB669tWQ2LVg90H21EOLACvtfcHk0lgJJZjObYreyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xpt1Cit7Y%253D&md5=c32444e3c74dbe8916e41011ca11930b</span></div><a href="/servlet/linkout?suffix=cit18d&amp;dbid=16384&amp;doi=10.1021%2Fja305123v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja305123v%26sid%3Dliteratum%253Aachs%26aulast%3DLucas%26aufirst%3DB.%2BS.%26aulast%3DFisher%26aufirst%3DB.%26aulast%3DMcGee%26aufirst%3DL.%2BR.%26aulast%3DOlson%26aufirst%3DS.%2BH.%26aulast%3DMedina%26aufirst%3DJ.%2BC.%26aulast%3DCheung%26aufirst%3DE.%26atitle%3DAn%2520expeditious%2520synthesis%2520of%2520the%2520MDM2-p53%2520inhibitor%2520AM-8553%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2012%26volume%3D134%26spage%3D12855%26epage%3D12860" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit18e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Gonzalez-Lopez de Turiso, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rew, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartberger, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beck, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chow, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Correll, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Julian, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kayser, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, M.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMinn, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliner, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osgood, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powers, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saiki, A. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaffer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, S.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yakowek, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medina, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, S. H.</span><span> </span><span class="NLM_article-title">Rational design and binding mode of MDM2-p53 inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">4053</span><span class="NLM_x">–</span> <span class="NLM_lpage">4070</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm400293z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4053-4070&author=F.+Gonzalez-Lopez+de+Turisoauthor=D.+Sunauthor=Y.+Rewauthor=M.+D.+Bartbergerauthor=H.+P.+Beckauthor=J.+Canonauthor=A.+Chenauthor=D.+Chowauthor=T.+L.+Correllauthor=X.+Huangauthor=L.+D.+Julianauthor=F.+Kayserauthor=M.-C.+Loauthor=A.+M.+Longauthor=D.+McMinnauthor=J.+D.+Olinerauthor=T.+Osgoodauthor=J.+P.+Powersauthor=A.+Y.+Saikiauthor=S.+Schneiderauthor=P.+Shafferauthor=S.-H.+Xiaoauthor=P.+Yakowekauthor=X.+Yanauthor=Q.+Yeauthor=D.+Yuauthor=X.+Zhaoauthor=J.+Zhouauthor=J.+C.+Medinaauthor=S.+H.+Olson&title=Rational+design+and+binding+mode+of+MDM2-p53+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18e&amp;dbid=16384&amp;doi=10.1021%2Fjm400293z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400293z%26sid%3Dliteratum%253Aachs%26aulast%3DGonzalez-Lopez%2Bde%2BTuriso%26aufirst%3DF.%26aulast%3DSun%26aufirst%3DD.%26aulast%3DRew%26aufirst%3DY.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DBeck%26aufirst%3DH.%2BP.%26aulast%3DCanon%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DA.%26aulast%3DChow%26aufirst%3DD.%26aulast%3DCorrell%26aufirst%3DT.%2BL.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DJulian%26aufirst%3DL.%2BD.%26aulast%3DKayser%26aufirst%3DF.%26aulast%3DLo%26aufirst%3DM.-C.%26aulast%3DLong%26aufirst%3DA.%2BM.%26aulast%3DMcMinn%26aufirst%3DD.%26aulast%3DOliner%26aufirst%3DJ.%2BD.%26aulast%3DOsgood%26aufirst%3DT.%26aulast%3DPowers%26aufirst%3DJ.%2BP.%26aulast%3DSaiki%26aufirst%3DA.%2BY.%26aulast%3DSchneider%26aufirst%3DS.%26aulast%3DShaffer%26aufirst%3DP.%26aulast%3DXiao%26aufirst%3DS.-H.%26aulast%3DYakowek%26aufirst%3DP.%26aulast%3DYan%26aufirst%3DX.%26aulast%3DYe%26aufirst%3DQ.%26aulast%3DYu%26aufirst%3DD.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DMedina%26aufirst%3DJ.%2BC.%26aulast%3DOlson%26aufirst%3DS.%2BH.%26atitle%3DRational%2520design%2520and%2520binding%2520mode%2520of%2520MDM2-p53%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4053%26epage%3D4070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit18f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Bernard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span> </span><span class="NLM_article-title">AM-8553: A novel MDM2 inhibitor with a promising outlook for potential clinical development</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">4934</span><span class="NLM_x">–</span> <span class="NLM_lpage">4935</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm3007068" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4934-4935&author=D.+Bernardauthor=Y.+Zhaoauthor=S.+Wang&title=AM-8553%3A+A+novel+MDM2+inhibitor+with+a+promising+outlook+for+potential+clinical+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18f&amp;dbid=16384&amp;doi=10.1021%2Fjm3007068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3007068%26sid%3Dliteratum%253Aachs%26aulast%3DBernard%26aufirst%3DD.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DAM-8553%253A%2520A%2520novel%2520MDM2%2520inhibitor%2520with%2520a%2520promising%2520outlook%2520for%2520potential%2520clinical%2520development%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D4934%26epage%3D4935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="note"><p class="first last">Experimental details of assays can be found in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="note"><p class="first last">For a detailed description of the interactions between MDM2 and <b>2</b> please refer to ref <a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">17</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="note"><p class="first last">For reviews on acid bioisosteres see</p></div><div class="NLM_citation" id="cit21a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Meanwell, N. A.</span><span> </span><span class="NLM_article-title">Synopsis of some recent tactical application of bioisosteres in drug design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">2529</span><span class="NLM_x">–</span> <span class="NLM_lpage">91</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1013693" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=32&amp;doi=10.1021%2Fjm401911v&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsVCnu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2529-91&author=N.+A.+Meanwell&title=Synopsis+of+some+recent+tactical+application+of+bioisosteres+in+drug+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21aR"><div class="casContent"><span class="casTitleNuber">21a</span><div class="casTitle"><span class="NLM_cas:atitle">Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design</span></div><div class="casAuthors">Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2529-2591</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The established utility of bioisosteres is broad in nature, extending to improving potency, enhancing selectivity, altering phys. properties, reducing or redirecting metab., eliminating or modifying toxicophores, and acquiring novel intellectual property.  In this Perspective, some contemporary themes exploring the role of isosteres in drug design are sampled, with an emphasis placed on tactical applications designed to solve the kinds of problems that impinge on compd. optimization and the long-term success of drug candidates.  Interesting concepts that may have been poorly effective in the context examd. are captured, since the ideas may have merit in alternative circumstances.  A comprehensive cataloging of bioisosteres is beyond the scope of what will be provided, although a synopsis of relevant isosteres of a particular functionality is summarized in a succinct fashion in several sections.  Isosterism has also found productive application in the design and optimization of organocatalysts, and there are several examples in which functional mimicry established initially in a medicinal chem. setting has been adopted by this community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZ9z_aPcU4ubVg90H21EOLACvtfcHk0ljLYYmWzqI4kA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsVCnu7o%253D&md5=0637ab60c379bef535f3f709b26f3582</span></div><a href="/servlet/linkout?suffix=cit21a&amp;dbid=16384&amp;doi=10.1021%2Fjm1013693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1013693%26sid%3Dliteratum%253Aachs%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DSynopsis%2520of%2520some%2520recent%2520tactical%2520application%2520of%2520bioisosteres%2520in%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2529%26epage%3D91" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit21b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ballatore, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huryn, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, A. B.</span><span> </span><span class="NLM_article-title">Carboxylic acid (bio)isosteres in drug design</span> <span class="citation_source-journal">Chem. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">385</span><span class="NLM_x">–</span> <span class="NLM_lpage">395</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=16&amp;doi=10.1021%2Fjm401911v&amp;key=10.1002%2Fcmdc.201200585" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=8&amp;doi=10.1021%2Fjm401911v&amp;key=23361977" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=32&amp;doi=10.1021%2Fjm401911v&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFCms7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=385-395&author=C.+Ballatoreauthor=D.+M.+Hurynauthor=A.+B.+Smith&title=Carboxylic+acid+%28bio%29isosteres+in+drug+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21bR"><div class="casContent"><span class="casTitleNuber">21b</span><div class="casTitle"><span class="NLM_cas:atitle">Carboxylic Acid (Bio)Isosteres in Drug Design</span></div><div class="casAuthors">Ballatore, Carlo; Huryn, Donna M.; Smith, Amos B.</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">385-395</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  The carboxylic acid functional group can be an important constituent of a pharmacophore, however, the presence of this moiety can also be responsible for significant drawbacks, including metabolic instability, toxicity, as well as limited passive diffusion across biol. membranes.  To avoid some of these shortcomings while retaining the desired attributes of the carboxylic acid moiety, medicinal chemists often investigate the use of carboxylic acid (bio)isosteres.  The same type of strategy can also be effective for a variety other purposes, for example, to increase the selectivity of a biol. active compd. or to create new intellectual property.  Several carboxylic acid isosteres have been reported, however, the outcome of any isosteric replacement cannot be readily predicted as this strategy is generally found to be dependent upon the particular context (i.e., the characteristic properties of the drug and the drug-target).  As a result, screening of a panel of isosteres is typically required.  In this context, the discovery and development of novel carboxylic acid surrogates that could complement the existing palette of isosteres remains an important area of research.  The goal of this Minireview is to provide an overview of the most commonly employed carboxylic acid (bio)isosteres and to present representative examples demonstrating the use and utility of each isostere in drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVEcl3NtfHu7Vg90H21EOLACvtfcHk0ljLYYmWzqI4kA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFCms7g%253D&md5=cff8233af1c386439789a0e4ebcb4331</span></div><a href="/servlet/linkout?suffix=cit21b&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201200585&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201200585%26sid%3Dliteratum%253Aachs%26aulast%3DBallatore%26aufirst%3DC.%26aulast%3DHuryn%26aufirst%3DD.%2BM.%26aulast%3DSmith%26aufirst%3DA.%2BB.%26atitle%3DCarboxylic%2520acid%2520%2528bio%2529isosteres%2520in%2520drug%2520design%26jtitle%3DChem.%2520Med.%2520Chem.%26date%3D2013%26volume%3D8%26spage%3D385%26epage%3D395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="note"><p class="first last">Time-dependent inhibition, % remaining of CYP3A4 over positive control, Rifampin, after 30 min at 10 μM.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Shishkin, O V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konovalova, I. S.</span><span> </span><span class="NLM_article-title">Novel type of mixed O-H···N/O-H···π hydrogen bonds: monohydrate of pyridine</span> <span class="citation_source-journal">Struct. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">37</span><span class="NLM_x">–</span> <span class="NLM_lpage">41</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm401911v&amp;key=10.1007%2Fs11224-009-9412-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm401911v&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhvVCmtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2009&pages=37-41&author=O+V.+Shishkinauthor=I.+S.+Konovalova&title=Novel+type+of+mixed+O-H%C2%B7%C2%B7%C2%B7N%2FO-H%C2%B7%C2%B7%C2%B7%CF%80+hydrogen+bonds%3A+monohydrate+of+pyridine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Novel type of mixed O-H···N/O-H···π hydrogen bonds: monohydrate of pyridine</span></div><div class="casAuthors">Shishkin, Oleg V.; Konovalova, Irina S.; Gorb, Leonid; Leszczynski, Jerzy</div><div class="citationInfo"><span class="NLM_cas:title">Structural Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">37-41</span>CODEN:
                <span class="NLM_cas:coden">STCHES</span>;
        ISSN:<span class="NLM_cas:issn">1040-0400</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Investigation of characteristics of hydrogen bonding between pyridine and water by MP2/aug-cc-pvdz method reveals that these two mols. may form three types of hydrogen bonds depending on nature of proton withdrawal site of pyridine.  Change of orientation of water with respect to plane of arom. ring leads to transformation of the O-H···N bond to O-H···π bond via wide region of the potential energy surface where both lone pair of the nitrogen atom and π-system make significant contribution into hydrogen bonding.  Hydrogen bond in this intermediate region may be considered as mixed O-H···N/O-H···π bond representing new type of H bonds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoETGutL2M14bVg90H21EOLACvtfcHk0ljLYYmWzqI4kA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhvVCmtLs%253D&md5=2727c7fdf733d7b6b2f1abce6cc07925</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1007%2Fs11224-009-9412-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11224-009-9412-5%26sid%3Dliteratum%253Aachs%26aulast%3DShishkin%26aufirst%3DO%2BV.%26aulast%3DKonovalova%26aufirst%3DI.%2BS.%26atitle%3DNovel%2520type%2520of%2520mixed%2520O-H%25C2%25B7%25C2%25B7%25C2%25B7N%252FO-H%25C2%25B7%25C2%25B7%25C2%25B7%25CF%2580%2520hydrogen%2520bonds%253A%2520monohydrate%2520of%2520pyridine%26jtitle%3DStruct.%2520Chem.%26date%3D2009%26volume%3D20%26spage%3D37%26epage%3D41" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="note"><p class="first last">Experimental details of the BrdU proliferation and HCT116 p21 TaqMan assays can be found in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="note"><p class="first last">Experimental details of in vivo studies can be found in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="note"><p class="first last">Metabolites structures determined by analogy with previous results; see refs <a onclick="showRef(event, 'ref17 ref28'); return false;" href="javascript:void(0);" class="ref ref17 ref28">17 and 28</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Ye, Q.; Jiang, M.; Huang, W. T.; Ling, Y.; Olson, S. H.; Sun, D.; Xu, G.; Yan, X.; Jin, L.</span><span> </span><span class="NLM_article-title">Pharmacokinetics and metabolism of AMG 232, a novel and orally bioavailable inhibitor of the MDM2–p53 Interaction, in Rat, Dog, and Monkey: In vitro-in vivo correlation</span>, unpublished results.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Ye%2C+Q.%3B+Jiang%2C+M.%3B+Huang%2C+W.+T.%3B+Ling%2C+Y.%3B+Olson%2C+S.+H.%3B+Sun%2C+D.%3B+Xu%2C+G.%3B+Yan%2C+X.%3B+Jin%2C+L.+Pharmacokinetics+and+metabolism+of+AMG+232%2C+a+novel+and+orally+bioavailable+inhibitor+of+the+MDM2%E2%80%93p53+Interaction%2C+in+Rat%2C+Dog%2C+and+Monkey%3A+In+vitro-in+vivo+correlation%2C+unpublished+results."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DYe%26aufirst%3DQ.%26atitle%3DPharmacokinetics%2520and%2520metabolism%2520of%2520AMG%2520232%252C%2520a%2520novel%2520and%2520orally%2520bioavailable%2520inhibitor%2520of%2520the%2520MDM2%25E2%2580%2593p53%2520Interaction%252C%2520in%2520Rat%252C%2520Dog%252C%2520and%2520Monkey%253A%2520In%2520vitro-in%2520vivo%2520correlation" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Gonzalez, A. Z.; Eksterowicz, E.; Bartberger, M. D.; Beck, H. P.; Canon, J.; Chen, A.; Chow, D.; Duquette, J.; Fox, B. M.; Fu, J.; Huang, X.; Houze, J.; Jin, L.; Li, Y.; Li, Z.; Ling, Y.; Lo, M.-C.; Long, A. M.; McGee, L. R.; McIntosh, J.; McMinn, D. L.; Oliner, J. D.; Osgood, T.; Rew, Y.; Saiki, A. Y.; Shaffer, P.; Wortman, S.; Yakowec, P.; Yan, X.; Ye, Q.; Yu, D.; Zhao, X.; Zhou, J.; Olson, S. H.; Medina, J. C.; Sun, D.</span><span> </span><span class="NLM_article-title">Selective and Potent Morpholinone Inhibitors of the MDM2-p53 Protein-Protein Interaction</span>.  <span class="citation_source-journal">J. Med. Chem.</span> [Online early access]. DOI: <span class="refDoi"> DOI: 10.1021/jm401767k.</span>  Published Online: Feb 18,<span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm401911v&amp;key=10.1021%2Fjm401767k." title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=A.+Z.+Gonzalez&author=E.+Eksterowicz&author=M.+D.+Bartberger&author=H.+P.+Beck&author=J.+Canon&author=A.+Chen&author=D.+Chow&author=J.+Duquette&author=B.+M.+Fox&author=J.+Fu&author=X.+Huang&author=J.+Houze&author=L.+Jin&author=Y.+Li&author=Z.+Li&author=Y.+Ling&author=M.-C.+Lo&author=A.+M.+Long&author=L.+R.+McGee&author=J.+McIntosh&author=D.+L.+McMinn&author=J.+D.+Oliner&author=T.+Osgood&author=Y.+Rew&author=A.+Y.+Saiki&author=P.+Shaffer&author=S.+Wortman&author=P.+Yakowec&author=X.+Yan&author=Q.+Ye&author=D.+Yu&author=X.+Zhao&author=J.+Zhou&author=S.+H.+Olson&author=J.+C.+Medina&author=D.+Sun&title=Selective+and+Potent+Morpholinone+Inhibitors+of+the+MDM2-p53+Protein-Protein+Interaction&doi=10.1021%2Fjm401767k."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm401767k.&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401767k.%26sid%3Dliteratum%253Aachs%26aulast%3DGonzalez%26aufirst%3DA.%2BZ.%26atitle%3DSelective%2520and%2520Potent%2520Morpholinone%2520Inhibitors%2520of%2520the%2520MDM2-p53%2520Protein-Protein%2520Interaction%26jtitle%3DJ.%2520Med.%2520Chem.%26doi%3D10.1021%2Fjm401767k.%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Hazuda, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anthony, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jolly, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wai, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhuang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Embrey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guare, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egbertson, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huff, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felock, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witmer, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stillmock, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danovich, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grobler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espeseth, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, I.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kassahun, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearson, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schleif, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortese, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Summa, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, S. D.</span><span> </span><span class="NLM_article-title">A naphthyridine carboxamide provides evidence for discordant resistance between mechanistically identical inhibitors of HIV-1 integrase</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">11233</span><span class="NLM_x">–</span> <span class="NLM_lpage">11238</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm401911v&amp;key=10.1073%2Fpnas.0402357101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm401911v&amp;key=15277684" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm401911v&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmvVKgtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2004&pages=11233-11238&author=D.+J.+Hazudaauthor=N.+J.+Anthonyauthor=R.+P.+Gomezauthor=S.+M.+Jollyauthor=J.+S.+Waiauthor=L.+Zhuangauthor=T.+E.+Fisherauthor=M.+Embreyauthor=J.+P.+Guareauthor=M.+S.+Egbertsonauthor=J.+P.+Vaccaauthor=J.+R.+Huffauthor=P.+J.+Felockauthor=M.+V.+Witmerauthor=K.+A.+Stillmockauthor=R.+Danovichauthor=J.+Groblerauthor=M.+D.+Millerauthor=A.+S.+Espesethauthor=L.+Jinauthor=I.-W.+Chenauthor=J.+H.+Linauthor=K.+Kassahunauthor=J.+D.+Ellisauthor=B.+K.+Wongauthor=W.+Xuauthor=P.+G.+Pearsonauthor=W.+A.+Schleifauthor=R.+Corteseauthor=E.+Eminiauthor=V.+Summaauthor=M.+K.+Hollowayauthor=S.+D.+Young&title=A+naphthyridine+carboxamide+provides+evidence+for+discordant+resistance+between+mechanistically+identical+inhibitors+of+HIV-1+integrase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">A naphthyridine carboxamide provides evidence for discordant resistance between mechanistically identical inhibitors of HIV-1 integrase</span></div><div class="casAuthors">Hazuda, Daria J.; Anthony, Neville J.; Gomez, Robert P.; Jolly, Samson M.; Wai, John S.; Zhuang, Linghang; Fisher, Thorsten E.; Embrey, Mark; Guare, James P., Jr.; Egbertson, Melissa S.; Vacca, Joseph P.; Huff, Joel R.; Felock, Peter J.; Witmer, Marc V.; Stillmock, Kara A.; Danovich, Robert; Grobler, Jay; Miller, Michael D.; Espeseth, Amy S.; Jin, Lixia; Chen, I-Wu; Lin, Jiunn H.; Kassahun, Kelem; Ellis, Joan D.; Wong, Bradley K.; Xu, Wei; Pearson, Paul G.; Schleif, William A.; Cortese, Riccardo; Emini, Emilio; Summa, Vincenzo; Holloway, M. Katharine; Young, Steven D.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">11233-11238</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The increasing incidence of resistance to current HIV-1 therapy underscores the need to develop antiretroviral agents with new mechanisms of action.  Integrase, one of three viral enzymes essential for HIV-1 replication, presents an important yet unexploited opportunity for drug development.  The authors describe here the identification and characterization of L-870,810, a small-mol. inhibitor of HIV-1 integrase with potent antiviral activity in cell culture and good pharmacokinetic properties.  L-870,810 is an inhibitor with an 8-hydroxy-(1,6)-naphthyridine-7-carboxamide pharmacophore.  The compd. inhibits HIV-1 integrase-mediated strand transfer, and its antiviral activity in vitro is a direct consequence of this ascribed effect on integration.  L-870,810 is mechanistically identical to previously described inhibitors from the diketo acid series; however, viruses selected for resistance to L-870,810 contain mutations (integrase residues 72, 121, and 125) that uniquely confer resistance to the naphthyridine.  Conversely, mutations assocd. with resistance to the diketo acid do not engender naphthyridine resistance.  Importantly, the mutations assocd. with resistance to each of these inhibitors map to distinct regions within the integrase active site.  Therefore, the authors propose a model of the two inhibitors that is consistent with this observation and suggests specific interactions with discrete binding sites for each ligand.  These studies provide a structural basis and rationale for developing integrase inhibitors with the potential for unique and nonoverlapping resistance profiles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRpHqKKxVFjLVg90H21EOLACvtfcHk0ljhMUFQx0bKXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmvVKgtrY%253D&md5=a94bedb2c16c751c5a9298708504fa4d</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0402357101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0402357101%26sid%3Dliteratum%253Aachs%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26aulast%3DAnthony%26aufirst%3DN.%2BJ.%26aulast%3DGomez%26aufirst%3DR.%2BP.%26aulast%3DJolly%26aufirst%3DS.%2BM.%26aulast%3DWai%26aufirst%3DJ.%2BS.%26aulast%3DZhuang%26aufirst%3DL.%26aulast%3DFisher%26aufirst%3DT.%2BE.%26aulast%3DEmbrey%26aufirst%3DM.%26aulast%3DGuare%26aufirst%3DJ.%2BP.%26aulast%3DEgbertson%26aufirst%3DM.%2BS.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DHuff%26aufirst%3DJ.%2BR.%26aulast%3DFelock%26aufirst%3DP.%2BJ.%26aulast%3DWitmer%26aufirst%3DM.%2BV.%26aulast%3DStillmock%26aufirst%3DK.%2BA.%26aulast%3DDanovich%26aufirst%3DR.%26aulast%3DGrobler%26aufirst%3DJ.%26aulast%3DMiller%26aufirst%3DM.%2BD.%26aulast%3DEspeseth%26aufirst%3DA.%2BS.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DI.-W.%26aulast%3DLin%26aufirst%3DJ.%2BH.%26aulast%3DKassahun%26aufirst%3DK.%26aulast%3DEllis%26aufirst%3DJ.%2BD.%26aulast%3DWong%26aufirst%3DB.%2BK.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DPearson%26aufirst%3DP.%2BG.%26aulast%3DSchleif%26aufirst%3DW.%2BA.%26aulast%3DCortese%26aufirst%3DR.%26aulast%3DEmini%26aufirst%3DE.%26aulast%3DSumma%26aufirst%3DV.%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26aulast%3DYoung%26aufirst%3DS.%2BD.%26atitle%3DA%2520naphthyridine%2520carboxamide%2520provides%2520evidence%2520for%2520discordant%2520resistance%2520between%2520mechanistically%2520identical%2520inhibitors%2520of%2520HIV-1%2520integrase%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%26date%3D2004%26volume%3D101%26spage%3D11233%26epage%3D11238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="note"><p class="first last">The MDMX assay is performed exactly as the MDM2 HTRF assay (in the absence of human serum) described in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> with the exception that MDMX (10 μL) was dispensed to the reaction plate and incubated with the inhibitor for 20 min before p53 (20 μL, 1.25 nM) was added.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Riedinger, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonnell, J. M.</span><span> </span><span class="NLM_article-title">Inhibitors of MDM2 and MDMX: a structural perspective</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">1075</span><span class="NLM_x">–</span> <span class="NLM_lpage">1094</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm401911v&amp;key=10.4155%2Ffmc.09.75" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm401911v&amp;key=21425995" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm401911v&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVChs7%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2009&pages=1075-1094&author=C.+Riedingerauthor=J.+M.+McDonnell&title=Inhibitors+of+MDM2+and+MDMX%3A+a+structural+perspective"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of MDM2 and MDMX: a structural perspective</span></div><div class="casAuthors">Riedinger, Christiane; McDonnell, James M.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1075-1094</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  P53 is a potent tumor suppressor with a crucial role in preventing uncontrolled cell proliferation and is therefore frequently deleted or mutated in cancer.  For tumors with wild-type p53, its function can be overcome by overactive cellular antagonists, such as the ubiquitin ligase murine double minute clone 2 (MDM2).  Restoring p53 activity by inhibiting MDM2 in such cancers can eradicate tumors.  Consequently, the MDM2-p53 interaction has been extensively targeted for inhibition by small mols.  In recent years, MDM2-like protein (MDMX), another key downregulator of p53, has gained increasing importance as an addnl. target for drug development, in order to provide a complementary approach to MDM2 inhibition.  In this review, we describe how detailed structural knowledge of the MDM2-p53 interface and, more recently, of the MDMX-p53 interaction have helped advance the development of inhibitors against the two targets.  We present a summary of the functional biochem. of MDM2, MDMX and p53 as well as their interactions and examine recent progress in the development of inhibitors of MDM2 and MDMX.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQfRNKqaLAzbVg90H21EOLACvtfcHk0ljhMUFQx0bKXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVChs7%252FJ&md5=4b334f634d8b7346f0b5900a95523ce1</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.4155%2Ffmc.09.75&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.09.75%26sid%3Dliteratum%253Aachs%26aulast%3DRiedinger%26aufirst%3DC.%26aulast%3DMcDonnell%26aufirst%3DJ.%2BM.%26atitle%3DInhibitors%2520of%2520MDM2%2520and%2520MDMX%253A%2520a%2520structural%2520perspective%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2009%26volume%3D1%26spage%3D1075%26epage%3D1094" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><div class="note"><p class="first last">This procedure was adapted from:</p></div><span class="NLM_contrib-group">Ju, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippert, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bode, J. W.</span><span> </span><span class="NLM_article-title">Stereoselective synthesis and chemoselective amide-forming ligation of C-terminal peptide α-ketones</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">130</span><span class="NLM_x">, </span> <span class="NLM_fpage">4253</span><span class="NLM_x">–</span> <span class="NLM_lpage">4255</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja800053t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2008&pages=4253-4255&author=L.+Juauthor=A.+R.+Lippertauthor=J.+W.+Bode&title=Stereoselective+synthesis+and+chemoselective+amide-forming+ligation+of+C-terminal+peptide+%CE%B1-ketones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fja800053t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja800053t%26sid%3Dliteratum%253Aachs%26aulast%3DJu%26aufirst%3DL.%26aulast%3DLippert%26aufirst%3DA.%2BR.%26aulast%3DBode%26aufirst%3DJ.%2BW.%26atitle%3DStereoselective%2520synthesis%2520and%2520chemoselective%2520amide-forming%2520ligation%2520of%2520C-terminal%2520peptide%2520%25CE%25B1-ketones%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2008%26volume%3D130%26spage%3D4253%26epage%3D4255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12a','cit12b','cit12c','cit12d','cit12e','cit12f','cit12g','cit12h','cit12i','cit12j','cit12k','cit12l','cit12m','cit12n','cit12o','cit12p'],'ref13':['cit13h','cit13a','cit13b','cit13c','cit13d','cit13e','cit13f','cit13g'],'ref14':['cit14'],'ref15':['cit15a','cit15b'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18a','cit18b','cit18c','cit18d','cit18e','cit18f'],'ref19':[],'ref20':[],'ref21':['cit21a','cit21b'],'ref22':[],'ref23':['cit23'],'ref24':[],'ref25':[],'ref26':[],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':[],'ref31':['cit31'],'ref32':['cit32']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 32 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Natesh Singh, Ludovic Chaput, <span class="NLM_string-name hlFld-ContribAuthor">Bruno O. Villoutreix</span>. </span><span class="cited-content_cbyCitation_article-title">Fast Rescoring Protocols to Improve the Performance of Structure-Based Virtual Screening Performed on Protein–Protein Interfaces. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2020,</strong> <em>60 </em>
                                    (8)
                                     , 3910-3934. <a href="https://doi.org/10.1021/acs.jcim.0c00545" title="DOI URL">https://doi.org/10.1021/acs.jcim.0c00545</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.0c00545&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.0c00545%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DFast%252BRescoring%252BProtocols%252Bto%252BImprove%252Bthe%252BPerformance%252Bof%252BStructure-Based%252BVirtual%252BScreening%252BPerformed%252Bon%252BProtein%2525E2%252580%252593Protein%252BInterfaces%26aulast%3DSingh%26aufirst%3DNatesh%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D16052020%26date%3D11082020%26date%3D03082020%26volume%3D60%26issue%3D8%26spage%3D3910%26epage%3D3934" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hyelee  Lee</span>, <span class="hlFld-ContribAuthor ">Marcus  Fischer</span>, <span class="hlFld-ContribAuthor ">Brian K.  Shoichet</span>, and <span class="hlFld-ContribAuthor ">Shih-Yuan  Liu</span>  . </span><span class="cited-content_cbyCitation_article-title">Hydrogen Bonding of 1,2-Azaborines in the Binding Cavity of T4 Lysozyme Mutants: Structures and Thermodynamics. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2016,</strong> <em>138 </em>
                                    (37)
                                     , 12021-12024. <a href="https://doi.org/10.1021/jacs.6b06566" title="DOI URL">https://doi.org/10.1021/jacs.6b06566</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.6b06566&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.6b06566%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DHydrogen%252BBonding%252Bof%252B1%25252C2-Azaborines%252Bin%252Bthe%252BBinding%252BCavity%252Bof%252BT4%252BLysozyme%252BMutants%25253A%252BStructures%252Band%252BThermodynamics%26aulast%3DLee%26aufirst%3DHyelee%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D25062016%26date%3D12092016%26date%3D21092016%26date%3D07092016%26volume%3D138%26issue%3D37%26spage%3D12021%26epage%3D12024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shailesh N.  Mistry</span>, <span class="hlFld-ContribAuthor ">Manuela  Jörg</span>, <span class="hlFld-ContribAuthor ">Herman  Lim</span>, <span class="hlFld-ContribAuthor ">Natalie B.  Vinh</span>, <span class="hlFld-ContribAuthor ">Patrick M.  Sexton</span>, <span class="hlFld-ContribAuthor ">Ben  Capuano</span>, <span class="hlFld-ContribAuthor ">Arthur  Christopoulos</span>, <span class="hlFld-ContribAuthor ">J. Robert  Lane</span>, and <span class="hlFld-ContribAuthor ">Peter J.  Scammells</span>  . </span><span class="cited-content_cbyCitation_article-title">4-Phenylpyridin-2-one Derivatives: A Novel Class of Positive Allosteric Modulator of the M1 Muscarinic Acetylcholine Receptor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (1)
                                     , 388-409. <a href="https://doi.org/10.1021/acs.jmedchem.5b01562" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01562</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01562&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01562%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3D4-Phenylpyridin-2-one%252BDerivatives%25253A%252BA%252BNovel%252BClass%252Bof%252BPositive%252BAllosteric%252BModulator%252Bof%252Bthe%252BM1%252BMuscarinic%252BAcetylcholine%252BReceptor%26aulast%3DMistry%26aufirst%3DShailesh%2BN.%26date%3D2016%26date%3D2015%26date%3D2015%26date%3D06102015%26date%3D31122015%26date%3D14012016%26date%3D01122015%26volume%3D59%26issue%3D1%26spage%3D388%26epage%3D409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yujun  Zhao</span>, <span class="hlFld-ContribAuthor ">Angelo  Aguilar</span>, <span class="hlFld-ContribAuthor ">Denzil  Bernard</span>, and <span class="hlFld-ContribAuthor ">Shaomeng  Wang</span>  . </span><span class="cited-content_cbyCitation_article-title">Small-Molecule Inhibitors of the MDM2–p53 Protein–Protein Interaction (MDM2 Inhibitors) in Clinical Trials for Cancer Treatment. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (3)
                                     , 1038-1052. <a href="https://doi.org/10.1021/jm501092z" title="DOI URL">https://doi.org/10.1021/jm501092z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm501092z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm501092z%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSmall-Molecule%252BInhibitors%252Bof%252Bthe%252BMDM2%2525E2%252580%252593p53%252BProtein%2525E2%252580%252593Protein%252BInteraction%252B%252528MDM2%252BInhibitors%252529%252Bin%252BClinical%252BTrials%252Bfor%252BCancer%252BTreatment%26aulast%3DZhao%26aufirst%3DYujun%26date%3D2015%26date%3D2014%26date%3D2014%26date%3D18072014%26date%3D14112014%26date%3D12022015%26volume%3D58%26issue%3D3%26spage%3D1038%26epage%3D1052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yosup  Rew</span>, <span class="hlFld-ContribAuthor ">Daqing  Sun</span>, <span class="hlFld-ContribAuthor ">Xuelei  Yan</span>, <span class="hlFld-ContribAuthor ">Hilary P.  Beck</span>, <span class="hlFld-ContribAuthor ">Jude  Canon</span>, <span class="hlFld-ContribAuthor ">Ada  Chen</span>, <span class="hlFld-ContribAuthor ">Jason  Duquette</span>, <span class="hlFld-ContribAuthor ">John  Eksterowicz</span>, <span class="hlFld-ContribAuthor ">Brian M.  Fox</span>, <span class="hlFld-ContribAuthor ">Jiasheng  Fu</span>, <span class="hlFld-ContribAuthor ">Ana Z.  Gonzalez</span>, <span class="hlFld-ContribAuthor ">Jonathan  Houze</span>, <span class="hlFld-ContribAuthor ">Xin  Huang</span>, <span class="hlFld-ContribAuthor ">Min  Jiang</span>, <span class="hlFld-ContribAuthor ">Lixia  Jin</span>, <span class="hlFld-ContribAuthor ">Yihong  Li</span>, <span class="hlFld-ContribAuthor ">Zhihong  Li</span>, <span class="hlFld-ContribAuthor ">Yun  Ling</span>, <span class="hlFld-ContribAuthor ">Mei-Chu  Lo</span>, <span class="hlFld-ContribAuthor ">Alexander M.  Long</span>, <span class="hlFld-ContribAuthor ">Lawrence R.  McGee</span>, <span class="hlFld-ContribAuthor ">Joel  McIntosh</span>, <span class="hlFld-ContribAuthor ">Jonathan D.  Oliner</span>, <span class="hlFld-ContribAuthor ">Tao  Osgood</span>, <span class="hlFld-ContribAuthor ">Anne Y.  Saiki</span>, <span class="hlFld-ContribAuthor ">Paul  Shaffer</span>, <span class="hlFld-ContribAuthor ">Yu Chung  Wang</span>, <span class="hlFld-ContribAuthor ">Sarah  Wortman</span>, <span class="hlFld-ContribAuthor ">Peter  Yakowec</span>, <span class="hlFld-ContribAuthor ">Qiuping  Ye</span>, <span class="hlFld-ContribAuthor ">Dongyin  Yu</span>, <span class="hlFld-ContribAuthor ">Xiaoning  Zhao</span>, <span class="hlFld-ContribAuthor ">Jing  Zhou</span>, <span class="hlFld-ContribAuthor ">Julio C.  Medina</span>, and <span class="hlFld-ContribAuthor ">Steven H.  Olson</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of AM-7209, a Potent and Selective 4-Amidobenzoic Acid Inhibitor of the MDM2–p53 Interaction. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (24)
                                     , 10499-10511. <a href="https://doi.org/10.1021/jm501550p" title="DOI URL">https://doi.org/10.1021/jm501550p</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm501550p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm501550p%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BAM-7209%25252C%252Ba%252BPotent%252Band%252BSelective%252B4-Amidobenzoic%252BAcid%252BInhibitor%252Bof%252Bthe%252BMDM2%2525E2%252580%252593p53%252BInteraction%26aulast%3DRew%26aufirst%3DYosup%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D07102014%26date%3D04122014%26date%3D26122014%26date%3D10112014%26volume%3D57%26issue%3D24%26spage%3D10499%26epage%3D10511" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Krupa R.  Patel</span>, <span class="hlFld-ContribAuthor ">Hitesh D.  Patel</span>. </span><span class="cited-content_cbyCitation_article-title">p53: An Attractive Therapeutic Target for Cancer. </span><span class="cited-content_cbyCitation_journal-name">Current Medicinal Chemistry</span><span> <strong>2020,</strong> <em>27 </em>
                                    (22)
                                     , 3706-3734. <a href="https://doi.org/10.2174/1573406415666190621094704" title="DOI URL">https://doi.org/10.2174/1573406415666190621094704</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1573406415666190621094704&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1573406415666190621094704%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Medicinal%2520Chemistry%26atitle%3Dp53%25253A%252BAn%252BAttractive%252BTherapeutic%252BTarget%252Bfor%252BCancer%26aulast%3DPatel%26aufirst%3DKrupa%2BR.%26date%3D2020%26volume%3D27%26issue%3D22%26spage%3D3706%26epage%3D3734" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sandra  Ramos-Inza</span>, <span class="hlFld-ContribAuthor ">Carlos  Aydillo</span>, <span class="hlFld-ContribAuthor ">Carmen  Sanmartín</span>, <span class="hlFld-ContribAuthor ">Daniel  Plano</span>. </span><span class="cited-content_cbyCitation_article-title">Thiazole Moiety: An Interesting Scaffold for Developing New Antitumoral Compounds. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,<a href="https://doi.org/10.5772/intechopen.82741" title="DOI URL">https://doi.org/10.5772/intechopen.82741</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.5772/intechopen.82741&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.5772%2Fintechopen.82741%26sid%3Dliteratum%253Aachs%26atitle%3DThiazole%252BMoiety%25253A%252BAn%252BInteresting%252BScaffold%252Bfor%252BDeveloping%252BNew%252BAntitumoral%252BCompounds%26aulast%3DRamos-Inza%26aufirst%3DSandra%26date%3D2020%26date%3D2020%26pub%3DIntechOpen%26atitle%3DHeterocycles%252B-%252BSynthesis%252Band%252BBiological%252BActivities%26aulast%3DP.%2BNandeshwarappa%26aufirst%3DB.%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rafał  Rusiecki</span>, <span class="hlFld-ContribAuthor ">Jakub  Witkowski</span>, <span class="hlFld-ContribAuthor ">Joanna  Jaszczewska-Adamczak</span>. </span><span class="cited-content_cbyCitation_article-title">MDM2-p53 Interaction Inhibitors: The Current State-of-Art and Updated Patent Review (2010-Present). </span><span class="cited-content_cbyCitation_journal-name">Recent Patents on Anti-Cancer Drug Discovery</span><span> <strong>2020,</strong> <em>14 </em>
                                    (4)
                                     , 324-369. <a href="https://doi.org/10.2174/1574892814666191022163540" title="DOI URL">https://doi.org/10.2174/1574892814666191022163540</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1574892814666191022163540&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1574892814666191022163540%26sid%3Dliteratum%253Aachs%26jtitle%3DRecent%2520Patents%2520on%2520Anti-Cancer%2520Drug%2520Discovery%26atitle%3DMDM2-p53%252BInteraction%252BInhibitors%25253A%252BThe%252BCurrent%252BState-of-Art%252Band%252BUpdated%252BPatent%252BReview%252B%2525282010-Present%252529%26aulast%3DRusiecki%26aufirst%3DRafa%25C5%2582%26date%3D2020%26volume%3D14%26issue%3D4%26spage%3D324%26epage%3D369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Musa A.  Said</span>, <span class="hlFld-ContribAuthor ">Wael S.  Al-Harbi</span>, <span class="hlFld-ContribAuthor ">Mani  Shanmugam</span>, <span class="hlFld-ContribAuthor ">Faizah S.  Aljohani</span>, <span class="hlFld-ContribAuthor ">Nahla A.  Bouqellah</span>, <span class="hlFld-ContribAuthor ">Nadia S.  Al-Kaff</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, XRD, HAS,
              in silico
              molecular docking studies and biological assessment of novel Schiff base compounds as anti-cancer and antimicrobial agents. </span><span class="cited-content_cbyCitation_journal-name">Journal of Taibah University for Science</span><span> <strong>2020,</strong> <em>14 </em>
                                    (1)
                                     , 1590-1603. <a href="https://doi.org/10.1080/16583655.2020.1849492" title="DOI URL">https://doi.org/10.1080/16583655.2020.1849492</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/16583655.2020.1849492&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F16583655.2020.1849492%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Taibah%2520University%2520for%2520Science%26atitle%3DSynthesis%25252C%252BXRD%25252C%252BHAS%25252C%252Bin%252Bsilico%252Bmolecular%252Bdocking%252Bstudies%252Band%252Bbiological%252Bassessment%252Bof%252Bnovel%252BSchiff%252Bbase%252Bcompounds%252Bas%252Banti-cancer%252Band%252Bantimicrobial%252Bagents%26aulast%3DSaid%26aufirst%3DMusa%2BA.%26date%3D2020%26date%3D2020%26volume%3D14%26issue%3D1%26spage%3D1590%26epage%3D1603" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Adileh  Ayati</span>, <span class="hlFld-ContribAuthor ">Saeed  Emami</span>, <span class="hlFld-ContribAuthor ">Setareh  Moghimi</span>, <span class="hlFld-ContribAuthor ">Alireza  Foroumadi</span>. </span><span class="cited-content_cbyCitation_article-title">Thiazole in the targeted anticancer drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2019,</strong> <em>11 </em>
                                    (15)
                                     , 1929-1952. <a href="https://doi.org/10.4155/fmc-2018-0416" title="DOI URL">https://doi.org/10.4155/fmc-2018-0416</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2018-0416&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2018-0416%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DThiazole%252Bin%252Bthe%252Btargeted%252Banticancer%252Bdrug%252Bdiscovery%26aulast%3DAyati%26aufirst%3DAdileh%26date%3D2019%26volume%3D11%26issue%3D15%26spage%3D1929%26epage%3D1952" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gustavo  Fuertes</span>, <span class="hlFld-ContribAuthor ">Laura  Nevola</span>, <span class="hlFld-ContribAuthor ">Santiago  Esteban-Martín</span>. </span><span class="cited-content_cbyCitation_article-title">Perspectives on drug discovery strategies based on IDPs. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 275-327. <a href="https://doi.org/10.1016/B978-0-12-816348-1.00009-0" title="DOI URL">https://doi.org/10.1016/B978-0-12-816348-1.00009-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-816348-1.00009-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-816348-1.00009-0%26sid%3Dliteratum%253Aachs%26atitle%3DPerspectives%252Bon%252Bdrug%252Bdiscovery%252Bstrategies%252Bbased%252Bon%252BIDPs%26aulast%3DFuertes%26aufirst%3DGustavo%26date%3D2019%26spage%3D275%26epage%3D327%26pub%3DElsevier%26atitle%3DIntrinsically%252BDisordered%252BProteins%26date%3D2019%26volume%3D37" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guochao  Liao</span>, <span class="hlFld-ContribAuthor ">Deying  Yang</span>, <span class="hlFld-ContribAuthor ">Leilei  Ma</span>, <span class="hlFld-ContribAuthor ">Wenwei  Li</span>, <span class="hlFld-ContribAuthor ">Liqin  Hu</span>, <span class="hlFld-ContribAuthor ">Liming  Zeng</span>, <span class="hlFld-ContribAuthor ">Peng  Wu</span>, <span class="hlFld-ContribAuthor ">Lixin  Duan</span>, <span class="hlFld-ContribAuthor ">Zhongqiu  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">The development of piperidinones as potent MDM2-P53 protein-protein interaction inhibitors for cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>159 </em>, 1-9. <a href="https://doi.org/10.1016/j.ejmech.2018.09.044" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.09.044</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.09.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.09.044%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252Bdevelopment%252Bof%252Bpiperidinones%252Bas%252Bpotent%252BMDM2-P53%252Bprotein-protein%252Binteraction%252Binhibitors%252Bfor%252Bcancer%252Btherapy%26aulast%3DLiao%26aufirst%3DGuochao%26date%3D2018%26volume%3D159%26spage%3D1%26epage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nisha Susan  Thomas</span>, <span class="hlFld-ContribAuthor ">Kiran  George</span>, <span class="hlFld-ContribAuthor ">Athavan Alias Anand  Selvam</span>. </span><span class="cited-content_cbyCitation_article-title">Troxerutin subdues hepatic tumorigenesis
              via
              disrupting the MDM2–p53 interaction. </span><span class="cited-content_cbyCitation_journal-name">Food & Function</span><span> <strong>2018,</strong> <em>9 </em>
                                    (10)
                                     , 5336-5349. <a href="https://doi.org/10.1039/C8FO01111G" title="DOI URL">https://doi.org/10.1039/C8FO01111G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8FO01111G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8FO01111G%26sid%3Dliteratum%253Aachs%26jtitle%3DFood%2520%2526%2520Function%26atitle%3DTroxerutin%252Bsubdues%252Bhepatic%252Btumorigenesis%252Bvia%252Bdisrupting%252Bthe%252BMDM2%2525E2%252580%252593p53%252Binteraction%26aulast%3DThomas%26aufirst%3DNisha%2BSusan%26date%3D2018%26date%3D2018%26volume%3D9%26issue%3D10%26spage%3D5336%26epage%3D5349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jianzhong  Chen</span>, <span class="hlFld-ContribAuthor ">Jinan  Wang</span>, <span class="hlFld-ContribAuthor ">Laixue  Pang</span>, <span class="hlFld-ContribAuthor ">Weiliang  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibiting mechanism of small molecule toward the p53-MDM2 interaction: A molecular dynamic exploration. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2018,</strong> <em>92 </em>
                                    (4)
                                     , 1763-1777. <a href="https://doi.org/10.1111/cbdd.13345" title="DOI URL">https://doi.org/10.1111/cbdd.13345</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.13345&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.13345%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DInhibiting%252Bmechanism%252Bof%252Bsmall%252Bmolecule%252Btoward%252Bthe%252Bp53-MDM2%252Binteraction%25253A%252BA%252Bmolecular%252Bdynamic%252Bexploration%26aulast%3DChen%26aufirst%3DJianzhong%26date%3D2018%26date%3D2018%26volume%3D92%26issue%3D4%26spage%3D1763%26epage%3D1777" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Youngshim  Lee</span>, <span class="hlFld-ContribAuthor ">Dongsoo  Koh</span>, <span class="hlFld-ContribAuthor ">Seunghyun  Ahn</span>, <span class="hlFld-ContribAuthor ">Young Han  Lee</span>, <span class="hlFld-ContribAuthor ">Soon Young  Shin</span>, <span class="hlFld-ContribAuthor ">Yoongho  Lim</span>. </span><span class="cited-content_cbyCitation_article-title">Clonogenic long-term survival assay of HCT 116 colorectal cancer cells after treatment with the synthesized diphenyl imidazoline derivatives. </span><span class="cited-content_cbyCitation_journal-name">Applied Biological Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (3)
                                     , 303-312. <a href="https://doi.org/10.1007/s13765-018-0355-7" title="DOI URL">https://doi.org/10.1007/s13765-018-0355-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s13765-018-0355-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs13765-018-0355-7%26sid%3Dliteratum%253Aachs%26jtitle%3DApplied%2520Biological%2520Chemistry%26atitle%3DClonogenic%252Blong-term%252Bsurvival%252Bassay%252Bof%252BHCT%252B116%252Bcolorectal%252Bcancer%252Bcells%252Bafter%252Btreatment%252Bwith%252Bthe%252Bsynthesized%252Bdiphenyl%252Bimidazoline%252Bderivatives%26aulast%3DLee%26aufirst%3DYoungshim%26date%3D2018%26date%3D2018%26volume%3D61%26issue%3D3%26spage%3D303%26epage%3D312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mikhail  Krasavin</span>, <span class="hlFld-ContribAuthor ">Maxim A.  Gureyev</span>, <span class="hlFld-ContribAuthor ">Dmitry  Dar'in</span>, <span class="hlFld-ContribAuthor ">Olga  Bakulina</span>, <span class="hlFld-ContribAuthor ">Maria  Chizhova</span>, <span class="hlFld-ContribAuthor ">Anastasia  Lepikhina</span>, <span class="hlFld-ContribAuthor ">Daria  Novikova</span>, <span class="hlFld-ContribAuthor ">Tatyana  Grigoreva</span>, <span class="hlFld-ContribAuthor ">Gleb  Ivanov</span>, <span class="hlFld-ContribAuthor ">Aisulu  Zhumagalieva</span>, <span class="hlFld-ContribAuthor ">Alexander V.  Garabadzhiu</span>, <span class="hlFld-ContribAuthor ">Vyacheslav G.  Tribulovich</span>. </span><span class="cited-content_cbyCitation_article-title">Design, in silico prioritization and biological profiling of apoptosis-inducing lactams amenable by the Castagnoli-Cushman reaction. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (9)
                                     , 2651-2673. <a href="https://doi.org/10.1016/j.bmc.2018.04.036" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.04.036</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.04.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.04.036%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bin%252Bsilico%252Bprioritization%252Band%252Bbiological%252Bprofiling%252Bof%252Bapoptosis-inducing%252Blactams%252Bamenable%252Bby%252Bthe%252BCastagnoli-Cushman%252Breaction%26aulast%3DKrasavin%26aufirst%3DMikhail%26date%3D2018%26volume%3D26%26issue%3D9%26spage%3D2651%26epage%3D2673" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mahima  Bhat</span>, <span class="hlFld-ContribAuthor ">Boja  Poojary</span>, <span class="hlFld-ContribAuthor ">Bhuvanesh Sukhlal  Kalal</span>, <span class="hlFld-ContribAuthor ">Purawarga Matada  Gurubasavaraja Swamy</span>, <span class="hlFld-ContribAuthor ">Senthamaraikannan  Kabilan</span>, <span class="hlFld-ContribAuthor ">Vasantha  Kumar</span>, <span class="hlFld-ContribAuthor ">Nooji  Shruthi</span>, <span class="hlFld-ContribAuthor ">Selvam Athavan  Alias Anand</span>, <span class="hlFld-ContribAuthor ">Vinitha Ramanath  Pai</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and evaluation of thiazolidinone–pyrazole conjugates as anticancer and antimicrobial agents. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2018,</strong> <em>10 </em>
                                    (9)
                                     , 1017-1036. <a href="https://doi.org/10.4155/fmc-2017-0191" title="DOI URL">https://doi.org/10.4155/fmc-2017-0191</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2017-0191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2017-0191%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bevaluation%252Bof%252Bthiazolidinone%2525E2%252580%252593pyrazole%252Bconjugates%252Bas%252Banticancer%252Band%252Bantimicrobial%252Bagents%26aulast%3DBhat%26aufirst%3DMahima%26date%3D2018%26volume%3D10%26issue%3D9%26spage%3D1017%26epage%3D1036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mi  Zhou</span>, <span class="hlFld-ContribAuthor ">Qing  Li</span>, <span class="hlFld-ContribAuthor ">Wenna  Kong</span>, <span class="hlFld-ContribAuthor ">Renxiao  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Experimental Methods Used for Identifying Small-Molecule Inhibitors of Protein-Protein Interaction. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 95-133. <a href="https://doi.org/10.1007/978-981-13-0773-7_5" title="DOI URL">https://doi.org/10.1007/978-981-13-0773-7_5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-981-13-0773-7_5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-981-13-0773-7_5%26sid%3Dliteratum%253Aachs%26atitle%3DExperimental%252BMethods%252BUsed%252Bfor%252BIdentifying%252BSmall-Molecule%252BInhibitors%252Bof%252BProtein-Protein%252BInteraction%26aulast%3DZhou%26aufirst%3DMi%26date%3D2018%26date%3D2018%26spage%3D95%26epage%3D133%26pub%3DSpringer%2520Singapore%26atitle%3DTargeting%252BProtein-Protein%252BInteractions%252Bby%252BSmall%252BMolecules%26aulast%3DSheng%26aufirst%3DChunquan%26date%3D2018%26volume%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mani  Shanmugam</span>, <span class="hlFld-ContribAuthor ">Kuppusamy  Narayanan</span>, <span class="hlFld-ContribAuthor ">Kamatam Hari  Prasad</span>, <span class="hlFld-ContribAuthor ">Dhanapalan  Karthikeyan</span>, <span class="hlFld-ContribAuthor ">Loganathan  Chandrasekaran</span>, <span class="hlFld-ContribAuthor ">Raji  Atchudan</span>, <span class="hlFld-ContribAuthor ">V.  Chidambaranathan</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, characterization, and antiproliferative and apoptosis inducing effects of novel
              s
              -triazine derivatives. </span><span class="cited-content_cbyCitation_journal-name">New Journal of Chemistry</span><span> <strong>2018,</strong> <em>42 </em>
                                    (3)
                                     , 1698-1714. <a href="https://doi.org/10.1039/C7NJ03348F" title="DOI URL">https://doi.org/10.1039/C7NJ03348F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7NJ03348F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7NJ03348F%26sid%3Dliteratum%253Aachs%26jtitle%3DNew%2520Journal%2520of%2520Chemistry%26atitle%3DSynthesis%25252C%252Bcharacterization%25252C%252Band%252Bantiproliferative%252Band%252Bapoptosis%252Binducing%252Beffects%252Bof%252Bnovel%252Bs%252B-triazine%252Bderivatives%26aulast%3DShanmugam%26aufirst%3DMani%26date%3D2018%26date%3D2018%26volume%3D42%26issue%3D3%26spage%3D1698%26epage%3D1714" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel  Nguyen</span>, <span class="hlFld-ContribAuthor ">Wenjuan  Liao</span>, <span class="hlFld-ContribAuthor ">Shelya X.  Zeng</span>, <span class="hlFld-ContribAuthor ">Hua  Lu</span>. </span><span class="cited-content_cbyCitation_article-title">Reviving the guardian of the genome: Small molecule activators of p53. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology & Therapeutics</span><span> <strong>2017,</strong> <em>178 </em>, 92-108. <a href="https://doi.org/10.1016/j.pharmthera.2017.03.013" title="DOI URL">https://doi.org/10.1016/j.pharmthera.2017.03.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pharmthera.2017.03.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pharmthera.2017.03.013%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520%2526%2520Therapeutics%26atitle%3DReviving%252Bthe%252Bguardian%252Bof%252Bthe%252Bgenome%25253A%252BSmall%252Bmolecule%252Bactivators%252Bof%252Bp53%26aulast%3DNguyen%26aufirst%3DDaniel%26date%3D2017%26volume%3D178%26spage%3D92%26epage%3D108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alpana K.  Gupta</span>, <span class="hlFld-ContribAuthor ">Mausumi  Bharadwaj</span>, <span class="hlFld-ContribAuthor ">Anoop  Kumar</span>, <span class="hlFld-ContribAuthor ">Ravi  Mehrotra</span>. </span><span class="cited-content_cbyCitation_article-title">Spiro-oxindoles as a Promising Class of Small Molecule Inhibitors of p53–MDM2 Interaction Useful in Targeted Cancer Therapy. </span><span class="cited-content_cbyCitation_journal-name">Topics in Current Chemistry</span><span> <strong>2017,</strong> <em>375 </em>
                                    (1)
                                     <a href="https://doi.org/10.1007/s41061-016-0089-0" title="DOI URL">https://doi.org/10.1007/s41061-016-0089-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s41061-016-0089-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs41061-016-0089-0%26sid%3Dliteratum%253Aachs%26jtitle%3DTopics%2520in%2520Current%2520Chemistry%26atitle%3DSpiro-oxindoles%252Bas%252Ba%252BPromising%252BClass%252Bof%252BSmall%252BMolecule%252BInhibitors%252Bof%252Bp53%2525E2%252580%252593MDM2%252BInteraction%252BUseful%252Bin%252BTargeted%252BCancer%252BTherapy%26aulast%3DGupta%26aufirst%3DAlpana%2BK.%26date%3D2017%26date%3D2016%26volume%3D375%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ian Robert  Hardcastle</span>. </span><span class="cited-content_cbyCitation_article-title">Protein–Protein Interaction Inhibitors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 399-399. <a href="https://doi.org/10.1007/7355_2017_27" title="DOI URL">https://doi.org/10.1007/7355_2017_27</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7355_2017_27&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7355_2017_27%26sid%3Dliteratum%253Aachs%26atitle%3DProtein%2525E2%252580%252593Protein%252BInteraction%252BInhibitors%26aulast%3DHardcastle%26aufirst%3DIan%2BRobert%26date%3D2017%26spage%3D399%26epage%3D399%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DCancer%252BII%26aulast%3DWaring%26aufirst%3DMichael%2BJ.%26date%3D2018%26volume%3D28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">I.R.  Hardcastle</span>. </span><span class="cited-content_cbyCitation_article-title">Protein–Protein Interaction Inhibitors in Cancer. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 154-201. <a href="https://doi.org/10.1016/B978-0-12-409547-2.12392-3" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.12392-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.12392-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.12392-3%26sid%3Dliteratum%253Aachs%26atitle%3DProtein%2525E2%252580%252593Protein%252BInteraction%252BInhibitors%252Bin%252BCancer%26aulast%3DHardcastle%26aufirst%3DI.R.%26date%3D2017%26spage%3D154%26epage%3D201%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexander R.  Lippert</span>, <span class="hlFld-ContribAuthor ">Jian  Cao</span>. </span><span class="cited-content_cbyCitation_article-title">1-(Cyanomethyl)tetrahydro-1
              H
              -thiophen-1-ium Bromide. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 1-4. <a href="https://doi.org/10.1002/047084289X.rn01962" title="DOI URL">https://doi.org/10.1002/047084289X.rn01962</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/047084289X.rn01962&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F047084289X.rn01962%26sid%3Dliteratum%253Aachs%26atitle%3D1-%252528Cyanomethyl%252529tetrahydro-1%252BH%252B-thiophen-1-ium%252BBromide%26aulast%3DLippert%26aufirst%3DAlexander%2BR.%26date%3D2016%26date%3D2016%26spage%3D1%26epage%3D4%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Ltd%26atitle%3DEncyclopedia%252Bof%252BReagents%252Bfor%252BOrganic%252BSynthesis%26date%3D2001%26date%3D2001%26volume%3D130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Agostinho  Lemos</span>, <span class="hlFld-ContribAuthor ">Mariana  Leão</span>, <span class="hlFld-ContribAuthor ">Joana  Soares</span>, <span class="hlFld-ContribAuthor ">Andreia  Palmeira</span>, <span class="hlFld-ContribAuthor ">Madalena  Pinto</span>, <span class="hlFld-ContribAuthor ">Lucília  Saraiva</span>, <span class="hlFld-ContribAuthor ">Maria Emília  Sousa</span>. </span><span class="cited-content_cbyCitation_article-title">Medicinal Chemistry Strategies to Disrupt the p53-MDM2/MDMX Interaction. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2016,</strong> <em>36 </em>
                                    (5)
                                     , 789-844. <a href="https://doi.org/10.1002/med.21393" title="DOI URL">https://doi.org/10.1002/med.21393</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21393&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21393%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DMedicinal%252BChemistry%252BStrategies%252Bto%252BDisrupt%252Bthe%252Bp53-MDM2%25252FMDMX%252BInteraction%26aulast%3DLemos%26aufirst%3DAgostinho%26date%3D2016%26date%3D2016%26volume%3D36%26issue%3D5%26spage%3D789%26epage%3D844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dmitro M.  Khomenko</span>, <span class="hlFld-ContribAuthor ">Roman O.  Doroshchuk</span>, <span class="hlFld-ContribAuthor ">Oleksandr V.  Vashchenko</span>, <span class="hlFld-ContribAuthor ">Rostyslav D.  Lampeka</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and study of novel 1,2,4-triazolylacetic acid derivatives. </span><span class="cited-content_cbyCitation_journal-name">Chemistry of Heterocyclic Compounds</span><span> <strong>2016,</strong> <em>52 </em>
                                    (6)
                                     , 402-408. <a href="https://doi.org/10.1007/s10593-016-1901-z" title="DOI URL">https://doi.org/10.1007/s10593-016-1901-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10593-016-1901-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10593-016-1901-z%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520of%2520Heterocyclic%2520Compounds%26atitle%3DSynthesis%252Band%252Bstudy%252Bof%252Bnovel%252B1%25252C2%25252C4-triazolylacetic%252Bacid%252Bderivatives%26aulast%3DKhomenko%26aufirst%3DDmitro%2BM.%26date%3D2016%26date%3D2016%26volume%3D52%26issue%3D6%26spage%3D402%26epage%3D408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aditi  Singh</span>, <span class="hlFld-ContribAuthor ">Sukriti  Goyal</span>, <span class="hlFld-ContribAuthor ">Salma  Jamal</span>, <span class="hlFld-ContribAuthor ">Bala  Subramani</span>, <span class="hlFld-ContribAuthor ">Mriganko  Das</span>, <span class="hlFld-ContribAuthor ">Nikita  Admane</span>, <span class="hlFld-ContribAuthor ">Abhinav  Grover</span>. </span><span class="cited-content_cbyCitation_article-title">Computational identification of novel piperidine derivatives as potential HDM2 inhibitors designed by fragment-based QSAR, molecular docking and molecular dynamics simulations. </span><span class="cited-content_cbyCitation_journal-name">Structural Chemistry</span><span> <strong>2016,</strong> <em>27 </em>
                                    (3)
                                     , 993-1003. <a href="https://doi.org/10.1007/s11224-015-0697-2" title="DOI URL">https://doi.org/10.1007/s11224-015-0697-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11224-015-0697-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11224-015-0697-2%26sid%3Dliteratum%253Aachs%26jtitle%3DStructural%2520Chemistry%26atitle%3DComputational%252Bidentification%252Bof%252Bnovel%252Bpiperidine%252Bderivatives%252Bas%252Bpotential%252BHDM2%252Binhibitors%252Bdesigned%252Bby%252Bfragment-based%252BQSAR%25252C%252Bmolecular%252Bdocking%252Band%252Bmolecular%252Bdynamics%252Bsimulations%26aulast%3DSingh%26aufirst%3DAditi%26date%3D2016%26date%3D2015%26volume%3D27%26issue%3D3%26spage%3D993%26epage%3D1003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Natalia  Estrada-Ortiz</span>, <span class="hlFld-ContribAuthor ">Constantinos G.  Neochoritis</span>, <span class="hlFld-ContribAuthor ">Alexander  Dömling</span>. </span><span class="cited-content_cbyCitation_article-title">How To Design a Successful p53-MDM2/X Interaction Inhibitor: A Thorough Overview Based on Crystal Structures. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2016,</strong> <em>11 </em>
                                    (8)
                                     , 757-772. <a href="https://doi.org/10.1002/cmdc.201500487" title="DOI URL">https://doi.org/10.1002/cmdc.201500487</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201500487&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201500487%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DHow%252BTo%252BDesign%252Ba%252BSuccessful%252Bp53-MDM2%25252FX%252BInteraction%252BInhibitor%25253A%252BA%252BThorough%252BOverview%252BBased%252Bon%252BCrystal%252BStructures%26aulast%3DEstrada-Ortiz%26aufirst%3DNatalia%26date%3D2016%26date%3D2015%26volume%3D11%26issue%3D8%26spage%3D757%26epage%3D772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">George A.  Pantelopulos</span>, <span class="hlFld-ContribAuthor ">Sudipto  Mukherjee</span>, <span class="hlFld-ContribAuthor ">Vincent A.  Voelz</span>. </span><span class="cited-content_cbyCitation_article-title">Microsecond simulations of mdm2 and its complex with p53 yield insight into force field accuracy and conformational dynamics. </span><span class="cited-content_cbyCitation_journal-name">Proteins: Structure, Function, and Bioinformatics</span><span> <strong>2015,</strong> <em>83 </em>
                                    (9)
                                     , 1665-1676. <a href="https://doi.org/10.1002/prot.24852" title="DOI URL">https://doi.org/10.1002/prot.24852</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/prot.24852&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fprot.24852%26sid%3Dliteratum%253Aachs%26jtitle%3DProteins%253A%2520Structure%252C%2520Function%252C%2520and%2520Bioinformatics%26atitle%3DMicrosecond%252Bsimulations%252Bof%252Bmdm2%252Band%252Bits%252Bcomplex%252Bwith%252Bp53%252Byield%252Binsight%252Binto%252Bforce%252Bfield%252Baccuracy%252Band%252Bconformational%252Bdynamics%26aulast%3DPantelopulos%26aufirst%3DGeorge%2BA.%26date%3D2015%26date%3D2015%26volume%3D83%26issue%3D9%26spage%3D1665%26epage%3D1676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bian  Zhang</span>, <span class="hlFld-ContribAuthor ">Bernard T  Golding</span>, <span class="hlFld-ContribAuthor ">Ian R  Hardcastle</span>. </span><span class="cited-content_cbyCitation_article-title">Small-molecule MDM2-p53 inhibitors: recent advances. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2015,</strong> <em>7 </em>
                                    (5)
                                     , 631-645. <a href="https://doi.org/10.4155/fmc.15.13" title="DOI URL">https://doi.org/10.4155/fmc.15.13</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.15.13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.15.13%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DSmall-molecule%252BMDM2-p53%252Binhibitors%25253A%252Brecent%252Badvances%26aulast%3DZhang%26aufirst%3DBian%26date%3D2015%26volume%3D7%26issue%3D5%26spage%3D631%26epage%3D645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Selvam Athavan Alias  Anand</span>, <span class="hlFld-ContribAuthor ">Chandrasekaran  Loganathan</span>, <span class="hlFld-ContribAuthor ">Nisha Susan  Thomas</span>, <span class="hlFld-ContribAuthor ">Kuppusamy  Saravanan</span>, <span class="hlFld-ContribAuthor ">Antony Therasa  Alphonsa</span>, <span class="hlFld-ContribAuthor ">Senthamaraikannan  Kabilan</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, structure prediction, pharmacokinetic properties, molecular docking and antitumor activities of some novel thiazinone derivatives. </span><span class="cited-content_cbyCitation_journal-name">New Journal of Chemistry</span><span> <strong>2015,</strong> <em>39 </em>
                                    (9)
                                     , 7120-7129. <a href="https://doi.org/10.1039/C5NJ01369K" title="DOI URL">https://doi.org/10.1039/C5NJ01369K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5NJ01369K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5NJ01369K%26sid%3Dliteratum%253Aachs%26jtitle%3DNew%2520Journal%2520of%2520Chemistry%26atitle%3DSynthesis%25252C%252Bstructure%252Bprediction%25252C%252Bpharmacokinetic%252Bproperties%25252C%252Bmolecular%252Bdocking%252Band%252Bantitumor%252Bactivities%252Bof%252Bsome%252Bnovel%252Bthiazinone%252Bderivatives%26aulast%3DAnand%26aufirst%3DSelvam%2BAthavan%2BAlias%26date%3D2015%26date%3D2015%26volume%3D39%26issue%3D9%26spage%3D7120%26epage%3D7129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Constantinos  Neochoritis</span>, <span class="hlFld-ContribAuthor ">Natalia  Estrada-Ortiz</span>, <span class="hlFld-ContribAuthor ">Kareem  Khoury</span>, <span class="hlFld-ContribAuthor ">Alexander  Dömling</span>. </span><span class="cited-content_cbyCitation_article-title">p53–MDM2 and MDMX Antagonists. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 167-187. <a href="https://doi.org/10.1016/B978-0-12-800167-7.00012-2" title="DOI URL">https://doi.org/10.1016/B978-0-12-800167-7.00012-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-800167-7.00012-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-800167-7.00012-2%26sid%3Dliteratum%253Aachs%26atitle%3Dp53%2525E2%252580%252593MDM2%252Band%252BMDMX%252BAntagonists%26aulast%3DNeochoritis%26aufirst%3DConstantinos%26date%3D2014%26spage%3D167%26epage%3D187%26pub%3DElsevier%26date%3D2014%26volume%3D49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/medium/jm-2013-01911v_0021.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/large/jm-2013-01911v_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401911v&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/medium/jm-2013-01911v_0025.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/large/jm-2013-01911v_0025.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Co-crystal structures of potent piperidinone inhibitors bound to human MDM2 (6–110) highlighting their interaction to MDM2-His96. Coordinates for compounds <b>2</b> (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4OAB">4OAB</a>), <b>3</b> (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4OGN">4OGN</a>), and <b>4</b> (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4ODE">4ODE</a>) bound to MDM2 have been deposited in the PDB.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/large/jm-2013-01911v_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401911v&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/medium/jm-2013-01911v_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/large/jm-2013-01911v_0005.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/large/jm-2013-01911v_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401911v&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) trifluoromethanesulfonamide, DIEA, HATU, DMF, rt, 5 h, 41%; (b) <i>N</i>-methylmorpholine, 28% NH<sub>3</sub>/H<sub>2</sub>O, isobutyl chloroformate, THF, 0 °C, 3 h, 75%; (c) trifluoroacetic anhydride, TEA, 0 °C, 1 h, 92%; (d) NaN<sub>3</sub>, DMF, 90 °C, 5 days, 65%; (e) NaHCO<sub>3</sub>, NH<sub>4</sub>OH, MeOH, 70 °C, 12 h, quant.; (f) CDI, DBU, dioxane, 100 °C, 2 days, 15% (last two steps).</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/medium/jm-2013-01911v_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/large/jm-2013-01911v_0006.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/large/jm-2013-01911v_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401911v&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 1-(cyanomethyl)tetrahydro-1-<i>H</i>-thiophene-1-ium bromide, DIEA, HATU, DCM, rt, 4 h, quant.; then, oxone, DMF/H<sub>2</sub>O, rt, 3 h, 64%; (b) NH<sub>3</sub>, DIEA, HATU, 55 °C, 1 h, 88%; (c) trifluoroacetic anhydride, TEA, 0 °C, 1 h, 90%; (d) HCl, ethanol, 1 h, rt, quant.; (e) ethyl 3-hydrazinyl-3-oxopropanoate, EtOH, 12 h, 63%; (f) LiOH, MeOH/THF/H<sub>2</sub>O, 50 °C, 1 h; (g) NH<sub>3</sub>, ethanol, 12 h, rt, 100%; (h) ethyl trans-4-oxo-2-butenoate, 130 °C, 1 h, 8%; (i) ethyl-2-formyl-3-oxo-propionate, DMA, 100 °C, 2 h, 66%; (j) P<sub>2</sub>S<sub>5</sub>, ethanol, 70 °C, 12 h, 66%; (k) 4-chloroacetic acid methyl ester, EtOH, 90 °C, 3 h, 57% (both steps); (l) ethyl-2-chloro-3-oxopropanoate, toluene, 100 °C, 5 h, 66%; (m) ethyl bromo pyruvate, dioxane, 3 h, rt; then, pyridine and TFA, 12 h, rt, 22%; (n) oxalyl chloride, DMF, 1 h; then, tris(trimethylsilyloxy)ethylene, 90 °C, 12 h, 10%.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/medium/jm-2013-01911v_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/large/jm-2013-01911v_0007.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/large/jm-2013-01911v_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401911v&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (2-chloromethoxy)ethyltrimethylsilane, LDA, THF, −78 °C, 1 h, 52%; (b) BF<sub>3</sub>–OEt<sub>2</sub>, DCM, 0 °C, 3 h, 33%; (c) methanesulfonic anhydride, NEt<sub>3</sub>, DCM, 30 min, rt, quant.; (d) hydrazine, EtOH, 90 °C, 12 h, 40% conversion; (e) ethyl-2-formyl-3-oxo-propionate, 100 °C, DMA, 2 h, 38%; (f) mCPBA, DCM, 0 °C, 30 min, 30%; (g) LiOH, MeOH/THF/H<sub>2</sub>O, 50 °C, 1 h, 30% (last two steps).</p></p></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/medium/jm-2013-01911v_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/large/jm-2013-01911v_0008.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/large/jm-2013-01911v_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401911v&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) triphenylphosphine, CBr<sub>4</sub>, MeCN, 55 °C, 5 h, 86%; (b) 2-mercaptopyrimidine, K<sub>2</sub>CO<sub>3</sub>, DMF, rt, 12 h; (c) oxone, THF/H<sub>2</sub>O, rt, 12 h, 48% (last two steps); (d) hydroxylamine-<i>O</i>-sulfonic acid, K<sub>2</sub>CO<sub>3</sub>, MeOH, 12 h, rt, 46%.</p></p></figure><figure data-id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/medium/jm-2013-01911v_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/large/jm-2013-01911v_0009.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/large/jm-2013-01911v_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401911v&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) oxalyl chloride, THF, DMF, rt, 1 h, quant.; (b) ethyl 4-(bis(trimethylsilyl)amino)but-2-ynoate, TBAF, THF, rt, 12 h; then, HCl/water, 72%; (c) Lawesson’s reagent, toluene, 60 °C, 3 h, 63%; (d) LiOH, MeOH/THF/H<sub>2</sub>O, 50 °C, 1 h; (f) MeI, NaO<i><sup>t</sup></i>Bu, DMF, 0 °C, 30 min, 62%; (e) 1,2-dibromoethane, NaO<sup>t</sup>Bu, DMF, 0 °C, 30 min, 80%.</p></p></figure><figure data-id="sch6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/medium/jm-2013-01911v_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/large/jm-2013-01911v_0010.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 6. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/large/jm-2013-01911v_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401911v&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) glycine methyl ester hydrochloride, EDC, HOAt, NaHCO<sub>3</sub>, DMF, 40 °C, 3 h, quant.; (b) LiOH, MeOH/THF/H<sub>2</sub>O, 50 °C, 1 h; (c) MgCl<sub>2</sub>, CDI, methyl potassium malonate, 50 °C, 12 h, 63%; (d) Lawesson’s reagent, toluene, 100 °C, 3 h, 71%; (e) Burgess’ reagent, DCE, 120 °C, 7 h, 62%; (f) <i>N</i>-fluorobenzenesulfonimide, NaO<sup>t</sup>Bu, DMF, 0 °C, 1 h; then step b, <b>41</b>, 11%; <b>42</b>, 4%.</p></p></figure><figure data-id="sch7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/medium/jm-2013-01911v_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/large/jm-2013-01911v_0011.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 7. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/large/jm-2013-01911v_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401911v&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) methyl (6-bromomethyl)nicotinate, LDA, THF, −78 °C, 2 h, 78%,  1:1 d.r.; (b) TBAF, THF, rt, 12 h, 60%; (c) <sup>t</sup>BuSH, cyanomethyltri-<i>N</i>-butylphosphorane, 110 °C, 12 h, 61%; (d) mCPBA, DCM, 30 min, 0 °C, quant.; (e) LiOH, MeOH/THF/H<sub>2</sub>O, 50 °C, 1 h.</p></p></figure><figure data-id="sch8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/medium/jm-2013-01911v_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/large/jm-2013-01911v_0012.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 8. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/large/jm-2013-01911v_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401911v&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <i>tert</i>-butyl-2-(bromomethyl)isonicotinate, LDA, THF, −78 °C, 4 h, 71%, 3:1 d.r.; (b) mCPBA, DCM, 30 min, 0 °C, quant.; (c) LiOH, MeOH/THF/H<sub>2</sub>O, 50 °C, 1 h; (d) 5-bromo-2-(bromomethyl)pyridine, LDA, THF, −78 °C, 2 h, 18% (single isomer); (e) Pd(dba)<sub>2</sub>, Q-phos, (2-(<i>tert</i>-butoxy)-2-oxoethyl)zinc(II) chloride, THF, 60 °C, 4 h, 37%; (f) formic acid, 6 h, 75%.</p></p></figure><figure data-id="fig2" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/medium/jm-2013-01911v_0026.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/large/jm-2013-01911v_0026.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Co-crystal structure of <b>4</b> bound to human MDM2 (6–110). White labels indicate positions normally occupied by key p53 residues. MDM2 residues His96 and Gly58 are labeled in yellow. Coordinates for compound <b>4</b> (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4ODE">4ODE</a>) bound to MDM2 have been deposited in the PDB.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/large/jm-2013-01911v_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401911v&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/medium/jm-2013-01911v_0027.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/large/jm-2013-01911v_0027.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Cell activity of <b>4</b> is p53-dependent. (a) In HCT116 p53<sup>wt</sup> and p53<sup>–/–</sup> cells, the percentage of BrdU positive cells was measured 16 h postcompound treatment by flow cytometry. The DMSO control was designated as 0% inhibition. (b) In HCT116 p53<sup>wt</sup> and p53<sup>–/–</sup> cells, total RNA was extracted 7 h postcompound treatment, and p21 mRNA was measured by quantitative RT-PCR.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/large/jm-2013-01911v_0027.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401911v&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/medium/jm-2013-01911v_0028.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/large/jm-2013-01911v_0028.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. PD study results of <b>4</b> in the SJSA-1 tumor xenograft: Female athymic nude mice (<i>n</i> = 4/group) were implanted subcutaneously with 5 × 10<sup>6</sup> SJSA-1 cells. When tumors reached ∼175 mm<sup>3</sup>, 25 mg/kg of <b>4</b> or the vehicle was administered orally once daily (QD) for 4 days. Mice were sacrificed on day 4 at 1, 2, 4, 8, and 24 h postdose. Tumors were immediately removed and snap-frozen. p21 mRNA levels were measured by quantitative RT-PCR. Tumors treated with vehicle served as a negative control and indicated the baseline p21 mRNA level. Data are represented as the mean p21 fold induction over vehicle, and error bars represent standard error of the mean (SEM) of data from five mice. Concentrations in plasma (red dots) were analyzed by LC/MS/MS. *<i>p</i> < 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/large/jm-2013-01911v_0028.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401911v&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/medium/jm-2013-01911v_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/large/jm-2013-01911v_0001.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. SJSA-1 cells (5 × 10<sup>6</sup>) were implanted subcutaneously into female athymic nude mice. Treatment with vehicle or <b>4</b> at 5, 12.5, 25, or 50 mg/kg QD by oral gavage began on day 9 when tumors had reached ∼200 mm<sup>3</sup> (<i>n</i> = 10/group). Tumor sizes and body weights were measured twice per week. Data are represented as the mean tumor volumes, and the error bars represented the SEM of data from 10 mice. * <i>p</i> < 0.005.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/large/jm-2013-01911v_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401911v&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/medium/jm-2013-01911v_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/large/jm-2013-01911v_0002.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Chemical structures and potencies of some known MDM2 inhibitors currently being tested in the clinic: RG7112, RG7388, SAR299155, and <b>4</b>. <sup>a</sup> IC<sub>50</sub> in the EdU cell proliferation assay (SJSA-1 and 10% human serum).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/large/jm-2013-01911v_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401911v&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/medium/jm-2013-01911v_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/large/jm-2013-01911v_0003.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Metabolite profiles of <b>4</b> from hepatocyte incubation at 10 μM after 2 h.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/large/jm-2013-01911v_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401911v&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/medium/jm-2013-01911v_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/large/jm-2013-01911v_0004.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Co-crystal structures of (a) <b>46</b>, (b) <b>47</b>, (c) <b>48</b>, and (d) <b>49</b> bound to human MDM2 (<b>46</b>, <b>47</b> MDM2, 6–110; <b>48</b>, <b>49</b> MDM2, 17–111). <sup>a</sup> IC<sub>50</sub> in the biochemical assay using buffer containing 15% human serum. <sup>b</sup> Cellular potency in SJSA-1 osteosarcoma tumor cells in the presence of 10% human serum. Coordinates for compounds <b>46</b> (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4OGT">4OGT</a>), <b>47</b> (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4ODF">4ODF</a>), <b>48</b> (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4OCC">4OCC</a>), and <b>49</b> (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4OGV">4OGV</a>) bound to MDM2 have been deposited in the PDB.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401911v/production/images/large/jm-2013-01911v_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401911v&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i82">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07084" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07084" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 32 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Wells, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McClendon, C. L.</span><span> </span><span class="NLM_article-title">Reaching for high-hanging fruit in drug discovery at protein–protein interfacese</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">450</span><span class="NLM_x">, </span> <span class="NLM_fpage">1001</span><span class="NLM_x">–</span> <span class="NLM_lpage">1009</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=450&publication_year=2007&pages=1001-1009&author=J.+A.+Wellsauthor=C.+L.+McClendon&title=Reaching+for+high-hanging+fruit+in+drug+discovery+at+protein%E2%80%93protein+interfacese"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWells%26aufirst%3DJ.%2BA.%26aulast%3DMcClendon%26aufirst%3DC.%2BL.%26atitle%3DReaching%2520for%2520high-hanging%2520fruit%2520in%2520drug%2520discovery%2520at%2520protein%25E2%2580%2593protein%2520interfacese%26jtitle%3DNature%26date%3D2007%26volume%3D450%26spage%3D1001%26epage%3D1009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Levine, A. J.</span><span> </span><span class="NLM_article-title">p53, the cellular gatekeeper for growth and division</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">323</span><span class="NLM_x">–</span> <span class="NLM_lpage">331</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm401911v&amp;key=10.1016%2FS0092-8674%2800%2981871-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm401911v&amp;key=9039259" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm401911v&amp;key=1%3ACAS%3A528%3ADyaK2sXhtFahtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=1997&pages=323-331&author=A.+J.+Levine&title=p53%2C+the+cellular+gatekeeper+for+growth+and+division"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">p53, The cellular gatekeeper for growth and division</span></div><div class="casAuthors">Levine, Arnold J.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">323-331</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review, with 55 refs., of p53 transcription factor protein structure, function, and roles in cell cycle regulation, apoptosis, and cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGou4CgTSWvZVbVg90H21EOLACvtfcHk0licZ41DDIlf4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXhtFahtLg%253D&md5=bfbec429d10b9718fe9e9ea5dce9109b</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2981871-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252981871-1%26sid%3Dliteratum%253Aachs%26aulast%3DLevine%26aufirst%3DA.%2BJ.%26atitle%3Dp53%252C%2520the%2520cellular%2520gatekeeper%2520for%2520growth%2520and%2520division%26jtitle%3DCell%26date%3D1997%26volume%3D88%26spage%3D323%26epage%3D331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Lane, D. P.</span><span> </span><span class="NLM_article-title">p53, guardian of the genome</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">358</span><span class="NLM_x">, </span> <span class="NLM_fpage">15</span><span class="NLM_x">–</span> <span class="NLM_lpage">16</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=358&publication_year=1992&pages=15-16&author=D.+P.+Lane&title=p53%2C+guardian+of+the+genome"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLane%26aufirst%3DD.%2BP.%26atitle%3Dp53%252C%2520guardian%2520of%2520the%2520genome%26jtitle%3DNature%26date%3D1992%26volume%3D358%26spage%3D15%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Toledo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahl, G. M.</span><span> </span><span class="NLM_article-title">Regulating the p53 pathway: <i>in vitro</i> hypotheses, <i>in vivo</i> veritas</span> <span class="citation_source-journal">Nat. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_fpage">909</span><span class="NLM_x">–</span> <span class="NLM_lpage">923</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm401911v&amp;key=10.1038%2Fnrc2012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm401911v&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1Clsr3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=909-923&author=F.+Toledoauthor=G.+M.+Wahl&title=Regulating+the+p53+pathway%3A+in+vitro+hypotheses%2C+in+vivo+veritas"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Regulating the p53 pathway: in vitro hypotheses, in vivo veritas</span></div><div class="casAuthors">Toledo, Franck; Wahl, Geoffrey M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">909-923</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Mutations in TP53, the gene that encodes the tumor suppressor p53, are found in 50% of human cancers, and increased levels of its neg. regulators MDM2 and MDM4 (also known as MDMX) down-regulate p53 function in many of the rest.  Understanding p53 regulation remains a crucial goal to design broadly applicable anticancer strategies based on this pathway.  This review of in vitro studies, human tumor data and recent mouse models shows that p53 post-translational modifications have modulatory roles, and MDM2 and MDM4 have more profound roles for regulating p53.  Importantly, MDM4 emerges as an independent target for drug development, as its inactivation is crucial for full p53 activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqN3wMkB-VB7Vg90H21EOLACvtfcHk0licZ41DDIlf4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1Clsr3E&md5=0f87a2342dd6dcd4ab3de2a0245eabd6</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrc2012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2012%26sid%3Dliteratum%253Aachs%26aulast%3DToledo%26aufirst%3DF.%26aulast%3DWahl%26aufirst%3DG.%2BM.%26atitle%3DRegulating%2520the%2520p53%2520pathway%253A%2520in%2520vitro%2520hypotheses%252C%2520in%2520vivo%2520veritas%26jtitle%3DNat.%2520Rev.%26date%3D2006%26spage%3D909%26epage%3D923" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Hainaut, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollstein, M.</span><span> </span><span class="NLM_article-title">p53 and human cancers: the first ten thousand mutations</span> <span class="citation_source-journal">Adv. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">81</span><span class="NLM_x">–</span> <span class="NLM_lpage">137</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2000&pages=81-137&author=P.+Hainautauthor=M.+Hollstein&title=p53+and+human+cancers%3A+the+first+ten+thousand+mutations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHainaut%26aufirst%3DP.%26aulast%3DHollstein%26aufirst%3DM.%26atitle%3Dp53%2520and%2520human%2520cancers%253A%2520the%2520first%2520ten%2520thousand%2520mutations%26jtitle%3DAdv.%2520Cancer%2520Res.%26date%3D2000%26volume%3D77%26spage%3D81%26epage%3D137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Oliner, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinzler, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meltzer, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogelstein, B.</span><span> </span><span class="NLM_article-title">Amplification of a gene encoding a p53-associated protein in human sarcomas</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">358</span><span class="NLM_x">, </span> <span class="NLM_fpage">80</span><span class="NLM_x">–</span> <span class="NLM_lpage">83</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=358&publication_year=1992&pages=80-83&author=J.+D.+Olinerauthor=K.+W.+Kinzlerauthor=P.+S.+Meltzerauthor=D.+Georgeauthor=B.+Vogelstein&title=Amplification+of+a+gene+encoding+a+p53-associated+protein+in+human+sarcomas"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOliner%26aufirst%3DJ.%2BD.%26aulast%3DKinzler%26aufirst%3DK.%2BW.%26aulast%3DMeltzer%26aufirst%3DP.%2BS.%26aulast%3DGeorge%26aufirst%3DD.%26aulast%3DVogelstein%26aufirst%3DB.%26atitle%3DAmplification%2520of%2520a%2520gene%2520encoding%2520a%2520p53-associated%2520protein%2520in%2520human%2520sarcomas%26jtitle%3DNature%26date%3D1992%26volume%3D358%26spage%3D80%26epage%3D83" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Chene, P.</span><span> </span><span class="NLM_article-title">Inhibiting the p53-MDM2 interaction: An important target for cancer therapy</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">102</span><span class="NLM_x">–</span> <span class="NLM_lpage">109</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm401911v&amp;key=10.1038%2Fnrc991" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm401911v&amp;key=12563309" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm401911v&amp;key=1%3ACAS%3A528%3ADC%252BD3sXisVCru7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=102-109&author=P.+Chene&title=Inhibiting+the+p53-MDM2+interaction%3A+An+important+target+for+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibiting the p53-MDM2 interaction: An important target for cancer therapy</span></div><div class="casAuthors">Chene, Patrick</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">102-109</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  P53 is an attractive therapeutic target in oncol. because its tumor-suppressor activity can be stimulated to eradicate tumor cells.  Inhibiting the p53-MDM2 interaction is a promising approach for activating p53, because this assocn. is well characterized at the structural and biol. levels.  MDM2 inhibits p53 transcriptional activity, favors its nuclear export and stimulates its degrdn., so inhibiting the p53-MDM2 interaction with synthetic mols. should lead to p53-mediated cell-cycle arrest or apoptosis in p53-pos. stressed cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpC1Ihu0XrL47Vg90H21EOLACvtfcHk0lhLBxtsNgZrRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXisVCru7k%253D&md5=a66dab38cd424a4ca6f8b349aa72fd0e</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnrc991&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc991%26sid%3Dliteratum%253Aachs%26aulast%3DChene%26aufirst%3DP.%26atitle%3DInhibiting%2520the%2520p53-MDM2%2520interaction%253A%2520An%2520important%2520target%2520for%2520cancer%2520therapy%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2003%26volume%3D3%26spage%3D102%26epage%3D109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Vogelstein, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levine, A. J.</span><span> </span><span class="NLM_article-title">Surfing the p53 network</span> <span class="citation_source-journal">Nature (London)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">408</span><span class="NLM_x">, </span> <span class="NLM_fpage">307</span><span class="NLM_x">–</span> <span class="NLM_lpage">310</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm401911v&amp;key=10.1038%2F35042675" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm401911v&amp;key=11099028" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm401911v&amp;key=1%3ACAS%3A528%3ADC%252BD3cXosVemtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=408&publication_year=2000&pages=307-310&author=B.+Vogelsteinauthor=D.+Laneauthor=A.+J.+Levine&title=Surfing+the+p53+network"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Surfing the p53 network</span></div><div class="casAuthors">Vogelstein, Bert; Lane, David; Levine, Arnold J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">408</span>
        (<span class="NLM_cas:issue">6810</span>),
    <span class="NLM_cas:pages">307-310</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUz4RWc7xOzrVg90H21EOLACvtfcHk0lhu7kFNFdOayw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXosVemtrY%253D&md5=136728653fb9e30f8ac0c48bf7701a08</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2F35042675&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35042675%26sid%3Dliteratum%253Aachs%26aulast%3DVogelstein%26aufirst%3DB.%26aulast%3DLane%26aufirst%3DD.%26aulast%3DLevine%26aufirst%3DA.%2BJ.%26atitle%3DSurfing%2520the%2520p53%2520network%26jtitle%3DNature%2520%2528London%2529%26date%3D2000%26volume%3D408%26spage%3D307%26epage%3D310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Kussie, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorina, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcchal, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elenbaas, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreau, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levine, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavletich, N. P.</span><span> </span><span class="NLM_article-title">Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">274</span><span class="NLM_x">, </span> <span class="NLM_fpage">948</span><span class="NLM_x">–</span> <span class="NLM_lpage">953</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm401911v&amp;key=10.1126%2Fscience.274.5289.948" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm401911v&amp;key=8875929" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm401911v&amp;key=1%3ACAS%3A528%3ADyaK28XmslKnt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1996&pages=948-953&author=P.+H.+Kussieauthor=S.+Gorinaauthor=V.+Marcchalauthor=B.+Elenbaasauthor=J.+Moreauauthor=A.+J.+Levineauthor=N.+P.+Pavletich&title=Structure+of+the+MDM2+oncoprotein+bound+to+the+p53+tumor+suppressor+transactivation+domain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain</span></div><div class="casAuthors">Kussie, Paul H.; Gorina, Svetlana; Marechal, Vincent; Elenbaas, Brian; Moreau, Jacque; Levine, Arnold J.; Pavletich, Nikola P.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">274</span>
        (<span class="NLM_cas:issue">5289</span>),
    <span class="NLM_cas:pages">948-953</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The MDM2 oncoprotein is a cellular inhibitor of the p53 tumor suppressor in that it can bind the transactivation domain of p53 and downregulate its ability to activate transcription.  In certain cancers, MDM2 amplification is a common event and contributes to the inactivation of p53.  The crystal structure of the 109-residue amino-terminal domain of MDM2 bound to a 15-residue transactivation domain peptide of p53 revealed that MDM2 has a deep hydrophobic cleft on which the p53 peptide binds as an amphipathic α helix.  The interface relies on the steric complementarity between the MDM2 cleft and the hydrophobic face of the p53 α helix and, in particular, on a triad of p53 amino acids - Phe19, Trp23, and Leu26 - which insert deep into the MDM2 cleft.  These same p53 residues are also involved in transactivation, supporting the hypothesis that MDM2 inactivates p53 by concealing its transactivation domain.  The structure also suggests that the amphipathic α helix may be a common structural motif in the binding of a diverse family of transactivation factors to the TATA-binding protein-assocd. factors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotkRIRDnQnX7Vg90H21EOLACvtfcHk0lhu7kFNFdOayw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XmslKnt7k%253D&md5=3702422b0a761617cff1498f47f30eeb</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1126%2Fscience.274.5289.948&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.274.5289.948%26sid%3Dliteratum%253Aachs%26aulast%3DKussie%26aufirst%3DP.%2BH.%26aulast%3DGorina%26aufirst%3DS.%26aulast%3DMarcchal%26aufirst%3DV.%26aulast%3DElenbaas%26aufirst%3DB.%26aulast%3DMoreau%26aufirst%3DJ.%26aulast%3DLevine%26aufirst%3DA.%2BJ.%26aulast%3DPavletich%26aufirst%3DN.%2BP.%26atitle%3DStructure%2520of%2520the%2520MDM2%2520oncoprotein%2520bound%2520to%2520the%2520p53%2520tumor%2520suppressor%2520transactivation%2520domain%26jtitle%3DScience%26date%3D1996%26volume%3D274%26spage%3D948%26epage%3D953" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Garcia-Echevarria, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chene, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blommers, M. J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furet, P.</span><span> </span><span class="NLM_article-title">Discovery of potent antagonists of the interaction between human double minute 2 and tumor suppressor p53</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">3205</span><span class="NLM_x">–</span> <span class="NLM_lpage">3208</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=3205-3208&author=C.+Garcia-Echevarriaauthor=P.+Cheneauthor=M.+J.+J.+Blommersauthor=P.+Furet&title=Discovery+of+potent+antagonists+of+the+interaction+between+human+double+minute+2+and+tumor+suppressor+p53"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGarcia-Echevarria%26aufirst%3DC.%26aulast%3DChene%26aufirst%3DP.%26aulast%3DBlommers%26aufirst%3DM.%2BJ.%2BJ.%26aulast%3DFuret%26aufirst%3DP.%26atitle%3DDiscovery%2520of%2520potent%2520antagonists%2520of%2520the%2520interaction%2520between%2520human%2520double%2520minute%25202%2520and%2520tumor%2520suppressor%2520p53%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D3205%26epage%3D3208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Arkin, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, J. A.</span><span> </span><span class="NLM_article-title">Small-molecule inhibitors of protein–protein interactions: progressing towards the dream</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">301</span><span class="NLM_x">–</span> <span class="NLM_lpage">317</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=301-317&author=M.+R.+Arkinauthor=J.+A.+Wells&title=Small-molecule+inhibitors+of+protein%E2%80%93protein+interactions%3A+progressing+towards+the+dream"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArkin%26aufirst%3DM.%2BR.%26aulast%3DWells%26aufirst%3DJ.%2BA.%26atitle%3DSmall-molecule%2520inhibitors%2520of%2520protein%25E2%2580%2593protein%2520interactions%253A%2520progressing%2520towards%2520the%2520dream%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D3%26spage%3D301%26epage%3D317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="note"><p class="first last">For other small molecule MDM2-inhibitor scaffolds see imidazolines;</p></div><div class="NLM_citation" id="rightTab-cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Vassilev, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vu, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graves, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carvajal, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podlaski, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filipovic, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kammlott, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukacs, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fotouhi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, E. A.</span><span> </span><span class="NLM_article-title">In vivo activation of the p53 pathway by small molecule antagonists of MDM2</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">303</span><span class="NLM_x">, </span> <span class="NLM_fpage">844</span><span class="NLM_x">–</span> <span class="NLM_lpage">848</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=303&publication_year=2004&pages=844-848&author=L.+T.+Vassilevauthor=B.+T.+Vuauthor=B.+Gravesauthor=D.+Carvajalauthor=F.+Podlaskiauthor=Z.+Filipovicauthor=N.+Kongauthor=U.+Kammlottauthor=C.+Lukacsauthor=C.+Kleinauthor=N.+Fotouhiauthor=E.+A.+Liu&title=In+vivo+activation+of+the+p53+pathway+by+small+molecule+antagonists+of+MDM2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVassilev%26aufirst%3DL.%2BT.%26aulast%3DVu%26aufirst%3DB.%2BT.%26aulast%3DGraves%26aufirst%3DB.%26aulast%3DCarvajal%26aufirst%3DD.%26aulast%3DPodlaski%26aufirst%3DF.%26aulast%3DFilipovic%26aufirst%3DZ.%26aulast%3DKong%26aufirst%3DN.%26aulast%3DKammlott%26aufirst%3DU.%26aulast%3DLukacs%26aufirst%3DC.%26aulast%3DKlein%26aufirst%3DC.%26aulast%3DFotouhi%26aufirst%3DN.%26aulast%3DLiu%26aufirst%3DE.%2BA.%26atitle%3DIn%2520vivo%2520activation%2520of%2520the%2520p53%2520pathway%2520by%2520small%2520molecule%2520antagonists%2520of%2520MDM2%26jtitle%3DScience%26date%3D2004%26volume%3D303%26spage%3D844%26epage%3D848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Vu, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassilev, L.</span><span> </span><span class="NLM_article-title">Small-molecule inhibitors of the p53-MDM2 interaction</span> <span class="citation_source-journal">Curr. Top. Microbiol. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">348</span><span class="NLM_x">, </span> <span class="NLM_fpage">151</span><span class="NLM_x">–</span> <span class="NLM_lpage">172</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=348&publication_year=2011&pages=151-172&author=B.+T.+Vuauthor=L.+Vassilev&title=Small-molecule+inhibitors+of+the+p53-MDM2+interaction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVu%26aufirst%3DB.%2BT.%26aulast%3DVassilev%26aufirst%3DL.%26atitle%3DSmall-molecule%2520inhibitors%2520of%2520the%2520p53-MDM2%2520interaction%26jtitle%3DCurr.%2520Top.%2520Microbiol.%2520Immunol.%26date%3D2011%26volume%3D348%26spage%3D151%26epage%3D172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last">Benzodiazepinediones:</p></div><div class="NLM_citation" id="rightTab-cit12c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Parks, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaFrance, L. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calvo, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milkiewicz, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lattance, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramachandren, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carver, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrella, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maguire, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grasberger, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, T.</span><span> </span><span class="NLM_article-title">1,4-Benzodiazepine-2,5-diones as small molecule antagonists of the HDM2-p53 interaction: discovery and SAR</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">765</span><span class="NLM_x">–</span> <span class="NLM_lpage">770</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=765-770&author=D.+J.+Parksauthor=L.+V.+LaFranceauthor=R.+R.+Calvoauthor=K.+L.+Milkiewiczauthor=V.+Guptaauthor=J.+Lattanceauthor=K.+Ramachandrenauthor=T.+E.+Carverauthor=E.+C.+Petrellaauthor=M.+D.+Cummingsauthor=D.+Maguireauthor=B.+L.+Grasbergerauthor=T.+Lu&title=1%2C4-Benzodiazepine-2%2C5-diones+as+small+molecule+antagonists+of+the+HDM2-p53+interaction%3A+discovery+and+SAR"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DParks%26aufirst%3DD.%2BJ.%26aulast%3DLaFrance%26aufirst%3DL.%2BV.%26aulast%3DCalvo%26aufirst%3DR.%2BR.%26aulast%3DMilkiewicz%26aufirst%3DK.%2BL.%26aulast%3DGupta%26aufirst%3DV.%26aulast%3DLattance%26aufirst%3DJ.%26aulast%3DRamachandren%26aufirst%3DK.%26aulast%3DCarver%26aufirst%3DT.%2BE.%26aulast%3DPetrella%26aufirst%3DE.%2BC.%26aulast%3DCummings%26aufirst%3DM.%2BD.%26aulast%3DMaguire%26aufirst%3DD.%26aulast%3DGrasberger%26aufirst%3DB.%2BL.%26aulast%3DLu%26aufirst%3DT.%26atitle%3D1%252C4-Benzodiazepine-2%252C5-diones%2520as%2520small%2520molecule%2520antagonists%2520of%2520the%2520HDM2-p53%2520interaction%253A%2520discovery%2520and%2520SAR%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D765%26epage%3D770" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Parks, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaFrance, L. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calvo, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milkiewicz, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marugan, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raboisson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schubert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koblish, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franks, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lattanze, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carver, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maguire, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grasberger, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maroney, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, T.</span><span> </span><span class="NLM_article-title">Enhanced pharmacokinetic properties of 1,4-benzodiazepine-2,5-dione antagonists of the HDM2-p53 protein–protein interaction through structure-based drug design</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">3310</span><span class="NLM_x">–</span> <span class="NLM_lpage">3314</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=3310-3314&author=D.+J.+Parksauthor=L.+V.+LaFranceauthor=R.+R.+Calvoauthor=K.+L.+Milkiewiczauthor=J.+L.+Maruganauthor=P.+Raboissonauthor=C.+Schubertauthor=H.+K.+Koblishauthor=S.+Zhaoauthor=C.+F.+Franksauthor=J.+Lattanzeauthor=T.+E.+Carverauthor=M.+D.+Cummingsauthor=D.+Maguireauthor=B.+L.+Grasbergerauthor=A.+C.+Maroneyauthor=T.+Lu&title=Enhanced+pharmacokinetic+properties+of+1%2C4-benzodiazepine-2%2C5-dione+antagonists+of+the+HDM2-p53+protein%E2%80%93protein+interaction+through+structure-based+drug+design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DParks%26aufirst%3DD.%2BJ.%26aulast%3DLaFrance%26aufirst%3DL.%2BV.%26aulast%3DCalvo%26aufirst%3DR.%2BR.%26aulast%3DMilkiewicz%26aufirst%3DK.%2BL.%26aulast%3DMarugan%26aufirst%3DJ.%2BL.%26aulast%3DRaboisson%26aufirst%3DP.%26aulast%3DSchubert%26aufirst%3DC.%26aulast%3DKoblish%26aufirst%3DH.%2BK.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DFranks%26aufirst%3DC.%2BF.%26aulast%3DLattanze%26aufirst%3DJ.%26aulast%3DCarver%26aufirst%3DT.%2BE.%26aulast%3DCummings%26aufirst%3DM.%2BD.%26aulast%3DMaguire%26aufirst%3DD.%26aulast%3DGrasberger%26aufirst%3DB.%2BL.%26aulast%3DMaroney%26aufirst%3DA.%2BC.%26aulast%3DLu%26aufirst%3DT.%26atitle%3DEnhanced%2520pharmacokinetic%2520properties%2520of%25201%252C4-benzodiazepine-2%252C5-dione%2520antagonists%2520of%2520the%2520HDM2-p53%2520protein%25E2%2580%2593protein%2520interaction%2520through%2520structure-based%2520drug%2520design%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D3310%26epage%3D3314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Grasberger, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schubert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parks, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carver, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koblish, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaFrance, L. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milkiewicz, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calvo, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maguire, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lattanze, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franks, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramachandren, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bylebyl, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manthey, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrella, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pantoliano, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deckman, I. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spurlino, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maroney, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomczuk, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molloy, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bone, R. F.</span><span> </span><span class="NLM_article-title">Discovery and co-crystal structure of benzodiazepinedione HDM2 antagonists that activate p53 in cells</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">909</span><span class="NLM_x">–</span> <span class="NLM_lpage">912</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049137g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=909-912&author=B.+L.+Grasbergerauthor=T.+Luauthor=C.+Schubertauthor=D.+J.+Parksauthor=T.+E.+Carverauthor=H.+K.+Koblishauthor=M.+D.+Cummingsauthor=L.+V.+LaFranceauthor=K.+L.+Milkiewiczauthor=R.+R.+Calvoauthor=D.+Maguireauthor=J.+Lattanzeauthor=C.+F.+Franksauthor=S.+Zhaoauthor=K.+Ramachandrenauthor=G.+R.+Bylebylauthor=M.+Zhangauthor=C.+L.+Mantheyauthor=E.+C.+Petrellaauthor=M.+W.+Pantolianoauthor=I.+C.+Deckmanauthor=J.+C.+Spurlinoauthor=A.+C.+Maroneyauthor=B.+E.+Tomczukauthor=C.+J.+Molloyauthor=R.+F.+Bone&title=Discovery+and+co-crystal+structure+of+benzodiazepinedione+HDM2+antagonists+that+activate+p53+in+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12e&amp;dbid=16384&amp;doi=10.1021%2Fjm049137g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049137g%26sid%3Dliteratum%253Aachs%26aulast%3DGrasberger%26aufirst%3DB.%2BL.%26aulast%3DLu%26aufirst%3DT.%26aulast%3DSchubert%26aufirst%3DC.%26aulast%3DParks%26aufirst%3DD.%2BJ.%26aulast%3DCarver%26aufirst%3DT.%2BE.%26aulast%3DKoblish%26aufirst%3DH.%2BK.%26aulast%3DCummings%26aufirst%3DM.%2BD.%26aulast%3DLaFrance%26aufirst%3DL.%2BV.%26aulast%3DMilkiewicz%26aufirst%3DK.%2BL.%26aulast%3DCalvo%26aufirst%3DR.%2BR.%26aulast%3DMaguire%26aufirst%3DD.%26aulast%3DLattanze%26aufirst%3DJ.%26aulast%3DFranks%26aufirst%3DC.%2BF.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DRamachandren%26aufirst%3DK.%26aulast%3DBylebyl%26aufirst%3DG.%2BR.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DManthey%26aufirst%3DC.%2BL.%26aulast%3DPetrella%26aufirst%3DE.%2BC.%26aulast%3DPantoliano%26aufirst%3DM.%2BW.%26aulast%3DDeckman%26aufirst%3DI.%2BC.%26aulast%3DSpurlino%26aufirst%3DJ.%2BC.%26aulast%3DMaroney%26aufirst%3DA.%2BC.%26aulast%3DTomczuk%26aufirst%3DB.%2BE.%26aulast%3DMolloy%26aufirst%3DC.%2BJ.%26aulast%3DBone%26aufirst%3DR.%2BF.%26atitle%3DDiscovery%2520and%2520co-crystal%2520structure%2520of%2520benzodiazepinedione%2520HDM2%2520antagonists%2520that%2520activate%2520p53%2520in%2520cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D909%26epage%3D912" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolf, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bista, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meireles, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camacho, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holak, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Domling, A.</span><span> </span><span class="NLM_article-title">1,4-Thienodiazepine-2,5-diones via MCR (I): Synthesis, virtual space and p53-Mdm2 activity</span> <span class="citation_source-journal">Chem. Biol. Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">76</span><span class="NLM_x">, </span> <span class="NLM_fpage">116</span><span class="NLM_x">–</span> <span class="NLM_lpage">129</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12f&amp;dbid=16&amp;doi=10.1021%2Fjm401911v&amp;key=10.1111%2Fj.1747-0285.2010.00989.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12f&amp;dbid=8&amp;doi=10.1021%2Fjm401911v&amp;key=20492448" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12f&amp;dbid=32&amp;doi=10.1021%2Fjm401911v&amp;key=1%3ACAS%3A528%3ADC%252BC3cXptleqs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2010&pages=116-129&author=Y.+Huangauthor=S.+Wolfauthor=M.+Bistaauthor=L.+Meirelesauthor=C.+Camachoauthor=T.+A.+Holakauthor=A.+Domling&title=1%2C4-Thienodiazepine-2%2C5-diones+via+MCR+%28I%29%3A+Synthesis%2C+virtual+space+and+p53-Mdm2+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12fR"><div class="casContent"><span class="casTitleNuber">12f</span><div class="casTitle"><span class="NLM_cas:atitle">1,4-Thienodiazepine-2,5-diones via MCR (I): Synthesis, virtual space and p53-Mdm2 activity</span></div><div class="casAuthors">Huang, Yijun; Wolf, Siglinde; Bista, Michal; Meireles, Lidio; Camacho, Carlos; Holak, Tad A.; Domling, Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">116-129</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">1,4-Thienodiazepine-2,5-diones have been synthesized via the Ugi-Deprotection-Cyclization (UDC) approach starting from Gewald 2-aminothiophenes, e.g. I, in a convergent and versatile manner.  The resulting scaffold is unprecedented, cyclic, and peptidomimetic with four points of diversity introduced from readily available starting materials.  In addn. to eighteen synthesized and characterized compds., a virtual compd. library was generated and evaluated for chem. space distribution and drug-like properties.  A small focused compd. library of 1,4-thienodiazepine-2,5-diones, e.g. II, has been screened for the activity against p53-Mdm2 interaction.  Biol. evaluations demonstrated that some compds. exhibited promising antagonistic activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpK0Ctp2sc40rVg90H21EOLACvtfcHk0lg24LgifhmetQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXptleqs7s%253D&md5=030992e421fc773c9de45306758dcef0</span></div><a href="/servlet/linkout?suffix=cit12f&amp;dbid=16384&amp;doi=10.1111%2Fj.1747-0285.2010.00989.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1747-0285.2010.00989.x%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DWolf%26aufirst%3DS.%26aulast%3DBista%26aufirst%3DM.%26aulast%3DMeireles%26aufirst%3DL.%26aulast%3DCamacho%26aufirst%3DC.%26aulast%3DHolak%26aufirst%3DT.%2BA.%26aulast%3DDomling%26aufirst%3DA.%26atitle%3D1%252C4-Thienodiazepine-2%252C5-diones%2520via%2520MCR%2520%2528I%2529%253A%2520Synthesis%252C%2520virtual%2520space%2520and%2520p53-Mdm2%2520activity%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2010%26volume%3D76%26spage%3D116%26epage%3D129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last">Spiro-oxoindoles;</p></div><div class="NLM_citation" id="rightTab-cit12g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Ding, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikolovska-Coleska, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shangary, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stuckey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krajewski, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roller, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span> </span><span class="NLM_article-title">Structure-based design of spiro-oxindoles as potent, specific small-molecule inhibitors of the MDM2-p53 interaction</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">3432</span><span class="NLM_x">–</span> <span class="NLM_lpage">3435</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm051122a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12g&amp;dbid=32&amp;doi=10.1021%2Fjm401911v&amp;key=1%3ACAS%3A528%3ADC%252BD28XksFKksrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=3432-3435&author=K.+Dingauthor=Y.+Luauthor=Z.+Nikolovska-Coleskaauthor=G.+Wangauthor=S.+Qiuauthor=S.+Shangaryauthor=W.+Gaoauthor=D.+Qinauthor=J.+Stuckeyauthor=K.+Krajewskiauthor=P.+P.+Rollerauthor=S.+Wang&title=Structure-based+design+of+spiro-oxindoles+as+potent%2C+specific+small-molecule+inhibitors+of+the+MDM2-p53+interaction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12gR"><div class="casContent"><span class="casTitleNuber">12g</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design of Spiro-oxindoles as Potent, Specific Small-Molecule Inhibitors of the MDM2-p53 Interaction</span></div><div class="casAuthors">Ding, Ke; Lu, Yipin; Nikolovska-Coleska, Zaneta; Wang, Guoping; Qiu, Su; Shangary, Sanjeev; Gao, Wei; Qin, Dongguang; Stuckey, Jeanne; Krajewski, Krzysztof; Roller, Peter P.; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3432-3435</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Potent, specific, non-peptide small-mol. inhibitors of the MDM2-p53 interaction were successfully designed.  The most potent inhibitor (MI-63) has a Ki value of 3 nM binding to MDM2 and greater than 10,000-fold selectivity over Bcl-2/Bcl-xL proteins.  MI-63 is highly effective in activation of p53 function and in inhibition of cell growth in cancer cells with wild-type p53 status.  MI-63 has excellent specificity over cancer cells with deleted p53 and shows a minimal toxicity to normal cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptppiErNrFXrVg90H21EOLACvtfcHk0lg24LgifhmetQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XksFKksrc%253D&md5=186a2ba028ad9b8f71107aa1c2555421</span></div><a href="/servlet/linkout?suffix=cit12g&amp;dbid=16384&amp;doi=10.1021%2Fjm051122a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm051122a%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DK.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DNikolovska-Coleska%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DQiu%26aufirst%3DS.%26aulast%3DShangary%26aufirst%3DS.%26aulast%3DGao%26aufirst%3DW.%26aulast%3DQin%26aufirst%3DD.%26aulast%3DStuckey%26aufirst%3DJ.%26aulast%3DKrajewski%26aufirst%3DK.%26aulast%3DRoller%26aufirst%3DP.%2BP.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DStructure-based%2520design%2520of%2520spiro-oxindoles%2520as%2520potent%252C%2520specific%2520small-molecule%2520inhibitors%2520of%2520the%2520MDM2-p53%2520interaction%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D3432%26epage%3D3435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Yu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shangary, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McEachern, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikolovska-Coleska, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span> </span><span class="NLM_article-title">Potent and orally active small molecule inhibitors of the MDM2-p53 interaction</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">7970</span><span class="NLM_x">–</span> <span class="NLM_lpage">7973</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901400z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7970-7973&author=S.+Yuauthor=D.+Qinauthor=S.+Shangaryauthor=J.+Chenauthor=G.+Wangauthor=K.+Dingauthor=D.+McEachernauthor=S.+Qiuauthor=Z.+Nikolovska-Coleskaauthor=R.+Millerauthor=S.+Kangauthor=D.+Yangauthor=S.+Wang&title=Potent+and+orally+active+small+molecule+inhibitors+of+the+MDM2-p53+interaction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12h&amp;dbid=16384&amp;doi=10.1021%2Fjm901400z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901400z%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DS.%26aulast%3DQin%26aufirst%3DD.%26aulast%3DShangary%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DDing%26aufirst%3DK.%26aulast%3DMcEachern%26aufirst%3DD.%26aulast%3DQiu%26aufirst%3DS.%26aulast%3DNikolovska-Coleska%26aufirst%3DZ.%26aulast%3DMiller%26aufirst%3DR.%26aulast%3DKang%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DPotent%2520and%2520orally%2520active%2520small%2520molecule%2520inhibitors%2520of%2520the%2520MDM2-p53%2520interaction%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D7970%26epage%3D7973" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12i"><span><span class="NLM_label">(i) </span><span class="NLM_contrib-group">Wang, S.; Yu, S.; Sun, W.; Shangary, S. K.; Sun, D.; Zou, P.; McEachern, D.; Zhao, Y.</span><span> </span><span class="NLM_article-title">Preparation of Spiro-oxindole Derivatives as MDM2 Antagonists</span>. US2011/0112052A1,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=S.+Wang&author=S.+Yu&author=W.+Sun&author=S.+K.+Shangary&author=D.+Sun&author=P.+Zou&author=D.+McEachern&author=Y.+Zhao&title=Preparation+of+Spiro-oxindole+Derivatives+as+MDM2+Antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12i&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DS.%26atitle%3DPreparation%2520of%2520Spiro-oxindole%2520Derivatives%2520as%2520MDM2%2520Antagonists%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last">3-Imidazolyndole:</p></div><div class="NLM_citation" id="rightTab-cit12j"><span><span class="NLM_label">(j) </span><span class="NLM_contrib-group">Furet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chéne, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Pover, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stachyra Valat, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hergovich Lisztwan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kallen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masuya, K.</span><span> </span><span class="NLM_article-title">The central valine concept provides an entry in a class of non-peptide inhibitors of the p53-MDM2 interaction</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">3498</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=3498&author=P.+Furetauthor=P.+Ch%C3%A9neauthor=A.+De+Poverauthor=T.+Stachyra+Valatauthor=J.+Hergovich+Lisztwanauthor=J.+Kallenauthor=K.+Masuya&title=The+central+valine+concept+provides+an+entry+in+a+class+of+non-peptide+inhibitors+of+the+p53-MDM2+interaction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12j&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFuret%26aufirst%3DP.%26aulast%3DCh%25C3%25A9ne%26aufirst%3DP.%26aulast%3DDe%2BPover%26aufirst%3DA.%26aulast%3DStachyra%2BValat%26aufirst%3DT.%26aulast%3DHergovich%2BLisztwan%26aufirst%3DJ.%26aulast%3DKallen%26aufirst%3DJ.%26aulast%3DMasuya%26aufirst%3DK.%26atitle%3DThe%2520central%2520valine%2520concept%2520provides%2520an%2520entry%2520in%2520a%2520class%2520of%2520non-peptide%2520inhibitors%2520of%2520the%2520p53-MDM2%2520interaction%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D3498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12k"><span><span class="NLM_label">(k) </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, X.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartkovitz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karnachi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">So, S.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tovar, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filipovic, Z. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glenn, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Packman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassilev, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graves, B.</span><span> </span><span class="NLM_article-title">Discovery of potent and orally active p53-MDM2 inhibitors RO5353 and RO2468 for potential clinical development</span> <span class="citation_source-journal">Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">124</span><span class="NLM_x">–</span> <span class="NLM_lpage">7</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml400359z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12k&amp;dbid=32&amp;doi=10.1021%2Fjm401911v&amp;key=1%3ACAS%3A528%3ADC%252BC2cXksVal" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=124-7&author=Z.+Zhangauthor=X.-J.+Chuauthor=J.-J.+Liuauthor=Q.+Dingauthor=J.+Zhangauthor=D.+Bartkovitzauthor=N.+Jiangauthor=P.+Karnachiauthor=S.-S.+Soauthor=C.+Tovarauthor=Z.+M.+Filipovicauthor=B.+Higginsauthor=K.+Glennauthor=K.+Packmanauthor=Z.+Vassilevauthor=B.+Graves&title=Discovery+of+potent+and+orally+active+p53-MDM2+inhibitors+RO5353+and+RO2468+for+potential+clinical+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12kR"><div class="casContent"><span class="casTitleNuber">12k</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent and Orally Active p53-MDM2 Inhibitors RO5353 and RO2468 for Potential Clinical Development</span></div><div class="casAuthors">Zhang, Zhuming; Chu, Xin-Jie; Liu, Jin-Jun; Ding, Qingjie; Zhang, Jing; Bartkovitz, David; Jiang, Nan; Karnachi, Prabha; So, Sung-Sau; Tovar, Christian; Filipovic, Zoran M.; Higgins, Brian; Glenn, Kelli; Packman, Kathryn; Vassilev, Lyubomir; Graves, Bradford</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">124-127</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The development of small-mol. MDM2 inhibitors to restore dysfunctional p53 activities represents a novel approach for cancer treatment.  In a previous communication, the efforts leading to the identification of a non-imidazoline MDM2 inhibitor, RG7388, were disclosed and revealed the desirable in vitro and in vivo pharmacol. properties that this class of pyrrolidine-based inhibitors possesses.  Given this richness and the crit. need for a wide variety of chem. structures to ensure success in the clinic, research was expanded to evaluate addnl. derivs.  Here we report two new potent, selective, and orally active p53-MDM2 antagonists, RO5353 and RO2468 (I and II, resp.), as follow-ups with promising potential for clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhz706p6MGerVg90H21EOLACvtfcHk0li9m76Q-_kpjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXksVal&md5=30b9dff342ff18ce8dafe7f564d4a771</span></div><a href="/servlet/linkout?suffix=cit12k&amp;dbid=16384&amp;doi=10.1021%2Fml400359z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400359z%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DChu%26aufirst%3DX.-J.%26aulast%3DLiu%26aufirst%3DJ.-J.%26aulast%3DDing%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DBartkovitz%26aufirst%3DD.%26aulast%3DJiang%26aufirst%3DN.%26aulast%3DKarnachi%26aufirst%3DP.%26aulast%3DSo%26aufirst%3DS.-S.%26aulast%3DTovar%26aufirst%3DC.%26aulast%3DFilipovic%26aufirst%3DZ.%2BM.%26aulast%3DHiggins%26aufirst%3DB.%26aulast%3DGlenn%26aufirst%3DK.%26aulast%3DPackman%26aufirst%3DK.%26aulast%3DVassilev%26aufirst%3DZ.%26aulast%3DGraves%26aufirst%3DB.%26atitle%3DDiscovery%2520of%2520potent%2520and%2520orally%2520active%2520p53-MDM2%2520inhibitors%2520RO5353%2520and%2520RO2468%2520for%2520potential%2520clinical%2520development%26jtitle%3DMed.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D124%26epage%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12l"><span><span class="NLM_label">(l) </span><span class="NLM_contrib-group">Ding, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikolovska-Coleska, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qju, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stuckey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krajewski, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roller, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomita, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parrish, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deschamps, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span> </span><span class="NLM_article-title">Structure-based desing of potent non-peptide MDM2 inhibitors</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">127</span><span class="NLM_x">, </span> <span class="NLM_fpage">10130</span><span class="NLM_x">–</span> <span class="NLM_lpage">10131</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja051147z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2005&pages=10130-10131&author=K.+Dingauthor=Y.+Luauthor=Z.+Nikolovska-Coleskaauthor=S.+Qjuauthor=Y.+Dingauthor=W.+Gaoauthor=J.+Stuckeyauthor=K.+Krajewskiauthor=P.+P.+Rollerauthor=Y.+Tomitaauthor=D.+A.+Parrishauthor=J.+R.+Deschampsauthor=S.+Wang&title=Structure-based+desing+of+potent+non-peptide+MDM2+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12l&amp;dbid=16384&amp;doi=10.1021%2Fja051147z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja051147z%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DK.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DNikolovska-Coleska%26aufirst%3DZ.%26aulast%3DQju%26aufirst%3DS.%26aulast%3DDing%26aufirst%3DY.%26aulast%3DGao%26aufirst%3DW.%26aulast%3DStuckey%26aufirst%3DJ.%26aulast%3DKrajewski%26aufirst%3DK.%26aulast%3DRoller%26aufirst%3DP.%2BP.%26aulast%3DTomita%26aufirst%3DY.%26aulast%3DParrish%26aufirst%3DD.%2BA.%26aulast%3DDeschamps%26aufirst%3DJ.%2BR.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DStructure-based%2520desing%2520of%2520potent%2520non-peptide%2520MDM2%2520inhibitors%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2005%26volume%3D127%26spage%3D10130%26epage%3D10131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12m"><span><span class="NLM_label">(m) </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McEachern, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ochsenbein, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferey, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carry, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deschamps, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span> </span><span class="NLM_article-title">Diastereomeric spirooxindoles as highly potent and efficacious MDM2 inhibitors</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">135</span><span class="NLM_x">, </span> <span class="NLM_fpage">7223</span><span class="NLM_x">–</span> <span class="NLM_lpage">7234</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja3125417" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12m&amp;dbid=32&amp;doi=10.1021%2Fjm401911v&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntVWrtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2013&pages=7223-7234&author=Y.+Zhaoauthor=L.+Liuauthor=W.+Sunauthor=J.+Luauthor=D.+McEachernauthor=X.+Liauthor=S.+Yuauthor=D.+Bernardauthor=P.+Ochsenbeinauthor=V.+Fereyauthor=J.-C.+Carryauthor=J.+R.+Deschampsauthor=D.+Sunauthor=S.+Wang&title=Diastereomeric+spirooxindoles+as+highly+potent+and+efficacious+MDM2+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12mR"><div class="casContent"><span class="casTitleNuber">12m</span><div class="casTitle"><span class="NLM_cas:atitle">Diastereomeric Spirooxindoles as Highly Potent and Efficacious MDM2 Inhibitors</span></div><div class="casAuthors">Zhao, Yujun; Liu, Liu; Sun, Wei; Lu, Jianfeng; McEachern, Donna; Li, Xiaoqin; Yu, Shanghai; Bernard, Denzil; Ochsenbein, Philippe; Ferey, Vincent; Carry, Jean-Christophe; Deschamps, Jeffrey R.; Sun, Duxin; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">135</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">7223-7234</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Small-mol. inhibitors that block the MDM2-p53 protein-protein interaction (MDM2 inhibitors) are being intensely pursued as a new therapeutic strategy for cancer treatment.  We previously published a series of spirooxindole-contg. compds. as a new class of MDM2 small-mol. inhibitors.  We report herein a reversible ring-opening-cyclization reaction for some of these spirooxindoles, which affords four diastereomers from a single compd.  Our biochem. binding data showed that the stereochem. in this class of compds. has a major effect on their binding affinities to MDM2, with >100-fold difference between the most potent and the least potent stereoisomers.  Our study has led to the identification of a set of highly potent MDM2 inhibitors with a stereochem. that is different from that of our previously reported compds.  The most potent compd. (MI-888) binds to MDM2 with a Ki value of 0.44 nM and achieves complete and long-lasting tumor regression in an animal model of human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOEWm0CbFl2rVg90H21EOLACvtfcHk0li9m76Q-_kpjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntVWrtr0%253D&md5=5c05b0adc0d14506602d0884b64411b0</span></div><a href="/servlet/linkout?suffix=cit12m&amp;dbid=16384&amp;doi=10.1021%2Fja3125417&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja3125417%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DSun%26aufirst%3DW.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DMcEachern%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DYu%26aufirst%3DS.%26aulast%3DBernard%26aufirst%3DD.%26aulast%3DOchsenbein%26aufirst%3DP.%26aulast%3DFerey%26aufirst%3DV.%26aulast%3DCarry%26aufirst%3DJ.-C.%26aulast%3DDeschamps%26aufirst%3DJ.%2BR.%26aulast%3DSun%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DDiastereomeric%2520spirooxindoles%2520as%2520highly%2520potent%2520and%2520efficacious%2520MDM2%2520inhibitors%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2013%26volume%3D135%26spage%3D7223%26epage%3D7234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12n"><span><span class="NLM_label">(n) </span><span class="NLM_contrib-group">Hardcastle, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valeur, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmed, S. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackburn, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennaceur, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clegg, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drummond, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endicott, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golding, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gruber, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haggerty, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrington, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutton, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kemp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonnell, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newell, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noble, M. E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payne, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Revill, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riedinger, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lunec, J.</span><span> </span><span class="NLM_article-title">Isoindolinone inhibitors of the Murine Double Minute 2 (MDM2)-p53 protein–protein interaction: structure–activity studies leading to improved potency</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">1233</span><span class="NLM_x">–</span> <span class="NLM_lpage">1243</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1011929" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=1233-1243&author=J.+R.+Hardcastleauthor=J.+Liuauthor=E.+Valeurauthor=A.+Watsonauthor=S.+U.+Ahmedauthor=T.+J.+Blackburnauthor=K.+Bennaceurauthor=W.+Cleggauthor=C.+Drummondauthor=J.+A.+Endicottauthor=B.+T.+Goldingauthor=R.+J.+Griffinauthor=J.+Gruberauthor=K.+Haggertyauthor=R.+W.+Harringtonauthor=C.+Huttonauthor=S.+Kempauthor=X.+Luauthor=J.+M.+McDonnellauthor=D.+R.+Newellauthor=M.+E.+M.+Nobleauthor=S.+L.+Payneauthor=C.+H.+Revillauthor=C.+Riedingerauthor=Q.+Xuauthor=J.+Lunec&title=Isoindolinone+inhibitors+of+the+Murine+Double+Minute+2+%28MDM2%29-p53+protein%E2%80%93protein+interaction%3A+structure%E2%80%93activity+studies+leading+to+improved+potency"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12n&amp;dbid=16384&amp;doi=10.1021%2Fjm1011929&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1011929%26sid%3Dliteratum%253Aachs%26aulast%3DHardcastle%26aufirst%3DJ.%2BR.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DValeur%26aufirst%3DE.%26aulast%3DWatson%26aufirst%3DA.%26aulast%3DAhmed%26aufirst%3DS.%2BU.%26aulast%3DBlackburn%26aufirst%3DT.%2BJ.%26aulast%3DBennaceur%26aufirst%3DK.%26aulast%3DClegg%26aufirst%3DW.%26aulast%3DDrummond%26aufirst%3DC.%26aulast%3DEndicott%26aufirst%3DJ.%2BA.%26aulast%3DGolding%26aufirst%3DB.%2BT.%26aulast%3DGriffin%26aufirst%3DR.%2BJ.%26aulast%3DGruber%26aufirst%3DJ.%26aulast%3DHaggerty%26aufirst%3DK.%26aulast%3DHarrington%26aufirst%3DR.%2BW.%26aulast%3DHutton%26aufirst%3DC.%26aulast%3DKemp%26aufirst%3DS.%26aulast%3DLu%26aufirst%3DX.%26aulast%3DMcDonnell%26aufirst%3DJ.%2BM.%26aulast%3DNewell%26aufirst%3DD.%2BR.%26aulast%3DNoble%26aufirst%3DM.%2BE.%2BM.%26aulast%3DPayne%26aufirst%3DS.%2BL.%26aulast%3DRevill%26aufirst%3DC.%2BH.%26aulast%3DRiedinger%26aufirst%3DC.%26aulast%3DXu%26aufirst%3DQ.%26aulast%3DLunec%26aufirst%3DJ.%26atitle%3DIsoindolinone%2520inhibitors%2520of%2520the%2520Murine%2520Double%2520Minute%25202%2520%2528MDM2%2529-p53%2520protein%25E2%2580%2593protein%2520interaction%253A%2520structure%25E2%2580%2593activity%2520studies%2520leading%2520to%2520improved%2520potency%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D1233%26epage%3D1243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12o"><span><span class="NLM_label">(o) </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McEachern, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shargary, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernard, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span> </span><span class="NLM_article-title">A potent small-molecule inhibitor of the MDM2-p53 interaction (MI-888) achieve complete and durable tumor regression in mice</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">5553</span><span class="NLM_x">–</span> <span class="NLM_lpage">5561</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm4005708" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=5553-5561&author=Y.+Zhaoauthor=S.+Yuauthor=W.+Sunauthor=L.+Liuauthor=J.+Luauthor=D.+McEachernauthor=S.+Shargaryauthor=P.+Bernardauthor=X.+Liauthor=T.+Zhaoauthor=P.+Zouauthor=D.+Sunauthor=S.+Wang&title=A+potent+small-molecule+inhibitor+of+the+MDM2-p53+interaction+%28MI-888%29+achieve+complete+and+durable+tumor+regression+in+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12o&amp;dbid=16384&amp;doi=10.1021%2Fjm4005708&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4005708%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DS.%26aulast%3DSun%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DMcEachern%26aufirst%3DD.%26aulast%3DShargary%26aufirst%3DS.%26aulast%3DBernard%26aufirst%3DP.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DZhao%26aufirst%3DT.%26aulast%3DZou%26aufirst%3DP.%26aulast%3DSun%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DA%2520potent%2520small-molecule%2520inhibitor%2520of%2520the%2520MDM2-p53%2520interaction%2520%2528MI-888%2529%2520achieve%2520complete%2520and%2520durable%2520tumor%2520regression%2520in%2520mice%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D5553%26epage%3D5561" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12p"><span><span class="NLM_label">(p) </span><span class="NLM_contrib-group">Zhuang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheng, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span> </span><span class="NLM_article-title">Discovery, synthesis, and biological evaluation of orally active pyrrolidone derivatives as novel inhibitors of p53-MDM2 protein-protein interaction</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9630</span><span class="NLM_x">–</span> <span class="NLM_lpage">9642</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300969t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9630-9642&author=C.+Zhuangauthor=Z.+Miaoauthor=L.+Zhuauthor=G.+Dongauthor=Z.+Guoauthor=S.+Wangauthor=Y.+Zhangauthor=Y.+Wuauthor=J.+Yaoauthor=C.+Shengauthor=W.+Zhang&title=Discovery%2C+synthesis%2C+and+biological+evaluation+of+orally+active+pyrrolidone+derivatives+as+novel+inhibitors+of+p53-MDM2+protein-protein+interaction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12p&amp;dbid=16384&amp;doi=10.1021%2Fjm300969t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300969t%26sid%3Dliteratum%253Aachs%26aulast%3DZhuang%26aufirst%3DC.%26aulast%3DMiao%26aufirst%3DZ.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DDong%26aufirst%3DG.%26aulast%3DGuo%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DYao%26aufirst%3DJ.%26aulast%3DSheng%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DW.%26atitle%3DDiscovery%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520orally%2520active%2520pyrrolidone%2520derivatives%2520as%2520novel%2520inhibitors%2520of%2520p53-MDM2%2520protein-protein%2520interaction%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9630%26epage%3D9642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13h"><span>Information from <a href="http://www.clinicaltrials.gov" class="extLink">www.clinicaltrials.gov</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Information+from+www.clinicaltrials.gov."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13h&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13a"><span><span class="NLM_label">(a) </span> RG7112 (Hoffmann-La Roche) (see ref  <span class="NLM_xref">15b</span>.);</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+RG7112+%28Hoffmann-La+Roche%29+%28see+ref+15b.%29%3B"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13b"><span><span class="NLM_label">(b) </span> RG7388 (Hoffmann-La Roche) (see ref  <span class="NLM_xref">16</span>.);</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+RG7388+%28Hoffmann-La+Roche%29+%28see+ref+16.%29%3B"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13c"><span><span class="NLM_label">(c) </span> SAR299155 (Sanofi): <span class="NLM_contrib-group">Carry, J.-C.; Garcia-Echeverria, C.</span><span> </span><span class="NLM_article-title">Inhibitors of the p53/hdm2 protein-protein interaction- path to the clinic</span>.  <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">2480</span><span class="NLM_x">–</span> <span class="NLM_lpage">2485</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=2480-2485&author=J.-C.+Carry&author=C.+Garcia-Echeverria&title=Inhibitors+of+the+p53%2Fhdm2+protein-protein+interaction-+path+to+the+clinic"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCarry%26aufirst%3DJ.-C.%26atitle%3DInhibitors%2520of%2520the%2520p53%252Fhdm2%2520protein-protein%2520interaction-%2520path%2520to%2520the%2520clinic%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D2480%26epage%3D2485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13d"><span><span class="NLM_label">(d) </span> MK-8242 (Merck).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+MK-8242+%28Merck%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13e"><span><span class="NLM_label">(e) </span> AMG 232 (Amgen) (see ref  <span class="NLM_xref">17</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+AMG+232+%28Amgen%29+%28see+ref+17%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13f"><span><span class="NLM_label">(f) </span> CGM-097 (Novartis).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+CGM-097+%28Novartis%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13g"><span><span class="NLM_label">(g) </span> DS-3032b (Daiichi Sankyo).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+DS-3032b+%28Daiichi+Sankyo%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13g&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Kamal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azhar Mohammed, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaik, T. B.</span><span> </span><span class="NLM_article-title">p-53-MDM2 inhibitors: patent review (2009–2010)</span> <span class="citation_source-journal">Expert Opin. Ther. Patents</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">95</span><span class="NLM_x">–</span> <span class="NLM_lpage">105</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm401911v&amp;key=10.1517%2F13543776.2012.656593" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm401911v&amp;key=1%3ACAS%3A528%3ADC%252BC38Xit1yntLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=95-105&author=A.+Kamalauthor=A.+Azhar+Mohammedauthor=T.+B.+Shaik&title=p-53-MDM2+inhibitors%3A+patent+review+%282009%E2%80%932010%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">p53-Mdm2 inhibitors: patent review (2009 - 2010)</span></div><div class="casAuthors">Kamal, Ahmed; Mohammed, Ameruddin Azhar; Shaik, Thokhir B.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">95-105</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: p53 plays a central role in protecting the integrity of the genome.  Its activity is ubiquitously lost in cancers, either by inactivation of its protein (p53 pathway) or by mutation in the p53 gene, thereby indicating its importance in understanding cancer and as a therapeutic target.  Activated p53 is known to induce cell cycle arrest thereby leading to apoptosis and has been the subject of intensive research in the area of medicinal chem.  Efforts are in progress to synthesize a variety of scaffolds that could inhibit the p53-Mdm2 interaction by binding to Mdm2 in the region where p53 is likely to bind.  These mols. have the potential to be developed as anticancer drug candidates and have been largely explored by both academia and industry.  Interestingly, some of these mols. are in the early stage of clin. trials.Areas covered: Areas covered in this review include patents relating to p53-Mdm2 inhibitors during the time period 2009 - 2010.  The focus of the review was on small-mol. inhibitors.Expert opinion: Inducing apoptosis in cancerous cells by the activation of p53 is an area that is being actively explored.  There are strong indications that it could become a therapeutic method for the treatment of cancer.  As a result, extensive research is being performed by both academia and industry.  It is obsd. that small mols. that are present in early clin. trials are expected to be developed as potential drugs for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIGmUfa-aEL7Vg90H21EOLACvtfcHk0lgieRJ7dJXf2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xit1yntLw%253D&md5=26fe3be7f8d25e3a5e4913b306003b09</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1517%2F13543776.2012.656593&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2012.656593%26sid%3Dliteratum%253Aachs%26aulast%3DKamal%26aufirst%3DA.%26aulast%3DAzhar%2BMohammed%26aufirst%3DA.%26aulast%3DShaik%26aufirst%3DT.%2BB.%26atitle%3Dp-53-MDM2%2520inhibitors%253A%2520patent%2520review%2520%25282009%25E2%2580%25932010%2529%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Patents%26date%3D2012%26volume%3D22%26spage%3D95%26epage%3D105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Tovar, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graves, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Packman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filipovic, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tardell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrido, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolinsky, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">To, K.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podlaski, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wovkulich, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassilev, L. T.</span><span> </span><span class="NLM_article-title">MDM2 Small-molecule antagonist RG7112 activates p53 signaling and regresses human tumors in preclinical cancer models</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">2587</span><span class="NLM_x">–</span> <span class="NLM_lpage">2597</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2013&pages=2587-2597&author=C.+Tovarauthor=B.+Gravesauthor=K.+Packmanauthor=Z.+Filipovicauthor=B.+Higginsauthor=M.+Xiaauthor=C.+Tardellauthor=R.+Garridoauthor=E.+Leeauthor=K.+Kolinskyauthor=K.-H.+Toauthor=M.+Linnauthor=F.+Podlaskiauthor=P.+Wovkulichauthor=B.+Vuauthor=L.+T.+Vassilev&title=MDM2+Small-molecule+antagonist+RG7112+activates+p53+signaling+and+regresses+human+tumors+in+preclinical+cancer+models"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTovar%26aufirst%3DC.%26aulast%3DGraves%26aufirst%3DB.%26aulast%3DPackman%26aufirst%3DK.%26aulast%3DFilipovic%26aufirst%3DZ.%26aulast%3DHiggins%26aufirst%3DB.%26aulast%3DXia%26aufirst%3DM.%26aulast%3DTardell%26aufirst%3DC.%26aulast%3DGarrido%26aufirst%3DR.%26aulast%3DLee%26aufirst%3DE.%26aulast%3DKolinsky%26aufirst%3DK.%26aulast%3DTo%26aufirst%3DK.-H.%26aulast%3DLinn%26aufirst%3DM.%26aulast%3DPodlaski%26aufirst%3DF.%26aulast%3DWovkulich%26aufirst%3DP.%26aulast%3DVu%26aufirst%3DB.%26aulast%3DVassilev%26aufirst%3DL.%2BT.%26atitle%3DMDM2%2520Small-molecule%2520antagonist%2520RG7112%2520activates%2520p53%2520signaling%2520and%2520regresses%2520human%2520tumors%2520in%2520preclinical%2520cancer%2520models%26jtitle%3DCancer%2520Res.%26date%3D2013%26volume%3D73%26spage%3D2587%26epage%3D2597" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit15b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Vu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolkulich, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pizzolato, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glenn, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tovar, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Packman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassilev, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graves, B.</span><span> </span><span class="NLM_article-title">Discovery of RG7112: A small-molecule MDM2 inhibitor in clinical development</span> <span class="citation_source-journal">Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">466</span><span class="NLM_x">–</span> <span class="NLM_lpage">469</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml4000657" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=32&amp;doi=10.1021%2Fjm401911v&amp;key=1%3ACAS%3A528%3ADC%252BC3sXltV2nur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=466-469&author=B.+Vuauthor=P.+Wolkulichauthor=G.+Pizzolatoauthor=A.+Loveyauthor=Q.+Dingauthor=N.+Jiangauthor=J.-J.+Liuauthor=C.+Zhaoauthor=K.+Glennauthor=Y.+Wenauthor=C.+Tovarauthor=K.+Packmanauthor=L.+T.+Vassilevauthor=B.+Graves&title=Discovery+of+RG7112%3A+A+small-molecule+MDM2+inhibitor+in+clinical+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15bR"><div class="casContent"><span class="casTitleNuber">15b</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of RG7112: A Small-Molecule MDM2 Inhibitor in Clinical Development</span></div><div class="casAuthors">Vu, Binh; Wovkulich, Peter; Pizzolato, Giacomo; Lovey, Allen; Ding, Qingjie; Jiang, Nan; Liu, Jin-Jun; Zhao, Chunlin; Glenn, Kelli; Wen, Yang; Tovar, Christian; Packman, Kathryn; Vassilev, Lyubomir; Graves, Bradford</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">466-469</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The p53 tumor suppressor is a potent transcription factor that plays a key role in the regulation of cellular responses to stress.  It is controlled by its neg. regulator MDM2, which binds directly to p53 and inhibits its transcriptional activity.  MDM2 also targets p53 for degrdn. by the proteasome.  Many tumors produce high levels of MDM2, thereby impairing p53 function.  Restoration of p53 activity by inhibiting the p53-MDM2 interaction may represent a novel approach to cancer treatment.  RG7112 (2g) is the first clin. small-mol. MDM2 inhibitor designed to occupy the p53-binding pocket of MDM2.  In cancer cells expressing wild-type p53, RG7112 stabilizes p53 and activates the p53 pathway, leading to cell cycle arrest, apoptosis, and inhibition or regression of human tumor xenografts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZDyQMojUKIrVg90H21EOLACvtfcHk0lgieRJ7dJXf2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXltV2nur0%253D&md5=3965eb84198ff25eb9bc5f4c3823e850</span></div><a href="/servlet/linkout?suffix=cit15b&amp;dbid=16384&amp;doi=10.1021%2Fml4000657&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml4000657%26sid%3Dliteratum%253Aachs%26aulast%3DVu%26aufirst%3DB.%26aulast%3DWolkulich%26aufirst%3DP.%26aulast%3DPizzolato%26aufirst%3DG.%26aulast%3DLovey%26aufirst%3DA.%26aulast%3DDing%26aufirst%3DQ.%26aulast%3DJiang%26aufirst%3DN.%26aulast%3DLiu%26aufirst%3DJ.-J.%26aulast%3DZhao%26aufirst%3DC.%26aulast%3DGlenn%26aufirst%3DK.%26aulast%3DWen%26aufirst%3DY.%26aulast%3DTovar%26aufirst%3DC.%26aulast%3DPackman%26aufirst%3DK.%26aulast%3DVassilev%26aufirst%3DL.%2BT.%26aulast%3DGraves%26aufirst%3DB.%26atitle%3DDiscovery%2520of%2520RG7112%253A%2520A%2520small-molecule%2520MDM2%2520inhibitor%2520in%2520clinical%2520development%26jtitle%3DMed.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D466%26epage%3D469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Ding, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, X.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartkovitz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podlaski, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tovar, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filipovic, Z. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glenn, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Packman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassilev, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graves, B.</span><span> </span><span class="NLM_article-title">Discovery of RG7388, a potent and selective p53-MDM2 inhibitor in clinical development</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">5979</span><span class="NLM_x">–</span> <span class="NLM_lpage">5983</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm400487c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=5979-5983&author=Q.+Dingauthor=Z.+Zhangauthor=J.-J.+Liuauthor=N.+Jiangauthor=J.+Zhangauthor=T.+M.+Rossauthor=X.-J.+Chuauthor=D.+Bartkovitzauthor=F.+Podlaskiauthor=C.+Jansonauthor=C.+Tovarauthor=Z.+M.+Filipovicauthor=B.+Higginsauthor=K.+Glennauthor=K.+Packmanauthor=L.+T.+Vassilevauthor=B.+Graves&title=Discovery+of+RG7388%2C+a+potent+and+selective+p53-MDM2+inhibitor+in+clinical+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm400487c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400487c%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DJ.-J.%26aulast%3DJiang%26aufirst%3DN.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DRoss%26aufirst%3DT.%2BM.%26aulast%3DChu%26aufirst%3DX.-J.%26aulast%3DBartkovitz%26aufirst%3DD.%26aulast%3DPodlaski%26aufirst%3DF.%26aulast%3DJanson%26aufirst%3DC.%26aulast%3DTovar%26aufirst%3DC.%26aulast%3DFilipovic%26aufirst%3DZ.%2BM.%26aulast%3DHiggins%26aufirst%3DB.%26aulast%3DGlenn%26aufirst%3DK.%26aulast%3DPackman%26aufirst%3DK.%26aulast%3DVassilev%26aufirst%3DL.%2BT.%26aulast%3DGraves%26aufirst%3DB.%26atitle%3DDiscovery%2520of%2520RG7388%252C%2520a%2520potent%2520and%2520selective%2520p53-MDM2%2520inhibitor%2520in%2520clinical%2520development%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D5979%26epage%3D5983" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Sun, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rew, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartberger, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beck, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chow, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deignan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duquette, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eksterowicz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, A. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez-Lopez De Turiso, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gribble, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houze, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kayser, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, M.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGee, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntosh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mihalic, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliner, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osgood, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roveto, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saiki, A. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaffer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toteva, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wortman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yakowec, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medina, J. C.</span><span> </span><span class="NLM_article-title">Discovery of AMG 232, a potent, selective, and orally bioavailable inhibitor of the MDM2-p53 interaction</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">1454</span><span class="NLM_x">–</span> <span class="NLM_lpage">1472</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm401753e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=1454-1472&author=D.+Sunauthor=Z.+Liauthor=Y.+Rewauthor=M.+D.+Bartbergerauthor=H.+P.+Beckauthor=J.+Canonauthor=A.+Chenauthor=X.+Chenauthor=D.+Chowauthor=J.+Deignanauthor=J.+Duquetteauthor=J.+Eksterowiczauthor=B.+Fisherauthor=B.+M.+Foxauthor=J.+Fuauthor=A.+Z.+Gonzalezauthor=F.+Gonzalez-Lopez+De+Turisoauthor=M.+Gribbleauthor=J.+Houzeauthor=X.+Huangauthor=M.+Jiangauthor=L.+Jinauthor=F.+Kayserauthor=J.+Liuauthor=M.-C.+Loauthor=A.+M.+Longauthor=B.+Lucasauthor=L.+R.+McGeeauthor=J.+McIntoshauthor=J.+Mihalicauthor=J.+D.+Olinerauthor=T.+Osgoodauthor=M.+L.+Petersonauthor=P.+Rovetoauthor=A.+Y.+Saikiauthor=P.+Shafferauthor=M.+Totevaauthor=Y.+Wangauthor=Y.+C.+Wangauthor=S.+Wortmanauthor=P.+Yakowecauthor=X.+Yanauthor=Q.+Yeauthor=D.+Yuauthor=M.+Yuauthor=X.+Zhaoauthor=X.+Zhouauthor=J.+Zhuauthor=S.+H.+Olsonauthor=J.+C.+Medina&title=Discovery+of+AMG+232%2C+a+potent%2C+selective%2C+and+orally+bioavailable+inhibitor+of+the+MDM2-p53+interaction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm401753e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401753e%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DRew%26aufirst%3DY.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DBeck%26aufirst%3DH.%2BP.%26aulast%3DCanon%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DChow%26aufirst%3DD.%26aulast%3DDeignan%26aufirst%3DJ.%26aulast%3DDuquette%26aufirst%3DJ.%26aulast%3DEksterowicz%26aufirst%3DJ.%26aulast%3DFisher%26aufirst%3DB.%26aulast%3DFox%26aufirst%3DB.%2BM.%26aulast%3DFu%26aufirst%3DJ.%26aulast%3DGonzalez%26aufirst%3DA.%2BZ.%26aulast%3DGonzalez-Lopez%2BDe%2BTuriso%26aufirst%3DF.%26aulast%3DGribble%26aufirst%3DM.%26aulast%3DHouze%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DJiang%26aufirst%3DM.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DKayser%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DLo%26aufirst%3DM.-C.%26aulast%3DLong%26aufirst%3DA.%2BM.%26aulast%3DLucas%26aufirst%3DB.%26aulast%3DMcGee%26aufirst%3DL.%2BR.%26aulast%3DMcIntosh%26aufirst%3DJ.%26aulast%3DMihalic%26aufirst%3DJ.%26aulast%3DOliner%26aufirst%3DJ.%2BD.%26aulast%3DOsgood%26aufirst%3DT.%26aulast%3DPeterson%26aufirst%3DM.%2BL.%26aulast%3DRoveto%26aufirst%3DP.%26aulast%3DSaiki%26aufirst%3DA.%2BY.%26aulast%3DShaffer%26aufirst%3DP.%26aulast%3DToteva%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DY.%2BC.%26aulast%3DWortman%26aufirst%3DS.%26aulast%3DYakowec%26aufirst%3DP.%26aulast%3DYan%26aufirst%3DX.%26aulast%3DYe%26aufirst%3DQ.%26aulast%3DYu%26aufirst%3DD.%26aulast%3DYu%26aufirst%3DM.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DOlson%26aufirst%3DS.%2BH.%26aulast%3DMedina%26aufirst%3DJ.%2BC.%26atitle%3DDiscovery%2520of%2520AMG%2520232%252C%2520a%2520potent%252C%2520selective%252C%2520and%2520orally%2520bioavailable%2520inhibitor%2520of%2520the%2520MDM2-p53%2520interaction%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D1454%26epage%3D1472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="note"><p class="first last">For reports on our team’s efforts see:</p></div><div class="NLM_citation" id="rightTab-cit18a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Allen, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourbeau, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wohlhieter, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartberger, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michelsen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hungate, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gadwood, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaston, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mann, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matison, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reichelt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yakowec, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, E. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliner, J. D.</span><span> </span><span class="NLM_article-title">Discovery and optimization of chromenotriazolopyrimidines as potent inhibitors of the mouse double minute 2-tumor protein 53 protein–protein interaction</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">7044</span><span class="NLM_x">–</span> <span class="NLM_lpage">7053</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900681h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7044-7053&author=J.+G.+Allenauthor=M.+P.+Bourbeauauthor=G.+E.+Wohlhieterauthor=M.+D.+Bartbergerauthor=K.+Michelsenauthor=R.+Hungateauthor=R.+C.+Gadwoodauthor=R.+D.+Gastonauthor=B.+Evansauthor=L.+W.+Mannauthor=M.+E.+Matisonauthor=S.+Schneiderauthor=X.+Huangauthor=D.+Yuauthor=P.+S.+Andrewsauthor=A.+Reicheltauthor=A.+M.+Longauthor=P.+Yakowecauthor=E.+Y.+Yangauthor=T.+A.+Leeauthor=J.+D.+Oliner&title=Discovery+and+optimization+of+chromenotriazolopyrimidines+as+potent+inhibitors+of+the+mouse+double+minute+2-tumor+protein+53+protein%E2%80%93protein+interaction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18a&amp;dbid=16384&amp;doi=10.1021%2Fjm900681h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900681h%26sid%3Dliteratum%253Aachs%26aulast%3DAllen%26aufirst%3DJ.%2BG.%26aulast%3DBourbeau%26aufirst%3DM.%2BP.%26aulast%3DWohlhieter%26aufirst%3DG.%2BE.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DMichelsen%26aufirst%3DK.%26aulast%3DHungate%26aufirst%3DR.%26aulast%3DGadwood%26aufirst%3DR.%2BC.%26aulast%3DGaston%26aufirst%3DR.%2BD.%26aulast%3DEvans%26aufirst%3DB.%26aulast%3DMann%26aufirst%3DL.%2BW.%26aulast%3DMatison%26aufirst%3DM.%2BE.%26aulast%3DSchneider%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DYu%26aufirst%3DD.%26aulast%3DAndrews%26aufirst%3DP.%2BS.%26aulast%3DReichelt%26aufirst%3DA.%26aulast%3DLong%26aufirst%3DA.%2BM.%26aulast%3DYakowec%26aufirst%3DP.%26aulast%3DYang%26aufirst%3DE.%2BY.%26aulast%3DLee%26aufirst%3DT.%2BA.%26aulast%3DOliner%26aufirst%3DJ.%2BD.%26atitle%3DDiscovery%2520and%2520optimization%2520of%2520chromenotriazolopyrimidines%2520as%2520potent%2520inhibitors%2520of%2520the%2520mouse%2520double%2520minute%25202-tumor%2520protein%252053%2520protein%25E2%2580%2593protein%2520interaction%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D7044%26epage%3D7053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit18b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Beck, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeGraffenreid, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rew, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saiki, A. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliner, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salyers, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, S.</span><span> </span><span class="NLM_article-title">Improvement of the synthesis and pharmacokinetic properties of chromenotriazolopyrimidine MDM2-p53 protein–protein inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">2752</span><span class="NLM_x">–</span> <span class="NLM_lpage">2755</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=2752-2755&author=H.+P.+Beckauthor=M.+DeGraffenreidauthor=B.+Foxauthor=J.+G.+Allenauthor=Y.+Rewauthor=S.+Schneiderauthor=A.+Y.+Saikiauthor=D.+Yuauthor=J.+D.+Olinerauthor=K.+Salyersauthor=Q.+Yeauthor=S.+Olson&title=Improvement+of+the+synthesis+and+pharmacokinetic+properties+of+chromenotriazolopyrimidine+MDM2-p53+protein%E2%80%93protein+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBeck%26aufirst%3DH.%2BP.%26aulast%3DDeGraffenreid%26aufirst%3DM.%26aulast%3DFox%26aufirst%3DB.%26aulast%3DAllen%26aufirst%3DJ.%2BG.%26aulast%3DRew%26aufirst%3DY.%26aulast%3DSchneider%26aufirst%3DS.%26aulast%3DSaiki%26aufirst%3DA.%2BY.%26aulast%3DYu%26aufirst%3DD.%26aulast%3DOliner%26aufirst%3DJ.%2BD.%26aulast%3DSalyers%26aufirst%3DK.%26aulast%3DYe%26aufirst%3DQ.%26aulast%3DOlson%26aufirst%3DS.%26atitle%3DImprovement%2520of%2520the%2520synthesis%2520and%2520pharmacokinetic%2520properties%2520of%2520chromenotriazolopyrimidine%2520MDM2-p53%2520protein%25E2%2580%2593protein%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D2752%26epage%3D2755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit18c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Rew, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez Lopez De Turiso, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartberger, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beck, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chow, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deignan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kayser, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopecky, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michelsen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliner, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osgood, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ragains, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saiki, A. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toteva, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yakowec, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medina, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, S. H.</span><span> </span><span class="NLM_article-title">Structure-based design of novel inhibitors of the MDM2-p53 interaction</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">4936</span><span class="NLM_x">–</span> <span class="NLM_lpage">4954</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300354j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18c&amp;dbid=32&amp;doi=10.1021%2Fjm401911v&amp;key=1%3ACAS%3A528%3ADC%252BC38XlvV2ktbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4936-4954&author=Y.+Rewauthor=D.+Sunauthor=F.+Gonzalez+Lopez+De+Turisoauthor=M.+D.+Bartbergerauthor=H.+P.+Beckauthor=J.+Canonauthor=A.+Chenauthor=D.+Chowauthor=J.+Deignanauthor=B.+M.+Foxauthor=D.+Gustinauthor=X.+Huangauthor=M.+Jiangauthor=X.+Jiaoauthor=L.+Jinauthor=F.+Kayserauthor=D.+J.+Kopeckyauthor=Y.+Liauthor=M.+Loauthor=A.+M.+Longauthor=K.+Michelsenauthor=J.+D.+Olinerauthor=T.+Osgoodauthor=M.+Ragainsauthor=A.+Y.+Saikiauthor=S.+Schneiderauthor=M.+Totevaauthor=P.+Yakowecauthor=X.+Yanauthor=Q.+Yeauthor=D.+Yuauthor=X.+Zhaoauthor=J.+Zhouauthor=J.+C.+Medinaauthor=S.+H.+Olson&title=Structure-based+design+of+novel+inhibitors+of+the+MDM2-p53+interaction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18cR"><div class="casContent"><span class="casTitleNuber">18c</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design of Novel Inhibitors of the MDM2-p53 Interaction</span></div><div class="casAuthors">Rew, Yosup; Sun, Daqing; Gonzalez-Lopez De Turiso, Felix; Bartberger, Michael D.; Beck, Hilary P.; Canon, Jude; Chen, Ada; Chow, David; Deignan, Jeffrey; Fox, Brian M.; Gustin, Darin; Huang, Xin; Jiang, Min; Jiao, Xianyun; Jin, Lixia; Kayser, Frank; Kopecky, David J.; Li, Yihong; Lo, Mei-Chu; Long, Alexander M.; Michelsen, Klaus; Oliner, Jonathan D.; Osgood, Tao; Ragains, Mark; Saiki, Anne Y.; Schneider, Steve; Toteva, Maria; Yakowec, Peter; Yan, Xuelei; Ye, Qiuping; Yu, Dongyin; Zhao, Xiaoning; Zhou, Jing; Medina, Julio C.; Olson, Steven H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4936-4954</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Structure-based rational design led to the discovery of novel inhibitors of the MDM2-p53 protein-protein interaction.  The affinity of these compds. for MDM2 was improved through conformational control of both the piperidinone ring and the appended N-alkyl substituent.  Optimization afforded bis(chlorophenyl)piperidinylacetic acid deriv. I (AM-8553), a potent and selective MDM2 inhibitor with excellent pharmacokinetic properties and in vivo efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPKe8WW2Cuh7Vg90H21EOLACvtfcHk0lhjo5BspF1iUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlvV2ktbs%253D&md5=88ba0795dfab1b5e2dc1cd5977b9f335</span></div><a href="/servlet/linkout?suffix=cit18c&amp;dbid=16384&amp;doi=10.1021%2Fjm300354j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300354j%26sid%3Dliteratum%253Aachs%26aulast%3DRew%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DD.%26aulast%3DGonzalez%2BLopez%2BDe%2BTuriso%26aufirst%3DF.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DBeck%26aufirst%3DH.%2BP.%26aulast%3DCanon%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DA.%26aulast%3DChow%26aufirst%3DD.%26aulast%3DDeignan%26aufirst%3DJ.%26aulast%3DFox%26aufirst%3DB.%2BM.%26aulast%3DGustin%26aufirst%3DD.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DJiang%26aufirst%3DM.%26aulast%3DJiao%26aufirst%3DX.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DKayser%26aufirst%3DF.%26aulast%3DKopecky%26aufirst%3DD.%2BJ.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLo%26aufirst%3DM.%26aulast%3DLong%26aufirst%3DA.%2BM.%26aulast%3DMichelsen%26aufirst%3DK.%26aulast%3DOliner%26aufirst%3DJ.%2BD.%26aulast%3DOsgood%26aufirst%3DT.%26aulast%3DRagains%26aufirst%3DM.%26aulast%3DSaiki%26aufirst%3DA.%2BY.%26aulast%3DSchneider%26aufirst%3DS.%26aulast%3DToteva%26aufirst%3DM.%26aulast%3DYakowec%26aufirst%3DP.%26aulast%3DYan%26aufirst%3DX.%26aulast%3DYe%26aufirst%3DQ.%26aulast%3DYu%26aufirst%3DD.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DMedina%26aufirst%3DJ.%2BC.%26aulast%3DOlson%26aufirst%3DS.%2BH.%26atitle%3DStructure-based%2520design%2520of%2520novel%2520inhibitors%2520of%2520the%2520MDM2-p53%2520interaction%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D4936%26epage%3D4954" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit18d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Lucas, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGee, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medina, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, E.</span><span> </span><span class="NLM_article-title">An expeditious synthesis of the MDM2-p53 inhibitor AM-8553</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">134</span><span class="NLM_x">, </span> <span class="NLM_fpage">12855</span><span class="NLM_x">–</span> <span class="NLM_lpage">12860</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja305123v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18d&amp;dbid=32&amp;doi=10.1021%2Fjm401911v&amp;key=1%3ACAS%3A528%3ADC%252BC38Xpt1Cit7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2012&pages=12855-12860&author=B.+S.+Lucasauthor=B.+Fisherauthor=L.+R.+McGeeauthor=S.+H.+Olsonauthor=J.+C.+Medinaauthor=E.+Cheung&title=An+expeditious+synthesis+of+the+MDM2-p53+inhibitor+AM-8553"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18dR"><div class="casContent"><span class="casTitleNuber">18d</span><div class="casTitle"><span class="NLM_cas:atitle">An Expeditious Synthesis of the MDM2-p53 Inhibitor AM-8553</span></div><div class="casAuthors">Lucas, Brian S.; Fisher, Benjamin; McGee, Lawrence R.; Olson, Steven H.; Medina, Julio C.; Cheung, Eugene</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">12855-12860</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The development of the structurally complex MDM2/p53 inhibitor AM-8553 was impeded by the low yield of the initial synthesis.  A second generation synthesis is described that features a Noyori dynamic kinetic resoln. (DKR), a highly diastereoselective allylation, and a novel oxazoline-assisted piperidinone forming reaction to provide AM-8553 (I) in 35.6% yield and 11 steps.  Safety: significant exotherm obsd. in ketone α-arylation reaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQFB669tWQ2LVg90H21EOLACvtfcHk0ljMzfwAnVxIdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xpt1Cit7Y%253D&md5=c32444e3c74dbe8916e41011ca11930b</span></div><a href="/servlet/linkout?suffix=cit18d&amp;dbid=16384&amp;doi=10.1021%2Fja305123v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja305123v%26sid%3Dliteratum%253Aachs%26aulast%3DLucas%26aufirst%3DB.%2BS.%26aulast%3DFisher%26aufirst%3DB.%26aulast%3DMcGee%26aufirst%3DL.%2BR.%26aulast%3DOlson%26aufirst%3DS.%2BH.%26aulast%3DMedina%26aufirst%3DJ.%2BC.%26aulast%3DCheung%26aufirst%3DE.%26atitle%3DAn%2520expeditious%2520synthesis%2520of%2520the%2520MDM2-p53%2520inhibitor%2520AM-8553%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2012%26volume%3D134%26spage%3D12855%26epage%3D12860" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit18e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Gonzalez-Lopez de Turiso, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rew, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartberger, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beck, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chow, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Correll, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Julian, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kayser, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, M.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMinn, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliner, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osgood, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powers, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saiki, A. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaffer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, S.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yakowek, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medina, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, S. H.</span><span> </span><span class="NLM_article-title">Rational design and binding mode of MDM2-p53 inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">4053</span><span class="NLM_x">–</span> <span class="NLM_lpage">4070</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm400293z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4053-4070&author=F.+Gonzalez-Lopez+de+Turisoauthor=D.+Sunauthor=Y.+Rewauthor=M.+D.+Bartbergerauthor=H.+P.+Beckauthor=J.+Canonauthor=A.+Chenauthor=D.+Chowauthor=T.+L.+Correllauthor=X.+Huangauthor=L.+D.+Julianauthor=F.+Kayserauthor=M.-C.+Loauthor=A.+M.+Longauthor=D.+McMinnauthor=J.+D.+Olinerauthor=T.+Osgoodauthor=J.+P.+Powersauthor=A.+Y.+Saikiauthor=S.+Schneiderauthor=P.+Shafferauthor=S.-H.+Xiaoauthor=P.+Yakowekauthor=X.+Yanauthor=Q.+Yeauthor=D.+Yuauthor=X.+Zhaoauthor=J.+Zhouauthor=J.+C.+Medinaauthor=S.+H.+Olson&title=Rational+design+and+binding+mode+of+MDM2-p53+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18e&amp;dbid=16384&amp;doi=10.1021%2Fjm400293z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400293z%26sid%3Dliteratum%253Aachs%26aulast%3DGonzalez-Lopez%2Bde%2BTuriso%26aufirst%3DF.%26aulast%3DSun%26aufirst%3DD.%26aulast%3DRew%26aufirst%3DY.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DBeck%26aufirst%3DH.%2BP.%26aulast%3DCanon%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DA.%26aulast%3DChow%26aufirst%3DD.%26aulast%3DCorrell%26aufirst%3DT.%2BL.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DJulian%26aufirst%3DL.%2BD.%26aulast%3DKayser%26aufirst%3DF.%26aulast%3DLo%26aufirst%3DM.-C.%26aulast%3DLong%26aufirst%3DA.%2BM.%26aulast%3DMcMinn%26aufirst%3DD.%26aulast%3DOliner%26aufirst%3DJ.%2BD.%26aulast%3DOsgood%26aufirst%3DT.%26aulast%3DPowers%26aufirst%3DJ.%2BP.%26aulast%3DSaiki%26aufirst%3DA.%2BY.%26aulast%3DSchneider%26aufirst%3DS.%26aulast%3DShaffer%26aufirst%3DP.%26aulast%3DXiao%26aufirst%3DS.-H.%26aulast%3DYakowek%26aufirst%3DP.%26aulast%3DYan%26aufirst%3DX.%26aulast%3DYe%26aufirst%3DQ.%26aulast%3DYu%26aufirst%3DD.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DMedina%26aufirst%3DJ.%2BC.%26aulast%3DOlson%26aufirst%3DS.%2BH.%26atitle%3DRational%2520design%2520and%2520binding%2520mode%2520of%2520MDM2-p53%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4053%26epage%3D4070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit18f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Bernard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span> </span><span class="NLM_article-title">AM-8553: A novel MDM2 inhibitor with a promising outlook for potential clinical development</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">4934</span><span class="NLM_x">–</span> <span class="NLM_lpage">4935</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm3007068" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4934-4935&author=D.+Bernardauthor=Y.+Zhaoauthor=S.+Wang&title=AM-8553%3A+A+novel+MDM2+inhibitor+with+a+promising+outlook+for+potential+clinical+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18f&amp;dbid=16384&amp;doi=10.1021%2Fjm3007068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3007068%26sid%3Dliteratum%253Aachs%26aulast%3DBernard%26aufirst%3DD.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DAM-8553%253A%2520A%2520novel%2520MDM2%2520inhibitor%2520with%2520a%2520promising%2520outlook%2520for%2520potential%2520clinical%2520development%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D4934%26epage%3D4935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="note"><p class="first last">Experimental details of assays can be found in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="note"><p class="first last">For a detailed description of the interactions between MDM2 and <b>2</b> please refer to ref <a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">17</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="note"><p class="first last">For reviews on acid bioisosteres see</p></div><div class="NLM_citation" id="rightTab-cit21a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Meanwell, N. A.</span><span> </span><span class="NLM_article-title">Synopsis of some recent tactical application of bioisosteres in drug design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">2529</span><span class="NLM_x">–</span> <span class="NLM_lpage">91</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1013693" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=32&amp;doi=10.1021%2Fjm401911v&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsVCnu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2529-91&author=N.+A.+Meanwell&title=Synopsis+of+some+recent+tactical+application+of+bioisosteres+in+drug+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21aR"><div class="casContent"><span class="casTitleNuber">21a</span><div class="casTitle"><span class="NLM_cas:atitle">Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design</span></div><div class="casAuthors">Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2529-2591</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The established utility of bioisosteres is broad in nature, extending to improving potency, enhancing selectivity, altering phys. properties, reducing or redirecting metab., eliminating or modifying toxicophores, and acquiring novel intellectual property.  In this Perspective, some contemporary themes exploring the role of isosteres in drug design are sampled, with an emphasis placed on tactical applications designed to solve the kinds of problems that impinge on compd. optimization and the long-term success of drug candidates.  Interesting concepts that may have been poorly effective in the context examd. are captured, since the ideas may have merit in alternative circumstances.  A comprehensive cataloging of bioisosteres is beyond the scope of what will be provided, although a synopsis of relevant isosteres of a particular functionality is summarized in a succinct fashion in several sections.  Isosterism has also found productive application in the design and optimization of organocatalysts, and there are several examples in which functional mimicry established initially in a medicinal chem. setting has been adopted by this community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZ9z_aPcU4ubVg90H21EOLACvtfcHk0ljMzfwAnVxIdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsVCnu7o%253D&md5=0637ab60c379bef535f3f709b26f3582</span></div><a href="/servlet/linkout?suffix=cit21a&amp;dbid=16384&amp;doi=10.1021%2Fjm1013693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1013693%26sid%3Dliteratum%253Aachs%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DSynopsis%2520of%2520some%2520recent%2520tactical%2520application%2520of%2520bioisosteres%2520in%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2529%26epage%3D91" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit21b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ballatore, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huryn, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, A. B.</span><span> </span><span class="NLM_article-title">Carboxylic acid (bio)isosteres in drug design</span> <span class="citation_source-journal">Chem. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">385</span><span class="NLM_x">–</span> <span class="NLM_lpage">395</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=16&amp;doi=10.1021%2Fjm401911v&amp;key=10.1002%2Fcmdc.201200585" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=8&amp;doi=10.1021%2Fjm401911v&amp;key=23361977" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=32&amp;doi=10.1021%2Fjm401911v&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFCms7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=385-395&author=C.+Ballatoreauthor=D.+M.+Hurynauthor=A.+B.+Smith&title=Carboxylic+acid+%28bio%29isosteres+in+drug+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21bR"><div class="casContent"><span class="casTitleNuber">21b</span><div class="casTitle"><span class="NLM_cas:atitle">Carboxylic Acid (Bio)Isosteres in Drug Design</span></div><div class="casAuthors">Ballatore, Carlo; Huryn, Donna M.; Smith, Amos B.</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">385-395</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  The carboxylic acid functional group can be an important constituent of a pharmacophore, however, the presence of this moiety can also be responsible for significant drawbacks, including metabolic instability, toxicity, as well as limited passive diffusion across biol. membranes.  To avoid some of these shortcomings while retaining the desired attributes of the carboxylic acid moiety, medicinal chemists often investigate the use of carboxylic acid (bio)isosteres.  The same type of strategy can also be effective for a variety other purposes, for example, to increase the selectivity of a biol. active compd. or to create new intellectual property.  Several carboxylic acid isosteres have been reported, however, the outcome of any isosteric replacement cannot be readily predicted as this strategy is generally found to be dependent upon the particular context (i.e., the characteristic properties of the drug and the drug-target).  As a result, screening of a panel of isosteres is typically required.  In this context, the discovery and development of novel carboxylic acid surrogates that could complement the existing palette of isosteres remains an important area of research.  The goal of this Minireview is to provide an overview of the most commonly employed carboxylic acid (bio)isosteres and to present representative examples demonstrating the use and utility of each isostere in drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVEcl3NtfHu7Vg90H21EOLACvtfcHk0lhZhsXDnQcdIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFCms7g%253D&md5=cff8233af1c386439789a0e4ebcb4331</span></div><a href="/servlet/linkout?suffix=cit21b&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201200585&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201200585%26sid%3Dliteratum%253Aachs%26aulast%3DBallatore%26aufirst%3DC.%26aulast%3DHuryn%26aufirst%3DD.%2BM.%26aulast%3DSmith%26aufirst%3DA.%2BB.%26atitle%3DCarboxylic%2520acid%2520%2528bio%2529isosteres%2520in%2520drug%2520design%26jtitle%3DChem.%2520Med.%2520Chem.%26date%3D2013%26volume%3D8%26spage%3D385%26epage%3D395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="note"><p class="first last">Time-dependent inhibition, % remaining of CYP3A4 over positive control, Rifampin, after 30 min at 10 μM.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Shishkin, O V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konovalova, I. S.</span><span> </span><span class="NLM_article-title">Novel type of mixed O-H···N/O-H···π hydrogen bonds: monohydrate of pyridine</span> <span class="citation_source-journal">Struct. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">37</span><span class="NLM_x">–</span> <span class="NLM_lpage">41</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm401911v&amp;key=10.1007%2Fs11224-009-9412-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm401911v&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhvVCmtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2009&pages=37-41&author=O+V.+Shishkinauthor=I.+S.+Konovalova&title=Novel+type+of+mixed+O-H%C2%B7%C2%B7%C2%B7N%2FO-H%C2%B7%C2%B7%C2%B7%CF%80+hydrogen+bonds%3A+monohydrate+of+pyridine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Novel type of mixed O-H···N/O-H···π hydrogen bonds: monohydrate of pyridine</span></div><div class="casAuthors">Shishkin, Oleg V.; Konovalova, Irina S.; Gorb, Leonid; Leszczynski, Jerzy</div><div class="citationInfo"><span class="NLM_cas:title">Structural Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">37-41</span>CODEN:
                <span class="NLM_cas:coden">STCHES</span>;
        ISSN:<span class="NLM_cas:issn">1040-0400</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Investigation of characteristics of hydrogen bonding between pyridine and water by MP2/aug-cc-pvdz method reveals that these two mols. may form three types of hydrogen bonds depending on nature of proton withdrawal site of pyridine.  Change of orientation of water with respect to plane of arom. ring leads to transformation of the O-H···N bond to O-H···π bond via wide region of the potential energy surface where both lone pair of the nitrogen atom and π-system make significant contribution into hydrogen bonding.  Hydrogen bond in this intermediate region may be considered as mixed O-H···N/O-H···π bond representing new type of H bonds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoETGutL2M14bVg90H21EOLACvtfcHk0lhZhsXDnQcdIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhvVCmtLs%253D&md5=2727c7fdf733d7b6b2f1abce6cc07925</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1007%2Fs11224-009-9412-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11224-009-9412-5%26sid%3Dliteratum%253Aachs%26aulast%3DShishkin%26aufirst%3DO%2BV.%26aulast%3DKonovalova%26aufirst%3DI.%2BS.%26atitle%3DNovel%2520type%2520of%2520mixed%2520O-H%25C2%25B7%25C2%25B7%25C2%25B7N%252FO-H%25C2%25B7%25C2%25B7%25C2%25B7%25CF%2580%2520hydrogen%2520bonds%253A%2520monohydrate%2520of%2520pyridine%26jtitle%3DStruct.%2520Chem.%26date%3D2009%26volume%3D20%26spage%3D37%26epage%3D41" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="note"><p class="first last">Experimental details of the BrdU proliferation and HCT116 p21 TaqMan assays can be found in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="note"><p class="first last">Experimental details of in vivo studies can be found in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="note"><p class="first last">Metabolites structures determined by analogy with previous results; see refs <a onclick="showRef(event, 'ref17 ref28'); return false;" href="javascript:void(0);" class="ref ref17 ref28">17 and 28</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Ye, Q.; Jiang, M.; Huang, W. T.; Ling, Y.; Olson, S. H.; Sun, D.; Xu, G.; Yan, X.; Jin, L.</span><span> </span><span class="NLM_article-title">Pharmacokinetics and metabolism of AMG 232, a novel and orally bioavailable inhibitor of the MDM2–p53 Interaction, in Rat, Dog, and Monkey: In vitro-in vivo correlation</span>, unpublished results.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Ye%2C+Q.%3B+Jiang%2C+M.%3B+Huang%2C+W.+T.%3B+Ling%2C+Y.%3B+Olson%2C+S.+H.%3B+Sun%2C+D.%3B+Xu%2C+G.%3B+Yan%2C+X.%3B+Jin%2C+L.+Pharmacokinetics+and+metabolism+of+AMG+232%2C+a+novel+and+orally+bioavailable+inhibitor+of+the+MDM2%E2%80%93p53+Interaction%2C+in+Rat%2C+Dog%2C+and+Monkey%3A+In+vitro-in+vivo+correlation%2C+unpublished+results."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DYe%26aufirst%3DQ.%26atitle%3DPharmacokinetics%2520and%2520metabolism%2520of%2520AMG%2520232%252C%2520a%2520novel%2520and%2520orally%2520bioavailable%2520inhibitor%2520of%2520the%2520MDM2%25E2%2580%2593p53%2520Interaction%252C%2520in%2520Rat%252C%2520Dog%252C%2520and%2520Monkey%253A%2520In%2520vitro-in%2520vivo%2520correlation" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Gonzalez, A. Z.; Eksterowicz, E.; Bartberger, M. D.; Beck, H. P.; Canon, J.; Chen, A.; Chow, D.; Duquette, J.; Fox, B. M.; Fu, J.; Huang, X.; Houze, J.; Jin, L.; Li, Y.; Li, Z.; Ling, Y.; Lo, M.-C.; Long, A. M.; McGee, L. R.; McIntosh, J.; McMinn, D. L.; Oliner, J. D.; Osgood, T.; Rew, Y.; Saiki, A. Y.; Shaffer, P.; Wortman, S.; Yakowec, P.; Yan, X.; Ye, Q.; Yu, D.; Zhao, X.; Zhou, J.; Olson, S. H.; Medina, J. C.; Sun, D.</span><span> </span><span class="NLM_article-title">Selective and Potent Morpholinone Inhibitors of the MDM2-p53 Protein-Protein Interaction</span>.  <span class="citation_source-journal">J. Med. Chem.</span> [Online early access]. DOI: <span class="refDoi"> DOI: 10.1021/jm401767k.</span>  Published Online: Feb 18,<span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm401911v&amp;key=10.1021%2Fjm401767k." title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=A.+Z.+Gonzalez&author=E.+Eksterowicz&author=M.+D.+Bartberger&author=H.+P.+Beck&author=J.+Canon&author=A.+Chen&author=D.+Chow&author=J.+Duquette&author=B.+M.+Fox&author=J.+Fu&author=X.+Huang&author=J.+Houze&author=L.+Jin&author=Y.+Li&author=Z.+Li&author=Y.+Ling&author=M.-C.+Lo&author=A.+M.+Long&author=L.+R.+McGee&author=J.+McIntosh&author=D.+L.+McMinn&author=J.+D.+Oliner&author=T.+Osgood&author=Y.+Rew&author=A.+Y.+Saiki&author=P.+Shaffer&author=S.+Wortman&author=P.+Yakowec&author=X.+Yan&author=Q.+Ye&author=D.+Yu&author=X.+Zhao&author=J.+Zhou&author=S.+H.+Olson&author=J.+C.+Medina&author=D.+Sun&title=Selective+and+Potent+Morpholinone+Inhibitors+of+the+MDM2-p53+Protein-Protein+Interaction&doi=10.1021%2Fjm401767k."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm401767k.&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401767k.%26sid%3Dliteratum%253Aachs%26aulast%3DGonzalez%26aufirst%3DA.%2BZ.%26atitle%3DSelective%2520and%2520Potent%2520Morpholinone%2520Inhibitors%2520of%2520the%2520MDM2-p53%2520Protein-Protein%2520Interaction%26jtitle%3DJ.%2520Med.%2520Chem.%26doi%3D10.1021%2Fjm401767k.%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Hazuda, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anthony, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jolly, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wai, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhuang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Embrey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guare, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egbertson, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huff, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felock, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witmer, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stillmock, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danovich, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grobler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espeseth, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, I.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kassahun, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearson, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schleif, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortese, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Summa, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, S. D.</span><span> </span><span class="NLM_article-title">A naphthyridine carboxamide provides evidence for discordant resistance between mechanistically identical inhibitors of HIV-1 integrase</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">11233</span><span class="NLM_x">–</span> <span class="NLM_lpage">11238</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm401911v&amp;key=10.1073%2Fpnas.0402357101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm401911v&amp;key=15277684" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm401911v&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmvVKgtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2004&pages=11233-11238&author=D.+J.+Hazudaauthor=N.+J.+Anthonyauthor=R.+P.+Gomezauthor=S.+M.+Jollyauthor=J.+S.+Waiauthor=L.+Zhuangauthor=T.+E.+Fisherauthor=M.+Embreyauthor=J.+P.+Guareauthor=M.+S.+Egbertsonauthor=J.+P.+Vaccaauthor=J.+R.+Huffauthor=P.+J.+Felockauthor=M.+V.+Witmerauthor=K.+A.+Stillmockauthor=R.+Danovichauthor=J.+Groblerauthor=M.+D.+Millerauthor=A.+S.+Espesethauthor=L.+Jinauthor=I.-W.+Chenauthor=J.+H.+Linauthor=K.+Kassahunauthor=J.+D.+Ellisauthor=B.+K.+Wongauthor=W.+Xuauthor=P.+G.+Pearsonauthor=W.+A.+Schleifauthor=R.+Corteseauthor=E.+Eminiauthor=V.+Summaauthor=M.+K.+Hollowayauthor=S.+D.+Young&title=A+naphthyridine+carboxamide+provides+evidence+for+discordant+resistance+between+mechanistically+identical+inhibitors+of+HIV-1+integrase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">A naphthyridine carboxamide provides evidence for discordant resistance between mechanistically identical inhibitors of HIV-1 integrase</span></div><div class="casAuthors">Hazuda, Daria J.; Anthony, Neville J.; Gomez, Robert P.; Jolly, Samson M.; Wai, John S.; Zhuang, Linghang; Fisher, Thorsten E.; Embrey, Mark; Guare, James P., Jr.; Egbertson, Melissa S.; Vacca, Joseph P.; Huff, Joel R.; Felock, Peter J.; Witmer, Marc V.; Stillmock, Kara A.; Danovich, Robert; Grobler, Jay; Miller, Michael D.; Espeseth, Amy S.; Jin, Lixia; Chen, I-Wu; Lin, Jiunn H.; Kassahun, Kelem; Ellis, Joan D.; Wong, Bradley K.; Xu, Wei; Pearson, Paul G.; Schleif, William A.; Cortese, Riccardo; Emini, Emilio; Summa, Vincenzo; Holloway, M. Katharine; Young, Steven D.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">11233-11238</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The increasing incidence of resistance to current HIV-1 therapy underscores the need to develop antiretroviral agents with new mechanisms of action.  Integrase, one of three viral enzymes essential for HIV-1 replication, presents an important yet unexploited opportunity for drug development.  The authors describe here the identification and characterization of L-870,810, a small-mol. inhibitor of HIV-1 integrase with potent antiviral activity in cell culture and good pharmacokinetic properties.  L-870,810 is an inhibitor with an 8-hydroxy-(1,6)-naphthyridine-7-carboxamide pharmacophore.  The compd. inhibits HIV-1 integrase-mediated strand transfer, and its antiviral activity in vitro is a direct consequence of this ascribed effect on integration.  L-870,810 is mechanistically identical to previously described inhibitors from the diketo acid series; however, viruses selected for resistance to L-870,810 contain mutations (integrase residues 72, 121, and 125) that uniquely confer resistance to the naphthyridine.  Conversely, mutations assocd. with resistance to the diketo acid do not engender naphthyridine resistance.  Importantly, the mutations assocd. with resistance to each of these inhibitors map to distinct regions within the integrase active site.  Therefore, the authors propose a model of the two inhibitors that is consistent with this observation and suggests specific interactions with discrete binding sites for each ligand.  These studies provide a structural basis and rationale for developing integrase inhibitors with the potential for unique and nonoverlapping resistance profiles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRpHqKKxVFjLVg90H21EOLACvtfcHk0lhvwAflHndf9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmvVKgtrY%253D&md5=a94bedb2c16c751c5a9298708504fa4d</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0402357101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0402357101%26sid%3Dliteratum%253Aachs%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26aulast%3DAnthony%26aufirst%3DN.%2BJ.%26aulast%3DGomez%26aufirst%3DR.%2BP.%26aulast%3DJolly%26aufirst%3DS.%2BM.%26aulast%3DWai%26aufirst%3DJ.%2BS.%26aulast%3DZhuang%26aufirst%3DL.%26aulast%3DFisher%26aufirst%3DT.%2BE.%26aulast%3DEmbrey%26aufirst%3DM.%26aulast%3DGuare%26aufirst%3DJ.%2BP.%26aulast%3DEgbertson%26aufirst%3DM.%2BS.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DHuff%26aufirst%3DJ.%2BR.%26aulast%3DFelock%26aufirst%3DP.%2BJ.%26aulast%3DWitmer%26aufirst%3DM.%2BV.%26aulast%3DStillmock%26aufirst%3DK.%2BA.%26aulast%3DDanovich%26aufirst%3DR.%26aulast%3DGrobler%26aufirst%3DJ.%26aulast%3DMiller%26aufirst%3DM.%2BD.%26aulast%3DEspeseth%26aufirst%3DA.%2BS.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DI.-W.%26aulast%3DLin%26aufirst%3DJ.%2BH.%26aulast%3DKassahun%26aufirst%3DK.%26aulast%3DEllis%26aufirst%3DJ.%2BD.%26aulast%3DWong%26aufirst%3DB.%2BK.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DPearson%26aufirst%3DP.%2BG.%26aulast%3DSchleif%26aufirst%3DW.%2BA.%26aulast%3DCortese%26aufirst%3DR.%26aulast%3DEmini%26aufirst%3DE.%26aulast%3DSumma%26aufirst%3DV.%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26aulast%3DYoung%26aufirst%3DS.%2BD.%26atitle%3DA%2520naphthyridine%2520carboxamide%2520provides%2520evidence%2520for%2520discordant%2520resistance%2520between%2520mechanistically%2520identical%2520inhibitors%2520of%2520HIV-1%2520integrase%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%26date%3D2004%26volume%3D101%26spage%3D11233%26epage%3D11238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="note"><p class="first last">The MDMX assay is performed exactly as the MDM2 HTRF assay (in the absence of human serum) described in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> with the exception that MDMX (10 μL) was dispensed to the reaction plate and incubated with the inhibitor for 20 min before p53 (20 μL, 1.25 nM) was added.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Riedinger, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonnell, J. M.</span><span> </span><span class="NLM_article-title">Inhibitors of MDM2 and MDMX: a structural perspective</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">1075</span><span class="NLM_x">–</span> <span class="NLM_lpage">1094</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm401911v&amp;key=10.4155%2Ffmc.09.75" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm401911v&amp;key=21425995" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm401911v&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVChs7%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2009&pages=1075-1094&author=C.+Riedingerauthor=J.+M.+McDonnell&title=Inhibitors+of+MDM2+and+MDMX%3A+a+structural+perspective"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of MDM2 and MDMX: a structural perspective</span></div><div class="casAuthors">Riedinger, Christiane; McDonnell, James M.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1075-1094</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  P53 is a potent tumor suppressor with a crucial role in preventing uncontrolled cell proliferation and is therefore frequently deleted or mutated in cancer.  For tumors with wild-type p53, its function can be overcome by overactive cellular antagonists, such as the ubiquitin ligase murine double minute clone 2 (MDM2).  Restoring p53 activity by inhibiting MDM2 in such cancers can eradicate tumors.  Consequently, the MDM2-p53 interaction has been extensively targeted for inhibition by small mols.  In recent years, MDM2-like protein (MDMX), another key downregulator of p53, has gained increasing importance as an addnl. target for drug development, in order to provide a complementary approach to MDM2 inhibition.  In this review, we describe how detailed structural knowledge of the MDM2-p53 interface and, more recently, of the MDMX-p53 interaction have helped advance the development of inhibitors against the two targets.  We present a summary of the functional biochem. of MDM2, MDMX and p53 as well as their interactions and examine recent progress in the development of inhibitors of MDM2 and MDMX.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQfRNKqaLAzbVg90H21EOLACvtfcHk0lhvwAflHndf9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVChs7%252FJ&md5=4b334f634d8b7346f0b5900a95523ce1</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.4155%2Ffmc.09.75&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.09.75%26sid%3Dliteratum%253Aachs%26aulast%3DRiedinger%26aufirst%3DC.%26aulast%3DMcDonnell%26aufirst%3DJ.%2BM.%26atitle%3DInhibitors%2520of%2520MDM2%2520and%2520MDMX%253A%2520a%2520structural%2520perspective%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2009%26volume%3D1%26spage%3D1075%26epage%3D1094" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><div class="note"><p class="first last">This procedure was adapted from:</p></div><span class="NLM_contrib-group">Ju, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippert, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bode, J. W.</span><span> </span><span class="NLM_article-title">Stereoselective synthesis and chemoselective amide-forming ligation of C-terminal peptide α-ketones</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">130</span><span class="NLM_x">, </span> <span class="NLM_fpage">4253</span><span class="NLM_x">–</span> <span class="NLM_lpage">4255</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja800053t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2008&pages=4253-4255&author=L.+Juauthor=A.+R.+Lippertauthor=J.+W.+Bode&title=Stereoselective+synthesis+and+chemoselective+amide-forming+ligation+of+C-terminal+peptide+%CE%B1-ketones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fja800053t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja800053t%26sid%3Dliteratum%253Aachs%26aulast%3DJu%26aufirst%3DL.%26aulast%3DLippert%26aufirst%3DA.%2BR.%26aulast%3DBode%26aufirst%3DJ.%2BW.%26atitle%3DStereoselective%2520synthesis%2520and%2520chemoselective%2520amide-forming%2520ligation%2520of%2520C-terminal%2520peptide%2520%25CE%25B1-ketones%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2008%26volume%3D130%26spage%3D4253%26epage%3D4255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4OAB" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4OAB','PDB','4OAB'); return false;">PDB: 4OAB</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4OGN" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4OGN','PDB','4OGN'); return false;">PDB: 4OGN</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4ODE" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4ODE','PDB','4ODE'); return false;">PDB: 4ODE</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4OGT" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4OGT','PDB','4OGT'); return false;">PDB: 4OGT</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4ODF" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4ODF','PDB','4ODF'); return false;">PDB: 4ODF</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4OCC" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4OCC','PDB','4OCC'); return false;">PDB: 4OCC</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4OGV" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4OGV','PDB','4OGV'); return false;">PDB: 4OGV</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i77"><a href="/doi/suppl/10.1021/jm401911v">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_85055"></div></div></div></div></div><hr /></hr><p class="last">In vitro biological assays, in vivo protocols, determination of cocrystal structures of <b>3</b>, <b>4</b>, and <b>46</b>–<b>49</b> bound to MDM2. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm401911v/suppl_file/jm401911v_si_001.pdf">jm401911v_si_001.pdf (98.39 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Coordinates for compounds <b>3</b> (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4OGN">4OGN</a>), <b>4</b> (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4ODE">4ODE</a>), <b>46</b> (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4OGT">4OGT</a>), <b>47</b> (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4ODF">4ODF</a>), <b>48</b> (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4OCC">4OCC</a>), and <b>49</b> (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4OGV">4OGV</a>) bound to MDM2 have been deposited in the Protein Data Bank.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm401911v&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Fjm401911v%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2014.57.issue-7%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm401911v" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                5MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67996aad8c4c3285","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
